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ABSTRACT 
 
Previously our laboratory had identified a novel component of the Staphylococcus aureus 
regulatory network, an extracytoplasmic function σ factor, σS, involved in stress response 
and disease causation.  Here we present additional characterization of σS, demonstrating a 
role for it in protection against DNA damage, cell wall disruption and interaction with 
components of the innate immune system.  Promoter mapping reveals the existence of 
four unique sigS start sites, one of which appears to be subject to auto-regulation.  
Transcriptional profiling revealed that sigS expression remains low in a number of S. 
aureus wild-types, but is upregulated in the highly mutated strain RN4220.  Further 
analysis demonstrates sigS expression is inducible upon exposure to a variety of chemical 
stressors that elicit DNA damage, including methyl methanesulfonate (MMS) and 
ciprofloxacin, as well as those that disrupt cell wall stability, such as ampicillin and 
oxacillin.    Ex vivo transcriptional analysis reveals that significant expression of sigS can 
be induced upon phagocytosis by RAW 264.7 murine macrophage-like cells.  Regulation 
of σS appears to be unique, as the downstream encoded protein, SACOL1828, seemingly 
acts as a positive activator, rather than as an expected anti-sigma factor.  Using a global 
transposon screen we have elucidated additional genes implicated in the regulation of 
sigS, including those involved in cell wall stability, cellular detoxification, virulence and 
DNA base excision repair.  Phenotypically, σS mutants display sensitivity to a broad 
xi 
 
range of DNA damaging agents, such as ultraviolet light, MMS and ethidium bromide.  
These effects are seemingly mediated via regulation of the purine biosynthesis pathway, 
as microarray, proteomic and qRT-PCR analysis of σS mutants reveal decreased 
transcription of all genes involved.  Enzymatic profiling of PurA involved in adenine 
biosynthesis, demonstrates decreased activity in the σS mutant.  Finally, we provide 
further evidence for the role of σS in S. aureus pathogenesis, revealing that sigS mutants 
display decreased ability to cause localized infections and are impaired in their 
interactions with components of the human innate immune system.  Collectively, our data 
argues for the important, and perhaps novel, role of σS in the stress and virulence 
responses of S. aureus. 
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CHAPTER 1: 
INTRODUCTION 
 
Staphylococcus aureus.  Staphylococcus aureus is a non-spore forming, non-motile, 
coccus, belonging to the low G+C species of Gram-positive organisms (Woese, 1987).  
The Staphylococcal cell wall has a thick peptidoglycan layer and is cross-linked via a 
pentaglycine bridge, making it innately resistant to lysozyme, but susceptible to 
lysostaphin (Schindler and Schuhardt, 1964).  Cellular division of this organism occurs in 
multiple planes leading to the formation of its characteristic grape-like morphology, 
giving rise to the name staphylococci, which is derived from the Greek word staphyle, 
meaning bunch of grapes.  The word aureus, Latin for golden, refers to the characteristic 
golden color of S. aureus cells, which is a result the carotenoid pigment, staphyloxanthin.  
This pigment acts to protect S. aureus from reactive oxygen species through its 
antioxidant properties (Clauditz et al., 2006; Liu et al., 2005).  A facultative anaerobe, S. 
aureus exists throughout the environment in the soil, air and water.  Additionally, isolates 
can be found colonizing surfaces in hospitals, day care centers, schools, military barracks, 
locker rooms, weight rooms and even synthetic turf; thereby, creating a substantial 
disinfection and public health concern (Begier et al., 2004; Hewlett et al., 2009; 
Montgomery et al., 2010; Morrison-Rodriguez et al., 2010; Oller et al., 2010).  
Colonization of both inanimate and animate objects can lead to the development of 
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biofilms, which act as a protective matrix comprised of proteins, DNA and 
polysaccharides.  These biofilms result in long-term contamination and persistence, and 
the transfer of S. aureus to those coming in contact with colonized surfaces (Hall-
Stoodley et al., 2004).  Further to this, disinfection can be difficult, as a number of 
commonly used cleaning agents, such as sodium dichloroisocyanurate, hydrogen 
peroxide and peracetic acid, are ineffective at completely removing S. aureus biofilms 
from surfaces such as glass and stainless steel (Marques et al., 2007).  S. aureus also 
exists as a commensal of humans, where it colonizes the nares, axillae, vagina, pharynx 
and skin (Casewell and Hill, 1986; Noble et al., 1967).  Approximately 30% of healthy 
adults are colonized with S. aureus as part of the normal flora of their anterior nares; 
while transient carriage can occur in as much as 50% of the population, allowing ample 
opportunity for bacterial dissemination (Kuehnert et al., 2006).   
 
Staphylococcus aureus Pathogenesis.  Beyond its ability to exist as a commensal, S. 
aureus is also an opportunistic pathogen capable of causing a wide range of diseases from 
localized skin and soft tissue infections to life threatening septicemia.  First identified in 
1880 by the surgeon Sir Alexander Ogston in pus from a surgical abscess, this bacteria 
has become the most common cause of both hospital- and community-acquired 
infections, and is believed to be the leading cause of death by a single infectious agent in 
the United States (Emori and Gaynes, 1993; Klevens et al., 2007; Ogston, 1882).  Greater 
than one-half of all skin infections presented to emergency departments in 2004 was 
caused by S. aureus (Moran et al., 2006).  In 2005, S. aureus infections resulted in 
approximately 478,000 hospitalizations in the United States, with greater than 50% of 
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these attributable to methicillin resistant S. aureus (MRSA) strains (Klein et al., 2007).  
Further to this, the incidence of MRSA nosocomial infections has risen from 2% of 
staphylococcal infections in 1974, to an overwhelming 64% by 2003 (Klevens et al., 
2006a).  In 2005, 94,000 people were diagnosed with a first invasive MRSA infection; of 
these, 20% died even with antibiotic treatments available (Klevens et al., 2007).  In that 
same year, 14 million outpatient visits in the United States were attributed to skin and 
soft tissue infections (SSTIs) caused by S. aureus (Hersh et al., 2008).  These localized 
SSTIs, which can take the form of boils, furuncles and abscesses are typical of the 
primary onset of S. aureus disease (Shenoy et al., 2010).  S. aureus can then enter the 
bloodstream through dissemination from localized infections or via damaged skin 
surfaces, where it can cause severe life threatening conditions such as endocarditis and 
bacteremia, which have mortality rates of 48% or higher, even with aggressive treatment 
(Bone, 1994; Mortara and Bayer, 1993; Mylotte et al., 1987; Sanabria et al., 1990; 
Sandre and Shafran, 1996).  Upon dissemination into the body, S. aureus has the unique 
ability to cause a variety of metastatic infections, including sinusitis, tonsillitis, otitis, 
osteomyelitis, pyelonephritis and pneumonia.  It also is a leading cause of toxinoses, 
diseases that are mediated specifically by toxins, such as food poisoning, toxic shock 
syndrome (TSS) and scalded-skin syndrome.  As suggested earlier, S. aureus also has the 
ability to form biofilms, which can develop readily on indwelling devices, such as 
catheters and pacemakers, ultimately providing a source of infection for other areas of the 
body.  These protective bacterial matrices can be up to 1000 times less susceptible to 
antibiotics and disinfection, allowing for persistent and recurrent infections (Akagi et al., 
2008; Brook, 2009; Chambers et al., 1983; Goundan et al., 2010; Kempker et al., 2009; 
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Libman and Arbeit, 1984; Musher et al., 1994; Sheehy et al., 2010).  S. aureus is also a 
zoonotic agent, as it has the ability to infect animals as well as humans, including horses, 
cattle, dogs, cats and pigs (Baptiste et al., 2005; de Neeling et al., 2007; Huijsdens et al., 
2006; Khanna et al., 2008; Weese et al., 2005; Weese et al., 2006).  Of note, it is 
considered the most common cause of chronic mastitis in U.S. dairy herds.  Indeed a bio-
economic model from 2009 estimates the annual incidence of infection is as high as 88%, 
with an estimated net cost of $300 million annually (Halasa et al., 2009).  Additional 
reports demonstrate serious disease in humans resulting from infection by livestock-
associated strains, such as ST398.  For example, a recent study demonstrated infection of 
an otherwise healthy 14 year old girl that resulted in lethal necrotizing pneumonia and 
death within 6 days, underscoring the potential for fatal transmission from animals to 
humans (Rasigade et al., 2010).     
 
Antibiotic Resistance in S. aureus.  In 1928, Sir Alexander Fleming discovered the 
antimicrobial effects of penicillin, which were harnessed for mass use in 1941 (1944).  
Penicillin is active against Gram-positive bacteria, and functions via a β-lactam ring, 
which targets bacterial transpeptidase enzymes (also called penicillin-binding proteins, 
PBP), competitively inhibiting them, and blocking synthesis of the cell wall (Batchelor et 
al., 1959; Blumberg and Strominger, 1972).  The introduction of penicillin allowed once 
fatal infections to be cured; however, by 1943, 4% of S. aureus strains isolated from the 
wounds of soldiers serving in the Middle East were resistant to this drug (1944).  Twelve 
years later, a staggering 80% of S. aureus isolates from London hospitals had acquired 
resistance to penicillin via plasmid-encoded penicillinases. These enzymes act by 
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cleaving the β-lactam ring, rendering this antibiotic completely ineffective (Kirby, 1944; 
Ridley et al., 1970).  In 1959, the next generation of β-lactam antibiotics was developed.  
Methicillin, a semi-synthetic derivative of penicillin, is insensitive to penicillinases due to 
the presence of a large side chain, creating steric hindrance, and therefore blocking, the β-
lactam ring.  Within two years, however, methicillin resistant isolates of S. aureus were 
reported (Eriksen, 1961).  In these cases, the isolates had acquired the mecA gene, which 
encodes a low-affinity penicillin-binding protein (PBP2’), and, unlike the original PBPs, 
is not targeted by methicillin (Fuda et al., 2005).  The acquisition of this element allowed 
S. aureus to resist not only methicillin, but the entire β-lactam class of antibiotics, 
including penicillins, cephalosporins and carbapenems (Schaberg, 1994).  More recently, 
the drug of choice for combating severe methicillin-resistant S. aureus (MRSA) 
infections has been the glycopeptide vancomycin.  Therapeutically, it has been 
infrequently used, unless for life-threatening, drug-resistant Gram-positive infections that 
have failed to improve by treatment with other less toxic antibiotics, as it has the potential 
to cause severe kidney disease in patients and is poorly absorbed, making it most 
effective via multiple intravenous dosing (Farber and Moellering, 1983; Griffith, 1981; 
Levine, 2006; Moellering, 2006).  Like the penicillins, it too acts by inhibiting cell wall 
synthesis; however, it does so by binding the D-Ala-D-Ala motif of the peptidoglycan 
precursors, N-acetylmuramic acid (NAM) and N-acetylglucosamine (NAG), blocking 
transpeptidation (Evers et al., 1996).  Currently, three classes of vancomycin resistant S. 
aureus exist based on their susceptibilities: vancomycin-intermediate S. aureus (VISA), 
heterogeneous vancomycin-intermediate S. aureus (hVISA) and vancomycin-resistant S. 
aureus (VRSA).  The first VISA strain was isolated in Japan in 1996 and has 
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subsequently spread to a number of countries, including the United States where 1 year 
later, in 1997; two cases were reported (Hiramatsu et al., 1997; Smith et al., 1999).  
These isolates are also termed glycopeptide-intermediate S. aureus (GISA), as they have 
increased resistance to the entire glycopeptide class of antibiotics.  Phenotypically, they 
display thickening of the cell wall, altered peptidoglycan cross-linking, modified 
penicillin-binding protein expression and slower growth rates (Garnier et al., 2006; 
Howden et al., 2004; Maor et al., 2007; Maor et al., 2009).  It is hypothesized that this 
thicker cell wall provides a barrier, preventing the diffusion of vancomycin into the cell 
(Howden et al., 2010).  Those isolates considered to be hVISA have developed due to the 
selective pressure that exposure to vancomycin presents.  During this time a 
subpopulation of cells that are considered intermediary-resistant begin to outgrow those 
that are susceptible and continue to do so in the presence of vancomycin leading to a 
uniform population of VISA clones (Hiramatsu, 2001).  Approximately 30 years after the 
introduction of vancomycin, enterococci were reported that had high-level resistance to 
glycopeptides (Handwerger et al., 1992).  In 1992, in vitro and in vivo data demonstrated 
the ability of vancomycin resistance genes from Enterococcus faecalis to be acquired by 
S. aureus via horizontal gene transfer; however, it was not until 2002 in Michigan that the 
phenomenon was observed in a clinical setting (Chang et al., 2003; Noble et al., 1992).  
These fully resistant strains had acquired the Tn1546, transposon-encoded vanA gene, 
making them no longer susceptible to this drug (Clark et al., 2005; Courvalin, 2006; 
Evers et al., 1996).  To date, 11 MRSA strains have been reported that are vancomycin 
resistant (VRSA) in the United States (Finks et al., 2009; Sievert et al., 2008).  The 
ability of S. aureus to rapidly acquire resistance is true for a number of antibiotics 
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including the quinolones and aminoglycosides (Dornbusch et al., 1990; Hooper, 2002; 
Wildemauwe et al., 1996).  The threat to public health posed by the virulence of S. 
aureus increases as treatment becomes difficult, owing to the continued emergence of 
multi-drug resistant strains. As the acquisition of resistance mechanisms continues, we 
are perhaps faced with a return to the pre antibiotic era, where the majority of S. aureus 
bacteremia infections were fatal (Archer, 1998; Emori and Gaynes, 1993; Klevens et al., 
2007).  
 
Pathogenic Factors of S. aureus.  The success of S. aureus as a pathogen is due, in part, 
to its plethora of secreted and surface-associated virulence determinants encoded within 
its genome.  Collectively, these factors play a significant role in disease causation by 
allowing for adhesion, immune evasion and dissemination.  A number of superantigens 
(SAs), cytotoxins and tissue-degrading enzymes are secreted by S. aureus.  The SAs 
include enterotoxins A, B, C and D, which are responsible for food poisoning and toxic 
shock syndrome (TSS), as well as Exfoliatin A and B, which play a major role in scalded 
skin syndrome.  The hemolysins and leukocidins include alpha- (Hla), beta- (Hlb), delta- 
(Hld), gamma-hemolysin (HlgA, HlgB and HlgC) as well as LukAB, LukED and PVL; 
all of which have cytotoxic effects.  Alpha-toxin is a pore forming agent capable of 
targeting erythrocytes, mononuclear immune cells, epithelial/endothelial cells and 
platelets (Bhakdi and Tranum-Jensen, 1991).  Unlike Hla, Hlb, also termed 
phospholipase C, is specific for sphingomyelin, a phospholipid located in the cell 
membranes of animals.  It does not form pores, but induces hot-cold lysis by causing 
membrane invagination and lysis at cooler temperatures (Smyth et al., 1975).  Discovered 
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in 1947, Hld is small, heat-stable and active against a broad-range of cell types (Kantor et 
al., 1972).  Gamma-hemolysin, which lyses erythrocytes, and PVL, which damages 
neutrophils and macrophages, are both bicomponent toxins (Finck-Barbancon et al., 
1991; Sugawara et al., 1997; Woodin, 1959, 1960).  S. aureus also secretes a number of 
proteases, including the V8 serine protease (SspA), Staphopain A (ScpA), Staphopain B 
(SspB) and a metalloprotease, aureolysin.  These enzymes are important for 
dissemination of infection, as well as the cleavage of a number of S. aureus virulence 
determinants including alpha-hemolysin, fibrinogen-binding protein, surface protein A 
and clumping factor (Chan and Foster, 1998; Drapeau, 1978; Karlsson et al., 2001; 
Lindsay and Foster, 1999; McAleese et al., 2001; McGavin et al., 1997; Rice et al., 2001; 
Shaw et al., 2004).  Other secreted enzymes include thermostable nuclease (nuc), which 
is important for dispersal from biofilms, and degradation of neutrophil extracellular traps 
(Berends et al., 2010).  Coagulase (Coa) and von Willebrand factor binding protein 
(vWbp) both promote clotting of plasma or blood via the activation of prothrombin, and 
subsequently the conversion of fibrinogen to fibrin (Cheng et al., 2010). 
 
S. aureus also relies on several cell surface components, also termed microbial surface 
components recognizing adhesive matrix molecules (MSCRAMMs).  The MSCRAMMS 
are a group of adhesion proteins which aid in establishing initial infection through 
attachment of the bacteria to host tissues.  S. aureus contains a number of these, including 
protein A (Spa), which binds immunoglobulins in order to evade the immune system 
(Dossett et al., 1969).  Additionally, fibronectin binding proteins A and B, as well as the 
collagen-binding protein (Cna) bind the respective host components that their name 
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suggests (Jonsson et al., 1991; Menzies, 2003; Patti et al., 1992; Patti et al., 1994; Sinha 
et al., 2000).  Other surface proteins include capsular polysaccharides, such as the Cap5 
and Cap8 proteins, which aid in immune system avoidance through inhibiting phagocytic 
engulfment (O'Riordan and Lee, 2004).  Further adhesins in this group include the 
clumping factor proteins, ClfA and ClfB, which act as receptors for fibrinogen, and, as 
their names suggest, lead to clumping of bacterial cells (Hawiger et al., 1982).  All of 
these proteins bear an LPXTG motif, and are anchored to the cell surface via the enzyme 
sortase (Schneewind et al., 1995; Spirig et al., 2011).  
 
The Epidemiology of S. aureus Infections.  Classically, S. aureus diseases have been 
the result of hospital acquired-MRSA (HA-MRSA) isolates confined to nosocomial 
settings, and affecting those with immunosuppression, or indwelling medical devices 
(Thompson et al., 1982).  In the United States, the most common HA-MRSA isolates are 
CDC, pulsed field gel electrophoresis (PFGE) types USA100 and USA200, which 
typically carry a large SCCmec, type I, II or III (McDougal et al., 2003).  These HA-
MRSA strains generally lead to chronic rather than acute infections and are not typically 
fatal; however, they display a high level of antibiotic resistance, making treatment of HA-
MRSA infections exceptionally difficult (Naimi et al., 2003).  Recently, a distinct group 
of isolates have appeared, termed community acquired-MRSA (CA-MRSA).  These 
strains are hyper-virulent, display multi-drug resistance and are responsible for severe 
infections in young, healthy individuals with no ties to health care settings (Naimi et al., 
2003; Popovich et al., 2008).  They are commonly CDC PFGE types USA300 and 
USA400, and often carry a smaller, and metabolically less expensive SCCmec types IV, 
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V or IV (Tenover and Goering, 2009; Tristan et al., 2007).  Core-genome associated 
toxins are common amongst HA-MRSA and CA-MRSA strains; however, the level and 
timing of their expression often varies enormously, depending on the isolate.  This has 
significant impact on pathogenicity, as demonstrated by the increased virulence of CA-
MRSA isolates (Tenover and Goering, 2009).  Compared to major HA-MRSA strains, 
CA-MRSA isolates display increased production of a class of secreted staphylococcal 
peptides termed phenol-soluble modulins (PSMs) involved in the recruitment, activation 
and lysis of human neutrophils (Wang et al., 2007).  Mutation of these PSMs in CA-
MRSA backgrounds leads to decreased virulence in murine models of sepsis (Wang et 
al., 2007); thus increased production of these core-genome associated toxins is believed 
to play a role in the increased virulence of CA-MRSA clones.  Additionally, it has been 
proposed that the enhanced virulence of these strains is a direct result of the acquisition 
of mobile genetic elements, such as PVL (Boyle-Vavra and Daum, 2007).  PVL is a pore-
forming toxin comprised of two components (LukS-PV and LukF-PV), and displays a 
preference for neutrophils (Woodin, 1960).  Conflicting reports exist over the role of 
PVL in enhanced virulence, largely due to the specificity of this toxin to certain cell types 
(Loffler et al., 2010).  In addition to PVL, it is believed that the success of these isolates 
is due in part to the acquisition of the type I arginine catabolic mobile element (ACME).  
This genetic element, believed to be the result of horizontal transfer from S. epidermidis, 
contains both a gene encoding a secondary arginine deiminase system and an ABC 
transporter.  While not contributing directly to the pathogenesis of CA-MRSA isolates, 
this element is believed to allow a selective advantage and facilitate colonization of the 
human skin and mucosal surfaces (Diep et al., 2006; Diep et al., 2008; Montgomery et 
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al., 2009).  While CA-MRSA strains are currently more susceptible to antibiotics than 
HA-MRSA, resistance is on the rise, with community-associated strains believed to be 
replacing conventional hospital-associated strains in nosocomial settings (Klevens et al., 
2006b; Kourbatova et al., 2005; Popovich et al., 2008; Seybold et al., 2006).   
 
The Genetic Regulation of Virulence Determinant Expression.  S. aureus regulates 
virulence determinants in a highly complex, multifactorial manner via a regulatory 
network made up of a number of modulators, including, two-component systems, DNA-
binding proteins, regulatory RNAs and σ factors.  Central to the virulence of S. aureus is 
the quorum sensing, two-component system (TCS) agr (Janzon et al., 1986; Ji et al., 
1995).  The agr locus is expressed as growth progresses from exponential to stationary 
phase (Janzon et al., 1986; Ji et al., 1995).  During this time, there is a shift in gene 
expression profiles from surface proteins, to secreted proteases and toxins, in an effort to 
circumvent nutrient depletion (Janzon et al., 1986; Ji et al., 1995).   The accessory gene 
regulator (agr) consists of a locus containing divergent promoters, P2 and P3.  The P2 
promoter transcribes a TCS (AgrCA), a transmembrane protein (AgrB) and an 
autoinducing ligand (AIP).  AIP is encoded by agrD, which is processed and secreted 
into a cyclic octopeptide.  AgrB acts to cleave the carboxy-terminal region of AIP, with 
additional modification required by type I signal peptidase, SpsB, which acts to remove 
the N-terminal leader sequence (Kavanaugh et al., 2007).  Once a threshold of 
extracellular AIP is reached, AgrC activates AgrA, which in turn upregulates 
transcription from the P2 and P3 promoters.  The P3 transcript is RNAIII, which acts as 
the effector molecule, by serving as a regulatory RNA.  Other important TCSs include 
12 
 
SaeRS, which regulates a number of extracellular proteins in response to both 
environmental stimuli and agr activity (Giraudo et al., 2003; Goerke et al., 2005; Novick 
and Jiang, 2003b).  Additionally, ArlRS directly regulates certain accessory genes, 
autolysins, the sarA-encoded transcription factor, as well as negatively impacting agr 
expression (Liang et al., 2005).  
 
Further important global regulators include the Sar (staphylococcal accessory regulation) 
family of homologs.  These transcription factors are helix-turn-helix DNA binding 
proteins and include SarA, R, S, T, U, V, Rot, TcaR and MgrA (Cheung et al., 2004; 
Cheung et al., 2008; Ingavale et al., 2003; Luong et al., 2003; Manna et al., 2004; 
Schmidt et al., 2001).  These elements have the ability to interact not only with their 
specific target genes, but also with each other, and other regulators such as TCS and σ 
factors, leading to a highly complex regulatory network.  For example, SarA affects a 
broad array of genes, including virulence determinants such as hla, spa, fibronectin-
binding protein (fnb) and enterotoxin C (sec); however, it also regulates genes through an 
agr-dependant manner (Cheung et al., 1995; Chien et al., 1999).  SarA is negatively 
regulated by SarR, and itself negatively regulates SarT (Bronner et al., 2000; Manna and 
Cheung, 2001).  Furthermore, transcription of the sarA gene occurs partially through a 
σB-dependent promoter (Deora et al., 1997a).   
 
Primary Bacterial σ Factors.  All characterized bacterial systems utilize RNA 
polymerase (RNAP) to transcribe genes.  Core-RNAP is composed of 5 subunits: two 
identical α subunits, as well as β, β’ and ω subunits (Gruber and Gross, 2003; Ishihama, 
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2000; Paget and Helmann, 2003).  Firmicutes also encode a δ subunit that is nonessential, 
and its role in S. aureus is still unclear; however, it has been shown to be important for 
virulence in S. agalactiae (Jones et al., 2003; Pero et al., 1975; Spiegelman et al., 1978).  
An essential component of RNAP is σ factors, which bind to core-RNAP, creating the 
holoenzyme, and guide the complex to specific target promoters for transcription (Gruber 
and Gross, 2003; Ishihama, 2000; Paget and Helmann, 2003).  All Eubacterial systems 
contain an essential housekeeping or primary σ factor, known as σ70 or σA, which directs 
general transcription in the cell (Burgess and Anthony, 2001; Helmann, 2002; Murakami 
and Darst, 2003).  Binding of the σ factor occurs at amino acids 260-309 of the β’ subunit 
of core-RNAP (Burgess and Anthony, 2001), with weaker binding also mediated by 
several alternate sites on the β and β’ subunits (Anthony and Burgess, 2002; Arthur and 
Burgess, 1998; Arthur et al., 2000; Gruber et al., 2001; Katayama et al., 2000; Luo et al., 
1996).  During transcription initiation, the holoenzyme, directed by the σ factor, binds to 
DNA forming the closed complex.  As the DNA is unwound and the initiation site 
exposed, the DNA/holoenzyme structure forms the open complex, allowing elongation to 
proceed.  After transcription initiation, the σ factor is released from the RNAP/DNA 
complex, and can be recycled to bind additional core-RNAP complexes to again direct 
transcription (Craig et al., 1998; Mulligan et al., 1985; Saecker et al., 2002; Sen et al., 
2000).  The σ70 transcription factors contain 4 general protein domains as displayed in 
Figure 1 (Lonetto et al., 1992; Rodrigue et al., 2006; Wosten, 1998).  Region 1 acts to 
prevent promiscuous binding of the σ factor to DNA without RNAP, and is not conserved 
among all σ factors (Helmann and Chamberlin, 1988).  Region 2, or specifically, 2.1 and 
2.2, are required for binding to core-RNAP; while region 2.3 facilitates DNA promoter  
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Figure 1. The σ70 Family Protein Domain Organization. (A) A schematic of a typical 
promoter is shown, where +1 and the bent arrow represent the transcriptional start site 
and direction of transcription, respectively.  The -35, extended -10 and -10 sequences are 
represented as grey boxes.  These regions are recognized by regions 4.2, 3.0 and 2.4 
respectively of the sigma factor protein.  (B) A detailed depiction of the 4 different 
regions and subregions that comprise a typical Group 1 (σ70) sigma factor are displayed.  
(C) Each group of sigma factors have unique characteristics, one of which is the different 
regions that they possess.  Depicted here are the four σ70-like groups and the 
representative regions they possess.  Figure adapted from Rodrigue et al., 2006 and 
Gruber et al., 2003.  
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melting at the -10 promoter site, and region 2.4 recognizes the -10 consensus sequence, 
TATAAT, which consists of weak A-T bonds, facilitating DNA melting (Aiyar et al., 
1994; Gruber and Gross, 2003; Joo et al., 1997; Sharp et al., 1999; Shuler et al., 1995; 
Tatti and Moran, 1995).  The third region of σ70 factors interacts with DNA upstream of 
the -10 region, at extended -10 sequences, which act as alternate promoters and contain a 
TG motif located at approximately -15/-14 (Bashyam and Hasnain, 2004; Helmann and 
Chamberlin, 1988; Helmann, 1995; McCracken and Timms, 1999; Moran et al., 1982; 
Sabelnikov et al., 1995).  Finally, region 4 contains a helix-turn-helix motif, which 
interacts with the TTGACA consensus at the -35 sequence of the promoter (Campbell et 
al., 2002; Helmann, 1995; Murakami et al., 2002; Travers, 1987).    
 
Alternative σ Factors.  In addition to primary σ factors, bacteria contain alternative σ 
factors, which are non-essential, recognize distinct promoter sequences and are further 
classified based on structure and function (Burgess and Anthony, 2001; Helmann, 2002; 
Murakami and Darst, 2003).  All eubacterial σ factors are broken down into 5 distinct 
groups based on homology, the first of which comprises the housekeeping σ70 factors 
described above (Figure 1) (Burgess and Anthony, 2001; Helmann, 2002; Murakami and 
Darst, 2003).  The remaining groups represent alternative σ factors, which are used to 
respond to an ever changing environment to rapidly initiate changes in transcription of 
specific subsets of genes.  Group 2 of the alternative σ factors are structurally very 
similar to group 1 and contain regions 1-4; however they are nonessential (Gruber and 
Gross, 2003; Paget and Helmann, 2003).  Group 3 consists of σ factors involved in niche 
specific regulation and can be further divided based on their regulation of flagellar, heat 
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shock or sporulation genes.  Structurally, members of this group typically lack region 1 
(Gruber and Gross, 2003; Paget and Helmann, 2003).  Group 4 consists of the ECF or 
extracytoplasmic function σ factors, and is so named due to an initial observation that this 
group responds to periplasmic stress involving transport, secretion and environmental 
stimuli.  These proteins structurally contain only the essential σ factor domains, 2 and 4 
(Helmann, 2002; Paget and Helmann, 2003).  Finally, group 5 contains the σ54 family of 
σ factors which are the most uncommon, and are highly divergent both structurally and 
functionally.  Furthermore, they are believed to have evolved from DNA-binding 
proteins.  They recognize a unique class of promoter elements and require an activator 
protein for transcription initiation (Beynon et al., 1983; Buck et al., 2000; Merrick, 1983; 
Studholme et al., 2000).  As a result of their ability to rapidly shift gene expression 
profiles in response to changing environments, bacteria typically encode a number of 
alternative σ factors.  
 
The Extracytoplasmic Function σ Factors.  Group 4 of the alternative σ factors is 
comprised of the extracytoplasmic function (ECF) σ factors and has become important 
for the study of pathogenic organisms as there are increasing reports that demonstrate a 
role for them in virulence (Ando et al., 2003; Bashyam and Hasnain, 2004; Hahn et al., 
2005; Le Jeune et al., 2010b; Llamas et al., 2009; Schmitt et al., 1994; Sun et al., 2004).   
ECF σ factors represent a very distinct subfamily that displays a large degree of diversity 
within their own group (Helmann, 2002).  As stated earlier, these σ factors contain only 
regions 2 and 4 of σ70, and are characterized by a highly conserved AAC motif in their 
target promoter –35 region, and a clustering of CGT in the target -10 region.  As the 
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name suggests, a general characteristic of this group is that they respond to periplasmic 
stress involving transport, secretion and environmental stimuli (Helmann, 2002).  They 
are often the most numerate of the σ factors, for example Streptomyces coelicolor 
encodes 51 ECF σ factors, whilst Pseudomonas aeruginosa and Caulobacter crescentus 
contain 19 and 13 respectively (Helmann, 2002).  Classically, they are co-transcribed 
with a downstream gene that acts as a negative regulator, and they often recognize their 
own promoter in a positive feedback loop (Helmann, 2002).  The negative regulator, or 
anti-σ factor, is typically membrane bound, with an extracellular receiving domain and 
intracellular inhibitory domain that acts to sequester free σ factor and inhibit its activity 
(Helmann, 2002).  When a signal is received, the anti-σ factor is cleaved by a cascade of 
proteolysis achieved through membrane proteases.  Specifically, the stress signal is 
received by a site-1 membrane protease, which leads to initial cleavage of the anti-σ 
factor.  This protease activity then triggers cleavage by a site-2 membrane protease, 
releasing the σ factor; thereby, allowing it to bind core-RNAP and upregulate gene 
expression (Figure 2) (Helmann, 2002; Hughes and Mathee, 1998; Raivio and Silhavy, 
2001; Staron et al., 2009; Yoshimura et al., 2004).  This level of post-translational 
regulation allows for the rapid shift in gene expression that is necessary to survive harsh, 
ever-changing external conditions.   
 
ECF σ factor groups. The characteristics described above are typical for a number of 
ECF σ factors; however, this sub-family continues to expand as further factors are 
identified.  As such, the large diversity that exists for these proteins continues to be 
magnified; leading to a recent subdivision of the ECF σ factors into 43 subgroups  
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Figure 2. A Generalized Mechanism of the Classical ECF Sigma Factor Post-
Translational Regulation.  This figure depicts the proteolytic cascade that ensues after 
induction via environmental stress.  (A) In the absence of stress, the ECF-sigma factor is 
bound and held inactive by the anti-sigma factor located in the cell membrane.  (B) Once 
the bacteria encounters stress, the membrane associated site 1 protease (S1P) receives a 
signal and subsequently cleaves the anti-σ factor.  (C) This proteolytic action then 
triggers the site 2 protease (S2P) to cleave the anti-sigma factor at an additional site, 
thereby freeing the σ factor.  (D) The sigma factor can now bind core-RNA polymerase 
and direct it to upregulate a specific subset of genes to circumvent the stress.  
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(ECF01-ECF43) based on phylogeny (Staron et al., 2009).  Groups ECF01-ECF04 
comprises the RpoE-like σ factors, which are characterized by RpoE of Escherichia coli.  
RpoE upregulates genes involved in the heat shock response, and is triggered by 
misfolded proteins in the periplasm or outer membrane (Figure 3) (Dartigalongue et al., 
2001).  The anti-σ factor, RseA, encoded by the second gene in the rpoE four-gene-
operon, contains one transmembrane domain (TMD), and an N-terminus that is localized 
in the cytoplasm for σ factor binding (Missiakas et al., 1997).  The remaining genes in 
the operon, rseB and rseC encode for a negative regulator of RpoE, located in the 
periplasmic space, and an inner membrane protein that is a positive regulator of RpoE, 
respectively (Missiakas et al., 1997).  The proteolytic cascade that acts to release RpoE 
begins by the site 1 protease, DegS, being activated by misfolded outer membrane porins 
such as OmpA or OmpC (see Figure 3).  DegS cleaves the periplasmic domain of RseA 
between Val148 and Ser149 (Alba et al., 2002; Kanehara et al., 2002; Walsh et al., 2003).  
This process initiates the site 2 protease (S2P), RseP, which cleaves the anti-σ factor in 
its transmembrane domain (Ala108-Cys109) (Akiyama et al., 2004).  RpoE is released by 
degradation of the cytoplasmic domain of RseA, via ClpXP or other ATP-dependent 
proteases (Chaba et al., 2007).  Other σ factors in these groups include σW from Bacillus 
subtilis, which is involved in the response to alkaline shock (Wiegert et al., 2001), and 
AlgU from Pseudomonas aeruginosa that mediates the mucoid phenotype as a result of 
regulation of alginate biosynthesis genes (Jones et al., 2010; Staron et al., 2009). 
  
Groups ECF05-ECF10 make up the FecI-like σ factors, the majority of which are 
involved in iron acquisition (Staron et al., 2009).  As displayed in Figure 4, FecI is an  
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Figure 3. The Mechanism of RpoE Activation in E. coli.  This figure depicts the 
regulatory cascade by which RpoE from E. coli is activated.  (1) Exposure to high 
temperatures can lead to (2) misfolded outer membrane porins such as OmpA, which (3) 
triggers DegS to cleave the periplasmic domain of the anti-sigma factor RseA.  (4) The 
site 2 protease, RseP, then cleaves the anti-sigma factor in the transmembrane domain.  
(5) Final cleavage is achieved via ClpXP and other cytoplasmic ATP-dependant 
proteases  
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Figure 4. The Mechanism of FecI Regulation in E. coli.  This figure depicts the post-
translational activation of FecI in E. coli. Regulation begins when a signal (Ferric Citrate) 
is received by an outer membrane sensor, FecA.  This interaction then leads to a 
conformational change that signals to FecR to activate FecI, which can upregulate the 
ferric citrate transport system.  During times of high iron levels, transcription of fecIR is 
repressed by Fur.  
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ECF σ factor from E. coli that responds to ferric citrate, and subsequently upregulates the 
ferric citrate transport system genes fecABCDE.  This is accomplished through a 
regulatory cascade that begins with the binding of ferric citrate to an outer membrane 
receptor, FecA.  This binding leads to a conformational change that signals to FecR, a 
cytoplasmic membrane protein, to activate FecI in the cytoplasm through binding of the 
N-terminus of FecR to region 4 of FecI (Enz et al., 2000; Mahren et al., 2002; Stiefel et 
al., 2001).  Transcription of fecIR is activated by iron deficiency through derepression by 
the iron responsive regulator Fur (Braun et al., 2003).  Additional σ factors of this group 
include HasI from Serratia marcescens responsible for haem acquisition, PbrA from 
Pseudomonas fluorescens and PvdS from P. aeruginosa, both of which are involved in 
the response to iron starvation (Leoni et al., 2000; Sexton et al., 1995; Staron et al., 
2009). 
  
Groups ECF11-ECF15 are largely distinct subfamilies, yet a number of them respond to 
oxidative stress, and, more intriguingly, differ significantly from the classical definition 
of ECF σ factors, in that they are all cytoplasmic sensing regulators.  Examples from 
these groups include RpoE from Rhodobacter sphaeroides, which is inhibited by binding 
to a soluble zinc-dependant anti-σ factor, ChrR.  This inhibition is reversed upon 
activation by a redox sensing region in the C-terminal domain of ChrR in response to 
singlet oxygen (1O2) (Campbell et al., 2007; Dufour et al., 2008).  Additionally, Ecf of 
Neisseria gonorrhoeae is involved in response to oxidative damage through regulation of 
msrAB, which encodes a methionine sulfoxide reductase (Gunesekere et al., 2006).  
Further to this, σR from S. coelicolor, like the majority of σ factors in these groups, 
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responds to oxidative stress, specifically to the thiol-specific oxidant, diamide.  
Regulation of σR is accomplished by a thiol-disulfide redox sensing anti-σ factor, RsrA. 
Disulfide stress, more specifically redox changes within the cell, leads to the formation of 
disulfide bonds within RsrA, leading to the release of bound σR (Paget et al., 2001a).  
  
The remaining classes, ECF16-ECF43, make up a diverse set of σ factors, each with 
unique features that distinguish them from other members of the group.  Of note, these 
groups typically deviate from each other as well as the classical model of ECF σ factor 
biology.  A specific example includes ECF32 which make up the HrpL-like ECF σ 
factors.  This group completely lacks an anti-σ factor and is instead regulated at the 
transcriptional level through two-component systems (Merighi et al., 2003; Nizan-Koren 
et al., 2003).  Other examples that differ from the classical model of function and 
regulation include, RpoE of Xylella fastidiosa, which is involved in the response to heat-
shock, and, unlike other ECF σ factors, does not autoregulate itself, but negatively 
regulates its own activity through upregulation of its cognate anti-σ factor encoded 
immediate downstream of the σ factor (Figure 5).  This is achieved through upregulation 
of an internal promoter located downstream of rpoE (da Silva et al., 2007).  An 
interesting mode of regulation that exists for σR of Streptomyces coelicolor is that the 
protein exists in two forms (Figure 6).  A stable form of σR is constitutively expressed and 
has a half life upwards of 70 min.  In the absence of stress, σR is bound to its anti-σ factor 
RsrA; however, during exposure to thiol-oxidative stresses, σR is released and allowed to 
upregulate gene expression.  In a positive feedback loop, σR autoregulates transcription 
from its own promoter; however, an isoform from an upstream start codon is produced.   
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Figure 5. The Negative Feedback Loop of Regulation by RpoE in Xylella fastidiosa.  
In the absence of a stress, the rpoE/rseA operon is transcribed by the housekeeping sigma 
factor, σ70.  In the presence of high temperatures, RpoE is released from the anti-sigma 
factor and upregulates genes involved in protection against this stress. It also upregulates 
a promoter located internal to the rpoE/rseA operon (shown in red), creating a negative 
feedback loop as it increases the cellular concentration of its cognate anti-sigma factor. 
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Figure 6. The Mechanism of SigR Regulation in Streptomyces coelicolor.  (A) SigR 
and its anti-sigma factor are constitutively expressed under standard conditions.  (B)  In 
the absence of a stress, SigR is held inactive by its anti-sigma factor, RsrA.  (C) In the 
presence of thiol-oxidative stress, SigR is released from RsrA.  (D) SigR autoregulates its 
own transcript from an upstream promoter (shown in red) creating a larger isoform of 
itself.  (E)  Both forms of the sigma factor act to upregulate genes in the SigR regulon, 
including thiol reducers.  (F)  An additional set of genes in the SigR regulon are 
proteases.  The longer, unstable form of SigR is more readily cleaved by these proteases; 
thereby creating a negative feedback loop.  
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This unstable form of σR contains a 55 amino acid N-terminal extension, which allows it 
to be targeted for degradation by ClpP1/P2 proteases, thereby shortening its half life to 10 
min.  Subsequently, a negative feedback loop is formed through upregulation of the 
protease transcript by σR (Kim et al., 2009).  Furthermore, σF of Caulobacter crescentus 
is involved in protection against oxidative stress during stationary phase growth, and 
works with a cognate anti-σ factor that contains 6 TMDs.  This is yet another example 
that shows that while the classical model of 1 TMD for anti-σ factors is true for a 
majority of these proteins; wide variability exists, and is thus not a reliable tool for 
identifying possible anti-σ factors (Alvarez-Martinez et al., 2006).   
 
Sigma Factors of S. aureus.  S. aureus is an exceedingly virulent and successful 
pathogen that manages to fine tune its gene expression with only 4 σ factors.  The 
primary σ factor, σA, is the essential housekeeping σ factor and acts to transcribe genes 
for basic metabolic functions (Deora and Misra, 1995, 1996).  As with the majority of 
Firmicutes, S. aureus possesses an alternative σ factor, σB, which is the general stress 
response regulator.  In S. aureus it is involved in virulence and controls the expression of 
a variety of genes in response to challenging environmental conditions, such as exposure 
to alkaline and oxidative stress, and also heat shock (Deora et al., 1997a; Horsburgh et 
al., 2002; Kullik and Giachino, 1997; Pane-Farre et al., 2006; Shaw et al., 2006).  This σ 
factor recognizes a unique consensus sequence of GTTT followed by a 12-17 nt spacer 
and then GGGTAT, and has a regulon of 198 genes that it up-regulates, and 53 that it 
down-regulates (Bischoff et al., 2004; Gertz et al., 2000).  Included in its regulon are a 
number of genes involved in the defense against oxidative stress, intermediary 
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metabolism components and signaling pathway elements (Bischoff et al., 2004).  A 
number of genes in the σB regulon are directly up-regulated by it, such as coa, (Nicholas 
et al., 1999) sarA (Bayer et al., 1996) and sarS (Tegmark et al., 2000); however, a 
significant number are controlled indirectly, as part of the global regulatory network of S. 
aureus. Phenotypically, mutation of sigB leads to decreased pigmentation, as 
staphyloxanthin, a carotenoid produced by S. aureus, is upregulated by this σ factor.  The 
role of σB in the pathogenesis of S. aureus has previously been studied and it is believed 
to play a role in systemic infection, likely because it has a number of virulence factors 
under its control (Bischoff et al., 2004; Jonsson et al., 2004).  The third σ factor, σH, is an 
alternative σ factor demonstrating homology to σH, of Bacillus subtilis.  Overexpression 
of σH leads to upregulation of competence genes, and it has recently been demonstrated to 
have a role in the integration and excision of prophages (Morikawa et al., 2003; Tao et 
al., 2010).  Finally, a discovery by our laboratory demonstrated the existence of a fourth 
σ factor, σS, belonging to the ECF-family (Shaw et al., 2008).   
 
Project Aims.  Bacteria typically possess, on average, 6 ECF σ factors within their 
genomes; however, unlike many other organisms, σS is the lone ECF σ factor of S. aureus 
(Helmann, 2002; Staron et al., 2009).  Classically, ECF σ factors display maximal 
activity when cells are challenged by environmental stress, including disulfide, oxidative 
and cell wall destabilizing conditions, or exposure to antimicrobial agents.  This 
inducibility alleviates the metabolic burden of being constitutively expressed when not 
required (Helmann, 2002; Staron et al., 2009).  The subsequent response leads to 
upregulation of a unique subset of genes to protect the cell.  As σS is the only member of 
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the ECF family in S. aureus, we hypothesize that it likely plays an integral role in 
protecting this organism against a variety of stresses.  Therefore in order to understand its 
role, our initial focus will be to investigate sigS regulation through promoter mapping, 
and analysis of its expression both under standard growth conditions and in the presence 
of chemical stressors.  As previous work by our lab suggests a role for σS in the virulence 
response of S. aureus to systemic disease, we will also examine the inducibility of sigS 
during challenge by components of the innate immune system.  ECF σ factors are often 
involved in complex regulatory cascades that include regulation at the transcriptional, 
translational and post-translational levels (Bastiat et al., 2010; Brooks and Buchanan, 
2008; Dona et al., 2008; Mazurakova et al., 2006; Staron et al., 2009; White et al., 2010; 
Zhang et al., 2002).  Therefore, we will elucidate the extant regulatory network for 
control of sigS expression through the use of a global transposon screen.  Regulation of 
ECF σ factors is often controlled by a co-transcribed, downstream anti-σ factor.  The sigS 
locus contains a candidate gene, SACOL1828, located 112 bp 3’, and is conserved across 
all sequenced strains of the staphylococci.  We hypothesize that SACOL1828 plays a role 
in the regulation of σS as an anti-σ factor, which we will investigate in this work.   
 
In order to ascertain the role that this regulator plays in the cell, we will analyze the 
ability of the sigS mutant to survive under a number of stress conditions, including those 
that lead to induction of its expression based on our transcriptional analysis.  As ECF σ 
factors bind core-RNAP and target it to specific promoters to upregulate genes in 
response to particular stresses, we will examine this function for σS via transcriptomic 
and proteomic analyses.  Furthermore, there is mounting evidence to support the notion 
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that ECF σ factors often play a significant role in the virulence of pathogenic organisms 
including Mycobacterium tuberculosis, Pseudomonas aeruginosa, and Enterococcus 
faecalis (Ando et al., 2003; Bashyam and Hasnain, 2004; Hahn et al., 2005; Le Jeune et 
al., 2010a; Llamas et al., 2009; Schmitt et al., 1994; Sun et al., 2004).  Our group has 
previously demonstrated a role for σS in the pathogenesis of S. aureus septic arthritis 
infection.  As such, we will examine the ability of strains bearing sigS mutations to 
survive both during growth in whole human blood and post phagocytosis, which are 
important mechanisms for S. aureus to establish infection, and thus any defects observed 
might explain the avirulence of sigS mutants.  Due to the ability of S. aureus to cause a 
wide range of infections, we will also analyze the ability of the sigS mutant to cause 
disease during localized infections using murine models of wound formation.   
 
Collectively, the focus of this dissertation is to characterize σS; specifically the role it 
plays within the cell and how it contributes to S. aureus disease causation.  
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CHAPTER 2: 
MATERIALS AND METHODS 
 
Bacterial strains, Plasmids and Growth Conditions.  All buffers were prepared using 
diH20 and were stored at room temperature unless otherwise stated.  Solutions that were 
used in sterile work or for in vivo DNA manipulations were sterilized by autoclaving.  All 
of the methods in this chapter are as in (Sambrook et al., 1989) unless otherwise stated.  
S. aureus and E. coli strains and plasmids are listed in Table 1.  E. coli was grown in 
Luria-Bertani (LB) medium at 37°C.  S. aureus was grown in 100 ml Tryptic Soy Broth 
(TSB) (1:2.5 flask/volume ratio) at 37°C with shaking at 250 rpm, unless otherwise 
indicated. Synchronized cultures for growth experiments were obtained by the following 
protocol. One ml of relevant overnight S. aureus cultures were used to inoculate fresh 
media, and allowed to grow for 3h. These exponentially growing cultures were used to 
seed new media at an OD600 of 0.05. Test cultures were then allowed to grow for the 
experimentally required time period.  When required, antibiotics were added at the 
following concentrations:  ampicillin 100 mg l-1 (E. coli), tetracycline 5 mg l-1 (S. 
aureus), erythromycin 5 mg l-1 (S. aureus), lincomycin 25 mg l-1 (S. aureus), and 
chloramphenicol 5 mg l-1 (S. aureus).    
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Table 1. Strains, Plasmids and Primers Used in This Study. 
Strain, plasmid or primer Genotype or description        Reference or source 
E. coli 
DH5α Φ80 Δ(lacZ)M15 Δ(argF-lac)U169 endA1 recA1 Sambrook et al., 1989 
 hsdR17 (rK-mK+) deoR thi-1 supE44 gyrA96 relA1 
S. aureus 
RN4220 Restriction deficient transformation recipient Lab Stocks 
8325-4 Wild-Type Laboratory Strain rsbU mutant Lab Stocks 
RN6390 Wild-Type Laboratory Strain rsbU mutant Lab Stocks 
SH1000 Wild-Type Laboratory Strain rsbU functional Horsburgh et al., 2002 
Newman Wild-Type Laboratory Strain, human clinical isolate Lab Stocks 
USA300 LAC USA300-LAC MRSA isolate cured of pUSA300-LAC-MRSA                   Paul Fey UNMC 
UAMS-1790 Sequenced USA300-HOU MRSA isolate cured of pUSA300-HOU-MRSA  Kolar et al., 2010 
FPR Sequenced USA300-FPR MRSA isolate cured of pUSA300-FPR-MRSA Carroll et al., 2012  
LES57 SH1000 pAZ106::sigS-lacZ (P1-P4)  sigS + Shaw et al., 2008 
HKM01 RN4220 pAZ106::sigS-lacZ (P1-P4)   sigS + This study 
HKM02 8325-4 pAZ106::sigS-lacZ (P1-P4)   sigS + This study 
HKM03 Newman pAZ106::sigS-lacZ (P1-P4)   sigS + This study 
HKM04 USA300 LAC pAZ106::sigS-lacZ (P1-P4)   sigS + This study 
HKM05 UAMS-1790 pAZ106::sigS-lacZ (P1-P4)   sigS + This study 
HKM06 USA300 FPR pAZ106::sigS-lacZ (P1-P4)   sigS + This study 
HKM07 RN4220 pAZ106::sigS-lacZ (P1-P3)   sigS + This study 
HKM08 8325-4 pAZ106::sigS-lacZ (P1-P3)   sigS + This study 
HKM09 USA300 LAC pAZ106::sigS-lacZ (P1-P3)   sigS + This study 
HKM10 SH1000 ecfX::tet ecfX - pAZ106::sigS-lacZ (P1-P4)  sigS + This study 
LES59 RN4220 ecfX::tet ecfX - pAZ106::sigS-lacZ (P1-P4)  sigS + Shaw et al., 2008 
HKM11 8325-4 ecfX::tet ecfX - pAZ106::sigS-lacZ (P1-P4)  sigS + This study 
HKM12 SH1000 agr::tet agr+ pAZ106::sigS-lacZ (P1-P4)  sigS + This study 
HKM13 SH1000 sigB::tet sigB+ pAZ106::sigS-lacZ (P1-P4)  sigS + This study 
HKM14 RN6390 pAZ106::sigS-lacZ (P1-P4)   sigS + This study   
HKM15 SH1000 pAZ106::sigS-lacZ (P1-P4)  sigS + NTG A This study 
HKM16 SH1000 pAZ106::sigS-lacZ (P1-P4)  sigS + NTG B This study 
HKM17 8325-4 pSC-A::tet::sigS-lacZ sigS + This study 
HKM18 8325-4 pSC-A::tet::sigS-lacZ sigS + pRN3208 This study 
HKM19 SH1000 pSC-A::tet::sigS-lacZ sigS + This study 
HKM20 USA300 LAC pSC-A::tet::sigS-lacZ sigS + This study 
HKM21 8325-4 sbcC::Tn551  This study 
HKM22 SH1000 sbcC::Tn551  This study 
HKM23 USA300 LAC sbcC::Tn551  This study 
HKM24 8325-4 msa::Tn551  This study 
HKM25 SH1000 msa::Tn551  This study 
HKM26 USA300 LAC msa::Tn551  This study 
HKM27 8325-4 msrA::Tn551  This study 
HKM28 SH1000 msrA::Tn551  This study 
HKM29 USA300 LAC msrA::Tn551  This study 
LES55 SH1000 sigS::tet sigS -  Shaw et al., 2008 
HKM30 RN4220 sigS::tet sigS - This study 
HKM31 8325-4 sigS::tet sigS - This study 
HKM32 USA300 LAC sigS::tet sigS – This study 
LES56 SH1000 ecfX::tet ecfX - Shaw et al., 2008 
LES58 RN4220 ecfX::tet ecfX - Shaw et al., 2008 
HKM33 USA300 LAC sigS::tet pMK4::sigS + This study 
HKM34 USA300 LAC ecfX::tet pMK4::ecfX + This study 
 
Plasmids 
pAZ106 Promoterless lacZ erm insertion vector  Kemp et al., 1991 
pMK4 Shuttle vector                                                                                           Sullivan et al., 1984 
pSC-A TA clone suicide vector  StrataClone 
pRN3208 TS shuttle vector harboring Tn551  Kornblum et al.,1986 
pDG1515 Tetracycline resistance antibiotic cassette in Bluescript KS(+) (Ampr)  Guerout-Fleury et al., 1995 
pLES202 pAZ106 containing a 2.2 kb ecfX fragment Shaw et al., 2008 
pLES204 pLES202 containing a tetracycline cassette within ecfX Shaw et al., 2008 
pHKM1 pAZ106 containing a 1.0 kb sigS fragment  This study 
pHKM2 pMK4 containing a 2.1 kb sigS fragment  This study 
pHKM3 pMK4 containing a 2.1 kb ecfX fragment  This study 
pHKM4 pSC-A containing the sigS-lacZ fragment from pLES205  This study 
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Table 1. Continued. 
Strain, plasmid or primer Genotype or description        Reference or source 
 
pHKM5 pSC-A containing a tet cassette and sigS-lacZ fragment from pLES205  This study  
  
Primers (Restriction Sites are Underlined) 
OL281  ACT GGA TCC CAG TTG CAG ATG CAT CTC TCC 
OL285  ACT GGA TCC GAC CAT CAC GAT ACA TCA 
OL286   CTT CAC TGA CAA CTA TGC CG 
OL287   GCG ATT ACA TTC TAG AAG TTC C 
OL288   GGA ACT TCT AGA ATG TAA TCG C 
OL522  ATG TCT AGA GAG TAA TGC TAA CAT AGC 
OL523   ATG TCT AGA CCC AAA GTT GAT CCC TTA ACG 
OL909   ATG CTG CAG CAG GAC CCA ACG CTG CCC GAG 
OL1036  CCG CGC ACA TTT CCC CGA AA 
OL1184   AGC CGA CCT GAG AGG GTG A 
OL1185   TCT GGA CCG TGT CTC AGT TCC 
OL1275  ACC TTG AAG GAT ACA AGC AA 
OL1276  GGC ATT TAC GCT TAA CGG AC 
OL1366   ACG TGC ACC GAT ACA A 
OL1367   GGC TCA TCA ACT TCT AGC 
OL1568   CGA TTA CGC AAA TGA ATG 
OL1569   CAA GTA GTC ATT CTC CAA G 
OL1570  ATG GAA TTC TCA AGT AGT CAT TCT C 
OL1715  ATG CTG CAG CAA GTC TAT CTG GCG TAC  
OL1800  CGA AGC GCA TTT TCT CAA CA 
OL1801  TTT AAT CGC CCC TTA CCT GC 
OL1802   GAA GGT ATT AAA TAT GGC GGT ACA AG 
OL1803   ACA CTT TGC ATA CCG GCT G 
OL1804   CAA GGT GAT GGT ACT AGG GAA G 
OL1805   CTG TTG AAA ATG ACT ACC TGT TGG  
OL1806  CAG AGG TAA GAA AGG CTA CGA G 
OL1807  GCC CGT GGA ATG TTA AAT GC 
OL1808  CGA GGC ATG TAT AAC GGA GAC 
OL1809  ACG GTT ATC TAA TGC ACT CGG 
OL1843  GGG AGA CGA AGG AAA AGG AAA  
OL1844  AAA TTG AAT GGT ATG GCC TGC  
OL1845  CGG CAC ATT TAC CAG GTA TG 
OL1846  TTG CAA CCG GAA TAC CTC C 
OL1862   TCC AGG TAA TGA GGC AAT GAC 
OL1863   CGG CTG TTC TGG ACC TAT AAC 
OL1864  GGT CTG ATT TTC TCA CAA CGT G 
OL1865  CGG TGT TTT CGT TTC CCA AG 
OL1866  GTG GTA TGG GCT CTT TAG GTG  
OL1867  GTA ACG CAC CTT TAT AAG CCG  
OL1868  ACA CAG TAG GTA TTC GTG CAG  
OL1869  AGA CTT CCC AAT CGA TGC  
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Alternative Growth Media. Where specified, chemically defined minimal media 
(CDM) and metal ion limiting media (CL), were prepared as described previously 
(Horsburgh et al., 2001; Watson et al., 1998).  Porcine serum plates were created by 
adding filter sterilized porcine serum (Sigma) to preautoclaved and cooled 2% agar in 
diH20.   
 
Construction of the σS Mutant Strains.  All strains used in this study were created via 
φ11 mediated transduction from strains previously described (Table 1).  
 
Construction of the sigS-lacZ(P1-P4) Fusion Strains.  All strains used in this study were 
created via φ11 mediated transduction from strains previously described (Table 1).  
 
Construction of the sigS-lacZ(P1-P3) Fusion Strains.  The promoter region of sigS 
including just the three upstream promoters was amplified as a 1 kb PCR fragment using 
primer pair OL-281/OL-1570 (Table 1).  The purified DNA fragment was digested with 
BamH1 and EcoRI and cloned into similarly digested pAZ106 (Kemp et al., 1991).  S. 
aureus RN4220 was transformed with the resulting plasmid, pHKM1, and integrants 
were confirmed by PCR analysis.  A representative clone was then used to transduce S. 
aureus SH1000 using 11, with clones again confirmed by PCR analysis.  This created 
strain HKM07 (sigS-lacZ(P1-P3 )). 
 
Construction of the ecfX Mutant Strains.  A plasmid for the mutagenesis of ecfX was 
constructed by PCR amplification. Two approximately 1kb fragments were PCR 
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generated surrounding the ecfX coding region (1 located upstream, primer pairs OL-
285/OL-288; and 1 located downstream, primer pairs OL-286/OL-287).  Primers OL-287 
and OL-288 are identical, but divergent to each other, and contain mismatching that 
converts the wild type sequence of TCTTAA (~100bp from the SACOL1828 Met) to a 
TCTAGA XbaI site.  These fragments were purified and used together as the template for 
further PCR using primer pair OL-285/OL-286.  The resultant 2.2 kb DNA fragment was 
digested with BamHI and SphI, and cloned into the suicide vector pAZ106 (Kemp et al., 
1991) to generate pLES202, using standard cloning techniques (Sambrook et al., 1989). 
 
The novel XbaI site in pLES202 were then used as a target sites for the insertion of a 
tetracycline resistance cassette, generated from pDG1515 (Guerout-Fleury et al., 1995) 
using primer pair OL-522/OL-523.  The XbaI digested cassette was cloned into 
pLES202, yielding pLES204.  This was then used to transform electrocompetent S. 
aureus RN4220, according to the method of Schenk and Ladagga (Schenk and Laddaga, 
1992), with clones selected for on the basis of tetracycline and erythromycin resistance. 
Integrants were confirmed by PCR analysis and used as donors for the transduction of S. 
aureus strain SH1000 using phage 11. Transductants were selected for their resistance 
to tetracycline (indicating the presence of the cassette) and sensitivity to erythromycin 
(indicating loss of the plasmid and associated functional copy of ecfX, before being 
confirmed by PCR analysis. This created strains LES56. 
 
Construction of σS Complement Strains.  The complement construct generated 
contains approximately 1 kb of upstream DNA, and 710 bp of downstream DNA, relative 
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to the σS coding region. This was PCR amplified using primer pair OL281 and OL1715 
(Table 1), and cloned into the Gram-positive shuttle vector pMK4 (Sullivan et al., 1984), 
creating pHKM2.  S. aureus RN4220 was transformed with this construct, with clones 
confirmed by PCR analysis, using a combination of gene and vector specific primers 
(OL-281/OL-1036). A representative clone was selected to transduce the USA300 LAC 
sigS mutant. Clones were again confirmed by PCR analysis, creating strain HKM33. 
 
Construction of ecfX Complement Strains.  The complement construct generated 
contains approximately 1.5 kb of upstream DNA through the ecfX coding region. This 
was PCR amplified using primer pair OL281 and OL1715 (Table 1), and cloned into the 
Gram-positive shuttle vector pMK4 (Sullivan et al., 1984), creating pHKM3.  S. aureus 
RN4220 was transformed with this construct, with clones confirmed by PCR analysis, 
using a combination of gene and vector specific primers (OL-281/OL-1036). A 
representative clone was selected to transduce the USA300 LAC sigS mutant. Clones 
were again confirmed by PCR analysis, creating strain HKM34. 
 
Rapid Amplification of cDNA End (RACE).  RACE was performed utilizing the 
TaKaRa 5’-Full RACE Core Set kit according to the manufacturer’s instructions as 
described previously (Carroll et al., 2012).  Briefly, total cellular mRNA was extracted 
via the Qiagen RNeasy Kit by first growing the culture in conditions conducive to 
maximal expression of the gene of interest.  Cultures were snap frozen by placing 2 mL 
into 1:1 ice-cold EtOH:acetone and stored in the -80oC overnight.  Cells were then 
pelleted and lysed via bead beating and the supernatant was treated with 7 µl β-
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mercaptethanol, 700 µl of RLT Buffer and 500 µl EtOH then collected onto an RNeasy 
mini spin column.  The column was then treated with 350 µl RW1 buffer followed by on 
column DNase treatment with the Qiagen DNase 1 Kit.  Following DNase treatment the 
sample was washed again the RW1 buffer and RPE buffer and finally eluted in 40 µl 
RNase-free H20.  The 1st strand cDNA was synthesized from the mRNA via reverse 
transcriptase with a 5’ end-phosphorylated primer.  The RT reaction was carried out in a 
thermal cycler for optimal reaction conditions (10 min at 30oC, 50 min at 50oC, and 2 min 
at 80oC).  The hybrid RNA was then degraded by addition of 5X hybrid RNA 
degradation buffer and 1 µl of RNase H and incubated for 1 h at 30oC.  The cDNA was 
then precipitated by addition of 5 volumes of 96 % (v/v) EtOH and 1 volume of 3 M 
sodium acetate, thoroughly vortexed and placed in the -80oC for 10 min.  The cDNA was 
then collected via centrifugation at 13,000 rpm for 10 min, washed with 250 µl of 70 % 
(v/v) EtOH and allowed to dry at room temperature for 5 min.  The cDNA was then 
ligated to form concatemers by addition of 8 µl of 5X RNA (ssDNA) ligation buffer, 20 
µl of 40 % PEG and 1 µl of T4 RNA ligase and incubated at 15oC for 18 h.  Standard 
PCR (94oC 3 min, 25 cycles of (94oC 30 sec, 55oC 30 sec, 72oC 0.5-5 min)) was carried 
out utilizing the forward primer S1 and the reverse primer A1.  The resulting PCR 
product was then used as a template for a second PCR reaction using the forward primer 
S2 with the reverse primer A2.  The resulting product was introduced into pSC-A via the 
StrataClone PCR Cloning Kit (Stratagene) then were sent to Eurofins MWG Operon for 
sequencing using primer T7. 
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Transcriptional Analysis of the lacZ Reporter Gene Fusion Strain.  Qualitative 
analysis of sigS activity was performed by plating the lacZ reporter gene fusion strains on 
tryptic soy agar (TSA) containing 25 µl of Ery at 5 µg ml-1 and 25 µl of 40 µg ml-1 X-
GAL which were then incubated overnight at 37oC and subsequently analyzed for the 
production of a blue color.  Quantitative analysis was performed by regular sampling of a 
synchronized culture grown under standard conditions in TSB at 37oC.  Analysis was 
performed by removing 500 µl aliquots every hour for a period of 12 hours and again at 
hour 24.  The cells were then recovered via centrifugation at 13,000 rpm for 10 min and 
finally stored at -80oC until the assay could be performed.  The assay was carried out by 
first allowing the samples to thaw before being resuspended in 500 µl of ABT buffer 
(100mM NaCl, 60mM K2HPO4, 40mM KH2PO4 and 0.1% v/v Triton-X-100) followed 
by addition of 100 µl of 4-MUG (4 mg ml-1).  The samples were inverted to mix and 
allowed to incubate at 25oC for 60 min at which time the reaction was stopped by the 
addition of 500 µl of 0.4 M Na2CO3.  Fluorescence was measured using a BioTek 
Synergy 2 plate reader and calibrated with standard concentrations of MU (4-methyl 
umbelliferone).  One unit of β-galactosidase activity was defined as the amount of 
enzyme that catalyzed the production of 1 pmol MU min-1 OD600 unit-1.  Assays were 
performed on duplicate samples and the values averaged. The results presented herein 
were representative of three independent experiments that showed less than 10 % 
variability.  The β-galactosidase activity was then determined from a calibration curve 
using the following equation. 
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(((Fluorescence – Background fluorescence) – C) / M) x ((A / B) / (T x OD600 x V)) = β-
galactosidase units ml-1 OD600-1 min-1 (C = Value of intercept of calibration curve 
(Determined from fluorescence readings of known concentrations of 4MU), M = 
Gradient of the calibration curve (Determined from fluorescence readings of known 
concentrations of 4MU), A = Volume of the assay (1.1 ml total of 500 µl ABT, 500 µl 
0.4 M Na2CO3 and 100 µl of 4-MUG), B = Volume in Microtitre well (0.225 ml), T = 
Reaction time (60 min), V = Volume of cells originally sampled (0.5 ml)). 
 
Plate Based Assay to Determine Alterations in Transcription Resulting From 
External Stress.  The lacZ reporter gene fusions were analyzed via disk diffusion 
techniques adapted to transcriptional profiling as described previously (Kolar et al., 
2011).  This was done by placing a sterile filter disk (7 mm, 3MM Whatman Paper) on a 
TSA plate overlayed with TSA top agar (0.7% agar) inoculated with 5 µl of an overnight 
culture of the sigS-fusion strain and 100 µl of 40 µg ml-1 X-GAL.  This was followed by 
the addition of 10 µl of the following stress chemicals: 6 M HCl, 85% phosphoric acid, 
100% TCA, 88% formic acid, 0.2 M acetic acid, 6 M sulphuric acid, 6 M nitric acid, 6 M 
sodium hydroxide, 2 M NaCl, 1 M glucose, 95% ethanol, 100% methanol, 100% 
isopropanol, 10% SDS, 10% Triton X-100, 10% Tween-20, 1 M N-lauroyl sarcosine, 
30% hydrogen peroxide, 1 M methyl viologen, 1% menadione, 2 mg ml-1 pyrogallol, 1 M 
sodium nitroprusside, 1 M ethyl methane sulfonate, 1 M methyl methane sulfonate, 5 mg 
ml-1 penicillin G, 5 mg ml-1 ciprofloxacin, 5 mg ml-1 nalidixic acid, 5 mg ml-1 cefotaxime, 
5 mg ml-1 vancomycin, 2 mg ml-1 phosphomycin, 5 mg ml-1 spectinomycin, 100 mg ml-1 
ampicillin, 100 mg ml-1 oxacillin, 5 mg ml-1 gramicidin, 5 mg ml-1 tetracycline, 50 mg ml-
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1 kanamycin, 50 mg ml-1 neomycin, 10 mg ml-1 chloramphenicol, 20 mg ml-1 puromycin, 
2 mg ml-1 bacitracin, 2 mg ml-1  mupirocin, 500 mM diamide, 12.8 mg ml-1 berberine 
chloride, 4.21 M peracetic acid, 0.1 M EDTA, 1 M DTT. Plates were incubated for 24 h 
at 37OC and subsequently analyzed for the presence of a blue ring at the edge of the zone 
of inhibition, indicating β-galactosidase activity and therefore sigS transcription. 
 
Quantitative Real-Time PCR. Quantitative Real-Time PCR (qRT-PCR) analysis was 
conducted by first collecting total cellular mRNA via the Qiagen RNeasy Kit as per the 
manufacturer’s protocol.  Briefly, cells were grown under conditions required to carry out 
the relative experiment.  Cultures were snap frozen by placing 2 mL into 1:1 ice-cold 
EtOH:acetone and stored in the -80oC overnight.  Cells were then pelleted, resuspended in 
100 µl of TE buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA) and lysed via bead beating 
for 40 sec.  Samples were then treated with 7 µl β-mercaptethanol, 700 µl of RLT Buffer 
and subjected to a second round of 40 sec lysing.  Samples were centrifuged and 600 µl 
of supernatant was added to 900 µl EtOH then collected onto an RNeasy mini spin 
column.  The column was then treated with 350 µl RW1 buffer followed by washes with 
2 x 500 µl RPE buffer and finally eluted in 40 µl RNase-free H20.  Samples were 
subjected to DNase treatment with Ambion’s TURBO DNA-free Kit as per the 
manufacturer’s instructions.  DNase treatment was carried out at 37oC for 40 min 
followed by inactivation of the DNase as per the manufacturer’s protocol.  Synthesis of 
cDNA from the mRNA was carried out via reverse transcriptase with random primers 
utilizing the iScript cDNA Synthesis Kit as per the manufacturer’s protocol.  The RT 
reaction was carried out in a thermal cycler for optimal reaction conditions (5 min at 
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25oC, 30 min at 42oC, and 5 min at 85oC).  Quantitative Real-Time PCR analysis was 
conducted using SYBR Green I PCR Master Mix at a ratio of (10 µl SYBR, 2 µl forward 
primer, 2 µl reverse primer, 4 µl diH20 and 2 µl cDNA (diluted to a total concentration of 
50 ng  µl-1).  Primers utilized were specific for sigS(P1-P3) located 47 bp upstream of P4 
(OL1568/OL1569), sigS(P1-P4) located 357 bp downstream of the translation start site 
(OL1275/OL1276), ecfX (OL1366/OL1367), purC (OL1800/OL1801), purA 
(OL1843/OL1844), purE (OL1845/OL1846), purD (OL1862/OL1863), purB 
(OL1864/OL1865), guaB (OL1866/OL1867) and guaA (OL1868/OL1869), mutM 
(OL1802/OL1803), ogt (OL1804/OL1805), SACOL2339 (OL1806/OL1807), uvrB 
(OL1808/OL1809).   Control primers were for the 16s rRNA gene (OL1184/OL1185), as 
described previously (Koprivnjak et al., 2006). Values were calculated from three 
independent experiments, and the data was analyzed using a Student t test, where p <0.05 
was considered statistically significant. 
 
Transcriptional Analysis During Growth in Porcine Serum.  Synchronous cultures of 
the sigS-lacZ fusion strains were standardized to an OD600 of 0.5, pelleted and washed 
twice in PBS before being resuspended in 1 ml of filter sterilized porcine serum (Sigma).  
The suspension was then incubated at 37oC in a rotator device for a period of 1, 5 or 24 h.  
At the appropriate time point 1 ml samples were pelleted and stored in -20oC for future 
analysis.  Concomitantly, the CFU per ml for each sample was determined via serial 
dilution and plating on TSA.  Harvested bacterial cells were assayed for β-galactosidase 
production as described previously, with the following alterations.  Arbitrary expression 
units were calculated as a measure of substrate cleavage (4-MUG) by β-galactosidase into 
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4MU, which was evaluated by measuring the fluorescence of each sample at 355 / 460 
nm, 0.1 sec, divided by the CFU ml-1.  Samples collected from the initial inocula were 
analyzed for β-galactosidase activity, and used as a measure of baseline expression to 
identify changes in transcription, as described previously (O'Croinin and Dorman, 2007; 
Walthers et al., 2007).  The data presented was generated from 3 independent replicates 
and analyzed using a Student t test with a 5% confidence limit to determine statistical 
significance. 
 
Macrophage Cell Culture and S. aureus Intracellular Transcriptional Analysis.  
Assays were carried out using the RAW 264.7 murine leukaemic monocyte macrophage 
cell line (ATCC TIB-71) as described previously (Walthers et al., 2007).  Cells were 
maintained in DMEM (Sigma) supplemented with 10% fetal bovine serum (Invitrogen) 
and 1% penicillin/streptomycin solution (Sigma) until infection, at which time antibiotics 
were used as described below.  RAW 264.7 cells were seeded into 6-well plates and 
allowed to grow to a density of 1.0 x 106 cells per well. These were then infected with S. 
aureus strains resuspended in cell culture medium at 1.0 x 108 CFU per well to give an 
MOI of 100. To synchronize infections and facilitate contact between bacteria and RAW 
264.7 cells, plates were centrifuged at 1000 rpm for 10 min.  Cells were subsequently 
incubated for 1 h at 37oC in a humidified atmosphere containing 5% CO2 to allow 
phagocytosis.  After this time, wells were washed twice with PBS and any remaining 
non-phagocytosed bacteria were killed by the addition of media containing 30 µg ml-1 
gentamicin, for 1 h. This was then replaced with fresh DMEM containing 5 µg ml-1 
gentamicin, and incubated for 24 h.  Following this, RAW 264.7 cells were washed twice 
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with PBS, and lysed using 500 μl PBS containing 0.5% Triton X-100. Samples were 
withdrawn to determine bacterial numbers and the remaining bacteria were pelleted by 
centrifugation.  Harvested bacterial cells were assayed for β-galactosidase production as 
described previously, with the following alterations.  Arbitrary expression units were 
calculated as a measure of substrate cleavage (4-MUG) by β-galactosidase into 4MU, 
which was evaluated by measuring the fluorescence of each sample at 355 / 460 nm, 0.1 
sec, divided by the CFU ml-1.  Samples collected from the initial inocula were analyzed 
for β-galactosidase activity, and used as a measure of baseline expression to identify 
changes in transcription during infection, as described previously (O'Croinin and 
Dorman, 2007; Walthers et al., 2007).  The data presented was generated from 6 
independent replicates and analyzed using a Student t test with a 5% confidence limit to 
determine statistical significance. 
 
DNA Sequencing of the sigS Promoter Region.  The sigS promoter region was 
amplified via PCR with primer pairs OL281/OL OL-1570.  The PCR product was then 
analyzed via gel electrophoresis and the resulting band extracted via the QIAGEN 
QIAquick PCR Purification kit according to the manufacturer’s instructions.  Briefly, the 
appropriate band was excised from the gel and allowed to dissolve in QG buffer 
(guanidine isothiocyanate) at 50oC.  The DNA was then bound to a QIAquick spin 
column and washed with a 500 µl aliquot of QG buffer (QIAGEN).  This is followed by 
addition of PE buffer and drying via centrifugation for 2 min in order to remove any 
residual buffer.  The membrane was placed over a clean eppendorf and the DNA eluted in 
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50 µl diH20.  The purified DNA was then sent to Eurofins MWG Operon for sequencing 
with the primers used in the original PCR reaction.  
   
Mutation via N-methyl-N'-nitro-N-nitrosoguanidine (NTG) Exposure.  An overnight 
culture was synchronized and allowed to grow to mid-exponential phase at which point 
NTG was added to a final concentration of 50 µg ml-1 and allowed to incubate at 37oC for 
60 min (Iordanescu and Surdeanu, 1976).  The cells were then collected via 
centrifugation at 3,500 rpm, washed, resuspended with tryptic soy broth (TSB) and 
allowed to recover at 37oC for 2 h (Adelberg and Pittard, 1965).  Following the recovery 
period, one ml aliquots were collected via centrifugation at 3,500 rpm for 10 min and 
resuspended in TSB glycerol (20% v/v) and stored in the -80oC for future analysis.  The 
CFU ml-1 for the culture was determined both prior to NTG exposure and after in order to 
determine if the survival rate is > 50%.  For analysis, the frozen samples were allowed to 
thaw and were then serially diluted in sterile PBS (8 g l-1 NaCl, 1.4 g l-1  Na2HPO4, 0.2 g 
l-1 KCl and 0.2 g l-1 KH2PO4) and the 100 through the 10-5 dilutions plated and CFU ml-1 
determined.   
 
Transposon Mutagenesis and DNA Sequencing of Insertion Sites.  Mutagenesis was 
carried out in strain HKM18 (Table 1) as previously described (Shaw et al., 2006).  Strain 
HKM18 was created via PCR amplification of the sigS-lacZ region from pLES205 
utilizing primer pair OL281/OL909 (Table 1) which was subsequently TA cloned into 
pSC-A utilizing StrataClone PCR Cloning Kit as per the manufacturer’s instructions.  In 
order to create a tetracycline marked fusion strain, primer pair OL522/OL523 was used to 
44 
 
amplify the tet cassette from pDG1515 (Guerout-Fleury et al., 1995) then digest with 
Xba1 and ligated into similarly cut pSC-A containing sigS-lacZ to create pHKM5 (Table 
1).  S. aureus RN4220 was transformed with this construct, with clones confirmed by 
PCR analysis, using a combination of gene and vector specific primers (OL-281/OL-
909).  A representative clone was selected to transduce the 8325-4 wild-type background. 
Clones were again confirmed by PCR analysis, creating strain HKM17.  This strain was 
then used as a receptor for the temperature sensitive Tn551 transposon containing 
plasmid pRN3208 (Kornblum et al., 1986) and grown at 30oC to aid in plasmid 
replication.  In order to construct the Tn551 mutant library, this strain was first grown 
overnight at 30oC on a TSA plate containing 0.25 mM CdCl2, 5 µg ml-1 Ery, 5 µg ml-1 
Tet (CET).  A flask of 100 ml TSBCET was inoculated from the plate and grown overnight 
at 30oC.  A 5 ml volume from the overnight was washed once with TSB and resuspended 
in 100 ml TSB containing Ery (5 µg ml-1) and grown at 43oC.  After 4 hours of growth, 
another 5 ml of culture was transferred to 100 ml TSB containing Ery (5 µg ml-1) and 
allowed to grow at 43oC until the OD600 reached 1.5 (Kornblum et al., 1986).  One ml 
aliquots were then collected via centrifugation at 3,500 rpm for 10 min and resuspended 
in TSB glycerol (20% v/v) and stored in the -80oC for future analysis.  The CFU ml-1 and 
insertion rate of the library was determined via serial dilution plating on TSA containing 
Ery (5 µg ml-1) and TSA containing CdCl2 (0.25 mM).  The glycerol stocks were then 
plated on TSA containing Ery (5 µg ml-1) at approximately 200 colonies per plate and 
analyzed for the appearance of blue colonies.  The blue colonies were then selected and 
glycerol stocked as before.  To confirm relevance of the insert, the transposon was 
transduced into 8325-4, SH1000 and Houston and the blue resulting transductants 
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glycerol stocked and whole genomic DNA collected utilizing the QIAGEN DNeasy 
Tissue Kit according to the manufacturer’s instructions.  Briefly, 5 ml of an overnight 
culture was collected via centrifugation at 4,500 rpm for 10 min and resuspended in 180 
µl Enzymatic lysis buffer (20 mM Tris-HCl pH 8.0, 2 mM NaEDTA, 1.2% Triton X-100, 
50 µg ml-1 RNase A, 5 µl Lysostaphin (5 mg ml-1) and incubated at 37oC for 30 min.  
This was followed by an addition of 25 µl proteinase K and 200 µl Buffer AL which was 
then vortexed and incubated at 60oC for 30 min.  Post incubation, 200 µl of 100% EtOH 
was added to the lysate and vortexed.  The lysate was then applied to a DNeasy column, 
washed and eluted in 400 µl of diH20 (QIAGEN).  The concentration of DNA was 
measured utilizing the NanoDrop Spectrophotometer and 10 µl of 500-1000 ng ml-1 
sample was sent to Eurofins MWG operon for sequencing.  Sequencing was performed 
utilizing single-strand DNA sequencing using primer OL1130 specific to Tn551.  
Sequencing runs through the end of Tn551 and into flanking genomic DNA which allows 
for approximately 500 bp of sequenced DNA outside of the transposon.  Insertion sites 
were then identified utilizing NCBI BLAST analysis. 
 
Disk Diffusion Analysis for Phenotypic Characterization.  Disk diffusion analysis was 
carried out as previously described for transcriptional analysis, with the following 
modifications.  Top agar overlay was seeded with cultures standardized to the same 
OD600 and without the addition of X-GAL.  Additionally, evaluation of survival ability 
was determined as a measure of the diameter of the zone of inhibition of mutant versus 
wild-type parent strain.   
 
46 
 
Competitive Growth Analysis.  Coculture studies were performed by inoculating 
complex liquid media with a 1:1 ratio of both mutant and wild-type strains. These were 
allowed to grow for defined periods of time, before colony enumeration via serial 
dilutions onto both TSA and TSA containing tetracycline. Because the mutant strain is 
marked with a tetracycline resistance cassette, only it will grow in the presence of 
tetracycline, whereas both parent and mutant will grow on TSA. As such, the CFU per ml 
of both parent and mutant strains can be obtained and a competitive index (CI) calculated 
as a measure of the relative proportion of the two strains.  
 
Sensitivity Assays.  Exponentially growing cultures were washed and resuspended in 
PBS before the addition of DNA damaging agents (5 mM H2O2, 25 mM MMS, 5 mM 
ethidium bromide (EtBr), 100 mM acridine orange, 25 mM ethyl methanesulfonate and 
450 mM 4-nitroquinoline N-oxide).  These were then placed at 37oC with shaking, and 
aliquots removed at the time intervals specified. Samples were serially diluted, and CFU 
ml-1 determined.  Control samples were also removed prior to exposure, and processed in 
an identical manner.  Percent survival was calculated by comparing initial CFU ml-1 to 
final CFU ml-1 from three independent assays and the data was analyzed using a Student t 
test, where p <0.05 was considered statistically significant.  Data is presented as fold 
change of each percent survival relative to the percent survival of the wild-type strain. 
 
Ultraviolet Radiation Survival Assay. This assay was performed as previously 
described (Chen et al., 2007).  Briefly, cultures were synchronized to an OD600 of 0.05 
and allowed to grow for 4 h.  Cultures were then serially diluted, and the 10-2 through 10-
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6 dilutions plated on TSA.  Dilutions 10-2 and 10-3 were then subjected to UV irradiation 
at 4,000 µJ/cm2 using a CL-1000 Ultraviolet Crosslinker (UVP).  Dilutions 10-4 through 
10-6 served as unexposed controls.  All plates were incubated in the dark at 37oC 
overnight.   Survival rates were calculated from three independent experiments, and the 
data was analyzed using a Student t test, where p <0.05 was considered statistically 
significant. 
 
Affymetrix S. aureus GeneChip Array.  The RN4220 wild-type and sigS mutant strains 
were grown in TSB under standard conditions to 3h, which corresponds to a window of 
maximal sigS expression.  Bacterial cell pellets were collected, stored and total bacterial 
RNA was isolated, processed and labeled as described previously with the following 
modifications.  Bacterial pellets were resuspended in 100 μl of TE buffer (10 mM Tris-
Cl, pH 7.5, 1 mM EDTA) and cells lysed via bead beating utilizing FastPrep lysing 
matrix tubes for 2 cycles of 40 sec with 2 min cooling intervals on ice (MP Biomedicals 
LLC).  Total bacterial RNA was isolated using the RNeasy Mini Columns according to 
the manufacturer’s directions (Qiagen, Inc., Valencia, Calif.)  Post isolation, RNA was 
freed of contaminating DNA via DNase treatment with RNase-free DNase 1 (Ambion®).  
RNA quantity and quality was checked utilizing Agilent 2100 Bioanalyzer (Agilent 
Technologies).  The GeneChip S.aureus Genome Array containing 3,300 ORFs and 
4,800 intergenic regions was used.  Data is from three independent experiments and was 
analyzed for a fold cut-off of > 2 utilizing a Student t test where p<0.05 was considered 
statistically significant.  ORF IDs in the list of differentially expressed genes were then 
mapped to S. aureus COL IDs where possible.  
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Intracellular Proteomic Analysis.  Intracellular proteins were harvested from 
synchronized cultures of 8325-4 wild-type and sigS mutant grown to 5 h in 2.5 mM MMS 
via centrifugation for 10 minutes at 4,150 rpm.  The pellets were washed with PBS and 
resuspended in 1 ml of UDS buffer (6 M urea, 5 mM DTT, 1 % SDS, 50 mM Tris-HCl 
pH 8) (Maresso and Schneewind, 2006).  After addition of 0.1 mm disruption beads, the 
cells were lysed at 4oC with a BioSpec Mini-BeadBeater for a total of 5 min allowing for 
cooling periods after every min.  The intracellular proteins were then separated from the 
cell wall debris by two rounds of centrifugation for 10 minutes each at 13,300 rpm and 
supernatants collected.  Resulting protein concentrations were determined using a Pierce 
660 nm protein assay kit and subsequently standardized to 1 mg ml-1.  The resulting 
samples were then reduced using dithiothreitol and alkylated via exposure to 
iodoacetamide, followed by a trypsin digest overnight at 37oC.  The digested proteins 
underwent de-salting before being fractionated via HPLC.  Approximately 20 fractions 
were collected at one min intervals from the time of initial peptide elution.  Fractions 
were then dried in a speed vacuum and resuspended in 20 µL of 0.1% formic acid (Rivera 
et al., 2012).  The resulting peptides were then identified via an LTQ XL mass 
spectrometer.  The experiment was performed in triplicate and the resulting proteins 
combined and evaluated for statistical significance.   
 
Purine Enzyme Activity Assays.  Bacterial extracts were harvested from 100 ml 
cultures grown in TSB to 3 h, pelleted via centrifugation, washed in PBS and lysed in 1 
ml of PBS containing lysostaphin (100 μg ml-1) and incubated at 37oC for 1 h.  Resulting 
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lysates were cleared via centrifugation and protein concentration determined via the 
Pierce 660 nm protein assay (Thermo Scientific) as per the manufacturer’s protocol.  
Equal amounts of protein were used in individual experiments.  Activity assays were 
carried out as previously described (Hoffee et al., 1978) with the following 
modifications.  All measurements were carried out utilizing the ND-1000 UV-Vis 
spectrophotometer (NanoDrop) with a light path of 0.0001 cm.  Specific activity was 
calculated from three independent experiments where the data was analyzed using a 
Student t test, where p <0.05 was considered statistically significant. 
 
Determination of Intracellular Nucleotide Pools.  Intracellular nucleotide pools were 
extracted as described previously (Rajagopal et al., 2005).  Briefly, USA300 LAC wild-
type and sigS mutant strains were grown in 100 ml of TSB for 3 h.  The cells were 
washed in an equal volume of PBS and the cell pellet was resuspended in 10 ml of ice-
cold 0.2 N HPLC grade formic acid (Fisher). Nucleotides were extracted at 4°C for 2 h 
and centrifuged for 10 min at 6000 g. Supernatants were filtered using a formic acid 
compatible 0.22 μm pore-size filter (Millipore, USA) and dried in a speed-vac for 1 h.  
The dried sample was then resuspended in 400 μl of buffer A (5 mM NH4H2PO4 pH 
2.8). Intracellular nucleotide concentrations were determined by HPLC using a Hypersil 
SAX column (4.6 × 250mm, Thermo Hypersil-Keystone, Bellefonte, PA) equipped with 
a guard column.  Twenty µl of sample were injected into the column, which was pre-
equilibrated with buffer A.  Nucleotides were eluted using a discontinuous gradient of 
5mM NH4H2PO4 pH 2.8 (buffer A) and 750 mM NH4H2PO4 pH 3.7 (buffer B) as per 
manufacturer's instructions.  The gradient employed was an increase in buffer B, from 
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0% to30% over 25 min and 30% to 100% buffer B, over the next 10 min at a constant 
flow rate of1.0 ml min−1.  The absorbance was recorded at 254 nm and the peaks 
generated and those peaks corresponding to purines adenine and guanine were identified 
by comparison to standard HPLC nucleotide markers.  These mono-, di- and triphosphate 
markers were purchased individually and combined at a 1:1 ratio.  The markers were 
analyzed in a manner identical to that of the samples and standard curves were obtained 
for individual experiments from the resulting peaks and the known standard 
concentrations.  The nucleotide concentrations of the individual samples were determined 
from the peak areas and standard curves, as described previously (Sigoillot et al., 2003).  
 
Whole Human Blood Survival Assay.  Synchronized cultures of the USA300 LAC 
wild-type, sigS and ecfX mutants and the respective complement strains were grown to 
exponential phase and subsequently washed three times with PBS and placed in 1 ml of 
whole human blood. The initial inocula for each strain was determined retroactively by 
serially dilution and plating on TSA. Blood cultures were allowed to incubate at 37°C 
with shaking for three hours, before the CFU ml-1 of each strain was determined, again by 
serial dilution and plating.  The data presented is the percentage survival of each strain 
compared to the beginning inoculum. Data is representative of three independent 
experiments where the data was analyzed using a Student t test, where p <0.05 was 
considered statistically significant. 
 
Macrophage Cell Culture and S. aureus Intracellular Survival Assay.  Infections 
were carried out as described above for transcription studies, with the following 
51 
 
alterations.  RAW 264.7 cells were infected with S. aureus strains resuspended in cell 
culture medium at 2.5 x 106 CFU per well to give an MOI of 1.  Samples were withdrawn 
24 hours post phagocytosis and CFU ml-1 determined via serial dilution and plating on 
TSA.  The data presented was generated from 3 independent replicates and analyzed 
using a Student t test with a 5% confidence limit to determine statistical significance. 
 
Murine Models of Abscess Formation. Analysis using a murine model of wound 
formation was performed by infecting hairless SKH1-E female mice via subcutaneous 
injection. Ten mice were injected on the thigh with an inoculum of 1.00 x 108 CFU per 
mouse with the wild-type strain while another 10 received the same inoculum of the triple 
σ mutant strain.  Each inoculum contained 0.01 ml of sterile Cytodex beads to act as 
foreign material microcarriers to aid in establishing infection (Bunce et al., 1992; Ford et 
al., 1989).  The lesions were evaluated based on size for a period of 6 days at which time 
the mice were humanely euthanized and abscesses recovered. The lesions were then 
analyzed for the presence of S. aureus by homogenizing the abscesses in PBS and serially 
diluting the suspension onto TSA plates which were incubated overnight at 37oC, and the 
resulting colonies counted to calculate CFU per abscess. Individual CFU per abscess 
values were averaged and percent recovery calculated as a measure of CFU per abscess 
over inoculum CFU.  Data was analyzed using a Student t test, where p <0.05 was 
considered statistically significant. 
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CHAPTER 3: 
ANALYSIS OF THE ENVIRONMENTAL INDUCIBILITY OF sigS 
EXPRESSION 
 
Note To Reader.  Portions of these results have been previously published (Miller et al., 
2012; Shaw et al., 2008) and are utilized with permission of the publisher (Appendix 1). 
 
Background.  Many components govern the adaptive nature of bacteria, including 
complex regulatory networks, which allow it to respond to constantly changing 
environments via rapid shifts in gene expression.  There are a number of different 
elements that mediate this fine-tuning, including DNA-binding proteins, two-component 
systems, regulatory RNAs and alternative σ factors (1944; Cheung et al., 1992; Deora et 
al., 1997b; Fournier et al., 2001; Giraudo et al., 2003; Janzon et al., 1986; McNamara et 
al., 2000; Novick et al., 1995; Novick and Jiang, 2003a).  This latter class act by binding 
to core-RNA polymerase and redirecting promoter recognition to coordinate gene 
expression, bringing about expedient and wide-reaching alterations within the cell.  These 
σ factors include the essential housekeeping factors (σA or σ70), which are responsible for 
the majority of transcription as well as alternative σ factors, which are important for 
niche-specific transcriptional regulation in response to environmental change (Gruber and 
Gross, 2003; Helmann, 2002; Lonetto et al., 1992; Lonetto et al., 1994).  During times of 
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stress, the housekeeping sigma factor is substituted for alternative σ factors, which 
control distinct regulons to circumvent detrimental condition.  These regulators are highly 
specific to the respective stress that they respond to and are often only transcribed when 
needed.  For example, σH of Mycobacterium tuberculosis displays minimal transcription 
during exponential phase growth compared to other σ factors in this organism.  Even 
after exposure to stresses, such as SDS, low aeration and low temperatures, the amount of 
sigH transcript remains low; however, following exposure to heat shock, its levels 
increase significantly (Manganelli et al., 1999).  The ECF (extracytoplasmic function) σ 
factors are a group of alternative sigma factors, which typically respond to perturbations 
in the cell envelope.  These are by far the most numerate of all sigma factors (Helmann, 
2002); for example, Streptomyces coelicolor contains approximately 65 σ factors, around 
50 of which are of the ECF subtype .  Examples include RpoE of E. coli, which responds 
to stress triggered by misfolded proteins in the periplasm or outer membrane as a result of 
heat shock or osmotic stress (Dartigalongue et al., 2001).  The ECF sigma factors, σM , 
σW and σX of B. subtilis all respond to extracytoplasmic stresses elicited by certain cell 
wall targeting antimicrobials (Cao et al., 2002a; Cao et al., 2002b; Helmann, 2006).  
Additionally a number of ECF sigma factors, including σFecI of E. coli respond to iron-
limiting conditions through transmembrane signaling (Enz et al., 2000).  Furthermore, 
there are examples within the ECF group of alternative sigma factors that respond to 
cytoplasmic stresses.  These include RpoE from R. sphaeroides and σR from S. 
coelicolor, which both respond to thiol specific oxidative stresses induced by diamide 
(Campbell et al., 2007; Dufour et al., 2008; Paget et al., 2001a); and Ecf of Neisseria 
gonorrhoeae, which responds to oxidative stress (Gunesekere et al., 2006).  Furthermore, 
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there are some ECF sigma factors which are constitutively expressed.  Specifically, σR of 
Streptomyces coelicolor is constitutively expressed from a downstream promoter through 
the action of the housekeeping sigma factor, σA, and then subsequently upregulates itself 
from an upstream promoter during times of induction (Kim et al., 2009).  As such, it is 
clear that ECF-sigma factors have extensive variations in their inducibility by external 
conditions.  Furthermore, they are employed to combat such stress in a variety of 
different ways.  As such, the focus of this chapter will be to explore the impact of 
external conditions on expression profile of the lone ECF σ factor of S. aureus, σS. 
Specifically, we seek to identify the environmental cues that lead to its upregulation.  We 
previously demonstrated that σS acts to upregulate itself from its own promoter region; 
therefore, in order to elucidate this promoter and any others, we set out to map the sigS 
promoter(s).  
 
Results 
 
Evaluation of the sigS Transcriptional Start Site Reveals Three Upstream 
Promoters and a Fourth Unique Internal Promoter.  We previously demonstrated that 
σS autoregulates itself from its own promoter region; therefore, in order to elucidate the 
specific promoter sequences responsible for this, we set out to map the sigS 
transcriptional start site.  To this end, we performed 5’ rapid amplification of cDNA ends 
(RACE) analysis.  This technique converts total cellular mRNA into full length cDNA, 
which through subsequent steps, can be used as a template for amplification and 
sequencing of the 5’ end of mRNAs using gene specific primers.  This was carried out in 
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the laboratory strain, SH1000, the same strain previously used for our preliminary 
characterization of σS. (Shaw et al., 2008) Cells were grown under standard conditions 
and collected at 3 h, before total mRNA was extracted utilizing the Qiagen RNeasy Kit as 
per the manufacturer’s protocol.  The sigS mRNA transcript was converted to cDNA 
utilizing a 5’ end-phosphorylated primer, which will convert the entire transcript through 
to the unknown 3’ end.  The cDNA was then ligated to form concatemers and used as a 
template for PCR where primers specific to known regions of the template will be used to 
PCR across the unknown 3’ region.  The resulting products were introduced into pSC-A 
via the StrataClone PCR Cloning Kit (Stratagene) then were sent to Eurofins MWG 
Operon for sequencing using primer T7 specific to pSC-A.  The resulting sequencing 
reaction will generate DNA sequences from pSC-A across the insertion site of the PCR 
product containing the unknown 3’ region of the sigS mRNA transcript.  A total of 3 
independently generated pSC-A constructs were analyzed by DNA sequencing, all of 
which identified a transcriptional start site 85 nucleotides downstream of the putative 
start codon, as displayed in Figure 7.  Later work conducted in our laboratory utilizing 
primer extension analysis with a primer positioned 174 nucleotides downstream of the 
sigS translation start site confirmed the existence of this internal promoter (P4).  Further 
analysis with a second primer located 12 nucleotides downstream of the sigS initiation 
codon led to the identification of 3 unique transcription start sites (Figure 7), the longest 
of which bears an adenine +1 residue, located 150 bp upstream of the translation start 
site.  This is 7 nt away from a putative σA promoter, denoted as P1, with a sequence of 
aTtACA, followed by a 17bp spacer, and then TATtta.  Promoter P2 is located 126 nt 
upstream of the translational start site, beginning with a thymine residue, and appears to  
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Figure 7.  Promoter Mapping of sigS Reveals the Existence of an Internal Promoter 
and Three Upstream Promoters.  5’ RACE analysis was performed on the sigS operon 
resulting in the identification of an internal promoter (P4) depicted in the cartoon above.   
Analysis of the sequence upstream of the identified +1 results in a putative weak σA 
promoter as marked.  Later analysis in our laboratory utilizing primer extension revealed 
the existence of three other, upstream promoters (P1-P3).  Both P1 and P3 contain 
putative σA consensus sequences, while P2 contains a putative σS consensus sequence. 
Adapted from Miller et al., 2012.  
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have no notable σA or σB promoter sequences. It does, however, bear a putative σS 
promoter of CAAAGT 12 bp upstream of TATCA.  The third transcription start site, 
positioned 107 nt upstream of the coding region, contains an adenine +1 residue and is 7 
nucleotides away from a putative σA promoter, denoted as P3, with a sequence of 
aTcACA, followed by an 11 bp spacer, and then acTtAT.    
 
Transcriptional Profiling of sigS Reveals Conditions Under Which it is Expressed.  
Transcriptional analysis of sigS was performed utilizing reporter gene fusion constructs 
in plasmid pAZ106, by placing the lacZ gene, which encodes the enzyme β-
galactosidase, under the control of the sigS promoters.  Figure 8 details construction of 
this strain, which is produced via chromosomal integration of the vector by homologous 
recombination, resulting in duplication of the four sigS promoters.  One copy controls the 
lacZ gene, whilst the other controls a functional sigS gene, downstream of the insertion 
site.  As this construct contains all four sigS promoters (P1, P2, P3 and P4), it is termed 
sigS-lacZ(P1-P4) (Figure 9).  A second fusion construct was created in order to assess just 
the upstream promoters (P1, P2 and P3) denoted as sigS-lacZ(P1-P3) (Figure 10).  
Production of β-galactosidase is then evaluated in these strains through the use of X-gal 
and 4-MUG, which, when cleaved by β-galactosidase, result in the production of either a 
blue color or a quantifiable fluorescent absorbance, respectively.  Thus, each of these can 
be used to measure expression from the sigS promoters.   
 
Expression of sigS is Increased in the RN4220 Background Under Standard 
Conditions.  Transcriptional analysis using the sigS-lacZ(P1-P4) fusion was first performed  
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Figure 8. Construct of a sigS-lacZ Fusion.  (A) Depiction of the sigS-ecfX locus in the 
S. aureus chromosome.  A portion of DNA 5’ of P1 to 3’ of P4 was amplified and cloned 
into pAZ106, upstream of a promoterless lacZ gene.  The pAZ106 plasmid contains both 
bla and erm for resistance against ampicillin and erythromycin, respectively.  Integration 
of pAZ106 sigS-lacZ results in (B) creation of a sigS-lacZ fusion, which contains a 
duplication of the sigS promoters, placing  lacZ under their control, followed by the rest 
of the pAZ106 plasmid.  Note that the sigS-ecfX locus is functional and uninterrupted.   
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Figure 9.  Promoter Map of the sigS-lacZ(P1-P4) Fusion Construct.  The sigS operon is 
shown containing three upstream promoters (P1, P2 and P3) and one internal promoter 
(P4), identified by 5’ RACE and primer extension analysis.  The fusion strain contains all 
four sigS promoters, and is termed sigS-lacZ (P1-P4).   
 
 
 
Figure 10.  Promoter Map of the sigS-lacZ(P1-P3) Fusion Construct.  The sigS operon is 
shown containing three upstream promoters (P1, P2 and P3) and one internal promoter 
(P4), identified by 5’ RACE and primer extension analysis. The fusion strain contains 
only the three upstream sigS promoters, and is denoted as sigS-lacZ (P1-P3).   
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by examining the strains for production of a blue coloration when plated on TSA 
containing X-gal, indicating expression from the sigS promoter.  As displayed in Figure 
11A, a variety of laboratory strains, including RN4220, 8325-4, SH1000 and Newman, as 
well as the USA300 clinical isolates, Houston, LAC and FPR were analyzed with only 
RN4220 demonstrating expression.  We then confirmed our findings in complex liquid 
media where again expression of sigS exhibited only baseline expression over a 24 h 
period in every strain, apart from RN4220 (Figure 11B).  In this latter strain, we observed 
an approximate 5-fold increase in sigS expression when compared to other S. aureus 
isolates, suggesting that there are features unique to this strain that allow for upregulation 
of sigS under standard conditions.  To ensure our findings were not an artifact of the 
fusion construct, we performed quantitative real-time PCR on these wild-type strains 
including RN4220, 8325-4, SH1000 and Newman, as well as the USA300 clinical 
isolates, Houston, LAC and FPR during a window of maximal sigS expression (3 h).  The 
primer pair utilized, termed sigS(P1-P4), is located 357 bp downstream of the sigS 
translation start site, and will detect transcript from any of the sigS promoters that extends 
to the end of the sigS coding region.  Using this approach we again observed robust 
expression of sigS in RN4220, with minimal transcription detected in the other isolates 
(Figure 12).  Curiously, whilst low expression was observed for the other backgrounds, 
transcriptional activity in Newman was almost entirely negligible. 
 
The Differential Expression Observed for sigS in S. aureus Wild-Type Strains is 
True Across the sigS Locus.  We repeated the analysis using the sigS-lacZ(P1-P3) RN4220 
fusion by again growing it on TSA containing X-gal.  We found that unlike the sigS- 
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Figure 11. Transcription Profiling of sigS in a Variety of S. aureus Wild-Type 
Strains. (A) sigS-lacZ(P1-P4) fusion strains were allowed to grow on TSA containing X-
gal at 37oC overnight.  Blue coloration indicates sigS upregulation.  (B) sigS-lacZ(P1-P4) 
fusion strains in RN4220 (+), 8325-4 (◊), USA 300 HOU (X), USA 300 FPR (●), 
SH1000 (▲), USA300 LAC (■) and Newman (□) were grown in TSB at 37oC and 
sampled every hour for 10 h and again at 24 h. β-galactosidase activity was measured to 
determine levels of sigS expression. Assays were performed on duplicate samples and the 
values averaged. The results presented herein were representative of three independent 
experiments that showed less than 10 % variability.  Adapted from Shaw et al., 2008 and 
Miller et al., 2012.  
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Figure 12. Transcription Profiling of sigS in a Variety of S. aureus Wild-Type 
Strains.  Quantitative real-time PCR was performed on S. aureus wild-type strains grown 
for 3 h in TSB at 37oC, with primers specific to sigS(P1-P4).  The data presented is from at 
least 3 independent experiments.  Error bars are shown as +/- SEM, *= p<0.05 using a 
Student t test.  Adapted from Miller et al., 2012.  
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lacZ(P1-P4) fusion, growth of RN4220 sigS-lacZ(P1-P3) led to no blue coloration, a finding 
that was mirrored in the β-galactosidase expression assays of the sigS-lacZ(P1-P3) fusion 
(Figure 13).  These findings suggest that the majority of expression observed in the 
RN4220 sigS-lacZ(P1-P4) fusion strain is a direct result of expression from the internal P4 
promoter.  We then continued our analysis to include evaluation of transcript throughout 
the sigS locus utilizing three separate primer pairs as displayed in Figure 14.  The first of 
which, termed sigS(P1-P3), is located 47 bp upstream of P4; as such analysis with these 
primers will include only transcript from the upstream promoters, excluding transcript 
from the internal P4 promoter.  The second primer pair, termed sigS(P1-P4), is the same as 
utilized before and is located 357 bp downstream of the sigS translation start site, and will 
detect transcript from any of the sigS promoters that extends to the end of the sigS coding 
region.  The sigS locus contains an additional gene that is likely to be transcriptionally 
linked, located 112 bp downstream of sigS, SACOL1828, which we have termed ecfX. 
The final primer pair, ecfX, is located in this downstream gene, at 254 bp 3’ of its 
translation start site, and will target transcripts that run through to the end of the ecfX 
coding region.  Using this approach, we observed that expression is elevated for the 
sigS(P1-P3), sigS(P1-P4) and ecfX primer pairs in RN4220, with minimal transcription 
detected from each of the three primer pairs in the other isolates again with negligible 
expression in the Newman background (Figure 15).  The ability to detect transcript 
utilizing our upstream sigS(P1-P3) qRT-PCR primer pair conflicts with our sigS-lacZ(P1-P3) 
fusion findings, suggesting that transcript generated from the upstream promoters may 
terminate prior to the fusion site of the lacZ construct.  Additionally, the blue coloration 
observed for the sigS-lacZ(P1-P4) may be a result of a combined effect of all four  
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Figure 13. Transcription Profiling of sigS(P1-P3) in RN4220.  (A) The RN4220 sigS-
lacZ(P1-P3) and sigS-lacZ(P1-P4) fusion strains were grown on TSA containing X-gal at 37oC 
overnight.  The appearance of blue coloration indicates expression of sigS.  (B) The sigS-
lacZ(P1-P3) (◊) and sigS-lacZ(P1-P4) (+) fusion strains in the RN4220 background were 
grown in TSB at 37oC and sampled every hour for 10 h and again at 24 h. β-galactosidase 
activity was measured to determine levels of sigS expression. Assays were performed on 
duplicate samples and the values averaged. The results presented herein were 
representative of three independent replicates that showed less than 10 % variability.   
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Figure 14.  The qRT-PCR Primer Locations in the sigS Operon. Displayed is the sigS 
operon and the location of each of primer pair used in qRT-PCR analysis.  Three separate 
primer pairs were generated: (A) termed sigS(P1-P3) located 47bp upstream of P4, (B) 
termed sigS(P1-P4) located 357bp downstream of the sigS translation start site, and (C) 
ecfX, located 254bp downstream of the ecfX translation start site.  
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Figure 15. Transcription Profiling of the sigS Locus in a Variety of S. aureus Wild-
Type Strains.  Quantitative real-time PCR was performed on S. aureus wild-type strains 
grown for 3 h in TSB at 37oC, with primers specific to sigS(P1-P3) (light grey), sigS(P1-P4) 
(black) or ecfX (dark grey).  The data presented is from at least 3 independent 
experiments.  Error bars are shown as +/- SEM, *= p<0.05 using a Student t test.  
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promoters acting on the lacZ fusion gene, while the strength of the upstream promoters 
alone may not lead to observable β-galactosidase activity.   
 
Expression of sigS is Inducible in Response to External Stimuli.  Given the low level 
of sigS expression observed amongst the majority of S. aureus strains under standard 
conditions, we next set out to explore whether transcription could be induced from this 
locus via external stress, as with other ECF σ factors (Helmann, 2002; Raivio and 
Silhavy, 2001; Staron et al., 2009).  This was performed using a modified disk diffusion 
assay where agar plates were overlayed with top agar containing X-gal, and seeded with 
the relevant fusion strain.  Subsequent to this, sterile filter disks are added to the plates, 
and impregnated with appropriate stress chemicals.  Following overnight incubation, 
plates were screened for the appearance of a blue ring around the zone of inhibition, 
indicating expression from the sigS promoters.  The sigS-lacZ(P1-P4) fusion strains in 
8325-4, Newman, SH1000 and USA300 LAC were grown in the presence of a plethora 
of stress conditions (Table 2).  Whilst we were unable to detect upregulation of sigS in 
most strains, we did observe significant inducibility in 8325-4 (Figure 16).  Specifically, 
we noted sigS expression in the presence of a variety of chemicals (Table 3), including a 
number of agents that induce cell wall stress, as well as compounds know to elicit DNA 
damage.  We also noted sigS upregulation in amino acid limiting media, metal ion 
limiting media, and during growth on pig serum.  Again to rule out artifacts of the screen, 
we sought to verify these findings during continuous growth in liquid media. This was 
performed with the 8325-4 sigS-lacZ(P1-P4) fusion strain grown in TSB containing sub-
lethal concentrations of select chemicals (MMS, H2O2 and NaOH) from Table 3, and  
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Table 2. Compounds Used to Screen for Expression of the sigS-lacZ Reporter 
Fusion.  
Stress  Agent Concentration 
Acid 
 
Hydrochloric Acid 6 M 
  
Phosphoric Acid 10 M 
  
Formic Acid 12 M 
  
Acetic Acid 1 M 
  
Sulphuric Acid 12 M 
  
Nitric Acid 6 M 
  
Trichloroacetic Acid 12 M 
  
  
Alkali 
 
Sodium Hydroxide 3 M 
  
  
Osmotic 
 
Sodium Chloride 1 M 
  
Glucose 1 M 
  
  
Alcohol 
 
Ethanol 100% 
  
Methanol 100% 
  
Isopropanol 100% 
  
  
Detergent 
 
Sodium Dodecyl Sulfate 10% 
  
Triton X-100 1% 
  
Tween-20 1% 
  
N-lauroyl Sarcosine 1% 
  
  
Oxidative 
 
Hydrogen Peroxide 30% 
  
Methyl Viologen 2 M 
  
Menadione 1% 
  
Pyrogallol 4 mg 
  
  
Nitrosative 
 
Sodium Nitroprusside 1M 
  
  
DNA Damage 
 
Methyl Methansulfonate 50 mM 
  
Ethyl Methanesulfonate 50 mM 
  
  
Antibiotics 
 
Penicillin G 20 µg 
  
Nalidixic Acid 50 µg 
  
Ciprofloxacin 50 µg 
  
Oxacillin 50 µg 
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Table 2. Continued.  
Stress  Agent Concentration  
 
  
Cefotaxime 50 µg 
  
Chloramphenicol 50 µg 
  
Phosphomycin 20 µg 
  
Vancomycin 20 µg 
  
Spectinomycin 50 µg 
  
Ampicillin 1 mg 
  
Tetracycline 50 µg 
  
Erythromycin 50 µg 
  
Lincomycin 250 µg 
  
Kanamycin 500 µg 
  
Neomycin 500 µg 
  
Puromycin 250 µg 
  
Mupirocin 20 µg 
  
  
  
Diamide 500 mM 
Disulfide 
 
  
  
Berberine Chloride 128 µg 
Miscellaneous 
 
Peracetic Acid 4.2 M 
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Table 3. Compounds Found to Induce Expression of a sigS-lacZ(P1-P4) Reporter 
Fusion in Strain 8325-4.   
 
  
 
Agent / Condition 
 
Stress / Mode of Action Overall Effect  
 
Sodium Hydroxide 
 
Alkali Stress DNA damage  
 
Hydrogen Peroxide 
 
Oxidative Stress DNA damage  
 
Methyl 
methanesulfonate  
Alkylates DNA DNA damage  
 
Ethyl methanesulfonate 
 
Alkylates DNA DNA damage  
 
Ciprofloxacin 
 
Inhibits DNA gyrase DNA damage  
 
Nalidixic Acid 
 
Inhibits DNA gyrase DNA damage  
 
Chloramphenicol 
 
Inhibits protein synthesis Miscellaneous  
 
Pig Serum 
 
Humoral immune system components Miscellaneous  
 
Amino acid limiting 
 
Minimal media Miscellaneous  
 Metal limiting  Minimal media Miscellaneous  
 Cefotaxime  Inhibits transpeptidation 
Cell wall 
weakening/disruption 
 
 Ampicillin  Inhibits transpeptidation 
Cell wall 
weakening/disruption 
 
 Oxacillin  Inhibits transpeptidation 
Cell wall 
weakening/disruption 
 
 
Sodium Dodecyl 
Sulfate 
 Disrupts cell walls 
Cell wall 
weakening/disruption 
 
 Phosphomycin  
Inhibits UDP-N-aceytglucosamine-3- 
enolpyruvyltransferase 
Cell wall 
weakening/disruption 
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Figure 16.  Transcription of sigS is Inducible in Response to External Stress. A 
modified disk diffusion assay was carried out to determine stress conditions that lead to 
sigS expression.  TSA plates were overlayed with top agar seeded with the 8325-4 sigS-
lacZ(P1-P4) fusion and 0.2 mg X-gal.  Sterile filter disks were placed on the solidified agar 
and 10 μl of appropriate chemical added.  The appearance of a blue ring around the zone 
of inhibition, as displayed here, indicates sigS activity.   
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revealed increased expression of sigS in each instance (Figure 17A-C).  In the presence of 
MMS, expression peaked at 5 h, with a 48.7-fold increase compared to standard 
conditions.  Maximal expression with both NaOH and H2O2 occurred at 10 h, with fold 
increases of 10 and 4.4 respectively, compared to unsupplemented media.  Additional 
qRT-PCR analysis was performed (Figure 17D) to verify this data, and again confirmed 
that the greatest fold increase in sigS expression was induced by exposure to MMS, 
resulting in a 102.6- fold increase in transcription.  Transcription of sigS upon exposure 
to NaOH and H2O2 was 63.3- and 57.2-fold higher, respectively.   
 
To explore if this upregulation was conserved for other S. aureus strains, but perhaps 
below the limit of detection for our plate based assay, we performed experiments with 
MMS, NaOH and H2O2 using SH1000 and USA300 LAC sigS-lacZ(P1-P4) fusion strains. 
Interestingly, despite a lack of blue coloration in the plate based assay, we again detected 
upregulation of sigS during growth in liquid media with sub-lethal concentrations of 
MMS and H2O2 (Figure 18A-B).  Expression with MMS in both SH1000 and USA300 
LAC was highest at 2 h, with fold increases of 3.6 and 8.1, respectively, compared to 
standard growth conditions. In the presence of H2O2, sigS expression in SH1000 
increased by 2.6-fold (2 h), and by 2.3-fold in USA300 LAC (7 h).  Conversely, we 
observed no increase in expression for NaOH when grown in these conditions, suggesting 
that greater, and perhaps more lethal concentrations of this agent may be required to 
induce expression. We again confirmed this data by qRT-PCR in SH1000 and USA300 
LAC grown in the presence of MMS and H2O2 (Figure 18C).  SH1000 displays a 16.9-
fold increased in sigS expression when cultured with MMS, and a 13.5-fold increase  
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Figure 17. Transcription of sigS is Inducible in Response to External Stress. The 
8325-4 sigS-lacZ(P1-P4) strain was grown (A-C) in either TSB (♦) or TSB supplemented 
with sub-lethal concentrations of the indicated stress chemicals (■). Cultures were 
sampled every hour for 10 h, and again at 24 h, to determine β-galactosidase activity. 
Additionally, growth was monitored via OD600 at the times indicated for both standard 
(◊) and supplemented (□) growth conditions. Assays were performed on duplicate 
samples and the values averaged. The results presented herein were representative of 
three independent replicates that showed less than 10 % variability. (D) Quantitative real-
time PCR analysis was performed with strain 8325-4 grown for 5 h under conditions 
identical to A-C, using primers specific to sigS(P1-P4).  The data presented is from at least 
3 independent experiments.  Error bars are shown as +/- SEM, *= p<0.05 using a Student 
t test (Miller et al., 2012).  
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Figure 18. The Inducibility of sigS Expression is Conserved Across S. aureus 
Strains. The SH1000 (∆) and USA300 LAC (○) sigS-lacZ fusion strains were grown (A-
B) in either TSB (open symbols) or TSB supplemented with sub-lethal concentrations of 
the indicated stress chemicals (closed symbols). Cultures were sampled every hour for 10 
h, and again at 24 h, to determine β-galactosidase activity.  Assays were performed on 
duplicate samples and the values averaged. The results presented herein were 
representative of three independent replicates that showed less than 10 % variability. (C) 
Quantitative real-time PCR analysis was performed with strain USA300 LAC (grey) and 
SH1000 (black) grown for 2 h under conditions identical to A-B, using primers specific 
to gS(P1-P4).  The data presented is from at least 3 independent experiments.  Error bars are 
shown as +/- SEM, *= p<0.05 using a Student t test, and represent significant variation 
from standard conditions (TSB) (Miller et al., 2012).  
.  
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when cultured with H2O2.  Expression of sigS in USA300 LAC grown with MMS or 
H2O2 displayed 4.6- and 2.8-fold increases in transcription, respectively.  Collectively, 
these findings demonstrate a significant inducibility of sigS in response to external 
stimuli that is conserved across S. aureus strains. 
 
Transcription is Increased Across the sigS Locus in 8325-4 Upon Exposure to 
External Stress.  Given our findings regarding expression from the upstream promoters 
(P1-P3) in RN4220, we next set out to examine the sigS-lacZ(P1-P3) in those stress 
conditions previously shown to induce expression of the sigS-lacZ(P1-P4) fusion. This 
analysis was again carried out in the 8325-4 as we observed the highest level of 
environmental inducibility from this strain.  We found that none of the conditions leading 
to expression for the sigS-lacZ(P1-P4) fusion resulted in observable expression with the 
sigS-lacZ(P1-P3) fusion using the disk diffusion assay (Figure 19).  In order to assess 
whether transcription was increased, but again below the limit of detection for our plate 
based assay, we performed qRT-PCR under these conditions with the sigS(P1-P3) and  ecfX 
primer pairs.  Interestingly, while the sigS-lacZ(P1-P3) fusion strain produced no visible 
expression via disk diffusion analysis, we did observed significant increase in sigS(P1-P3) 
transcript in the presence of each of the chemicals examined, although not to the levels 
observed for sigS(P1-P4) and ecfX.  Specifically, we observed 6.1-, 4.5- and 5.8-fold 
increases for sigS(P1-P3) in the presence of MMS, NaOH and H2O2, respectively compared 
to growth in TSB (Figure 20A).  Levels of ecfX transcript were also increased in the 
presence of MMS, NaOH and H2O2 with fold changes of 81.1, 42.5 and 38.6 
respectively, as displayed in Figure 20A.  Our findings again suggest that the  
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Figure 19. The Expression of sigS is Notable Only in the 8325-4 sigS-lacZ(P1-P4) 
Fusion Strain in Response to External Stress. A modified disk diffusion assay was 
carried out to determine stress conditions that lead to sigS expression.  TSA plates were 
overlayed with top agar seeded with either the 8325-4 sigS-lacZ(P1-P4) or the 8325-4 sigS-
lacZ(P1-P3) fusion and 0.2 mg X-gal.  Sterile filter disks were placed on the solidified agar 
and 10 μl of appropriate chemical added.  The appearance of a blue ring around the zone 
of inhibition, as displayed here, indicates sigS activity.   
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Figure 20. Transcription is Increased Across the sigS Locus in 8325-4 Upon 
Exposure to External Stress. (A) Quantitative real-time PCR analysis was performed 
with strain 8325-4 grown for 5 h in TSB, or TSB supplemented with various stress 
chemicals (0.5 mM H2O2, 25 mM NaOH or 2.5 mM MMS).  Three separate primer pairs 
were again used as described in figure 14. The data presented is from at least 3 
independent experiments.  Error bars are shown as +/- SEM, *= p<0.05 using a Student t 
test, and represent significant variation from standard conditions (TSB). (B) The fold 
changes are displayed for transcript measured from the sigS(P1-P4) and ecfX primer pairs 
relative to the transcript detected using the sigS(P1-P3) primer pair.  Specifically this shows 
the fold increase directly relating to transcript generated from the internal P4 promoter. 
The results presented herein were representative of three independent replicates that 
showed less than 10 % variability.  
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conflicting results generated between our reporter gene fusion and qRT-PCR studies may 
be  a result of truncated sigS transcript.  Additionally, this would suggest that the strength 
of the internal promoter combined with that of the upstream promoters leads to our 
observed β-galactosidase activity.  Comparison of the fold change for transcript measured 
by the sigS(P1-P3) primer pair compared to that of the sigS(P1-P4) and ecfX is displayed in 
Figure 20B.  Specifically this measures the fold increase directly relating to transcript 
generated from the internal P4 promoter.  During growth in H2O2, we observed a 2.4- 
and 2.1-fold increase for the sigS(P1-P4) and ecfX primer pairs compared to the sigS(P1-P3) 
primer pair respectively.  This difference was further enhanced during growth in NaOH, 
where we observed fold increases of 3.9 and 4.1 for sigS(P1-P4) and ecfX respectively.  
Finally, the greatest fold increase was observed during growth in the presence of MMS 
with 4.9- and 5-fold increases for sigS(P1-P4) and ecfX respectively.  
 
Transcription is Increased Across the sigS Locus in Both the SH1000 and USA300 
LAC Backgrounds During Growth in the Presence of DNA Damage Agents.  To 
explore if the upregulation found across the sigS locus in the 8325-4 background was 
conserved for other S. aureus strains, we performed experiments with MMS, NaOH and 
H2O2 using SH1000 and USA300 LAC with both the sigS(P1-P3) and ecfX primer pairs.  
We determined that expression from sigS(P1-P3) and ecfX was also increased upon 
exposure to MMS and H2O2 to levels comparable to that of sigS(P1-P4).  Specifically, in 
the SH1000 background, fold changes of 20.1 and 16 were observed for sigS(P1-P3) and 
ecfX in the presence of MMS (2 h), respectively (Figure 21).  Analysis using the sigS(P1-
P3) and ecfX primer pairs in the presence of H202 at 2 h led to 13.1- and  
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Figure 21. Transcription is Increased Across the sigS Locus in Both SH1000 and 
USA300 LAC Upon Exposure to External Stress.  Quantitative real-time PCR analysis 
was performed with strains SH1000 and USA300 LAC grown for 3 h in TSB, TSB 
supplemented with 0.5 mM H2O2 and TSB supplemented with 2.5 mM MMS.  Three 
separate primer pairs were used (A) located 47bp upstream of P4 (B) located 357bp 
downstream of the sigS translation start site and (C) located 254bp downstream of the 
ecfX translation start site.  The data presented is from at least 3 independent experiments.  
Error bars are shown as +/- SEM, *= p<0.05 using a Student t test, and represent 
significant variation from standard conditions (TSB).  
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15.9- fold increases, respectively in the SH1000 background.  As displayed in Figure 21, 
analysis in the USA300 LAC background at 2 h in the presence of MMS led to fold 
increases of 4.8 and 3.6 for sigS(P1-P3) and ecfX respectively.  Finally, 2.4- and 2.1-fold 
increases were observed for sigS(P1-P3) and ecfX respectively in the presence of H2O2 at 2 
h.  Collectively, these findings demonstrate significant inducibility of the transcripts 
across the sigS operon, which is conserved across S. aureus strains.  Interestingly, these 
findings suggest that the internal promoter, P4, is disregulated in 8325-4 and RN4220, 
but not in the SH1000 and USA300 LAC backgrounds, suggesting that the observable β-
galactosidase activity in the aforementioned strains may be a direct result of increased 
transcript from the internal promoter. 
 
Expression of sigS is Strongly Upregulated During Growth in Pig Serum.  Despite 
limited expression under standard laboratory growth conditions, we have previously 
demonstrated a role for σS in the virulence of S. aureus (Shaw et al., 2008).  Working on 
a hypothesis that sigS transcription would be increased during infection, we performed 
expression profiling of both sigS-lacZ fusion constructs upon ex vivo challenge by 
components of the innate immune system.  Indeed, our plate based analysis already 
suggests that sigS expression is increased by exposure to pig serum, at least from P1-P4 
(Table 3).  In order to confirm these findings, and quantify this increase across different 
strains, we performed transcriptional analysis using both the sigS-lacZ(P1-P4) and sigS-
lacZ(P1-P3) fusions strains grown in TSB, and then subcultured into pig serum.  We 
determined that after just 1 h of growth in serum, sigS expression increased by 3.4-fold in 
strain 8325-4 sigS-lacZ(P1-P4), compared to TSB.  Expression continued to rise over time, 
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with fold increases of 21.2 and 20.5 observed at hours 5 and 24, respectively (Figure 
22A).  Additionally we observed a similar effect in strains SH1000 and USA300 LAC.  
Specifically, over the course of growth, we noted fold increases of 13.8, 36.2 and 44.0 in 
SH1000 sigS-lacZ(P1-P4) for hours 1, 5 and 24, respectively (Figure 22A).  Finally, in 
USA300 LAC sigS-lacZ(P1-P4), sigS expression increased 6.8-, 15.6- and 26.3-fold at 
hours 1, 5 and 24, respectively (Figure 22A).  Analysis performed in the 8325-4 sigS-
lacZ(P1-P3) fusion strain led to increases of 6.4-, 7.3- and 22-fold observed at hours 1, 5 
and 24 respectively (Figure 22B).  In the SH1000 sigS-lacZ(P1-P3) fusion, expression 
increased 2.4-, 1.6- and 12.5-fold over 1, 5 and 24 hours respectively (Figure 22B).  
Finally, expression in USA300 LAC increased 1.6- and 1.3 fold during hours 1 and 5, 
with a significant increase of 8.6-fold by hour 24 (Figure 22B).  Comparison of the sigS-
lacZ(P1-P4) and sigS-lacZ(P1-P3) fusion strains shows the highest increases occurring in the 
8325-4 sigS-lacZ(P1-P4) fusion, with the greatest increase of 4-fold observed for hour 24 
(Figure 22C).  These findings further support our expression analysis which suggests that 
the internal promoter, P4, is disregulated in the 8325-4 background.   
 
Expression of sigS is Strongly Upregulated During Phagocytosis.  We continued this 
line of investigation by performing expression profiling of sigS-lacZ(P1-P4) and sigS-
lacZ(P1-P3) fusion strains upon phagocytosis by RAW 264.7 macrophage-like cells.  
Accordingly, macrophages were infected with strains 8325-4, SH1000, and USA300 
LAC bearing either the sigS-lacZ(P1-P4) or the sigS-lacZ(P1-P3) fusion. β-galactosidase 
expression was measured both prior to infection, as well as 24 h post phagocytosis 
(Figure 23).  Expression from the sigS-lacZ(P1-P4) fusion was significantly increased after  
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Figure 22. Profiling of sigS Expression During Growth in Pig Serum. (A) The sigS-
lacZ(P1-P4), (B) the sigS-lacZ(P1-P3) fusion, and (C) both the sigS-lacZ(P1-P4) (black) and the 
sigS-lacZ(P1-P3) (grey) fusion strains were assayed for β-galactosidase activity prior to 
(TSB), and during (1h, 5h and 24h), growth in pig serum.  The data presented is from at 
least 3 independent experiments. Error bars are presented as +/- SEM, *= p<0.001 using a 
Student t test. Adapted from Miller et al., 2012.  
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Figure 23. Profiling of sigS Expression Post Phagocytosis. (A) The sigS-lacZ(P1-P4), (B) 
the sigS-lacZ(P1-P3) fusion, and (C) both the sigS-lacZ(P1-P4) (black) and the sigS-lacZ(P1-P3) 
(grey) fusion strains were assayed for β-galactosidase activity prior to phagocytosis (grey 
bars) and 24 h post phagocytosis (black bars) by RAW 264.7 murine macrophage-like 
cells.  Cells were infected at an MOI of 1:100 and incubations carried out at 37oC in a 
humidified atmosphere of 5% CO2. The data presented is from at least 3 independent 
experiments. Error bars are presented as +/- SEM, *= p<0.001 using a Student t test. 
Adapted from Miller et al., 2012.  
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phagocytosis in all strains tested (Figure 23A), with the highest levels again observed in 
8325-4.  In this strain we found a 286.6-fold increase in sigS(P1-P4) expression compared 
to pre-phagocytosis levels.  In SH1000 and USA300 expression increased by 7.5- and 
7.4-fold, compared to background levels.  Analysis with the sigS-lacZ(P1-P3) fusion strains 
again led to significantly increased expression in all of the strains tested (Figure 23B).  
As with the sigS-lacZ(P1-P4) fusion strain, the highest level of expression was observed in 
the 8325-4 background with a fold increase of 43.2.  The expression increase in SH1000 
and USA300 was 5.4-, 3.8-fold respectively.  Upon examination of the sigS-lacZ(P1-P3) 
against the sigS-lacZ(P1-P4) fusion, we observed expression profiles similar to that for our 
previous findings.  Specifically during phagocytosis, we noted an approximately 15-fold 
increase for the 8325-4 sigS-lacZ(P1-P4) fusion compared to the sigS-lacZ(P1-P3) fusion 
strain (Figure 23C).  In contrast, only slight increases in expression were observed for the 
sigS-lacZ(P1-P4) fusion compared to the sigS-lacZ(P1-P3) fusion strain in SH1000 and 
USA300 LAC.  This data suggests that both the upstream and internal promoters are 
active during challenge by components of the innate immune system; however, the 
internal promoter again appears to be disregulated in the 8325-4 background.  
Collectively, this further supports our hypothesis that suggests that σS is required during 
the interaction of S. aureus with its host. 
   
Expression of sigS is Not Influenced by Either agr or sigB, Two Major Global 
Regulators of S. aureus, Under Standard Conditions.  Due to the variable expression 
observed amongst strains of S. aureus, we sought to determine if this variation was due to 
mutation of the global regulators agr and sigB.  Specifically, under standard conditions 
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we noted that RN4220 had markedly higher levels of sigS expression compared to other 
wild-type strains.  Of the many mutations within its genome, RN4220 carries both a cis 
SNP in agr as well as a trans SNP in sigB, mutations which render them nonfunctional 
(Nair et al., 2011).  As such, we sought to determine the effect of these individual 
disruptions on the expression of sigS.  We introduced the sigS-lacZ(P1-P4) fusion into a 
SH1000 sigB::tet mutant strain, and analyzed it via β-galactosidase assays.  It was found 
that there was no observable difference in sigS expression in this strain when compared to 
the wild-type (Figure 24A).  The sigS-lacZ(P1-P4)  fusion was then introduced into an 
SH1000 agr::tet mutant strain, and the analysis repeated.  Again we found that 
expression of sigS in this strain led to no observable change compared to the parent 
(Figure 24B).  This shows that neither agr nor sigB individually regulate expression of 
sigS.  With this, we then sought to examine sigS expression in 8325-4 agr::tet, a strain 
containing both the same trans SNP in sigB that exists in RN4220 as well as a mutation 
introduced into agr, thereby creating a double mutant.  Expression in this strain again 
showed no observable increases (data not shown).  These findings indicate further that 
the altered expression profile of RN4220 is likely attributed to other SNPs within its 
genome.  
 
The Observed sigS Transcriptional Inducibility is Not Dependent on a Functional 
σB.  As demonstrated earlier, the laboratory strain 8325-4 displays inducible sigS 
expression, indicating that there may be characteristics unique to this strain that allow for 
amplified expression of sigS.  The closely related strain SH1000 is almost identical to 
8325-4, but contains a functional rsbU gene (Horsburgh et al., 2002).  RsbU is a positive  
86 
 
 
 
 
 
 
Figure 24. Expression of sigS is Not Influenced by the Global Regulators agr or sigB 
in S. aureus.  Mutations in agr (A) and sigB (B) were introduced into the SH1000 sigS-
lacZ(P1-P4) fusion strain. Both the wild-type fusion (■) and the fusion bearing the 
respective mutation (□) were grown in TSB at 37oC, and sampled every hour for 10 h, 
and again at 24 h. β-galactosidase activity was measured to determine levels of sigS 
expression. Assays were performed on duplicate samples and the values averaged. The 
results presented herein were representative of three independent replicates that showed 
less than 10 % variability.  
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regulator of the general stress response σ factor, σB, which is non-functional in 8325-4 as 
a result of a naturally occurring 11-bp deletion (Giachino et al., 2001).  Strain SH1000 
was created by introducing a functional rsbU gene into 8325-4, thereby restoring σB 
expression (Horsburgh et al., 2002).  Therefore, if the increase in σB expression is 
responsible for decreased sigS expression in SH1000, then mutation of sigB in SH1000 
should restore sigS expression to that of 8325-4 levels.  As mentioned previously, 
mutation of sigB in the SH1000 background under standard conditions led to no 
observable increase in expression; however, we sought to examine the expression of sigS 
in this background under inducing conditions.  We found, however, that even under 
inducing conditions, such as growth in MMS, the SH1000 sigB mutant strain was not 
comparable to strain 8325-4 in terms of sigS expression, as shown in Figure 25.  This 
further suggests that σB is not solely responsible for the differential regulation of sigS 
between these 2 strains.  Given recent findings showing a role for RsbU outside of its 
influence of σB activity (Truong-Bolduc and Hooper, 2010), this led us to believe that 
these differences may be directly related to rsbU, the gene disrupted in 8325-4, rather 
than directly to sigB.  Therefore, we analyzed the expression of sigS in the RN6390 
background.  8325-4 and RN6390 are identical, in that they originate from the 
NCTC8325 strain, have been UV phage cured, and both possess a mutation in rsbU 
(Traber and Novick, 2006).  We found the inducible expression profile of sigS in RN6390 
does not mirror that of 8325-4, indicating that there are likely additional factors beyond 
rsbU that are responsible for the variable expression amongst these strains (Figure 26).  
As such, it is likely that SNPs may exist in the RN6390 background compared to 8325-4 
that have yet to be determined, which may impact sigS expression. Indeed, the RN6390  
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Figure 25. The sigS Transcriptional Inducibility is Not Dependent on a Functional 
σB.  The sigS-lacZ(P1-P4) fusion in 8325-4 (■) and SH1000 sigB::tet (♦) backgrounds were 
grown in TSB containing 2.5 mM MMS at 37oC, and sampled every hour for 10 h and 
again at 24 h. β-galactosidase activity was measured to determine levels of sigS 
expression. Assays were performed on duplicate samples and the values averaged. The 
results presented herein were representative of three independent replicates that showed 
less than 10 % variability.   
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Figure 26. Expression of sigS is Not Dependent on rsbU. A modified disk diffusion 
assay was carried out to determine if sigS expression is comparable between 8325-4 and 
RN6390.  TSA plates were overlayed with top agar seeded with 0.2 mg X-gal and the 
sigS-lacZ(P1-P4) fusion strains in the 8325-4 and RN6390 backgrounds (both rsbU- 
strains).  Sterile filter disks were placed on the solidified agar and 10 μl of appropriate 
chemical added.  The appearance of a blue ring around the zone of inhibition indicates 
sigS activity, which is observed only in the 8325-4 background.   
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strain was subjected to insertion of a TN551 containing plasmid and subsequently cured 
of this plasmid leading to the creation of the current strain; therefore, it is likely that this 
process allowed for the acquisition of additional SNPs unique to RN6390 (Traber and 
Novick, 2006). 
 
DNA Sequencing and Alignment of the sigS Operon Reveals Only Minor 
Differences Between Strains of S. aureus.  In order to evaluate which cis modifications, 
if any, may be attributed to the variable expression observed between S. aureus strains, 
we performed sequence analysis of the sigS locus. Specifically, this was performed from 
336 nt 5’ of the sigS start codon to the sigS stop codon for strains RN4220, RN6390, 
8325-4, SH1000, Newman, USA300 FPR and USA100 (Figure 27). Surprisingly, 
homology in this region is highly consistent between strains, with only minor deviations 
occurring in the 8325 lineage strains (RN4220, RN6390, 8325-4 and SH1000) and strain 
USA100.  As displayed in Table 4, the 8325 lineage strains each carry the same 
mutations in the 11th codon, replacing CAC (Histidine) with CAG (Glutamine), as well as 
the 16th codon, replacing CAT (Histidine) with TAT (Tyrosine).  Additionally, USA100 
carries different mutations, in the 63rd codon replacing TTT (Phenylalanine) with TAT 
(Tyrosine), and in the 111th codon, where CAT (Histidine) replaces CAA (Glutamine).  
As such, it appears that the sigS locus, and specifically the promoter region, is well 
conserved amongst S. aureus strains.  Additionally, as there are no unique mutations in 
those strains exhibiting increased sigS expression (RN4220 and 8325-4), the differential 
expression observed cannot be attributed to SNPs (single-nucleotide polymorphisms) 
within the sigS operon. 
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Table 4.  Genetic Polymorphisms Specific to the sigS Locus Between Laboratory 
and Clinical Isolates of S. aureus, Relative to Reference Genome COL. 
Strain Nucleotide Change Amino Acid Change 
NCTC8325 Lineage Strains 
(RN4220, RN6390, 8325-4,   
SH1000) 
C -> G 
C -> T 
H11Q 
H16Y 
   
Newman NONE NONE 
   
USA300 LAC NONE NONE 
   
USA100 T -> A 
T -> A 
F63Y 
H111Q 
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Figure 27. Sequencing Alignment of the sigS Locus Reveals no SNPs Accountable 
for the Variable Expression Profiles Amongst S. aureus Strains.  DNA sequencing of 
the sigS locus including 336 bp upstream of the putative start codon through the end of 
the sigS gene was performed.  Displayed below is the multiple sequence alignment of all 
strains analyzed.  Numbered base pair (bp) labels denote stretches of DNA with no 
differences in sequence.  Black boxes highlight the nucleotides where changes occur and 
the putative start and stop codons are denoted as such.   
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Exploration of Additional sigS Transcriptional Start Sites as a Result of 
Environmental Inducibility.  As our previous promoter mapping analysis was 
performed under conditions where sigS expression is minimal, we sought to reevaluate 
the transcription start site under conditions shown to induce sigS expression.  Evaluation 
under these conditions may potentially reveal the existence of alternative promoter(s) 
only active under induction conditions.  As done previously, we performed 5’ rapid 
amplification of cDNA ends (RACE) analysis, using the laboratory strain 8325-4, in the 
presence of 2.5 mM of the DNA damage agent methyl methanesulfonate (MMS) at hour 
5, a condition previously determined to elicit maximal expression of sigS.  Total mRNA 
was again extracted and sigS mRNA transcript converted to cDNA utilizing the 5’ end-
phosphorylated primer.  Subsequently, PCR amplification and TA cloning was carried 
out as before.  A total of 14 independently generated pSC-A constructs were analyzed by 
DNA sequencing, each of which identified the identical transcriptional start site as 
before, located 85 nucleotides downstream of the putative start codon (Table 5).  We then 
repeated these experiments in other S. aureus strains, in order to ensure that our findings 
were not specific to 8325-4.  In SH1000 in the presence of MMS at 2 h, we again saw 2 
of the three sequences identifying the exact +1 as before; however, the third sequence 
presented a start site 82 nucleotides downstream of the putative start codon.   
 
Discussion.  Promoter mapping of the sigS locus reveals four discrete transcriptional start 
sites. Promoters, P1 and P3, both appear to be under the control of the housekeeping σ 
factor, σA, however both are severely corrupted from consensus sequences and/or 
spacing.  Due to the relative weakness of these promoters it is likely that other regulatory  
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Table 5. Promoter Mapping of the sigS Locus.  5’ rapid amplification of cDNA ends 
(RACE) was employed to determine the transcriptional start site(s) of sigS.  Analysis was 
carried out in a number of backgrounds and environmental conditions as displayed 
below.  
Strain Conditionsa # Submitted Sequences Returnedbc 
SH1000 Standard Conditions 3 h 3 3 (GAGTATTATCAACT) 
8325-4 2.5 mM MMS 5 h 14 14 (GAGTATTATCAACT) 
 
SH1000 2.5 mM MMS 2 h 3 2 
1 
(GAGTATTATCAACT) 
(GCTGAGTATTATCAACT) 
 
a Conditions utilized are during windows of maximal sigS expression as determined via 
lacZ fusion analysis. 
b Underlined nucleotides represent the experimentally determined +1 of the sigS 
transcript. 
c Red nucleotides indicate those that differ from the published sequence. 
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elements must act to activate transcription from these sequences.  This likely explains the 
low levels of sigS expression observed in the majority of S. aureus strains, and argues for 
a genetic regulatory network that controls expression of this regulator.  In previous work, 
our group demonstrated that sigS can direct transcription from its own promoter in a type 
of autoregulation akin to many other ECF sigma factors (Helmann, 2002; Missiakas et 
al., 1997; Shaw et al., 2008).  During our mapping of the sigS promoters through primer 
extension analysis, we have identified a potential σS driven promoter, P2 (CAAAGT -12 
bp- TATCA), with an AAG motif 27 nucleotides upstream of the +1.  Typically ECF 
sigma factor consensus sequences display a conserved AAC motif in the -35 region 
(Helmann, 2002; Missiakas et al., 1997); however, exceptions exist.  Specifically, the 
ECF sigma factor of Neisseria gonorrhoeae does not recognize an AAC motif 
(Gunesekere et al., 2006), while σR of Streptomyces coelicolor recognizes an AAT motif 
(Paget et al., 2001a).  More importantly, σX, an ECF sigma factor in several 
Pseudomonas spp, specifically recognizes an AAG motif, as seen here for σS (Brinkman 
et al., 1999).  Furthermore, AAC motifs appear to contribute to the interaction between σ 
factor and promoter (Lane and Darst, 2006).  As such, the imperfect AAG sequence may 
act as an additional level of regulation for the sigS promoter.   
 
ECF σ factors typically have significant divergence, and decreased homology, within 
their region 2.4 (Lonetto et al., 1992; Missiakas et al., 1997), which specifically 
recognizes -10 promoter elements. Accordingly, such sites are often difficult to ascertain, 
however the identified putative -10 element is strikingly similar to the TCTGA 
recognized sequence of RpoE in E. coli (Dartigalongue et al., 2001).  Promoter 4 is 
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unusual in that it lies within the sigS coding region; however, this situation is not 
exclusive to sigS, as the ECF sigma factor σR of Streptomyces coelicolor contains a 
promoter internal to its coding region as well.  This promoter is constitutively expressed 
through the action of the housekeeping sigma factor, σA. This is interesting, as analysis of 
P4 also reveals a relatively strong consensus sequence for σA. During times of induction, 
σR upregulates itself from a promoter located further upstream leading to an elongated σR 
translated from an upstream start codon (Kim et al., 2009).  This system may be utilized 
for sigS as well; however, no notable ribosome bindings and start codon pairing could be 
identified within the sigS coding region 3’ of P4.   Another example of an ECF sigma 
factor containing a promoter within the coding region is RpoE of Xylella fastidiosa.  This 
promoter is recognized by RpoE in order to increase transcription of the cotranscribed 
downstream gene, encoding its anti-sigma factor, which enables RpoE to negatively 
regulate its own activity (da Silva et al., 2007).  As suggested above, however, the sigS 
P4 promoter contains a notable σA motif, more closely resembling consensus than P1 and 
P2; thereby suggesting that this internal promoter does not exist as a means for negative 
regulation by σS.  However, transcript initiated from this promoter potentially includes 
the downstream gene, ecfX, leading to an extended 5’ untranslated region, which may 
serve as an additional level of regulation.  
 
We demonstrate herein that expression of sigS is minimal during growth under standard 
laboratory conditions in strain SH1000 (Shaw et al., 2008).  This phenomenon is 
conserved across a variety of S. aureus strains, including laboratory (8325-4, SH1000 and 
Newman) and clinical isolates (USA300 LAC, FPR and HOU).  In each case, we again 
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observed low levels of expression of sigS during growth under standard conditions in rich 
media.  These results may not be surprising, as the majority of ECF σ factors are 
employed to protect the cell during times of stress, and are often only transcribed when 
required (Helmann, 2002; Raivio and Silhavy, 2001; Staron et al., 2009).  Interestingly, 
we did observe robust sigS expression in the highly mutated laboratory strain, RN4220.  
Amongst the many mutations present in this strain are those that render the activity of 
other global regulators nonfunctional, including agr and sigB (de Azavedo et al., 1985; 
Traber and Novick, 2006).  This increased expression of sigS does not appear to be 
mediated directly through either Agr or σB, as we have demonstrated that mutations in 
these genes alone, at least in the SH1000 background, do not affect sigS expression.  We 
mention previously that the laboratory strain 8325-4 contains a naturally occurring 11-bp 
deletion in RsbU, a positive regulator of the general stress response σ factor, σB. 
Therefore, one would suggest that the differences observed between strain 8325-4 and 
SH1000 and USA300 LAC are likely attributed directly to the lack of a functional σB in 
strain 8325-4.  However, we show herein that mutation of it in the SH1000 background 
does not restore this strain to 8325-4 levels even in the presence of the inducer MMS.  As 
such, it is possible that as yet unidentified SNPs exist in 8325-4 and RN4220 that lead to 
its higher activity in these backgrounds.  Therefore, based on our findings regarding the 
differential expression of sigS observed across S. aureus strains we analyzed the sigS 
promoter region of each strain in order to determine which modifications, if any, may be 
attributed to the variable expression profile between strains.  In each case, we found this 
region to be highly conserved across all strains, indicating that sigS activity amongst 
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these strains cannot be attributed to SNPs within the promoter or regulatory regions of 
sigS.    
 
 Mutation of the sigS promoter region cannot account for its increased expression in the 
RN4220 background.  As such, the regulatory circuits in place in this strain are likely to 
be highly disordered, potentially explaining sigS disregulation, and therefore 
upregulation.  Recent sequencing of the RN4220 genome has revealed a total of 121 
SNPs (single-nucleotide polymorphisms) and 4 deletions relative to the parent NCTC 
8325.  Of interest, a number of these are involved in DNA metabolism, replication, 
recombination and repair (Berscheid et al., 2012; Nair et al., 2011).  Most notably, 
RN4220 carries a SNP in UvrC, a component of the UvrABC exonuclease which in 
Escherichia coli repairs DNA damage induced by a number of mechanisms, including 
UV light (Sancar and Rupp, 1983).  Additionally, SNPs in RN4220 are located in a 
putative helicase, SAOUHSC_02790 as well as a truncated resolvase, 
SAOUHSC_02392.  Collectively, these observations suggest that RN4220 is perhaps far 
more prone to DNA damage than other wild-type strains, as a result of mutated and non-
functional repair pathways.  Indeed we have observed that the varying levels of sigS 
activity between different wild-type strains directly correlates with their sensitivity to 
DNA damaging agents, such as MMS (Figure 28).  As such, this might explain why sigS 
is upregulated in RN4220 at levels greater than other S. aureus wild-type strains.   
 
This correlates with our environmental inducibility analysis, which revealed those 
chemicals that induce DNA damage, such as methyl methanesulfonate (MMS), are the  
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Figure 28. S. aureus Wild-Type Strains Exhibit Variable Sensitivity to the DNA 
Damage Agent, MMS.  The RN4220, 8325-4, USA300 and SH1000 strains, were grown 
in TSB  containing increasing concentrations of the DNA damage agent, MMS, in a 96-
well plate format.  The cultures were allowed to grow overnight  at 37oC and 
subsequently analyzed for the minimum inhibitory concentration (MIC).  The data is 
representative of at least three independent experiments that showed less than 10% 
variability.  
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most effective in upregulating sigS.  Specifically, MMS, an alkylating agent, and EMS, a 
methylating agent, both result in base mispairing and replication blocks (Beranek, 1990).  
The damages are often repaired via base excision repair and DNA alkyltransferases 
(Lindahl and Wood, 1999).  Exposure of S. aureus to the antibiotics ciprofloxacin and 
nalidixic acid also lead to strong induction of sigS, further supporting the notion that it 
responds to DNA damage, as these compounds target DNA gyrase, leading to inhibition 
of DNA replication and subsequent chromosomal damage (LeBel, 1988).  Of note, 
evidence exists that suggests these antibiotics may also lead to DNA damage similar to 
that observed for oxidative stresses (Gurbay et al., 2006).  Interestingly, a number of 
agents were identified that are not typically thought of as inducing DNA damage, but can 
also induce this kind of stress.  For example, H202 resulted in sigS upregulation, and can 
react with intracellular iron to form hydroxyl radicals, which cause damage to DNA 
(Chang et al., 2006a; Imlay et al., 1988; Imlay and Linn, 1988; Repine et al., 1981).  
Further to this, a number of ECF σ factors have been shown to be involved in the 
response to oxidative stress through cytoplasmic sensing, such as RpoE of Rhodobacter 
sphaeroides, and σR from Streptomyces coelicolor (Campbell et al., 2007; Dufour et al., 
2008; Paget et al., 2001a)  As such, it is plausible that σS behaves in an analogous 
manner, by responding to oxidative challenge.  Additionally, SOS and DNA damage 
repair genes have previously been shown in Escherichia coli to be upregulated during 
alkali stress caused by excess NaOH, which also upregulates sigS expression (Goodson, 
1989; Schuldiner et al., 1986).  Finally, the protein synthesis inhibiting antibiotic, 
chloramphenicol upregulated sigS, and has been shown to lead to the degradation of 
dsDNA and the inhibition of DNA synthesis (Murray et al., 1983).   
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A consideration with these studies is that a large number of sigS inducing agents lead to 
damage in DNA. Therefore, it is possible that they are not directly upregulating sigS 
expression, but are perhaps causing mutations within the S. aureus genome, leading to 
SNPs.  In such a scenario this could result in disregulation of regulatory circuits, leading 
to sigS upregulation in a manner akin to that proposed for RN4220.  To examine this, we 
analyzed sigS-lacZ fusion strains exposed to DNA damaging agents for a 24 h period.  
Upon removal of the stressor, strains were grown on agar plates containing X-gal.  We 
found that no blue coloration was detectable on such plates, indicating DNA damage 
induced upregulation of sigS does not appear to be mediated via heritable SNPs, but 
results directly from exposure to these agents.  As such, the increase in expression of sigS 
is due solely to exposure to agents such as MMS, and suggests that σS may be utilized by 
the cell to adapt during times of DNA damage.   
 
In addition to DNA repair pathway factors, RN4220 also carries mutations in two genes 
involved in peptidoglycan synthesis, UDP-N-acetylglucosamine 1-
carboxyvinyltransferase (murA) and a putative UDP-N-acetylmuramyl tripeptide 
synthetase (Gunetileke and Anwar, 1968; Wickus and Strominger, 1973).  MurA is 
targeted by the antibiotic phosphomycin, and as shown here, sigS is induced upon 
exposure to this drug (Eschenburg et al., 2005).  As such, there may be increased 
instability of the cell envelope in this strain, leading to enhanced sigS expression. This is 
further supported by our studies focused on sigS inducibility in response to external 
stress. Specifically, we observe substantial increases in expression of this element post 
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exposure to a number of cell-envelope targeting chemicals, such as cefotaxime, 
ampicillin, oxacillin, phosphomycin and SDS; again suggesting a role for σS in protection 
against this type of stress.  These findings may not be surprising as a unifying feature of 
the ECF sigma factors is involvement in cell-envelope functions, such as secretion, 
transport and extracytoplasmic stress (Helmann, 2002).  Specifically, σW and σM of 
Bacillus subtilis both respond to cell wall biosynthesis inhibiting antibiotics, and σM is 
important for survival during exposure to phosphomycin (Cao et al., 2002a; Cao et al., 
2002b; Thackray and Moir, 2003).  Furthermore, the ECF sigma factor, σE of 
Mycobacterium tuberculosis responds to challenge by SDS (Manganelli et al., 1999).  
We also found sigS to be upregulated during growth on metal limiting media, and 
previous reports demonstrate that divalent cations can stabilize the cell wall in Gram 
positive organisms (Kihm et al., 1994; Marquis, 1968; Murray et al., 1998).  As such, the 
absence of metals may lead to destabilization of the S. aureus cell wall, necessitating sigS 
upregulation.  Furthermore, a correlation between ECF sigma factors and a requirement 
for metal ions has been established in S. coelicolor, as strains containing a mutation in 
sigE require the presence of divalent cations in the media for normal growth and 
sporulation (Paget et al., 1999).  This expression analysis also corroborates our previous 
work, which demonstrates that σS mutants are more susceptible to Triton X-100 induced 
lysis (Shaw et al., 2008).  Taken together these findings implicate σS in the protection of 
S. aureus against cell envelope instability. 
 
Previous reports have demonstrated increased expression of sigS during exposure to 
peracetic acid and berberine chloride (Chang et al., 2006b; Wang et al., 2008).  However, 
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our analysis of the fusion strains in the presence of either chemical led to no observable 
induction of expression (data not shown), possibly owing to the different strains used 
between the studies, as we have demonstrated here that expression of sigS can vary 
between S. aureus backgrounds.  With that said, peracetic acid does lead to oxidative 
damage (Nde et al., 2011), thus there is a correlation with our findings here that sigS may 
be involved in the response to this type of stress.  Additionally, microarray analysis has 
been carried out by others in some of the conditions that we show here to induce 
expression of sigS; however, those works do not indicate changes in its transcription.  
Specifically, global transcriptomic analysis of S. aureus in the presence of hydrogen 
peroxide, ciprofloxacin and the cell wall targeting antibiotic, oxacillin has been 
performed (Chang et al., 2006a; Cirz et al., 2007); however, as we have demonstrated 
here, sigS expression is increase in the presence of these chemicals and it appears to be 
tightly regulated leading to maximum expression within a certain window, even under 
inducing conditions.  Therefore, as microarray analysis may not have been performed 
under a period of peak sigS expression, its effects on the cell in the presence of these 
stressors may have been as yet overlooked.   
 
We demonstrate here that sigS activity is increased when S. aureus is challenged by 
complement during growth in pig serum.  Further to this, we also present evidence for 
sigS upregulation during ex vivo infection, as we demonstrate a strong upregulation 
(regardless of background) upon phagocytosis by murine macrophage-like cells.  This 
supports our previous work, which reveals a major requirement for σS during virulence 
(Shaw et al., 2008).  As part of the microbicidal mechanism employed by macrophages, 
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reactive oxygen species (ROS) and reactive nitrogen intermediates (RNI) are excreted at 
very high levels, leading to DNA damage in invading organisms during infection 
(Kennedy et al., 1997; Lancaster, 1997; MacMicking et al., 1997; Salgo et al., 1995; 
Spencer et al., 1996).  Moreover, it has been observed that pathogenic organisms such as 
Burkholderia spp., B. abortus and Vibrio cholerae defective in DNA damage repair 
pathways are attenuated in virulence, underscoring that pathogenic bacteria are 
bombarded by DNA damaging conditions during infection (Cuccui et al., 2007; Davies et 
al., 2011; Roux et al., 2006; Yeager et al., 2001).  Together this suggests that, upon entry 
into the host, bacterial pathogens are faced with an array of DNA damaging conditions, 
which requires extensive use of repair pathways, and likely goes some way to explaining 
the avirulence of sigS mutants.  Furthermore, we have also presented here findings which 
indicate that sigS activity is influenced by cell-envelope stress; a stable cell wall has been 
implicated in the virulence of many pathogenic organisms, including S. aureus (Bae et 
al., 2004; Miyazaki et al., 2012).  In L. monocytogenes, penicillin-binding proteins are 
important for in vivo survival of using a murine model of intraperitoneal infection 
(Guinane et al., 2006).  During infection, S. aureus is faced with a multitude of stresses; 
therefore it is likely that the response of sigS to both DNA damage as well as cell-
envelope destabilization go some way to explaining the virulence defect observed in σS 
mutants.  
 
Through the use of our lacZ reporter gene fusions, we have demonstrated that during 
growth in inducing conditions, the majority of transcription appears to be a direct result 
of upregulation of the internal promoter, P4.  However, upon examination of the sigS 
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locus via qRT-PCR analysis, we find conflicting results in that transcript originating from 
the upstream promoters (sigS(P1-P3)) is only slightly decreased in the RN4220 and 8325-4 
backgrounds compared to transcript measured towards the end of the sigS coding region 
(sigS(P1-P4)).  Furthermore, in the SH1000 and USA300 LAC backgrounds, mRNA levels 
are comparable across the sigS locus, which suggests that transcript originating from the 
upstream promoters terminates prior to the sigS coding region.  Specifically, transcript 
originating from the upstream promoters and continuing through the end of sigS will be 
measured by both the sigS(P1-P3) and sigS(P1-P4) primer pairs; whereas, transcript from P4 
will only be measured by sigS(P1-P4).  Following this logic, levels of sigS(P1-P4) would be 
equal to that of sigS(P1-P3) if P4 were not generating transcript.  However, if P4 is active as 
suggested by our lacZ fusion analysis, then sigS(P1-P4) should be greater than that of 
sigS(P1-P3), with the increase being a direct result of transcript from P4.  Furthermore, if 
the upstream promoters are active, as demonstrated here by our qRT-PCR analysis, then 
the sigS-lacZ(P1-P3) fusion strain should display increased expression levels with higher 
levels observed for the sigS-lacZ(P1-P4) fusion strain, owing to added activity from P4.  
However, our findings were different from expected, in that we were only able to observe 
increased expression from the sigS-lacZ(P1-P4) fusion strain with no notable increases 
observed for the sigS-lacZ(P1-P3) fusion.  A possible explanation for these discrepancies is 
that the majority of transcription may terminate prior to the lacZ gene in the sigS-lacZ(P1-
P3) fusion strain.  As displayed in Figure 29, the sigS mRNA contains a hairpin loop 
spanning a 62 nucleotide region beginning 69 nucleotides upstream of the start codon 
with minimum free energy of -9.09 kcal/mol.  In this scenario, the sigS mRNA would be 
detected via qRT-PCR analysis as the beginning of the reverse primer pair is contained  
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Figure 29.  Possible Premature Termination May Result in a Truncated sigS mRNA.  
The predicted structure of the truncated sigS mRNA transcript terminated due to the 
formation of a hairpin loop, with a minimum free energy of -9.09 kcal/mol.  
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within this region (Figure 30).  However, termination would occur prior to the lacZ gene, 
as shown in Figure 31, which would explain why qRT-PCR primer pairs sigS(P1-P3) and 
sigS(P1-P4)  display similar levels of transcript, yet the sigS-lacZ(P1-P3) fusion strain is much 
weaker than that of sigS-lacZ(P1-P4).  Such a model of attenuation occurs throughout nature 
as a means for regulation of gene expression.  The classic example of this is the trp 
operon in E. coli, where an attenuator lies 3’ of the promoters and 5’ of the coding region, 
resulting in premature termination of the transcript in the presence of tryptophan (Morse 
et al., 1969; Yanofsky, 1981).  As such, transcription of sigS may be regulated in a 
similar manner.  Further, it is possible that this increased activity from the upstream 
promoters during exposure to inducing conditions may help drive some transcript through 
the terminator in order to upregulate sigS when needed by the cell. 
 
The higher level of expression observed in both 8325-4 (upon induction) and RN4220 
(under standard conditions) appear to be a result of increased transcript across the entire 
sigS locus (from both the upstream P1, P2, P3 and internal promoters, P4), as we 
observed higher level of transcript in these backgrounds from each of the primer pairs 
examined, compared to SH1000 and USA300 LAC.  The higher level of β-galactosidase 
activity in the RN4220 and 8325-4 backgrounds can also be attributed to disregulation of 
the internal promoter, P4.  Specifically, in RN4220, there was a difference of 2 fold for 
the downstream primer pair compared to that of the upstream primer pair.  In 8325-4, we 
observe fold increases between 2 and 5, depending on the conditions tested, for transcript 
measured by the primer pair located at the end of the sigS coding region compared to that 
of the upstream primer pair.  These increases are not found for SH1000 and USA300  
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Figure 30. The Terminated sigS mRNA Transcript is Recognized by the qRT-PCR 
sigS(P1-P3) Primer Pair.  (A) The sigS operon is shown with the upstream promoters, and 
putative hairpin loop, ribosome binding site, transcription termination site, start site and 
finally the internal promoter.  During transcription, the predicted architecture of the 
truncated sigS mRNA transcript contains a hairpin loop, with a minimum free energy of -
9.09 kcal/mol.  This structure may lead to premature termination of the sigS transcript. 
(B)  As displayed above, the sigS(P1-P3) primers are able to amplify this truncated sigS 
transcript due to the location of the primers.   
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Figure 31. Premature Termination Inhibits Transcription of β-galactosidase in the 
sigS-lacZ(P1-P3) Fusion Strain.  The sigS-lacZ(P1-P3) fusion is shown above with the 
upstream promoters and putative hairpin loop, ribosome binding site, transcription 
termination site and start site labeled. During transcription, the predicted architecture of 
the truncated sigS mRNA transcript contains a hairpin loop, with a minimum free energy 
of -9.09 kcal/mol. As displayed above, this hairpin formation leads to termination of the 
transcript prior to the lacZ gene.  Therefore, no lacZ bearing transcript is produced, which 
may explain the lack of β-galactosidase activity observed for the sigS-lacZ(P1-P3) fusion 
strain. 
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LAC, as the transcript measured by the two primer pairs is comparable.  These findings 
suggest that higher levels of transcript are generated from the P4 internal promoter than 
the upstream promoters in the RN4220 and 8325-4 backgrounds.  This goes some way to 
explain why these strains both produce visible blue coloration on TSA containing X-gal 
under inducing conditions; whereas, the other backgrounds examined do not.  This 
disregulation is likely due to mutation of regulatory networks that control the internal 
promoter in the RN4220 and 8325-4 backgrounds. 
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CHAPTER 4: 
ANALYSIS OF THE GENETIC REGULATION OF sigS 
 
Note To Reader.  Portions of these results have been previously published (Shaw et al., 
2008) and are utilized with permission of the publisher (Appendix 1). 
 
Background.  Alternative σ factors are subject to coordinated and temporal regulation by 
a number of different mechanisms; in order to ensure their effects are expediently 
brought about, only when needed.  Some σ factors are controlled at the transcriptional 
level via regulation at key steps during initiation.  For example, transcription of the ECF 
sigma factor, σT of Caulobacter crescentus, is controlled by the two-component system 
PhyRK (Lourenco et al., 2011).  Further to this, in order to be transcribed, promoters of 
genes encoding ECF sigma factors must first be recognized by a sigma factor bound to 
RNAP.  In many cases within the ECF subfamily, the ECF sigma factor autoregulates 
itself, as we have previously demonstrated for σS.  However, there are examples of ECF 
sigma factor promoters being recognized by housekeeping sigma factors, other 
alternative sigma factors (including other ECF sigma factors), or a combination of the 
above.  For example, the downstream promoter for σR of Streptomyces coelicolor is 
transcribed by the housekeeping sigma factor, σA (Kim et al., 2009), while σM of 
Corynebacterium glutamicum is controlled by another ECF sigma factor, σH (Nakunst et 
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al., 2007).  Further to this, σ factor synthesis is also controlled via mRNA stability and 
translation efficiency.  For example, RpoS of E. coli is controlled by three different small 
non-coding RNAs, OxyS, DsrA and RprA.  Both DsrA and RprA interfere with a hairpin 
structure at the 5’ end of the rpoS transcript to expose the ribosome binding site for 
translation (Majdalani et al., 1998; Updegrove et al., 2008).  In contrast, OxyS reduces 
levels of RpoE by a mechanism not fully understood.  It has been shown that OxyS may 
form a complex with rpoS and Hfq, a Sm-like protein that has a high affinity for many 
sRNAs and is required for efficient translation of rpoS (Muffler et al., 1996; Zhang et al., 
1998; Zhang et al., 2002).  Additional regulation of σ factors occurs at the post-
translational level through protein-protein interaction, and complex proteolytic cascades.  
S. aureus employs this type of regulation with its general stress response σ factor, σB.  
Specifically, the sigB locus consists of rsbU, rsbV, rsbW and sigB (Kullik and Giachino, 
1997; Wu et al., 1996).  RsbW acts as an anti-σ factor, which binds free σB, thereby 
blocking its activity (Miyazaki et al., 1999); while both RsbU, a serine phosphatase, and 
RsbV, an anti- anti-σ factor, act as positive regulators of σB (Palma and Cheung, 2001).  
Regulation occurs as a result of stress, such as low pH, activating RsbU, which in turn 
dephosphorylates RsbV, leading to interaction with RsbW (Senn et al., 2005).  This 
results in the release and activation of free σB. Examples of this type of post-translational 
regulation are also common within the ECF family of proteins as well.  For example, the 
ECF σ factor RpoE of E. coli is transcribed and translated into a functional protein in the 
cell; yet is sequestered by the cotranscribed anti-σ factor, RseA when its activity is not 
required.  This type of regulation allows for a rapid response to detrimental 
environmental conditions as functional σ factor protein is already present in the cell and 
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can become active through a series of rapid proteolytic steps.  Specifically, RpoE 
responds to misfolded proteins in the periplasm as a result of heat shock (Mecsas et al., 
1993; Missiakas et al., 1996a; Missiakas et al., 1996b; Missiakas et al., 1997; Rouviere et 
al., 1995).  These proteins are sensed by the serine protease, DegS, which initiates a 
regulated intramembrane proteolysis (RIP) cascade.  DegS first processes the anti-σ 
factor, RseA, in its periplasmic region in a mechanism known as site 1 cleavage.  
Subsequently, the remaining RseA becomes a substrate for site 2 cleavage in the inner 
membrane spanning region by the metalloprotease, RseP.  The remaining RseP/RpoE 
complex is released from the membrane where it is recognized by the adapter protein, 
SspB, which directs it to ClpXP for final degradation (Ades et al., 1999; Alba et al., 
2002; Flynn et al., 2004; Grigorova et al., 2004; Kanehara et al., 2002).  At this point, 
freed RpoE is now able to associate with core-RNAP, directing it to transcribe genes 
essential for growth during high temperatures, including numerous chaperones and 
proteases involved in the repair of misfolded cytoplasmic proteins (Erickson and Gross, 
1989; Hiratsu et al., 1995; Wang and Kaguni, 1989).  The process of ECF σ factor 
regulation can vary drastically at each stage, from different signaling proteins/proteases, 
anti-σ factors and adapter proteins involved in regulation.  As such, the focus of this 
chapter is on exploring the regulation of the lone ECF σ factor of S. aureus, σS.  
Specifically, we seek to identify the regulatory network involved in its control. 
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Results 
 
Expression of sigS is Positively Regulated by the Downstream Gene, EcfX.  
Typically, ECF σ factors are cotranscribed with a downstream gene whose product acts 
as an inhibiting anti-σ factor.  Located 113 bp 3’ of sigS is the gene ecfX, whose 
translational product may fulfill such a function due to its close proximity. To investigate 
this, we began by examining whether ecfX was cotranscribed with sigS.  To this end, we 
utilized reverse transcription of total cellular mRNA using primers that would amplify the 
113 bp intergenic region between ecfX and sigS.  The primers employed are displayed in 
Figure 32A, with the forward located 247 bp into sigS and the reverse positioned 107 bp 
into ecfX.  Analysis showed the presence of a 462 bp band demonstrating that transcript 
exists between sigS and ecfX, which is absent in the control lane containing no reverse 
transcriptase (Figure 32B).  Our data shows potential transcriptional linkage of ecfX with 
sigS; thus if it functions as an anti-σ factor, then its inactivation should result in free σS 
protein, and upregulation of the sigS gene via autoregulation.  To this end, we introduced 
an ecfX::tet mutation into our sigS-lacZ(P1-P4) fusion strains in SH1000, 8325-4 and 
USA300 LAC backgrounds.  Each of the fusions were then grown on TSA containing X-
gal, and in each case, no notable increase in sigS expression was observed (data not 
shown).  We then performed our analysis in complex liquid media in SH1000, in order to 
see if there were any alterations in expression not observed on solid media.  Analysis 
showed that the presence of a mutation in ecfX led to no change in expression of sigS in 
the SH1000 background under standard conditions (Figure 33A).  Next we sought to 
determine if an ecfX mutation had any effect under conditions in which sigS is expressed  
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Figure 32. sigS and ecfX are Cotranscribed. Reverse transcriptase (RT) PCR was 
performed on total cellular mRNA collected from SH1000 grown under standard 
conditions to hour 3 utilizing primer pairs encompassing the sigS-ecfX intergenic region.  
(A) the sigS locus displaying the primer pairs used for reverse transcriptase (RT) 
analysis; (B) a 2% agarose gel showing the resulting RT-PCR product. A 462 bp band 
corresponding to amplification of the transcript between the displayed primer pairs is 
highlighted.   
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Figure 33. EcfX Acts as a Positive Regulator of sigS.  The sigS-lacZ(P1-P4) fusion wild-
type (■) and ecfX mutant (□) strains were grown in: (A) SH1000 and (B) RN4220 in TSB 
at 37oC; or (C) in 8325-4 grown in TSB containing 2.5 mM MMS at 37oC.  Each was 
sampled every hour for 10 h and again at 24 h.  β-galactosidase activity was measured to 
determine levels of expression. Assays were performed on duplicate samples and the 
values averaged. The results presented herein were representative of three independent 
replicates that showed less than 10 % variability. Adapted from Shaw et al., 2008. 
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and/or upregulated.  Therefore, we repeated these experiments using conditions identified 
in chapter 3 that lead to increased sigS expression.  We introduced the ecfX::tet mutation 
into our RN4220 sigS-lacZ(P1-P4) fusion strain, and, when plated on TSA containing X-
gal, a condition previously shown to result in sigS expression, we observed no blue 
coloration of the ecfX::tet fusion strain (data not shown).  Our analysis was then carried 
out in complex liquid media where we found an approximately 21-fold decrease in sigS 
expression in the ecfX mutant background (Figure 33B).  We next repeated our 
transcriptional disk diffusion analyses in 8325-4 using chemicals that upregulate sigS 
expression.  In each case, the transcriptional upregulation was abrogated upon mutation 
of ecfX (data not shown).  To confirm our findings, we again performed liquid β-
galactosidase activity assays in liquid media in the presence of sub-MIC levels of MMS.  
Mutation of ecfX led to an approximately 16.9-fold decrease in sigS expression in this 
analysis (Figure 33C).  Due to close proximity of the integration sites for the reporter-
fusion and ecfX mutation, we next regenerated the ecfX mutant strains via an alternative 
method.  Where the RN4220 sigS-lacZ(P1-P4) fusion strain had previously been used as the 
recipient strain for the ecfX construct, we created the new strain in the opposite manner, 
using the fusion as the donor strain.  Resulting clones were confirmed and 2 
representatives were selected for analysis.  We found that regeneration of the strain again 
led to no detectible upregulation of sigS (data not shown).  Collectively, this data argues 
that ecfX functions to enhance σS expression, rather than repress it. 
 
Induction of sigS Expression Can be Achieved Through Random Genome Mutation.  
Given the inducible nature of sigS expression, and the differential expression between 
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wild-type strains, we hypothesized that genetic components within the S. aureus cell 
serve to modulate expression from this locus.  In an effort to test this hypothesis, we 
assessed whether induction of sigS expression could be achieved through the introduction 
of random mutations throughout the genome, by exposure to the mutagen N-methyl-N'-
nitro-N-nitrosoguanidine (NTG).  NTG works by introducing base substitutions into 
DNA during replication, and can also result, albeit rarely, in small deletions.  NTG is 
commonly utilized as a mutagen as it creates a high number of mutations, while 
maintaining a 50% or greater survival rate of treated organisms (Burns et al., 1988).  To 
this end, an SH1000 sigS-lacZ(P1-P4) fusion strain was grown to mid-exponential phase, at 
which point NTG was added to a final concentration of 50 µg ml-1, and allowed to 
incubate at 37oC for 60 min.  This was then followed by washing to remove NTG, and 
growth in TSB at 37oC for a period of 2 h to allow recovery.  Following this period, 1 ml 
aliquots were collected via centrifugation at 3,500 rpm for 10 min and resuspended in 
TSB containing 20% glycerol, before being stored at -80oC.  The CFU ml-1 for the culture 
was determined both prior to NTG exposure and immediately following in order to 
ensure a survival rate of > 50%.  For analysis, the frozen samples were allowed to thaw 
and subsequently plated on TSB containing X-gal, where the appearance of blue colonies 
indicate increased expression of sigS as a result of mutations within the genome.  Post 
exposure, upwards of 10,000 colonies were screened for increased expression of sigS 
based on a blue coloration when plated on X-gal containing TSB.  Interestingly, we found 
no colonies had acquired mutations that led to augmented sigS expression (data not 
shown).  As such, a 1 ml aliquot of this first round of treatment was allowed to grow 
overnight, and was then subjected to a second round of NTG exposure.  Examination of 
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approximately 5,000 colonies from the resulting library following this secondary 
treatment led to the isolation of 98 colonies expressing high levels of sigS (Figure 34A).  
Two representative clones, as displayed in Figure 34B, were chosen to quantify 
expression by measuring β-galactosidase levels in complex liquid media.  The strains, 
termed NTG A and NTG B, both resulted in high levels of sigS transcription, equating to 
approximately 75.4-fold higher levels of sigS expression at 5h (Figure 34C), when 
compared to the un-mutated strain.  In order to determine if the observed expression 
increases were due to cis SNPs, we transduced the sigS-lacZ(P1-P4) fusion from 10 blue 
NTG isolates into a clean SH1000 background.  Transduction of the fusion using 
bacteriophage phi 11 results in the transfer of approximately 40 kb of additional 
sequences flanking the fusion.  If the increased expression is a result of mutation within 
the sigS locus, or surrounding DNA, then any increase in sigS expression will be carried 
over to the clean background post transduction.  We found that transduction of these 
strains led to a loss of sigS expression in each example (data not shown), indicating that 
any sigS modulating SNPs are trans acting in nature. As such, in addition to significant 
environmental inducibility, sigS expression is seemingly also controlled internally at the 
genetic level.  This observation likely explains the differential nature of transcription for 
this element across S. aureus strains, perhaps resulting from trans SNP variations, or 
alterations in global regulatory circuits, between isolates. 
 
Exploring the Molecular Mechanisms of sigS Regulation.  Given our findings 
regarding the induction of sigS, and altered levels of its expression amongst wild-type 
strains, we hypothesized that regulatory cascades exist to control the expression of this σ  
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Figure 34. Profiling of sigS Expression Following Random Mutagenesis. The SH1000 
sigS-lacZ(P1-P4) fusion strain was subjected to treatment with the mutagen NTG, and the 
resulting library of mutants analyzed for increased expression of sigS expression via 
growth on TSA containing X-gal (A). Two representative colonies (B) were selected for 
further analysis during growth in TSB at 37oC (C). sigS-lacZ(P1-P4) fusions in SH1000 (□), 
NTG A (■) and NTG B (♦) were grown alongside the parent, with samples removed 
every hour for 10 h, and again at 24 h. β-galactosidase activity was measured to 
determine levels of sigS expression. Assays were performed on duplicate samples and the 
values averaged. The results presented herein were representative of three independent 
replicates that showed less than 10 % variability.  
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factor.  Therefore, we performed a transposon screen using Tn551 and a sigS-lacZ(P1-P4) 
fusion.  We performed this screen using strain 8325-4 as it has already proven to be the 
most sensitive to sigS modulation, and provides results that are conserved in other wild-
type strains.  The disruption by Tn551 of a gene involved in the regulation of sigS may 
lead to its upregulation; therefore, analysis of the transposon insertion sites for those 
strains that display increased sigS expression will elucidate potential members of the sigS 
regulatory cascade.  During a screen of >10,000 colonies, we identified 123 isolates with 
increased sigS expression.  We performed a secondary screen on 96 of these mutants, 
transducing them into a clean 8325-4 sigS-lacZ(P1-P4) fusion background in order to 
ensure that the observed increases in expression were due directly to disruption by Tn551 
insertion and not a result of indirect effects through accumulation of SNPs during library 
construction.  We again observed blue coloration of each of the strains during growth in 
the presence of X-gal.  The strains were then subjected to sequence analysis to identify 
sites of insertion that impact sigS expression.  Of the 96 mutants analyzed, 51 were 
unique insertions in different genes (Table 6), whilst the rest were duplicate insertions in 
already identified loci.  In order to verify that our findings were not specific to strain 
8325-4, we transduced 18 of these Tn551 mutations into SH1000 and USA300 
backgrounds containing the sigS-lacZ(P1-P4) fusion.  In each case, a blue coloration on X-
gal, indicating sigS upregulation, was observed (data not shown). 
 
Disruption of DNA Replication, Recombination and Repair Pathways Leads to 
Increased Expression of sigS.  We have previously shown that exposure of S. aureus to 
DNA damage inducing chemicals leads to increases in expression of sigS.  Interestingly,  
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Table 6. Transposon Insertions Resulting in Increased Expression of sigS. 
Accession Number Tn551 Insertion Site Gene Hitsa Uniqueb 
DNA metabolism: DNA replication, recombination, and repair 
SACOL0566 nucleoside permease nupC 1 1 
SACOL1315 DNA mismatch repair protein hexA 1 1 
SACOL1382 Exonuclease sbcC 3 2 
SACOL1413 Hypothetical Protein (putative 
 
 1 1 SACOL1479 putative, 5'-3' exonuclease  2 1 
INTERGENIC 
SACOL1412 
 
hydrolase-related protein/ hypothetical 
   
 2 1 Regulators 
SACOL0513 transcriptional regulatory protein glcT 1 1 
SACOL1136 Hypothetical Protein (nucleic acid 
  
 1 1 SACOL1393 transcriptional antiterminator LicT, 
 
licT 3 1 
SACOL1436 Msa (modulator of SarA) msa 1 1 
SACOL2086 transcriptional regulator, TenA family tenA 1 1 
Toxin Production and Resistance 
SACOL1441 tellurite resistance protein, putative  3 1 Cell Envelope Associated 
SACOL1411 Aminoacyltransferase femB 1 1 
SACOL1472 cell wall associated fibronectin-
  
ebh 6 2 
SACOL1490 Penicillin binding protein 2 pbp2 1 1 
Transporters 
SACOL0682 putative antiporter  1 1 SACOL0684 Na+/H+ antiporter, MnhE component, 
 
 2 1 SACOL0993 oligopeptide ABC transporter, ATP-
   
oppD
 
1 1 
SACOL1319 glycerol uptake facilitator protein  5 1 SACOL1392 sodium:alanine symporter family protein  3 1 SACOL1414 peptide ABC transporter, ATP-binding 
 
 4 1 SACOL1416 peptide ABC transporter, permease 
  
 1 1 SACOL1443 branched-chain amino acid transport 
     
brnQ3 3 1 
INTERGENIC 
SACOL1441 
 
Tellurite resistance protein, putative / 
    
     
 2 1 SACOL1893 
 
ABC transporter, ATP-binding 
    
 1 1 Amino Acid Biosynthesis 
SACOL0168 glutamate N-acetyltransferase/amino-
  
argJ 2  
SACOL1349 Hypothetical Protein (Aspartate 
  
 1 1 SACOL1429 Aspartate-semialdehyde dehydrogenase  1 1 SACOL1434 Alanine racemase family 
  
 1 1 SACOL1448 2-oxoglutarate dehydrogenase, E2 
  
 
 1 1 SACOL1449 2-oxoglutarate dehydrogenase, E1 
 
 3 1 SACOL1478 alanine dehydrogenase  1 1 SACOL2045 Ketol-acid reductoisomerase  1 1 
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Table 6. Continued. 
Accession Number Tn551 Insertion Site Gene Hitsa Uniqueb 
INTERGENIC 
SACOL1447 
 
conserved hypothetical protein/ 2-
   
  
 
 1 1 SACOL1449 
 
2-oxoglutarate dehydrogenase, E1 
    
/arlS 2 1 
Metabolism 
SACOL2188 lactose phosphotransferase system 
 
 5 1 Protein Synthesis and Modification 
SACOL1369 50S ribosomal protein L33  4 1 SACOL1397 peptide methionine sulfoxide reductase msrA 4 1 
SACOL1455 Carboxyl-terminal protease  1 1 SACOL1480 Hypothetical Protein (ribosome 
   
 1 1 
INTERGENIC 
SACOL1369 
 
50S ribosomal protien L33/ 30S 
   
 1 1 SACOL1396 
 
5' side:  fmtC protein; 3' side: peptide 
   
fmtC 
 
1 1 
SACOL1555 
 
peptidase, M20/M25/M40 family/ 
  
 1 1 Biosynthesis of Cofactors 
INTERGENIC 
SACOL1820 
 
riboflavin biosynthesis protein RibD/1 
   
ribD 1 1 
Unknown Function 
SACOL1452 PAP2 family protein pap2 1 1 
SACOL1602 metallo-beta-lactamase family protein  1 1 
INTERGENIC 
SACOL1451 
 
DNA-binding response regulator ArlR/ 
   
arlR/ 
 
1 1 
Hypothetical Proteins 
SACOL0940 Hypothetical Protein (No conserved 
 
 1 1 SACOL1469 Hypothetical Protein (No conserved 
 
 1 1 SACOL1556 Hypothetical Protein (No conserved 
 
 1 1 SACOL2642 Hypothetical Protein (No conserved 
 
 1 1 
INTERGENIC 
SACOL1445 
 
CbbQ/NirQ/NorQ/GpvN family 
    
 1 1 SACOL1620 
 
Conserved hypothetical protein/ CBS 
  
 1 1 a The hits refers to the total number of Tn551 insertion sites identified for a particular 
gene. 
b The unique number of insertions sites refers to those insertions that are a result of 
distinctive insertion events. 
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our screen identified that the disruption of genes involved in the response to DNA 
damage also resulted in enhanced levels of sigS expression.  Specifically, insertions were 
found in two exonucleases, SACOL1479, a putative 5’-3’ exonuclease, and SACOL1382, 
which encodes the SbcC component of the SbcDC exonuclease.  Both exonucleases were 
identified multiple times, two of which were unique insertions into sbcC.  In S. aureus, 
SbcDC is believed to be involved in the SOS response and aids in survival during UV 
induced damage (Chen et al., 2007).  A mutation was identified in SACOL1413, a 
putative helicase demonstrating homology to a Snf2 family protein believed to be 
involved in DNA damage repair (Durr et al., 2005).  This mutation was identified by 
multiple insertions, of which 2 are unique including an intergenic insertion located 5’ of 
SACOL1413.  The DNA mismatch repair protein, SACOL1315 or hexA, was also 
identified in this screen.  HexA, also termed MutS, is a major component of the methyl-
mismatch repair system (O'Neill, 2010).  Finally, disruption of SACOL0566, nupC, 
which encodes a nucleoside permease, increased expression of sigS.  Collectively these 
findings suggest that sigS is employed in response to impairment in the ability of S. 
aureus to effectively repair DNA damage.   
 
A Number of Tn551 Insertions in S. aureus Regulators and Genes Whose Products 
are Involved in Protein Modification/Biosynthesis Leads to Augmented sigS 
Transcription.  Our analysis of sigS expression thus far suggests that it is under the 
control of transcriptional regulation.  During our examination of the transposon mutations 
that lead to increased expression of sigS, we found a number of regulators.  Specifically, 
mutation of SACOL0513, encoding GltC, a transcriptional regulator involved in 
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glutamate synthesis, led to increased expression of sigS.  Disruption of SACOL1393, 
which encodes a putative LicT transcriptional antiterminator also raised the level of sigS 
transcript in the cell and was identified multiple times.  In addition, disruption of msa, a 
modulator of sarA expression (Sambanthamoorthy et al., 2006), led to increased sigS 
transcription, suggesting that it may be a global regulator of gene expression in S. aureus.  
SACOL2086 belonging to the TenA family of transcriptional regulators was also 
identified in this screen.  We have previously shown that expression of sigS is increased 
during exposure to oxidative stress induced by hydrogen peroxide.  Interestingly, we 
found multiple disruptions in the oxidative stress response gene, SACOL1397, which 
encodes a peptide methionine sulfoxide reductase (MsrA) involved in oxidative stress 
repair, which led to increased expression of sigS.  We also identified an insertion in the 
carboxyl-terminal protease, ctpA or SACOL1455 that led to increased expression of sigS.   
 
Transcription of sigS Increases as a Result of Disruptions in Transporters and 
Genes Involved in Cell Wall Biosynthesis.  Our expression analysis of sigS 
demonstrated inducibility post exposure to cell wall weakening antimicrobial agents.  In 
this screen we find that sigS expression is also dependent on a number of cell wall 
associated proteins.  Multiple insertions of Tn551 into SACOL1319, which encodes a 
glycerol uptake facilitator protein, increased the level of sigS transcript.  Insertions were 
also identified in SACOL1392, a predicted sodium:alanine symporter, which belongs to a 
family that functions to import L-alanine and Na+ into the cell (Kamata et al., 1992; 
MacLeod and MacLeod, 1992).  We also identified a disruption in SACOL0684, a 
sodium/hydrogen antiporter involved in pH and sodium homeostasis (Padan and 
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Schuldiner, 1993).  Transposon insertion into a number of peptide, amino acid and amine 
ABC transporters also lead to increased sigS expression, including SACOL1414 (4 
insertions), SACOL1416 and SACOL0993; as well as the branched-chain amino acid 
transport system carrier protein, brnQ3.  Further to this, multiple disruptions of ebh, a cell 
wall associated fibronectin-binding protein led to increased expression of sigS, of which 
two were unique insertions.  Finally, inactivation of both SACOL1411 (femB), as well as 
pbp2, a penicillin binding protein,  both of which are involved in cell wall biosynthesis, 
also affected sigS expression.   
 
Elevation of sigS Expression is Observed Upon Disruption of Amino Acid 
Biosynthesis Pathway Genes.  Growth of the 8325-4 sigS-lacZ(P1-P4) fusion strain on 
amino acid limiting media led to an increase in its expression (Chapter 3).  In support of 
this, during our analysis of the transposon screen, we identified a number of insertions 
into amino acid biosynthesis pathways that also increase the expression of sigS.  These 
insertions include SACOL1429, involved in the biosynthesis of the amino acid, aspartate 
as well as SACOL0168 (argJ), encoding a glutamate N-acetyltransferase.  Two insertions 
into genes involved in alanine biosynthesis were identified, including alanine 
dehydrogenase (SACOL1478), and alanine racemase (SACOL1434).  Collectively these 
findings further suggest the involvement of σS in S. aureus amino acid biosynthesis. 
   
Validation of Select Tn551 Transposon Mutants and Their Impact on sigS 
Expression.  To ensure that our findings did not result from an artifact of our fusion 
system, we performed qRT-PCR analysis to quantify sigS transcription in three wild-type 
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strains (lacking the sigS-lacZ(P1-P4) fusion), into which we had transduced representative 
mutations of sbcC, an exonuclease involved in DNA damage repair post UV exposure, 
msrA a peptide methionine sulfoxide reductase involved in repairing proteins following 
oxidative damage and msa a modulator of the global regulator, SarA.  Analysis in 8325-4 
during exponential growth (3 h, a window of maximal sigS expression in RN4220), 
displayed increases of 3.2-, 3.5-and 4.6-fold for sigS(P1-P3), sigS(P1-P4) and ecfX primer 
pairs, respectively, in the sbcC Tn551 mutant background (Figure 35).  Mutation of msrA 
in 8325-4 led to a substantial fold increase of 35 for sigS(P1-P3), yet only fold increases of 
2.6 and 3.8 for the downstream primer pairs, sigS(P1-P4) and ecfX, respectively.  In the 
presence of a mutation in msa in the 8325-4 background, a 5.9-fold increase of sigS(P1-P3) 
was observed, with fold increases of 3.3 and 4.6 for sigS(P1-P4) and ecfX respectively.   
 
The Impact of Tn551 Transposon Mutants on sigS Expression is Conserved Across 
S. aureus Backgrounds.  We performed further qRT-PCR confirmation of the 
transposon screen using the alternate wild-types SH1000 and USA300 LAC to determine 
if these findings were conserved, as suggested by transduction analysis. In each case, we 
again observed increased sigS expression in the presence of the mutations examined 
(Figures 36A and 36B respectively).  Specifically, upon disruption of sbcC, fold 
increases of 5.6-, 8.6- and 3.9 where noted for sigS(P1-P3), sigS(P1-P4) and ecfX, 
respectively, in the SH1000 background. When using USA300 LAC, we determined fold 
increases of 9.0-, 12- and 5.9 for sigS(P1-P3), sigS(P1-P4) and ecfX, respectively.  Using an 
msa transposon mutant, increases for sigS(P1-P3), sigS(P1-P4) and ecfX were 4.5-, 6.4- and 
4.4–fold, respectively, in SH1000; while the same conditions in the USA300 LAC led to  
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Figure 35. Transcription is Increased Across the sigS Locus in 8325-4 msa, msrA 
and sbcC Tn551 Mutants. Quantitative real-time PCR analysis was performed with 
wild-type 8325-4, or derivatives bearing msa::Tn551, msrA::Tn551 or sbcC::Tn551 
mutations, grown for 3 h in TSB.  Three separate primer pairs were used: (sigS(P1-P3)) 
located 47bp upstream of P4, (sigS(P1-P4)) located 357bp downstream of the sigS 
translation start site, and (ecfX) located 254bp downstream of the ecfX translation start 
site.  The data presented is from at least 3 independent experiments.  Error bars are shown 
as +/- SEM, *= p<0.05 using a Student t test, and represent significant variation from the 
wild-type.  
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Figure 36. The Impact of msa, msrA and sbc Disruption on sigS Expression is 
Conserved Across S.  aureus Wild-Type Strains. Quantitative real-time PCR analysis 
was performed with (A) SH1000 and (B) USA300 wild-types, or derivatives of which 
bearing msa, msrA and sbcC Tn551 mutations, grown for 3 h in TSB. Three separate 
primer pairs were used: (sigS(P1-P3)) located 47bp upstream of P4, (sigS(P1-P4)) located 
357bp downstream of the sigS translation start site, and (ecfX) located 254bp 
downstream of the ecfX translation start site. The data presented is from at least 3 
independent experiments.  Error bars are shown as +/- SEM, *= p<0.05 using a Student t 
test, and represent significant variation from the wild-type.  
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increases of 4.4-, 3.9- and 4.3-fold.  Finally, we examined a mutation in msrA and 
observed fold increases of 5.2, 5.9 and 3.3 for the sigS(P1-P3), sigS(P1-P4) and ecfX 
transcripts, respectively, in the SH1000 background.  In the USA300 LAC background 
we observe 14-, 17.6- and 15.5-fold increases in sigS(P1-P3), sigS(P1-P4) and ecfX 
respectively. As such, these findings suggest that, in addition to significant environmental 
inducibility, sigS expression is also controlled internally at the genetic level. This 
observation likely explains the differential nature of transcription for this element across 
S. aureus strains, perhaps resulting from SNP variations, or alterations in global 
regulatory circuits/signaling pathways, between isolates.  
 
Discussion.  As discussed previously, ECF sigma factors are typically sequestered by a 
membrane bound anti-sigma factor during times of non-induction, in order to keep the 
sigma factor inactive when not needed by the cell.  These anti-sigma factors are typically 
cotranscribed downstream of the sigma factor. In this work we investigated the gene 
located immediately downstream of sigS as a possible anti-σ factor.  This downstream 
gene, ecfX, is atypical of the classic model of anti-sigma factors in that it does not contain 
any membrane spanning regions.  However, examples exist for soluble anti-sigma factors 
that regulate ECF sigma factors that respond to cytoplasmic stresses, including RpoE 
from Rhodobacter sphaeroides, which is inhibited by binding to a cytoplasmically 
located, zinc-dependant anti-σ factor, ChrR (Campbell et al., 2007; Dufour et al., 2008).  
Due to our findings regarding the response of sigS to the cytoplasmic stress created by 
DNA damage, ecfX may be an ideal candidate anti-sigma factor.  However, we observed 
that mutation of this gene led to no notable change in sigS expression in strain SH1000 
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under standard laboratory conditions.  We then sought to evaluate the effect of this 
mutation during conditions of sigS expression.  Our data herein actually demonstrates a 
requirement for a functional EcfX for expression of sigS, suggesting that this gene acts as 
a positive activator.  These findings appear counterintuitive as the general mechanism 
previously established for ECF σ factors include negative regulation by a downstream co-
transcribed gene (Helmann, 2002).  Bioinformatic analysis of EcfX reveals a ComK-like 
domain located in its C-terminus.  In B. subtilis, ComK acts as a DNA-binding protein 
involved in the upregulation of itself and other competence genes (van Sinderen et al., 
1995).  Therefore, EcfX may act as a DNA-binding protein in a manner akin to that of 
ComK, which would suggest novel regulation of this transcriptional regulator.  
Additionally, we have sequenced SACOL1828 in each of the backgrounds discussed 
herein to elucidate whether any SNPs exist that could account for the differential 
expression exhibited between strains. We have determined that no notable disparity is 
detectable in the sequence of this gene in any manner (data not shown).  
 
We have previously shown that the highly mutated laboratory strain RN4220 displayed 
markedly higher levels of sigS expression under standard conditions compared to other 
wild-type strains.  We attributed this increase to mutations in regulatory networks that 
control the expression of sigS.  As such, we attempted to reproduce these findings by 
introducing random mutations into the SH1000 background, which displays low levels of 
sigS expression under standard conditions.  Such treatment did indeed prove successful, 
as, post exposure to the alkylating agent NTG, we were able to create a number of 
SH1000 mutants which display elevated levels of sigS expression.  We have verified that 
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these mutations are trans, which confirms our hypothesis that regulatory networks are in 
place in the S. aureus cell acting to govern sigS expression.  In order to elucidate which 
mutations contribute to this disregulation, we are currently performing whole genome 
sequencing of strains NTG A and NTG B.   
 
As an extension of this approach, we next performed a transposon mutagenesis screen, 
which provided evidence not only that sigS appears to be regulated genetically within the 
S. aureus cell, but also supporting information for its response to cell-envelope and DNA 
damage stresses.  Specifically, we observed upregulation of sigS in multiple sbcC 
insertions, which encodes part of the SbcDC exonuclease.  Interestingly, in E. coli, this 
exonuclease functions to repair DNA and maintain genome stability through cleavage of 
DNA hairpins caused by intrastrand base pairing of palindromic DNA (Chalker et al., 
1988; Connelly et al., 1998; Connelly et al., 1999; Leach and Stahl, 1983).  Its function 
in S. aureus is not completely understood; however, it has been documented to be 
induced by the SOS response, and has a role in protection against DNA damage created 
by UV irradiation (Chen et al., 2007).  Previously, sbcC as well as a number of DNA 
damage repair genes were also shown to be induced upon exposure to heat shock in S. 
aureus (Fleury et al., 2009).  In our earlier work, we demonstrated a role for σS during 
growth in increased temperatures (Shaw et al., 2008).  As such, our current findings 
suggest that the sensitivity of the σS mutant to increased temperatures may be attributed 
to the DNA damage that occurs during the exposure of S. aureus to high heat.  
Additionally, expression of sigS was increased upon disruption of SACOL1479, which 
encodes another 5’-3’ exonuclease and was identified by multiple insertions.  While little 
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is known about this protein, it has been demonstrated that E.coli deficient in 5’-3’ 
exonucleases are more susceptible to DNA damage induced by UV exposure (Chase and 
Masker, 1977).  Therefore, it is plausible that this 5’-3’ exonuclease and SbcC may be 
necessary to repair DNA in S. aureus that has been damaged by UV irradiation.  A 
mutation was also identified in HexA (also termed MutS), a DNA mismatch repair 
protein.  Disruption of this gene leads to a mutator phenotype in S. aureus (O'Neill, 
2010), meaning that strains acquire random SNPs at a higher frequency.  In E. coli, MutS 
has a role in preventing homologous recombination; however, in S. aureus it appears to 
only have a minor role in this process (Matic et al., 1994; Prunier and Leclercq, 2005; 
Rayssiguier et al., 1989).  Collectively, these findings further suggest involvement of σS 
in DNA damage repair of S. aureus.   
 
The nucleoside permease NupC was also identified in our transposon screen as being 
involved in the expression of sigS.  NupC from E. coli functions to import nucleosides 
(excluding guanosine or deoxyguanosine), and is dependent on proton motive force for 
function.  These imported nucleosides serve as precursors for DNA, RNA and histidine, 
as well as other various co-factors (Komatsu, 1973; Munch-Petersen et al., 1979; Saier, 
2000).  Additionally, nupC is repressed by CytR, a regulatory protein important for 
expression of genes involved in nucleoside utilization (Munch-Petersen and Mygind, 
1976).  These findings would suggest that sigS is utilized by S. aureus in response to a 
limitation in the acquisition of exogenous nucleotides.  Another gene in our screen with 
multiple insertions was msrA, which encodes a peptide methionine sulfoxide reductase.  
This protein is widely conserved across all forms of life and functions to reduce 
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methionine sulfoxide in oxidatively damaged proteins to methionine, for repair purposes 
(Boschi-Muller et al., 2005; Lowther et al., 2002; Weissbach et al., 2002; Weissbach et 
al., 2005).  In Chapter 3 we demonstrate the increased expression of sigS in the presence 
of the oxidative stress inducing chemical H2O2.  This perhaps suggests a role for σS in 
the response to oxidative stress, which, as detailed earlier, may also subsequently lead to 
DNA damage (Singh et al., 2001).  Of note, another ECF sigma factor, encoded by 
Neisseria gonorrhoeae, has previously been shown to have a role in regulation of msrA 
(Gunesekere et al., 2006).  Disruption of SACOL1602, encoding a metallo-beta-
lactamase protein, led to increased expression of sigS. This is not the first example of a 
correlation between this type of gene and ECF sigma factors; σP of many Bacillus species 
is also involved in the control of β lactamase genes (Ross et al., 2009).  Furthermore, this 
protein contains a domain that demonstrates homology to a predicted exonuclease, and it 
is characteristic of proteins in this group to possess functional nuclease activity. Indeed, a 
number have been identified as possessing a role in RNA and DNA metabolism 
(Dominski, 2007). Additionally, downstream of SACOL1602 are genes that encode 
competence proteins; therefore this transposon insertion may also affect expression of 
these genes.  It has been demonstrated in Bacillus subtilis that DNA damage-inducible 
genes, as well as other SOS response genes, are transcriptionally active during the 
development of competence (Love et al., 1985; Lovett et al., 1989).  Thus, there may also 
be a link between S. aureus competence genes and DNA damage that is mediated by σS. 
 
Further analysis of sigS expression through the transposon screen reveals mutations in a 
number of genes involved in cell-envelope metabolism and integrity.  These findings 
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further support our expression data, which suggests involvement of σS in the 
extracytoplasmic stress response, similar to that of other ECF sigma factors.  Specifically, 
we identified disruptions in cell wall associated genes, as well as other genes involved in 
cell-envelope metabolism, all leading to increased expression of sigS.  These include ebh, 
a cell wall associated protein of S. aureus, which binds human fibronectin and is involved 
in cellular adhesion during infection (Clarke et al., 2002).  Also identified was a mutation 
in pbp2, which is one of 5 such proteins in S. aureus, involved in catalyzing the 
transpeptidase reaction during cell wall synthesis (Georgopapadakou and Liu, 1980a, b; 
Waxman and Strominger, 1983; Wyke, 1984).  In S. aureus, Pbp2 has been shown to 
contribute to β-lactam resistance, and we have demonstrated here that sigS expression is 
increased in the presence of the β-lactam antibiotics cefotaxime, ampicillin and oxacillin 
(Chambers and Miick, 1992; Leski and Tomasz, 2005).  Further to this, a glycerol uptake 
facilitator protein, SACOL1319 was identified in this screen, and previous work has 
demonstrated the importance of glycerol for the synthesis of membrane components, 
therefore disruption of this gene may lead to a weakening of the cell wall (Ray et al., 
1972; Ray and White, 1972).  The aminoacyltransferase, FemB, encoded by 
SACOL1411, was also identified as having an effect on expression of sigS, and is 
involved in cell wall assembly as it is aids in the formation of the pentaglycine cross-
bridge (Henze et al., 1993).  Further to this, inactivation of femB leads to increased 
susceptibility of S. aureus to β-lactam antibiotics, which again also leads to expression of 
sigS.  As stated previously, our prior work suggests a role for σS during the survival of S. 
aureus to cell-envelope stress, specifically from Triton X-100 induced lysis. Collectively, 
these findings may explain our current data regarding sigS upregulation in both the 
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presence of cell-envelope targeting chemicals, as well as the absence of genes involved in 
cell-envelope stability (Shaw et al., 2008).   
 
Additionally, an insertion was identified in SACOL0682 encoding a Na+/H+ antiporter, 
as well as in SACOL1392, which is a predicted sodium:alanine symporter belonging to a 
family that functions to import L-alanine and Na+ into the cell (Kamata et al., 1992; 
MacLeod and MacLeod, 1992).  As alanine is an important component of teichoic acids 
and other cell envelope constituents, the absence of this transporter may limit the 
availability of this amino acid within the cell, possibly hampering cell wall turnover or 
increasing pressure for de novo alanine biosynthesis.  An additional connection between 
amino acid biosynthesis and sigS expression was also identified through insertion into 
SACOL1429, involved in the biosynthesis of the amino acid, aspartate.  Insertion in 
SACOL0168 (argJ), which encodes a glutamate N-acetyltransferase was also identified.  
In Bacillus stearothermophilus it is involved in catalyzing the reaction between glutamate 
and acetylglutamate during arginine biosynthesis, and between glutamate and 
aceytlornithine in ornithine biosynthesis (Sakanyan et al., 1993).  As argJ is encoded on 
a transcript upstream of argB, an acetylglutamate kinase, it is possible that the transposon 
insertion into argJ leads to polar effects on argB; however, both genes encode proteins 
involved in the same pathway.  These findings suggest that σS may be involved in amino 
acid metabolism.  Additionally, we have shown earlier in this work that sigS expression is 
increased during growth in amino acid limiting media.  As such, these findings may 
explain our earlier study that details an importance for functional σS during extended 
survival under starvation conditions (Shaw et al., 2008).  Mutation of SACOL0513 
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encoding GltC, a transcriptional regulator, led to increased expression of sigS.  In the 
closely related organism, B. subtilis, GltC is a member of the LysR family of 
transcriptional activators, and serves to upregulate gltA and gltB, genes encoding 
glutamate synthase, further supporting a role for σS in amino acid biosynthesis 
(Bohannon and Sonenshein, 1989; Henikoff et al., 1988; Schell, 1993).  Disruption of 
SACOL1393, which encodes a putative LicT transcriptional antiterminator raised the 
level of sigS transcript in the cell.  In the previous chapter, we identify a potential hairpin 
located 5’ of the sigS coding region, as such this may play a role in regulating termination 
of the sigS transcript.  Another regulator possibly involved in the expression of sigS is 
SACOL2086, belonging to the TenA family of transcriptional regulators, which was also 
identified in the screen.  Collectively, this further supports a role for σS in amino acid 
biosynthesis and elucidates a number of potential sigS transcriptional regulators.  
 
As discussed earlier, ECF sigma factors are subject to post translational regulation 
typically through a complicated proteolytic cascade involving cleavage of a membrane 
spanning anti-sigma factor.  Through the use of our transposon screen, we identified two 
membrane proteins that potentially play a role in the regulation of sigS.  The first of 
which, Msa, was previously determined to play a role in modulating expression of SarA, 
a global regulatory protein involved in virulence determinant expression 
(Sambanthamoorthy et al., 2006).  Interestingly, Msa contains three membrane spanning 
regions and when mutated leads to increased expression of sigS.  As such, this protein 
may serve as a potential anti-sigma factor for σS, whereby disruption of it would lead to 
an increase in free σS within the cell, and subsequently an increase in its expression 
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through autoregulation.  Additionally, a membrane spanning, C-terminal protease was 
also identified in our screen as potentially regulating sigS expression.  This serine 
protease contains a conserved DegS domain, and, in E. coli, DegS initiates the proteolytic 
cascade to free the ECF sigma factor RpoE during the response to heat shock (Grigorova 
et al., 2004).  As such, this protease may serve in the regulatory pathway of σS.   
 
  
139 
 
 
 
 
CHAPTER 5: 
FUNCTIONAL ANALYSIS OF σS 
 
Note To Reader.  Portions of these results have been previously published (Miller et al., 
2012; Shaw et al., 2008) and are utilized with permission of the publisher (Appendix 1). 
 
Background.  ECF sigma factors often respond to detrimental environmental conditions 
brought on by a variety of stresses, ranging from heat shock to oxidative stress.  During 
this response, the sigma factor binds core-RNAP and redirects the complex to upregulate 
genes that would otherwise remain inactive.  These genes comprise a specific regulon, 
and subsequently help the cell combat stress (Helmann, 2002).  In B. subtilis, the ECF 
sigma factor, σW, is expressed during growth in the presence of cell wall targeting 
antibiotics such as vancomycin; thus mutation of this gene leads to decreased survival 
during growth in the presence of these antibiotics.  The reason for this is that σW is no 
longer able to direct transcription of its regulon, which includes pbpE (a penicillin-
binding protein involved in cell wall biosynthesis) and fosB (a fosfomycin resistance 
enzyme), which help protect the cell during growth under these conditions  (Cao et al., 
2001; Huang et al., 1999).  In S. coelicolor, σR responds to diamide and subsequently 
upregulates genes involved in both thiol metabolism, as well as those genes whose 
products produce the major thiol buffer, mycothiol (Newton et al., 1996; Paget et al., 
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1998; Paget et al., 2001b; Park and Roe, 2008).  In the context of pathogenic organisms, 
and survival within the harsh environment of the host, the regulon of a number of ECF 
sigma factors include genes important for disease causation and virulence (Bashyam and 
Hasnain, 2004).  For example, the ECF sigma factor AlgU of P. aeruginosa upregulates 
the alginate synthesis gene cluster, including algD, the first in a 12-gene operon that 
encodes GDP mannose dehydrogenase, an enzyme involved in the conversion of GDP 
mannose into GDP mannuronate, the precursor for alginate polymerization.  Activation 
of these alginate biosynthesis genes by AlgU subsequently produces the mucoid capsule 
(Hershberger et al., 1995; Martin et al., 1993; Yu et al., 1995), which is important for full 
protection of the bacterium from antibiotics, oxidative stress and factors of the immune 
system.  These mucoid enclosed bacteria can persist in human lungs, and cause high 
mortality rates in patients suffering from conditions such as cystic fibrosis (Govan and 
Harris, 1986).  Furthermore, RpoE in S. typhimurium, amongst other genes, upregulates 
htrA, which is an extracellular protease important in virulence.  As a result, mutations in 
RpoE decrease invasion of, and replication in, macrophages and epithelial cells 
(Chatfield et al., 1992; Humphreys et al., 1999; Johnson et al., 1991).  In the context of 
this study, we have shown previously, and herein, that expression of the lone ECF sigma 
factor of S. aureus, sigS, is minimal under standard conditions, except in the highly 
mutated laboratory strain RN4220.  We were, however, able to identify a number of 
conditions that led to upregulation of sigS, including exposure to DNA damaging agents 
and cell wall destabilizing antimicrobial compounds; as well as challenge by components 
of the innate immune system.  As such, the first objective of this aim is to analyze the 
sensitivity of sigS mutants to those chemicals shown to induce its expression.  
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Additionally, we will perform microarray analysis in order to elucidate the σS regulon in 
an effort to understand how it aids in circumventing stress.  We have also previously 
demonstrated a role for σS in systemic S. aureus infections (Shaw et al., 2008); therefore, 
we will continue to explore the involvement of this factor in the pathogenesis of S. aureus 
and investigate the mechanisms by which it contributes to disease causation. 
 
Results 
  
RN4220 sigS Mutants Have a Growth Defect Upon Exit From Stationary Phase.  
Examination of the sigS mutant was first conducted through growth curve analysis under 
standard conditions in order to determine whether loss of this gene leads to a defect in 
growth.  Analysis was carried out in the 8325-4, SH1000 and USA300 LAC backgrounds 
and OD600 readings were taken every hour for 6 hours, and again at hour 24.  As 
displayed in Figure 37A, mutation of σS led to no notable defects in growth across each 
of the backgrounds examined.  These findings are perhaps not surprising as we have 
previously demonstrated that expression of sigS is minimal in these strains under the 
conditions examined.  We did, however, demonstrate that sigS is expressed under 
standard conditions in the highly mutated laboratory strain, RN4220.  Therefore, we 
repeated our analysis using a sigS mutant in this background.  Mutation of σS in RN4220 
resulted in a significant growth defect, which occurs as stationary phase cells are 
introduced into new growth media, prior to exponential phase (Figure 37B).  At hour 2 
we noted a 4.4-fold decrease in optical density of the sigS mutant compared to the wild-
type, which peaks at hour 3 with a fold change of 5.3.  This trend continues through hour  
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Figure 37. RN4220 sigS Mutants Have a Growth Defect Upon Exit From Stationary 
Phase. (A) Optical density readings  (OD600) of the wild-type (filled symbols) and sigS 
mutant strains (empty symbols) were taken every hour for 6 hours, and again at 24 h.  
Growth curve analysis was performed in 8325-4 (■), SH1000 (♦) and USA300 LAC (▲) 
backgrounds during growth at 37oC with shaking in TSB. (B) RN4220 wild-type (■), 
sigS mutant (□) and the sigS complemented strain (♦) were grown at 37oC with shaking in 
TSB, with growth monitored via OD600 every hour for 6 h, and again at 24 h.  Growth 
curves are representative of at least three independent experiments that showed less than 
10 % variability. * = p<0.05 using a Student t test and indicate significant difference in 
growth between the sigS mutant and its parental and complemented strains.  (C) RN4220 
(■) and its sigS mutant (□) were sub-cultured from mid exponential phase cells (denoted 
by arrows in B) and grown at 37oC with shaking in fresh TSB, with growth monitored via 
OD600 every hour for 6 h, and again at 24 h.  Growth curves are representative of at least 
three independent experiments that showed less than 10 % variability. (D) Viability 
(CFU/mL) of stationary phase cells was determined via serial dilution of the RN4220 
wild-type (WT) and sigS mutant (M) strains after growth at 37oC with shaking in TSB for 
24 h.  Adapted from Miller et al., 2012.  
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4 with a fold decrease of 3; however by hour 5, growth of the sigS mutant is comparable 
to that of the parent strain.  Growth of the sigS complement strain was comparable to that 
of the wild-type at all time points, as displayed in Figure 37B.  This is particularly 
interesting as sigS expression peaks at hour 3 in RN4220, which corresponds to the time 
point at which we observe the highest fold decrease in growth for the mutant strain.  This 
deficiency seemingly occurs only upon the introduction of stationary phase cells into 
fresh media, as RN4220 sigS mutant cells sub-cultured from mid exponential phase 
display growth rates comparable to that of the parent strain, as displayed in Figure 37C.  
Examination of the viability of stationary phase RN4220 sigS mutant cells compared to 
the wild-type reveals equivalent CFU per mL values after 24 h of growth (Figure 37D), 
suggesting that the observed growth defect was not a result of fewer viable inoculating 
cells for the sigS mutant.  Collectively this suggests that σS has a role upon exit from 
stationary phase in RN4220. 
 
Disk Diffusion Analysis Reveals Similar Sensitivities Between the σS Mutant and 
Wild-Type Strains.  In order to determine the conditions under which σS aids in the 
protection of the cell, we performed disk diffusion analysis using a variety of stress 
inducing compounds.  This assay was carried out as a rapid means to assess a variety of 
chemicals in order to determine their effect on the σS mutant compared to the wild-type.  
TSA plates were overlayed with top agar seeded with either the wild-type or σS mutant 
strains.  Sterile filter disks were placed on the solidified agar and 10 μl of appropriate 
chemical added.  The conditions tested include those chemicals shown to increase sigS 
expression based on our transcriptional analysis, and are displayed in Table 7.  The  
144 
 
Table 7. Stress Compounds Used in Disk Diffusion Analysis.                                  
 
Stress Agent Concentrationc 8325-4a SH1000a USA300 LACa 
    WT
b Mb WTb Mb WTb Mb 
 
Acid Hydrochloric Acid 6 M 16 16 12 12 13 13 
  
Phosphoric Acid 10 M 28 28 16 17 17 17 
  
Formic Acid 12 M 27 28 13 16 24 23 
  
Acetic Acid 1 M 6 6 6 6 6 6 
  
Sulphuric Acid 12 M 25 26 25 21 24 24 
  
Nitric Acid 6 M 13 13 30 28 15 16 
  
Trichloroacetic Acid 12 M 14 14 12 13 16 16 
 
Alkali Sodium Hydroxide 3 M 11 11 9 9 8 8 
 
Osmotic Sodium Chloride 1 M 6 6 6 6 6 6 
  
Glucose 1 M 6 6 6 6 6 6 
 
Alcohol Ethanol 100% 6 6 6 6 6 6 
  
Methanol 100% 6 6 6 6 6 6 
  
Isopropanol 100% 6 6 6 6 6 6 
 
Detergent Sodium Dodecyl Sulfate 10% 20 21 18 18 16 16 
  
Triton X-100 1% 6 6 6 6 6 6 
  
Tween-20 1% 6 6 6 6 6 6 
  
N-lauroyl Sarcosine 1% 20 20 15 15 18 17 
 
Oxidative Hydrogen Peroxide 30% 50 51 45 43 47 47 
  
Methyl Viologen 2 M 8 6 30 27 25 24 
  
Menadione 1% 35 35 27 27 24 24 
  
Pyrogallol 4 mg 11 11 6 6 9 9 
 
Nitrosative Sodium Nitroprusside 1M 6 6 8 8 6 6 
 
DNA Damage Methyl Methanesulfonate 50 mM 13 13 6 6 9 9 
 
Antibiotics Penicillin G 20 µg 50 50 45 45 47 47 
  
Chloramphenicol 50 µg 36 36 34 35 34 34 
  
Phosphomycin 20 µg 20 20 30 27 25 26 
  
Vancomycin 20 µg 16 15 7 7 15 14 
  
Spectinomycin 50 µg 20 20 12 13 11 11 
  
Ampicillin 1 mg 47 50 40 40 11 11 
  
Erythromycin 50 µg 33 33 35 35 35 35 
  
Lincomycin 250 µg 36 36 35 35 35 35 
  
Kanamycin 500 µg 27 27 23 23 22 22 
  
Neomycin 500 µg 25 25 24 24 23 23 
  
Puromycin 250 µg 27 27 24 25 18 18 
  
Mupirocin 20 µg 37 37 36 36 34 34 
 
Disulfide Diamide 500 mM 13 12 15 17 11 11 
 
Miscellaneous Berberine Chloride 128 µg 11 11 12 12 11 11 
  
Peracetic Acid 4.2 M 39 40 38 40 30 31 
aNumbers represent the diameter of the zone of inhibition.  All numbers displayed are in 
millimeters (mm).   
bAnalysis was performed utilizing both wild-type (WT) and sigS mutant strains (M). 
cNumbers displayed are the final concentration added to the filter disk.  
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resulting zones of inhibition were measured and analyzed for an increase or decrease in 
diameter, indicating sensitivity or resistance to the chemical respectively (Figure 38).  
Disk diffusion analysis was carried out in the 8325-4, SH1000 and USA300 LAC 
backgrounds and subsequently revealed no notable difference in the susceptibility of the 
sigS mutants to the tested chemicals across each of the backgrounds examined (Table 7).  
These findings indicate that there seems to be little to no requirement for σS in the 
conditions tested; however, as these analyses were conducted during stationary phase, 
examination of earlier growth phases may be required to elicit a response.  Furthermore, 
we find in our laboratory that these assays are far more qualitative rather than quantitative 
in nature, and were therefore used as an initial screening method.  
 
S. aureus sigS Mutants are Sensitive to DNA Damage.  Thus far we have demonstrated 
that chemicals known to induce DNA damage stress as well as genes/proteins known to 
mediate this response, strongly impact sigS transcription.  Beyond the growth defect 
observed for the RN4220 sigS mutant, we have yet to determine whether these inducing 
conditions lead to notably impaired growth phenotypes.  We next sought to perform 
death-curve kill studies to examine the viability of sigS mutants during exposure to lethal 
concentrations of these agents in strains 8325-4, SH1000 and USA300.  Therefore, we 
performed assays in liquid media, exposing exponentially growing cultures to 5X the 
MIC of select chemical stressors, and monitoring their viability over time.  This was 
initially performed by spot plating 5 µl aliquots of 10-1 through 10-6 dilutions onto TSA, 
both prior to and 30 min post exposure of cells to 25 mM MMS.  We found that under 
these conditions, there was a decline in mutant cell viability across strains 8325-4,  
146 
 
 
 
 
 
 
Figure 38.  Disk Diffusion Analysis Reveals no Discernible Differences in Growth 
Upon sigS Deletion. Disk diffusion assays were carried out to determine stress 
conditions that lead to variations in the survivability of the σS mutant compared to the 
wild-type strain in the 8325-4, SH1000 and USA300 LAC backgrounds, SH1000, which 
is representative, is displayed here.  TSA plates were overlayed with top agar seeded with 
either SH1000 wild-type or SH1000 σS mutant strains.  Sterile filter disks were placed on 
the solidified agar and 10 μl of appropriate chemical added.  The resulting zones of 
inhibition were measured in mm, and analyzed for an increase or decrease in diameter 
indicating sensitivity or resistance to the chemical, respectively.  This data is 
representative of at least three independent experiments that showed less than 10 % 
variability.  
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SH1000 and USA300 LAC (Figure 39).  We then repeated this analysis in the USA300 
LAC background, and performed CFU per mL determinations both pre- and post 
exposure in order to quantify this decrease in viability (Figure 40A).  Upon examination, 
we recovered 3.33-fold less sigS mutant cells compared to the wild-type, following 
exposure to this agent.  Complementation of the σS mutation reduced the observed 
growth impairment significantly, although not completely to that of wild-type levels.  
This lack of full complementation is likely attributed to the instability of the plasmid in 
the presence of DNA damaging conditions, as suggested by others previously 
(Bouanchaud et al., 1968; Hashimoto et al., 1964; Nakamura, 1990; Salgo et al., 1995; 
Voureka, 1952; Willetts, 1967).  Our previous investigations into the downstream gene, 
ecfX as a potential anti-sigma factor led to the finding that it likely acts as a positive 
activator of sigS.  Therefore, if ecfX fulfills such a function, then any phenotypes 
observed for the sigS mutant should be reproducible in the ecfX mutant strain as well.  As 
such, our analysis included evaluation of a strain bearing a mutation in ecfX in an effort 
to validate our previous transcriptional findings.  We found that 30 min post exposure to 
MMS, we did observe a decrease in the ability of the ecfX mutant to survive compared to 
the wild-type, however, the decrease was only 1.8 fold, and thus not as substantial as that 
observed for sigS alone.  Complementation of ecfX resulted in a fold decrease of 1.1 in 
sensitivity, again possibly owing to plasmid instability described earlier.     
 
In order to determine whether the role of σS was limited to protection against DNA 
alkylation (as induced by MMS), we next examined the ability of the USA300 σS mutant 
to survive exposure to agents that induce other types of DNA damage.  As such, analysis  
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Figure 39.  sigS Mutants are Sensitive to DNA Alkylation Damage.  The  wild-type 
(WT) and sigS mutant (M) strains were analyzed for viability in the presence of the DNA 
damage inducing agent, MMS (25 mM).  Spot plating of 5 µl aliquots of dilutions 10-1 
through 10-6 on TSA was performed both pre- and post-exposure.  Analysis was 
conducted using (A) 8325-4, (B) SH1000 and (C) USA300 LAC.  
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was carried out for oxidative stress resulting from the addition of 5 mM H2O2.  
Following a 5 min exposure to this agent we observed 3.9- and 1.6-fold decreases in sigS 
and ecfX mutant viability, respectively, compared to the parent strain (Figure 40B); which 
was completely complementable in both cases.  We next used 5 mM of the DNA 
intercalating agent ethidium bromide (EtBr), and found that the sigS mutant displayed a 
2.1–fold decrease in viability, while the ecfX mutant resulted in a 1.6-fold decrease 
compare to the wild-type strain after 15 min of exposure (Figure 40C).  We again saw 
that complementation was able to abrogate these affects; however, in the case of the sigS 
mutant it was not completely to levels of the wild-type strain. This is likely attributed to 
the ability of EtBr to cure plasmids upon exposure, as observed by others previously 
(Bouanchaud et al., 1968).  In order to determine if σS mediates protection against UV 
induced lesions and double strand breaks, we compared the survivability of the wild-type 
strain and its sigS and ecfX mutants in response to this stress.  Exponentially growing 
cultures were serially diluted on TSA and subjected to UV at a dosage of 4,000 µJ cm-2.  
Exposure at this level resulted in a 2.1- decrease in viability for the sigS mutant, whilst 
there was only a negligible decrease for the ecfX mutant (Figure 40D).  Complementation 
in this assay is not possible because of plasmid instability, as we observed >83% loss 
upon exposure (data not shown).  These assays were repeated in the presence of other 
DNA damage stressors, listed in Table 8, to ensure that the observed effects were due to 
the specific action of the drug on the cell, and not a result of an indirect effect of the 
chosen chemical.  To this end, we repeated the spot plating method as described before 
with an alkylating agent (in addition to MMS): ethyl methanesulfonate. We also used the 
intercalating agent acridine orange, and the UV mimetic 4-nitroquinoline-1-oxide.  All of  
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Figure 40.  sigS Mutants are Sensitive to a Variety of DNA Damage-Inducing 
Stresses.  The USA300 LAC wild-type (W), sigS mutant (SM), sigS complement strain 
(SC), ecfX mutant  (EM), and ecfX complement strain (EC) were analyzed for viability in 
the presence of DNA damage inducing stressors.  CFU counts were determined both pre- 
and post-exposure, and the survivability determined. The data is presented as fold change 
relative to the wild-type strain and is representative of at least three independent 
experiments that showed less than 10 % variability.  (A) 30 min exposure to 25 mM 
MMS (B) 5 min exposure to 150 mM H2O2 (C) 15 min exposure to 5 mM EtBr (D) 
exposed to UV at 4,000 μJ per cm2. * = p<0.05 using a Student t test.  Adapted from 
Miller et al., 2012. 
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Table 8. DNA Damage Inducing Chemicals Utilized for Death Curve Analysis.                              
 Stress  Agent  Concentration 
 
Alkylates DNA  Methyl Methanesulfonate (MMS)  25 mM 
  
 Ethyl Methanesulfonate  25 mM 
  
 Nitrosoguanidine  0.04 ng mL-1 
  
    
 
Oxidative Damage  Hydrogen Peroxide (H2O2)  150 mM 
  
    
 
Intercalating 
Agents 
 Ethidium Bromide (EtBr)  5 mM 
  
 Acridine Orange  100 mM 
  
    
 
Causes Double 
Strand Breaks and 
Lesions 
 
Ultraviolet Light (UV) 
4-nitroquinoline-1-oxide 
 
4,000 µJ cm-2 
450 mM 
 
  
152 
 
these agents resulted in sensitivities similar to that displayed for the conditions above 
(Figure 41).   
 
Competitive Growth Analysis of the σS Mutant Against the Wild-Type.  Thus far, we 
have demonstrated that a growth defect exists for the sigS mutant strain compared to the 
wild-type in the RN4220 background.  Additionally, we see increased sensitivity of the 
sigS mutant during growth in lethal concentrations of a range of DNA damaging agents.  
With this in mind, we next sought to examine whether the mutant would survive when 
grown together with the wild-type.  To this end, coculture studies comparing the viability 
of the sigS mutant to its parental strain were undertaken, both under standard conditions, 
and in the presence of chemical stressors.  These assays were performed by taking 
exponentially growing cultures of both the wild-type and sigS mutant, and inoculating 
them into fresh media at a 1:1 ratio.  This ratio was established by inoculating the media 
with both the wild-type and sigS mutant at an OD600 of 0.05.  To ensure accuracy of this 
ratio, CFU per mL was determined for both the wild-type and sigS mutant at hour 0 via 
serial dilution and plating on both TSA, which allows the growth of both wild-type and 
the sigS mutant, and TSA containing tetracycline, which allows for growth of only the 
sigS mutant.  The cultures were allowed to grow under the respective conditions, at which 
point viability was determined through serial dilution and plating as described above.  As 
demonstrated in Figure 42, evaluation after a period of 24 hours resulted in a 3.6-fold 
decrease (ratio of 1:0.28) in viable σS mutant cells compared to the wild-type.  This 
finding was further exacerbated after 7 days of growth, resulting in a 25-fold decrease 
(ratio of 1:0.04) in mutant cell viability. Following this, both strains were subjected to  
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Figure 41. sigS Mutants are Sensitive to a Variety of DNA Damage-Inducing 
Stresses.  The  wild-type (WT), sigS (SM) and ecfX (EM) mutant strains along with the 
sigS and ecfX complements (SC and SE) were analyzed for viability in the presence of 
DNA damage inducing agents.  Spot plating of 5 µl aliquots of dilutions 10-1 through 10-6 
on TSA was performed both pre- and post-exposure.  Analysis was performed:  
(Control) prior to exposure, (EMS) 30 min post exposure to 25 mM ethyl 
methanesulfonate (EMS), (AO) 1 h post exposure to 100 mM acridine orange (AO), and 
(4NQO) 1 h post exposure to 450 mM 4-nitroquinoline-1-oxide (4NQO).  
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Figure 42. Competitive Growth Analysis of the sigS Mutant.  SH1000 and its sigS 
mutant were cocultured in TSB for a period of 24 hour (24h) or 7 days (7d).  
Additionally, cocultures were performed in TSB containing subinhibitory concentrations 
of: hydrogen peroxide (1 mM), diamide (1.5 mM), HCl (10 mM), NaOH (10 mM), 
EDTA (0.1 mM), penicillin G (0.01 µg ml−1) or ethanol (5%). The competitive index (CI) 
was determined for each strain after the respective growth periods, and represents the 
relative proportion of the two strains after inoculation at a 1:1 ratio. Data is indicative of 
at least 3 independent cultures that showed less than 10 % variability (Shaw et al., 2008). 
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similar testing, however sub-MIC concentrations of a variety of stress chemicals were 
also included in the growth media. In doing so, it was found that upon exposure to the 
oxidative stress chemicals hydrogen peroxide (1mM) and diamide (1.5 mM) for 7 days, a 
fold decrease of 50 (1:0.02) and 100 (1:0.01), respectively, was observed.  When 
subjected to growth in 10 mM HCl, 0.1 mM EDTA or 10 mM NaOH an even greater 
reduction in sigS mutant survivability was observed, with fold decreases of 200 (1:0.005), 
333.3 (1:0.003)  and 1666 (1:0.0006), respectively.  Finally, and most notably, we were 
unable to recover any viable sigS mutant cells after 7 days in the presence of the cell wall 
affecting chemicals Penicillin G (10 ng ml-1) and ethanol (5%). These findings 
demonstrate a drastic decrease in the ability of sigS mutant to outcompete its parental 
strain, indicating that it likely contributes to starvation survival, and overall fitness of the 
cell. 
 
Exploring the Role of σS Using Microarray Analysis.  Thus far we have demonstrated 
that expression of sigS is significantly increased following DNA damage stress, cell wall 
destabilizing conditions and challenge by components of the innate immune system.  We 
have shown that mutation of genes/proteins involved in DNA damage repair pathways, 
transport, regulation, membrane stability and amino acid biosynthesis also enhances sigS 
transcription.  Further to this, we present evidence to suggest a role for σS in the 
protection of S. aureus against DNA damage created by a number of different 
chemicals/conditions.  In order to understand the mechanistic contribution of σS to these 
processes, we next performed transcriptomic analysis to determine which genes are 
controlled by this regulator.  This was undertaken in the RN4220 background, as sigS is 
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expressed in this strain under standard conditions.  As noted earlier, the RN4220 sigS 
mutant displays an increased lag phase during growth in TSB.  Therefore, in order to 
correct for this, 1 ml of overnight cultures of the wild-type and mutant strains was used to 
inoculate fresh TSB and allowed to grow to an OD600 of 1.0. This was achieved more 
rapidly by the wild-type strain (3 h), than the mutant (5 h).  These were then used to 
inoculate fresh TSB to an OD600 of 0.05, before being allowed to grow for 3 h (a window 
of maximum sigS expression).  After this time, both strains were found to grow equally 
well; therefore RNA was extracted from these samples, and used for microarray analysis. 
These studies were performed in triplicate for both the wild type and sigS mutant using 
the A-AFFY-147 Affymetrix GeneChip S. aureus Genome Array.  Genes that 
demonstrated a 2-fold or greater variation in expression, and were deemed significant by 
t-test (p<0.05) analysis, were submitted to the NIAID DAVID bioinformatic resource for 
pathway and gene ontology analysis (Table 9).  In total, 52 genes were identified with 
altered expression of 2-fold or greater and statistical significance of p<0.05.  
Surprisingly, 46 of these were negatively regulated by sigS and only 6 were positively 
affected by it.  Genes found to be upregulated in the sigS mutant include those whose 
products form the cell envelope, as well as a number known to be involved in virulence 
(Table 10).  Of the cell envelope genes that were induced, a number of lipoproteins and 
capsule genes appear to be increased in the absence of σS.  Additionally, lacA, lacB and 
lacD of the lactose operon are increased in the mutant, with fold changes of 3.4-, 5.9- and 
3.5-fold respectively.  Furthermore, there is a 4.5-fold increase in transcription of the 
staphyloxanthin biosynthesis protein, which forms the carotenoid pigment that protects S. 
aureus from reactive oxygen species through its antioxidant properties (Clauditz et al., 
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2006; Liu et al., 2005).  Of note, there was a 3.6-fold increase in the thermonuclease 
precursor, nuc, which, when cleaved and activated, forms NucB (a membrane protein) 
and NucA (a secreted protein).  Both of these enzymes participate in the hydrolysis of 
nucleic acids, possibly serving as a method for nucleotide salvage from the extracellular 
milieu (Cuatrecasas et al., 1967; Davis et al., 1977; Okabayashi and Mizuno, 1974).  An 
increase was observed in a number of agr regulated virulence determinants including a 
truncated beta-hemolysin as well as secreted proteases splB, splC, aur, sspA and sspB.  
We were only able to identify a decrease in 6 genes in the sigS mutant background, 3 of 
which are hypothetical proteins (Table 11).  Two of these, SAV1031 and SAV2430, 
displayed fold decreases of 3.2 and 2.5, respectively, in the mutant.  These are both 
hypothetical proteins that appear only in S. aureus and contain no conserved domains.  
The third, SACOL2433 demonstrated a decrease of 2.1-fold, and is homologous to a 
putative lipoprotein in S. capitis.  A 2.5-fold decrease in the fermentative protein D-
lactate dehydrogenase gene, SACOL2535, was also identified in the mutant strain.  A 
fold decrease of 2.0 was observed for SACOL0799, which encodes a transferrin receptor. 
As the name suggests, this protein acts to recognize and bind transferrin, which is a 
human iron-transporting molecule, in an effort to scavenge iron from the environment 
during infection (Modun et al., 1998).  Finally, a 4.0-fold decrease was found for 
SACOL1729, encoding a threonyl-tRNA synthetase.  Such extensive negative regulation 
by σS is unlikely to be the result of direct influence on these loci, as σ factors only 
mediate positive-regulation directly; therefore it suggests indirect control through other 
factors. When analyzing the complete gene set, no regulatory elements were immediately 
apparent, possibly suggesting that this finding is mediated via small RNAs. Given that  
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Table 9. Ontology Table of Genes Affected by σS Identified via Microarray Analysis. 
Down-Regulated Ontologies   Number of 
Significant Genesa                      
Total Number of 
Genesb     
Purine Biosynthesis 0 12 
Hypothetical Proteins  3 3 
Central Intermediary Metabolism 1 1 
Cell Envelope 1 1 
Protein Synthesis 1 1 
Total 6 18 
   
Up-Regulated Ontologies       
Virulence  17 23 
Cell Envelope  13 16 
Hypothetical Proteins  7 14 
Transporters 4 4 
Energy Metabolism 3 3 
Regulators  1 1 
DNA Metabolism  1 1 
Total 46 62 
aStatistical significance is based on a Student t test with a cut-off of p <0.05 
bGenes listed include all that have a change of 2-fold or greater. 
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Table 10. Genes Repressed by σS, Identified by Microarray Analysis.                                                                                                
Gene Category ORF no.a Description Gene Fold up regulationb 
Virulence (17) SAV1939 truncated beta-hemolysin hlb 4.93 
 
0275 
essB superfamily:type VII secretion 
virulence protein EssB  4.79 
 
0270 
staphyloxanthin biosynthesis protein, 
putative  
4.53 
 
0278 esXB superfamily: virulence factor  4.34 
 
2003 phospholipase C hlb 3.89 
 
0271 
ESAT-6/Esx family secreted protein 
EsxA/YukE  
3.53 
 
1864 serine protease SplF, putative  3.42 
 
0272 type VII secretion protein EsaA  3.11 
 
0276 diarrheal toxin yukA 3.00 
 
1868 serine protease SplB splB 2.94 
 
1865 serine protease SplE, putative 
 
2.85 
 
1057 V8 Protease sspA 2.78 
 
2659 zinc metalloproteinase aureolysin aur 2.63 
 
1867 serine protease SplC splC 2.54 
 
0277 Virulence protein EsaC  2.39 
 
0273 Virulence protein EssA 
 
2.30 
 
1056 cysteine protease precursor SspB sspB1 2.15 
 
Cell Envelope 
(13) 
1825 
N-acetylmuramoyl-L-alanine amidase, 
family 4  6.51 
 
1532 homologous to lipoprotein 
 
4.60 
 
0139 
capsular polysaccharide synthesis 
enzyme Cap5D cap5D 4.22 
 
1533 lipoprotein, putative 
 
3.89 
 
0608 sdrC protein (cell adhesion) sdrC 3.83 
 
1531 lipoprotein, putative  3.78 
 
0080 staphylococcus tandem lipoprotein 
 
3.55 
 
0851 lipoprotein, putative  3.53 
 
0137 
capsular polysaccharide biosynthesis 
protein Cap5B cap5B 3.04 
 
0299 lipoprotein, putative  2.93 
 
0082 staphylococcus tandem lipoprotein  2.92 
 
0484 Staphylococcus tandem lipoprotein  2.17 
160 
 
Table 10. Continued. 
Gene Category ORF no.a Description Gene Fold up regulationb 
 
0083 staphylococcal tandem lipoprotein  2.16 
 
Hypothetical 
Proteins (7) 
1826 
Hypothetical protein (No conserved 
domains)  15.92 
 
0850 
Hypothetical protein (No conserved 
domains)  3.65 
 
2338 
Hypothetical protein (Probable 
membrane protein)  3.27 
 
1529 
Hypothetical protein (No conserved 
domains)  3.19 
 
0643 
Hypothetical protein (Putative 
conserved transposase domain)  
2.66 
 
0645 
Hypothetical protein (Putative 
membrane protein)  2.11 
 
0267 
Hypothetical protein (Putative exported 
protein)  2.03 
 
Transporters (4) 
2483 transporter, putative 
 
2.53 
 
0265 ABC-2 type transport system permease  2.36 
 
0620 osmoprotectant proline transporter proP 2.10 
 
0264 ABC transporter, ATP-binding protein 
 
2.08 
     Energy 
Metabolism (3) 
2185 
galactose-6-phosphate isomerase, LacB 
subunit lacB 5.91 
 
2183 tagatose 1,6-diphosphate aldolase lacD 3.45 
 
 
2186 
galactose-6-phosphate isomerase, LacA 
subunit lacA 3.38 
Regulator (1) 2070 sensor histidine kinase KdpD kdpD 2.04 
 
DNA 
Metabolism (1) 
0860 Thermonuclease precursor nuc 3.55 
aORF IDs are derived from the S. aureus COL genome unless otherwise stated. 
bFold change is of the sigS mutant relative to the wild-type strain. 
161 
 
Table 11. Genes Activated by σS, Identified by Microarray Analysis. 
Gene Category ORF no.a Description Gene 
Fold 
Down-
Regulationb 
Hypothetical 
Protein (3) 
SAV1031 Hypothetical protein 
 
-3.24 
 
SAV2430 Hypothetical protein 
 
-2.48 
 
2433 Hypothetical protein 
 
-2.10 
 
Central 
Intermediary 
Metabolism (1) 
2535 
D-isomer specific 2-hydroxyacid 
dehydrogenase family protein  
-2.48 
 
Cell Wall (1) 
0799 Transferrin receptor 
 
-2.03 
 
Protein Synthesis 
(1) 
1729 Threonyl-tRNA  synthetase thrS -4.02 
aORF IDs are derived from the S. aureus COL genome unless otherwise stated. 
bFold change is of the sigS mutant relative to the wild-type strain. 
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many of these elements are encoded within existing ORFs, or in intergenic regions 
(Geissmann et al., 2009; Vogel and Wagner, 2007; Waters and Storz, 2009), their 
influence would be difficult to detect in this analysis.   
 
In S. aureus σS Regulates Transcription of the Purine Biosynthesis Pathway.  None 
of the genes contained within the microarray analysis obviously account for the increased 
susceptibility of sigS mutants to DNA damage.  In an attempt to gain greater insight into 
this, we examined the microarray data in more detail.  In doing so, we identified 16 genes 
upregulated in the mutant strain, and 12 downregulated genes, in addition to those that 
are statistically significant, and discussed previously.  Of the 16 newly identified 
upregulated genes, 6 of which are associated with the virulence of S. aureus, as well as 3 
genes encoding cell-envelope associated proteins (Table 12).  These virulence associated 
genes include agrB, agrD and argC with fold increases of 3.1, 2.4 and 2.3 respectively.  
We also observed 6.0- and 2.7-fold increases in the agr regulated virulence determinants 
hld and splA respectively.  Of the cell-envelope associated genes, we saw fold increases 
of 5.4, 3.0 and 2.5 in a putative lipoprotein, cap8E and cap5G, respectively.  The only 
genes that were identified as being downregulated in the sigS mutant after relaxing the 
statistical significance cut off were the genes involved in purine biosynthesis.  Due to 
variation among replicate samples, these genes were not deemed statistically significant 
using the cut-off criteria imposed.  Specifically, as listed in Table 13, purQ was 
decreased 3.37-fold, along with a number of other genes from the same locus, including 
purE, purC and purF, with fold changes of 3.09, 3.33 and 2.34 respectively.  
Furthermore, purA, located distally on the chromosome from this locus, displayed a 2.94- 
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Table 12.  Genes Repressed by σS Identified by Microarray Analysis That are Not 
Statistically Significantb.                     
Gene 
Category ORF no.
a Description Gene Fold up regulationc 
Virulence 
(23) 
2022 delta-hemolysin hld 6.00 
 
0276 diarrheal toxin yukA 4.62 
 
2023 
accessory gene regulator protein 
B agrB 3.14 
 
1869 serine protease SplA splA 2.65 
 
2024 
accessory gene regulator protein 
D agrD 2.41 
 
2025 
accessory gene regulator protein 
C 
argC2 2.27 
 
Cell 
Envelope 
(16) 
1225 putative lipoprotein 
 
5.43 
 
0140 
capsular polysaccharide 
synthesis enzyme cap8E 3.02 
 
0142 
capsular polysaccharide 
synthesis enzyme cap5G 2.48 
 
Hypothetical 
Proteins 
(14) 
0274 Hypothetical protein  6.42 
 
2602 Hypothetical protein 
 
5.82 
 
0300 Hypothetical protein  2.76 
 
0849 Hypothetical protein 
 
2.25 
 
0266 Hypothetical protein  2.20 
 
0489 Hypothetical protein  2.02 
 
2294 Hypothetical protein  2.01 aORF IDs are derived from the S. aureus COL genome unless otherwise stated. 
bStatistical significance is based on Student t test with a cut-off of p <0.05 
cFold change is of the sigS mutant relative to the wild-type strain. 
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Table 13. Genes Activated by σS Identified by Microarray Analysis That are Not 
Statistically Significantb. 
Gene 
Category 
ORF 
no.a Description Gene 
Fold down 
regulationc 
Purines, 
pyrimidines, 
nucleosides, 
and 
nucleotides 
metabolism 
(12) 
1077 
Phosphoribosylformylglycinamindine 
synthase I 
purQ -3.37 
 
1075 
Phosphoribosylaminoimidazole-
succinocarboxamide synthase purC -3.33 
 
1073 
Phosphoribosylaminoimidazole 
carboxylase,catalytic subunit purE -3.09 
 
0018 Adenylosuccinate synthetase purA -2.94 
 
1076 
Phosphoribosylformylglycinamidine 
synthase purS -2.82 
 
1078 
Phosphoribosylformylglycinamidine 
synthase II purL -2.52 
 
1080 
Phosphoribosylformylglycinamidine cyclo-
ligase purM -2.47 
 
1074 
Phosphoribosylaminoimidazole carboxylase, 
ATPase subunit 
purK -2.35 
 
1079 Amidophosphoribosyltransferase purF -2.34 
 
1081 
Phosphoribosylglycinamide 
formyltransferase purN -2.28 
 
2242 Xanthine/uracil permease family protein 
 
-2.09 
 
1082 
Phosphoribosylaminoimidazolecarboxamide 
formyltransferase purH -2.05 
aORF IDs are derived from the S. aureus COL genome unless otherwise stated. 
bStatistical significance is based on Student t test with a cut-off of p <0.05 
cFold change is of the sigS mutant relative to the wild-type strain. 
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fold down-regulation in the mutant strain.  To investigate this further, and determine if 
this affect was biologically meaningful, the role of σS in purine biosynthesis regulation 
was explored using qRT-PCR.  Accordingly, we examined transcription of the four loci 
encoding de novo purine biosynthesis pathway genes: purEKCSQLFMNHD, purA, purB 
and guaBA, the chromosomal locations of which are depicted in Figure 43.  As such, we 
carried out qRT-PCR analysis on purE, purC and purD, which resulted in 2.3-, 9.2- and 
2.0-fold decreases, respectively, in the RN4220 σS mutant after 3 hours of growth (Figure 
44).  Transcription of purA, purB, guaB and guaA resulted in 2.0-, 4.6-, 2.1- and 4.6-fold 
decreases, respectively, in the mutant strain.  
 
To verify that our findings were not specific to RN4220, studies were also carried out in 
USA300 LAC. When the same genes were profiled, we again observed a significant 
decrease in transcription in the σS mutant.  Specifically, purE, purC and purD 
transcription resulted in 13.9-, 7.6- and 4.4-fold decreases, respectively, in the σS mutant 
(Figure 45). Transcription of purA, purB, guaB and guaA resulted in 2.5-, 8.8-, 5.4- and 
5.3-fold decreases, respectively, in the mutant strain.  We also repeated these analyses in 
the context of the downstream gene, ecfX, to assess its impact on the expression of purine 
biosynthesis genes. This was performed in an ecfX mutant in the USA300 LAC 
background, revealing there to be negligible decreases in the expression of the pur and 
gua genes compared to that of the wild-type strain; certainly not to the same levels as the 
sigS mutant (Figure 46).  Collectively, this data supports our microarray analysis, and 
suggests a role for σS in the response to DNA damage via regulation of de novo purine 
biosynthesis.  
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Figure 43. Chromosomal Locations of the Purine Biosynthesis Genes in S. aureus.  
The genes comprising the purine biosynthesis pathway are located at 4 distinct genetic 
loci throughout the S. aureus genome. oriC is shown for orientation.  
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Figure 44. σS Regulates Expression of de novo Purine Biosynthesis Pathway Genes in 
RN4220.  Quantitative real-time PCR analysis of RN4220 (black) and its sigS mutant 
(grey) was performed with cultures grown in TSB at 37oC for 3 h.  The data presented is 
from at least 3 independent experiments.  Error bars are shown as +/- SEM, * = p<0.05 
using a Student t test.  
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Figure 45.  The Regulation of Purine Biosynthesis Genes by σS is Conserved Across 
S. aureus Strains.  Quantitative real-time PCR analysis of USA300 wild-type (black) 
and its sigS mutant (grey) was performed with cultures grown in TSB at 37oC for 3 h. 
The data presented is from at least 3 independent experiments.  Error bars are shown as 
+/- SEM, * = p<0.05 using a Student t test. 
 
 
 
 
 
 
 
 
169 
 
 
 
 
 
 
Figure 46.  Transcription of the Purine Biosynthesis Genes is Unaffected by 
Mutation of ecfX.  Quantitative real-time PCR analysis of USA300 wild-type (black), 
and its ecfX (light grey) and sigS (dark grey) mutants, was performed with cultures grown 
in TSB at 37oC for 3 h. The data presented is from at least 3 independent experiments.  
Error bars are shown as +/- SEM, * = p<0.05 using a Student t test. 
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Purine Biosynthetic Activity is Decreased in σS Mutant Strains. We have presented 
evidence to suggest a role for σS in the upregulation of purine biosynthesis genes at the 
transcriptional level.  As such, we next investigated whether these affects translate into 
alterations in enzymatic function.  Accordingly, we performed activity based profiling for 
PurA (adenylosuccinate synthetase), which facilitates one of the later steps in adenosine 
generation (Figure 47A). Crude extracts of a USA300 LAC wild-type, its sigS mutant and 
complemented strain were used to measure the rate of formation of adenylosuccinate 
(sAMP).  When assayed, we observed a 3.7-fold decrease in activity of PurA in the sigS 
mutant compared to its parent strain (Figure 47B).  This change in activity was fully 
restored upon complementation.  These findings specifically show that the decrease in 
transcription observed for purine biosynthesis genes correlates to altered enzymatic 
activity within the cell.  
Deletion of σS Results in Decreased Levels of Both ADP and GDP in the Mutant 
Strain.  Our transcriptional profiling and enzymatic activity assays strongly suggest that 
σS impacts the DNA damage response of S. aureus via regulation of the purine 
biosynthesis pathway.  With this in mind, we sought to examine the levels of purines in 
the cell for strains bearing a mutation in σS.  Total intracellular fractions were collected 
from cultures of the USA300 LAC wild-type and σS mutant strains grown as previously 
described for both the transcriptional and enzymatic analysis.  Samples were 
deproteinated through acid precipitation, and the nucleotide concentrations of the 
resulting supernatants determined by HPLC using a Hypersil SAX column (4.6 × 
250mm, Thermo Hypersil-Keystone, Bellefonte, PA) equipped with a guard column.  
Nucleotides were eluted using a discontinuous gradient at a constant flow rate of 1.0 ml  
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Figure 47. Adenylosuccinate Synthetase Activity is Decreased in a sigS Mutant. (A) 
The purine biosynthesis pathway. The conversion of inosine-5’-phosphate to adenylo-
succinate by the enzyme adenylosuccinate synthetase is highlighted in red.  (B) The 
USA300 LAC wild-type (W), its sigS mutant (M) and complement strain (C) were grown 
for 3 h in TSB.  Bacterial cell extracts were generated, and PurA activity assays 
performed. One unit is defined as the amount of enzyme required to utilize or release one 
nanomole of substrate or product per minute.  Specific activity is expressed as units of 
activity per mg of protein.  Data presented is representative of at least three independent 
experiments with error bars presented as +/- SEM , * = p<0.001 using a Student t test.  
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min−1 with absorbance recorded at 254 nm.  The nucleotide concentrations were 
determined from the peak areas, and standard curves from known concentrations of 
HPLC nucleotide markers.  As displayed in Figure 48A-B, the resulting spectrums 
showed notable differences between the wild-type and σS mutants, particularly during 
elution between 5 and 10 minutes.  Quantification of these differences in peaks through 
comparison to the HPLC nucleotide standards led to the finding that σS mutants display a 
decrease in the concentration of both ADP and GDP in the cytoplasm, with fold 
decreases of 2.0 and 6.2 respectively (Figure 48C).  This suggests that the observed 
decreases in transcription as well as a decrease in enzymatic activity of the purine 
biosynthesis proteins, leads to decreases in the intracellular concentration of purine 
nucleotides.  
Proteomic Analysis of the σS Mutant During DNA Damage Induced Stress.  We next 
sought to further explore the role of σS through examination of the cytoplasmic proteome 
of the mutant against its parental strain. This was performed using strain 8325-4 in the 
presence of MMS, which resulted in the highest level of sigS expression.  These 
conditions were selected to further supplement our transcriptomic analysis, with the aim 
of both validating the microarray and further elucidating components of the σS regulon.  
Thus, intracellular proteins were harvested from cultures of 8325-4 grown for 5 h in the 
presence of sub-MIC concentrations (2.5 mM) of MMS.  Our analysis revealed 52 
proteins to be negatively regulated by σS, and 95 to be positively affected.  Of those 
proteins negatively regulated by σS, we observed a number involved in protein synthesis 
and modification as well as cell envelope associated ontologies.  As displayed in Table 
14, two fold increases were observed for SACOL1946 and SACOL2125, encoding a  
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Figure 48. σS Deletion Results in Decreased Levels of Both ADP and GDP in the 
Mutant Strain. (A) Total intracellular components were collected from cultures of the 
USA300 LAC wild-type (WT) or the σS mutant (M) strains grown in TSB to hour 3.  
Samples were deproteinated and the nucleotide concentrations of the resulting 
supernatants determined by HPLC.  Nucleotides were eluted using a discontinuous 
gradient at a constant flow rate of 1.0 ml min−1 with absorbance recorded at 254 nm.  
Differences in peak areas indicate alterations in the nucleotide pools.  These differences 
found between the wild-type and sigS mutant strains are noted by red circles.  (B) 
Nucleotide concentrations were determined for both the USA300 LAC wild-type (W) and 
σS mutant (M) by comparison to peaks from standard curves generated with HPLC 
nucleotide markers.  Displayed are the resulting concentrations for purines ADP and 
GDP.  The data presented is from at least 3 independent experiments.  Error bars are 
shown as +/- SEM, * = p<0.05 using a Student t test. 
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Table 14. Proteins Negatively Influenced by σS Identified by Proteomic Analysis. 
Description ORF ID            Protein 
Fold 
Increasea 
DNA metabolism: replication, recombination and repair 
Thermonuclease family protein SACOL1357 
 
2 
Probable endonuclease 4 SACOL1614 Nfo 3 
DNA polymerase III, delta subunit SACOL1643 HolA 6 
Protein Synthesis/Modifications 
Foldase protein SACOL0544 PrsA 2 
Putative zinc metalloprotease SACOL1281 RseP 3 
Methionine aminopeptidase SACOL1946 Map 2 
10 kDa chaperonin SACOL2017 GroS 3.5 
Peptidase, M20/M25/M40 family SACOL2125 
 
2 
50S ribosomal protein L17 SACOL2212 RplQ 2 
30S ribosomal protein S19 SACOL2235 RpsS 3 
50S ribosomal protein L3 SACOL2239 RplC 4 
Energy Metabolism 
Indole-3-pyruvate decarboxylase SACOL0173 IpdC 2 
FMN-dependent NADH-azoreductase SACOL0190 AzoR 2.3 
Cytochrome d ubiquinol oxidase, 
subunit I 
SACOL1094 CydA 2.5 
Polyprenyl synthetase SACOL1510 
 
3 
Glucose-6-phosphate 1-dehydrogenase SACOL1549 Zwf 2.3 
Alpha-glucosidase SACOL1551 MalA 2 
glycine dehydrogenase SACOL1594 GcvPA 9 
Chorismate mutase SACOL1787 
 
2.7 
ATP synthase subunit alpha SACOL2097 AtpA 2.2 
ATP synthase subunit b SACOL2099 AtpF 2.3 
Cell Division 
Putative septation protein SACOL0541 SpoVG 4 
Septation ring formation regulator ezrA SACOL1767 EzrA 2.2 
Regulators 
Response regulator protein vraR SACOL1942 VraR 2 
Anti-sigma-B factor antagonist SACOL2056 RsbV 2.5 
Transcriptional regulator, AraC family SACOL2378 
 
3 
Cellular Detoxification 
Alkyl hydroperoxide reductase subunit 
C 
SACOL0452 AhpC 2.3 
Unknown Function/Hypothetical Proteins 
Hypothetical Protein SACOL0003 
 
2 
YycI protein SACOL0022 YycL 3 
aminotransferase, class II SACOL0596 
 
5 
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Table 14. Continued. 
Description ORF ID            Protein 
Fold 
Increasea 
 
Hypothetical Protein SACOL0669 
 
2 
GTP cyclohydrolase SACOL0789 FolE2 8 
Hypothetical Protein SACOL0984 
 
2 
Hypothetical Protein SACOL1089 
 
2 
DegV domain-containing protein SACOL1460 
 
2 
Aminotransferase, class V SACOL1677 
 
2 
Hypothetical Protein SACOL1973 
 
2 
Hypothetical Protein SACOL2020 
 
3 
Probable DEAD-box ATP-dependent 
RNA helicase 
SACOL2072 
 
2 
Hypothetical Protein SACOL2307 
 
3 
Hypothetical Protein SACOL2338 
 
4 
Hypothetical Protein SACOL2447 
 
2 
Isochorismatase family protein SACOL2667 
 
2 
Biosynthesis of Cofactors 
Glutamate-1-semialdehyde 2,1-
aminomutase 1 
SACOL1714 HemL1 2 
Biotin synthase SACOL2426 BioB 2 
Cell Envelope 
Serine-aspartate repeat-containing 
protein C (cell adhesion) 
SACOL0608 SdrC 3.3 
Penicillin-binding protein 1 SACOL1194 Pbp1 2 
Glutamine synthetase SACOL1329 GlnA 3.6 
Aminoacyltransferase SACOL1410 FemA 2 
Penicillin-binding protein 2 SACOL1490 Pbp2 2.4 
N-acetylmuramoyl-L-alanine amidase SACOL1687 Sle1 3 
Transporters 
Osmoprotectant ABC transporter, ATP-
binding protein, putative 
SACOL0781 
 
2 
aFold increase refers to the amount of protein in the sigS mutant relative to the wild-type 
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methionine aminopeptidase and a M20/M25/M40 family peptidase respectively.  Most 
notable, was an increase of 3-fold observed for SACOL1281, encoding a zinc 
metalloprotease demonstrating homology to RseP of B. subtilis; the site-2 membrane 
protease involved in activation of ECF sigma factor σE.  We observed a 3.3-fold increase 
in SACOL0608, encoding SdrC, a cell adhesion protein also identified as being 3.8-fold 
upregulated in our microarray analysis.  Fold increases of 2 and 2.4 were also observed 
for the penicillin-binding proteins Pbp1 and Pbp2 respectively.  An osmoprotectant ABC 
transporter, SACOL0781 displayed a 2-fold increase, which is comparable to that of 
SACOL0620, which encodes an osmoprotectant proline transporter indentified in our 
microarray analysis.  Further proteins found to be increased in the sigS mutant compared 
to the wild-type include SACOL1357, a thermonuclease family protein involved in the 
degradation and turnover of DNA, which displayed a 2-fold increase.  Of those proteins 
decreased in the sigS mutant, many were involved in cell wall metabolism, including a D-
alanine – D-alanine ligase involved in peptidoglycan biosynthesis, which was 4-fold less 
abundant in the mutant strain (Table 15).  In addition, we observed decreases in DdlA, 
MurF, MurC and FemX, all of which are involved in peptidoglycan synthesis, and were 
4-, 2-, 2- and 2.3-fold decreases respectively.  There was also a 2.5-fold decrease in the 
teichoic acid biosynthesis protein SACOL0238, as well as a 3-fold decrease in DltD, 
which is involved in biosynthesis of surface polysaccharides and lipopolysaccharides, 
and contributes to the overall net charge of the cell wall (Peschel et al., 1999). These 
findings corroborate our earlier transcriptional analyses, which demonstrate that sigS 
expression is increased upon exposure to cell wall destabilizing antimicrobial agents. 
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Table 15. Proteins Positively Influenced by σS Identified by Proteomic Analysis. 
Description ORF ID            Protein 
Fold 
Decreasea 
DNA metabolism: replication, recombination and repair 
DNA gyrase subunit B SACOL0005 GyrB 5 
DNA polymerase III, gamma and tau 
subunits  SACOL0520 DnaX 3 
DNA replication Initiation-control 
protein  SACOL0528 YabA 5 
Exoribonuclease, VacB/RNase II family SACOL0846 
 
2 
MutS2 protein SACOL1154 MutS2 2 
UvrABC system protein C SACOL1157 UvrC 3 
DNA mismatch repair protein SACOL1315 MutS 2 
Nuclease sbcCD subunit C  SACOL1381 SbcC 5 
Nuclease sbcCD subunit D SACOL1382 SbcD 2 
DNA topoisomerase 4 subunit A SACOL1390 ParC 2 
5'-3' exonuclease, putative  SACOL1479 
 
2 
Helicase, putative, RecD/TraA family SACOL1674 
 
2 
DNA polymerase I SACOL1737 PolA 2.25 
DNA ligase SACOL1965 LigA  2.25 
DNA mistmatch repair MutS family 
protein  SACOL2037 
 
2 
Chromosome partioning protein SACOL2735 ParB 4 
Nucleotide Biosynthesis 
Phosphopentomutase  SACOL0124 DeoB 2.5 
Thymidylate kinase SACOL0524 Tmk 3 
Deoxynucleoside kinase family protein  SACOL0603 
 
4 
Pyridine nucleotide-disulfide 
oxidoreductase SACOL0640 
 
4 
nucleotide-binding protein SACOL0830 
 
3 
Phosphoribosylformylglycinamidine 
synthase  SACOL1077 PurQ 4 
Phosphoribosylformylglycinamidine 
synthase 2 SACOL1078 PurL 5 
Phosphoribosylformylglycinamidine 
cyclo-ligase  SACOL1080 PurM 2 
Bifunctional purine biosynthesis protein 
purH SACOL1082 PurH 2 
Phosphoribosylamine--glycine ligase SACOL1083 PurD 3 
Pyridine nucleotide-disulfide 
oxidoreductase SACOL1520 
 
2.3 
Adenylosuccinate lyase  SACOL1969 PurB 2.8 
NH(3)-dependent NAD(+) synthetase SACOL1974 NadE 2.5 
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Table 15. Continued. 
Description ORF ID            Protein 
Fold 
Decreasea 
Protein Synthesis/Modifications 
Seryl-tRNA synthetase SACOL0009 SerS 2 
50S ribosomal protein L9 SACOL0015 RplI 3 
Heat induced protein SACOL0457 YflT 2 
30S ribosomal protein S15  SACOL1292 RpsO 2.5 
Elongation factor P  SACOL1587 Efp 2 
Chaperone protein dnaJ  SACOL1636 DnaJ 2.5 
Peptidase, U32 family SACOL1667 
 
2 
GTPase SACOL1699 Obg 4 
Aminopeptidase PepS  SACOL1937 PepS 2 
30S ribosomal protein S8  SACOL2225 RpsH 2.3 
30S ribosomal protein S17 SACOL2230 RpsQ 3.5 
50S ribosomal protein L23 SACOL2237 RplW 2 
Iron sulfur cluster assembly protein 
FeS assembly ATPase  SACOL0914 SufC 3.5 
FeS assembly protein SufD SACOL0915 SufD 3 
putative FeS assembly protein SACOL0918 
 
4 
Cell Wall Metabolism 
Teichoic acid biosynthesis protein, 
putative SACOL0238 
 
2.5 
DltD protein  SACOL0938 DltD 3 
UDP-N-acetylmuramate--L-alanine 
ligase SACOL1790 MurC 2 
UDP-N-acetylmuramoyl-tripeptide--D-
alanyl-D-alanine ligase SACOL2073 MurF 2 
D-alanine--D-alanine ligase SACOL2074 DdlA 4 
Aminoacyltransferase femX  SACOL2253 FemX 2.25 
Cell Wall Associated 
Hypothetical protein (putative 
lipoprotein)  SACOL1306 
 
2 
TPR repeat lipoprotein  SACOL1503 
 
3 
Cellular Detoxification 
Arsenate reductase, putative  SACOL0876 
 
3.3 
Glutathione peroxidase homolog SACOL1325 BsaA 5 
Disulphide isomerase  SACOL1558 
 
3 
Amino Acid Biosynthesis 
5-methyltetrahydropteroyltriglutamate--
homocysteine methyltransferase  SACOL0428 MetE 2 
Homoserine dehydrogenase SACOL1362 Hom 2 
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Table 15. Continued. 
Description ORF ID            Protein 
Fold 
Decreasea 
Diaminopimelate decarboxylase SACOL1435 LysA 3.25 
Pyrroline-5-carboxylate reductase SACOL1546 ProC 3 
2-oxoisovalerate dehydrogenase, E1 
component, beta subunit  SACOL1561 
 
3.3 
Aminotransferase, putative  SACOL2000 
 
3 
Energy Metabolism 
acyl-CoA synthetase SACOL0164 
 
3 
Triosephosphate isomerase  SACOL0840 TpiA 2 
Protein nagD homolog SACOL0931 
 
2.3 
Glycerol kinase SACOL1320 GlpK 2 
Aminomethyltransferase  SACOL1595 GcvT 2 
6-phosphofructokinase SACOL1746 PfkA 2 
Putative aldehyde dehydrogenase 
SACOL2114  SACOL2114 
 
3 
Glucosamine--fructose-6-phosphate 
aminotransferase SACOL2145 GlmS 2.7 
Zinc-type alcohol dehydrogenase-like 
protein  SACOL2177 
 
2 
Putative NAD(P)H nitroreductase SACOL2534 
 
2 
Regulators 
Transcriptional regulatory protein  SACOL1535 SrrA 2 
N utilization substance protein B 
homolog SACOL1569 NusB 2 
Transcriptional regulator, putative SACOL1904 
 
2 
Serine-protein kinase rsbW  SACOL2055 RsbW 2 
RNA-binding protein SACOL2133 
 
4 
Unknown Function/Hypothetical Proteins 
Nitroreductase family protein  SACOL0874 
 
2 
Hypothetical protein (No conserved 
domains)  SACOL1258 
 
3 
Β-lactamase SACOL1870  
 
3 
Acetyltransferase, GNAT family  SACOL2532 
 
2 
Biosynthesis of Cofactors 
2-C-methyl-D-erythritol 4-phosphate 
cytidylyltransferase 2  SACOL0240 
 
6 
Folylpolyglutamate 
synthase/dihydrofolate synthase  SACOL1709 FolC 2 
Delta-aminolevulinic acid dehydratase SACOL1715 HemB 3 
Pyridoxamine 5'-phosphate oxidase; SACOL2379 
 
3 
Fatty Acid and Phospholipid Metabolism
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Table 15. Continued. 
Description ORF ID            Protein 
Fold 
Decreasea 
Carboxylesterase  SACOL0845 Est 2 
Enoyl-(Acyl-carrier-protein) reductase  SACOL1016 FabI 5 
Phosphate acyltransferase  SACOL1243 PlsX 4 
Diacylglycerol kinase  SACOL1626 DgkA 2.5 
Acetyl-coenzyme A carboxylase 
carboxyl transferase subunit beta SACOL1748 AccD 3 
Adaptation to Atypical Conditions (Stringent Response) 
Guanosine polyphosphate 
pyrophosphohydrolases/synthetases SACOL1689 RelA2 3 
Cell Division 
Cell division protein ftsA  SACOL1198 FtsA 2.5 
Cell division protein FtsY, putative  SACOL1251 FtsY 3 
DNA translocase ftsK  SACOL1295 FtsK 2 
aFold decrease refers to the amount of protein in the sigS mutant relative to the wild-type 
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A large number of proteins positively influenced by σS were in the DNA metabolism, 
recombination and repair, and nucleotide biosynthesis ontologies.  There are 15 proteins 
involved in DNA replication, recombination and repair that were identified by proteomic 
analysis as being decreased in the σS mutant compared to the parent.  We found a 
decrease in the bi-component exonuclease SbcDC, with fold decreases of 2 and 5 for 
SbcD and SbcD, respectively.  A decrease was also observed for a putative 5’-3’ 
exonuclease, which demonstrated a fold change of 2.  These exonucleases were also 
identified in our transposon screen, mutations in which led to increased expression of 
sigS.  A fold decrease of 2 was observed for both the DNA mismatch repair proteins 
MutS and MutS2, while the observed decrease in the UvrC protein of the nucleotide 
excision repair protein was 3-fold.  Sensitivity of the σS mutant was demonstrated during 
challenge by alkylating agents and UV radiation, both of which result in damage that can 
be repaired by MutS and UvrC respectively.  A 5-fold decrease was observed for the 
DNA gyrase subunit B, the target of nalidixic acid and ciprofloxacin; antibiotics 
identified in our transcriptional analysis as leading to the upregulation of sigS expression.  
Collectively, this suggests a role for σS in the regulation of genes whose products help 
protect against and repair DNA damage.    
 
We also identified 13 proteins involved in nucleotide biosynthesis as being decreased in 
the σS mutant. Included in this are the purine biosynthesis proteins PurL, PurQ, PurM, 
PurD, PurH and PurB, which demonstrated fold decreases of 5, 4, 2, 3, 2 and 2.8 
respectively.  This is comparable to that of our microarray analysis, where we observed 
2.5, 3.4, 2.5 and 2.1- fold decreases for PurL, PurQ, PurM and PurH respectively.  These 
182 
 
findings supplement our microarray analysis and further support a role for σS in the 
upregulation of purine biosynthesis genes in response to DNA damaging conditions. 
 
Exploring the Importance of σS During S. aureus infection.  We have previously 
established a role for σS in the pathogenesis of S. aureus using a murine model of septic 
arthritis.  Specifically, we noted that mice infected with the σS mutant displayed 
decreased weight loss, bacterial load in the kidneys and mortality, which demonstrates a 
role for σS in systemic infections (Shaw et al., 2008).  Transcriptional analysis 
demonstrates a significant increase in expression of sigS across both laboratory and 
clinical strains of S. aureus post exposure to pig serum, as well as following phagocytosis 
by RAW 264.7 murine macrophage-like cells.  Therefore, we sought to further examine 
the role of σS in combating the host immune system, and in the pathogenesis of S. aureus 
localized infections. 
 
In S. aureus, σS Aids in Protection During Interaction with Components of the 
Innate Immune System.  We first sought to determine the importance of σS during 
challenge by components of the innate immune system.  This was first performed using 
whole human blood and the USA300 wild-type, sigS and ecfX mutants, and their 
complemented strains.  As such, exponentially growing cells were inoculated into whole 
human blood, and incubated for 4 hours. After this time we recovered 2.1- and 1.3-fold 
less viable cells of the sigS and ecfX mutants, compared to the wild-type strain (Figure 
49A). Complementation analysis of both mutants restored viability to levels similar to 
that of the wild-type.  Following this, we also conducted macrophage survival assays,  
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Figure 49. σS Aids in Protection of the S. aureus Cell During Interaction with 
Components of the Innate Immune System. (A) The USA300 wild-type (W), sigS 
mutant (SM) and ecfX mutant (EM) along with sigS complement (SC) and ecfX 
complement (EC) strains, were analyzed for viability 4 h post-exposure to whole human 
blood.  (B) The USA300 wild-type (W), sigS mutant (SM) and ecfX mutant (EM) strains 
were analyzed for viability 24 h post phagocytosis by 264.7 RAW murine macrophage-
like cells.  CFU counts were determined both pre- and post-exposure, and the percent 
survival determined. Error bars are shown as +/- SEM, *= p<0.05 using a Student t test. 
Adapted from Miller et al., 2012.  
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again in the USA300 background, to assess the ability of the sigS mutant to persist upon 
phagocytosis.  At 24 h post-phagocytosis by RAW 264.7 cells, we observed a 4.5- and 
2.2-fold decrease in survivability of the sigS and ecfX mutant compared to the parent, 
respectively (Figure 49B).  Complementation was not possibly due to loss of plasmid, 
which is likely explained by significantly instability of the vector during phagocytosis, 
which we routinely observe when performing this assay.  Collectively, these findings 
support our earlier work, which indicates an important role for σS in the virulence of S. 
aureus.   
 
In S. aureus σS is Required for Full Virulence in Localized Infections. Given our 
findings regarding the importance of σS in systemic models of infection, we set out to 
determine if this is true for virulence in localized infections as well.  As such, 10, 5-wk 
old female SKH1-E nude mice were injected subcutaneously between the scapula with an 
inoculum of 1 X 108 cells of either SH1000 wild-type, or its sigS mutant.  After 6 days of 
infection, the mice were euthanized and abscesses harvested.  When determining the 
bacterial load per abscess, our studies revealed a reduction in the infectious capacity of 
the σS mutant.  We were able to recover an average of 8.38 x 107 CFU per abscess or 
84% of the mutant strain compared to a 6.61 x 108 CFU per abscess, or a 661% recovery, 
of the wild-type (Figure 50). This indicates that σS plays an important role in both 
localized and systemic S. aureus infections.   
 
Discussion.  As discussed previously, RN4220 contains a number of mutations 
throughout its genome that suggest it is perhaps far more prone to DNA damage than  
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Figure 50. σS is Required for Full Virulence in Localized Infections of S. aureus. Five 
week old, female SKH1-E nude-mice were infected with 1x108 CFU ml-1 of either the 
SH1000 wild-type (W) or sigS mutant (M) strains between the scapula.  Mice were 
sacrificed and abscesses collected 6 days post infection.  The data is presented as total 
bacterial load per abscess, with vertical bars representing sample mean and the average 
percent recovery listed. The statistical significance of bacterial recovery was evaluated 
using a Student t test with a 5% confidence limit. 
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other wild-type strains as a result of mutated and non-functional repair pathways.  We 
have proposed this as an explanation as to why sigS is upregulated in RN4220 at levels 
greater than other S. aureus wild-type strains.  Herein we show a significant growth 
defect for the sigS mutant in the RN4220 background as cells transition from stationary 
phase to exponential phase.  We show that the viability of RN4220 sigS mutant cells are 
comparable to that of the wild-type during late stationary phase; however, upon 
introduction to ample nutrients the sigS mutant cells stall far longer than the parent strain 
before reaching exponential phase.  This suggests that mutation of sigS coupled with the 
existing mutations in this strain leads to a decrease in the ability of the cell to sense and 
respond to the changing environment during exit from stationary phase.  Previous reports 
demonstrate that an accumulation of iron occurs during lag phase, which increases 
sensitivity of the cells to oxidative stress (Rolfe et al., 2012).  Additionally, an increase 
occurs in nucleotide metabolism during lag phase as cells prepare for growth and division 
during exponential phase (Rolfe et al., 2012).  As such, it is likely that lag phase cells are 
more prone to DNA damage and subsequently require the use of DNA damage repair 
pathways and nucleotide precursors; both of which seem to require a functional σS.  This 
suggests that upon entering into exponential phase, the RN4220 sigS mutant is decreased 
in its ability to both repair DNA damage and rapidly synthesize nucleotides, resulting in 
an inability to survive and replicate as efficiently as the wild-type.  Indeed, this 
contention is further supported by the observation that in addition to the DNA damage 
repair pathways, RN4220 also carries a mutation in orotate phosphoribosyltransferase, 
which is involved in pyrimidine biosynthesis.  This mutation also occurs in the 
NCTC8325 lineage strains 8325-4, as well as SH1000 (O'Neill, 2010); therefore, this 
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mutation alone is unlikely to lead to the observed growth defect of the sigS mutant.  
However, the additive effect of multiple mutations in DNA damage repair genes, as well 
as a decreased ability to synthesize DNA precursors, may lead to a greater need for σS in 
RN4220.   
 
Following on from our transcription studies we also performed phenotype profiling by 
first utilizing disk diffusion analysis.  We found that even under conditions leading to 
sigS expression, we observed no notable differences in the viability of the sigS mutant 
compared to the parent strain.  This indicates that under the conditions tested, the σS 
mutant is equally well adapted as the parent strain.  However, while this assay proves to 
be a valuable initial screen, it is also commonly qualitative, based on our findings.  
Furthermore, disk diffusion methods only allow end point analysis, thus phenotypic 
differences occurring during early growth phases may be overlooked.  The RN4220 σS 
mutant growth defect occurs only during exponential phase, and by hour 6 growth 
seemingly reverts to that of the wild-type.  Therefore, comprehensive analysis requires 
examination of time points prior to stationary growth, the single time point observed 
during disk diffusion analysis.   
 
As such, we performed death curve analysis with exponentially growing cells exposed to 
lethal concentrations of DNA damage agents and found that σS mutants have increased 
sensitivity to a broad range of DNA damage inducing stresses.  This data contradicts our 
previous findings from the disk diffusion assay, which showed no difference in the zone 
of inhibition of the mutant versus the wild-type.  As stated earlier, this observation 
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indicates that the affect may be growth phase dependant, and therefore would not be seen 
with disk diffusions.  Similar to MICs, disk diffusions allow only for analysis of 
stationary phase cultures, while the kill assays presented herein allow for examination of 
multiple times points during exposure.  The range of DNA damage agents that sigS 
mutants are susceptible to include alkylating and intercalating agents, reactive oxygen 
species and UV induced damage; each of which leads to the activation of specific and 
distinct repair pathways.  When we analyzed transcription of a number of DNA repair 
pathway genes in both sigS mutants and S. aureus wild-types, we observed no alterations 
in expression (Figure 51).  However, during transcriptomic profiling we did identify 
decreased transcription for genes involved in de novo purine biosynthesis.  Following 
challenge by DNA damage agents, there may be increased pressure for the cell to 
synthesize purines as the nucleotide pool is being depleted by activated repair pathways.  
As de novo purine biosynthesis appears to be σS dependent, this would explain why sigS 
is induced following DNA-damage, and why sigS mutants have impaired survival under 
such stress.  Collectively these findings corroborate our transcriptional analysis, and 
suggest a role for σS in the protection of S. aureus to general DNA damage stress, as 
opposed to one specific repair pathway.   
 
We show in our coculture studies, where the parent and mutant strains were grown 
together under a variety of conditions, that the sigS mutant is important for survival and 
fitness.  When the SH1000 sigS mutant was forced to compete with its parental strain, it 
displayed significantly reduced abilities for growth and proliferation.  This phenotype 
was only exacerbated during prolonged growth periods (7 days), or in the presence of  
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Figure 51. Expression of a Variety of DNA Repair Pathway Genes are Not Altered 
in the σS Mutant. Quantitative real-time PCR analysis of RN4220 (black) and its sigS 
mutant (grey) was performed with cultures grown in TSB at 37oC with shaking for 3h.  
The data presented is from at least 3 independent experiments.  Error bars are shown as 
+/- SEM.  
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external stressors.  Of those external stressors examined, a number have been implicated 
in leading to DNA damage, including hydrogen peroxide, diamide and acid/alkali stress.  
This supports both our previous transcriptional analysis, as well as our phenotypic 
analysis, which reveals a role for σS in the protection of S. aureus against DNA damage 
stress.  We demonstrate a decreased ability of the sigS mutant to survive against the wild-
type in the presence of EDTA, a chelating agent that acts to sequester metals.  This 
connects well with our transcriptional analysis, which shows that sigS transcription is 
increased during growth in metal limiting media.  As discussed earlier, this is likely a 
result of a decrease in cell wall stability in the absence of divalent cations.  The decreased 
ability of the sigS mutant to survive against the parent strain in the presence of the cell 
wall targeting compounds, Penicillin G and ethanol, further supports our previous 
transcriptional analyses, which shows sigS transcription to be increased during exposure 
to cell wall destabilizing chemicals.  Collectively, this suggests that sigS is advantageous 
to S. aureus both during standard growth conditions, as well as during times of starvation 
and/or stress.   
 
Microarray analysis revealed increases in the lactose fermentation genes, lacA, lacB and 
lacD in the absence of σS.  This connects well with previous findings that show mutation 
of the lactose repressor, lacR, leads to increased expression of sigS.  This would suggest 
that sigS responds to carbohydrate limitation, and may provide additional explanation as 
to why sigS mutants are less able to survive under starvation conditions.  We performed 
carbohydrate utilization assays on the RN4220 and USA300 LAC sigS mutants against 
the parent strains and found no notable differences in the ability to ferment lactose or any 
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other carbohydrate, including xylose, D-glucosamin HCl, mannose, ribose, galactose, 
fructose, raffinose and trehalose (Figure 52).  This analysis is similar to our disk diffusion 
assays, in that it only provides end point data when cells are deep into stationary phase. 
As such, there may be differences in the rapidity at which the sigS mutant utilizes these 
carbohydrates during earlier growth phases.  However, as the genes in the lactose operon 
are increased in the sigS mutant, this would suggest that they are not direct targets of this 
regulator, and thus carbohydrate utilization may not be the major role for σS in S. aureus 
cells.   
 
Another increase found in the sigS mutant through microarray analysis is the gene 
encoding staphyloxanthin.  This protein is a carotenoid pigment that gives S. aureus its 
characteristic golden color, which would suggest that in a sigS mutant pigmentation is 
increased.  More importantly, this protein acts as an antioxidant to help protect the cell 
against oxidative stress (Clauditz et al., 2006).  These findings support our transcriptional 
and phenotypic analyses, which show both sigS expression, and sigS mutant sensitivity, 
to be increased during exposure to hydrogen peroxide.  Further to this, previous reports 
demonstrate a correlation between staphyloxanthin production and purine biosynthesis 
and as such corroborate our findings that σS is involved in de novo nucleotide synthesis 
(Lan et al., 2010).  There was also an increase in genes encoding cell envelope associated 
proteins, such capsule (which helps inhibit phagocytosis), and the serine aspartate rich 
adhesion protein, SdrC.  It has been shown in E. coli, that post exposure to antibiotics, 
capsular genes are increased; and we have previously shown that expression of sigS is 
increased under these conditions (Drayson et al., 2011).  This suggests that the cell may  
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Figure 52. Carbohydrate Utilization Does Not Appear to be Mediated by σS.  The 
RN4220 and USA300 LAC wild-type and sigS mutant strains were grown in purple 
indicator broth containing different carbohydrates at a concentration of 1%.  Transition of 
the media from purple to yellow indicates that fermentation has occurred.   
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compensate for a loss of σS by increasing capsule production, which may serve as a 
barrier to external stress, such as antibiotics.  We also noted that an increase in 
transcription of the gene encoding the cell adhesion protein, SdrC, corresponds to 
increased clumping of the RN4220 sigS mutant during growth in rich media at 37oC 
(Figure 53).  This increase in adhesion may aid in protection of the cell from antibiotics 
in the absence of σS, as previous work demonstrates that exposure to antibiotics alters the 
cells adhesive capacity (Beachey et al., 1981).  We further see an increase in a number of 
secreted virulence determinants in the mutant strain, including both hemolysins and 
proteases, possibly as a means to acquire nutrients from the surrounding environment in 
order to enhance survival in the absence of σS.  We also discovered an increase in the 
thermonuclease precursor, nuc, which may serve to degrade DNA and RNA in the 
extracellular milieu in an effort to circumvent nucleotide depletion.   
 
This corresponds to the decrease we find across the purine biosynthesis genes in the 
absence of σS, suggesting that they are likely targets of regulation by σS, and by extension 
that it plays a role in de novo nucleotide synthesis.  This is confirmed in multiple S. 
aureus backgrounds through qRT-PCR analysis of each of the transcripts encoding 
purine biosynthesis genes located throughout the genome.  These findings were further 
confirmed at the enzymatic level through observation of decreased activity of the purine 
biosynthesis enzyme, adenylosuccinate synthetase, which catalyzes the conversion of 
inosine 5’ phosphate to adenylosuccinate in the generation of adenosine.  We also show a 
decrease in the levels of ADP and GDP in the cell in the absence of σS, which, taken  
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Figure 53. The Absence of σS Leads to Increased Clumping in RN4220.  The RN4220 
wild-type and sigS mutant strains were grown in complex liquid media at 37oC with 
shaking overnight.  The flasks shown here display an increase in the accumulation or 
clumping of cells in the sigS mutant on the sides of the flasks, as denoted by the red 
arrows.  These findings are repeatedly observed.  
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together with our transcriptional and enzymatic analyses, further confirms a role for this 
regulator in S. aureus purine biosynthesis.    
 
Proteomic analysis of the 8325-4 sigS mutant compared to the wild-type strain grown in 
the presence of MMS demonstrates a number of proteins altered in abundance.  The zinc 
metalloprotease, RseP, was increased in the sigS mutant, and is an intramembrane 
protease demonstrating homology to RseP of E. coli.  In this organism, it acts as the site-
2-protease involved in the cleavage of the RpoE anti-sigma factor (Akiyama et al., 2004).  
As such, our findings suggest that RseP of S. aureus may serve in the σS regulatory 
cascade. In such a scenario, upon deletion of sigS, the cell would attempt to increase 
RseP levels in order to generate more free and active σS protein.  Another protein 
increased in this analysis was a putative thermonuclease family protein, possibly involved 
in degradation of DNA and RNA to provide nucleotide precursors.  This corroborates our 
microarray analysis, which shows in the absence of σS the cell requires increases in 
transcription of the thermonuclease, nuc, possibly as a means for nucleotide salvage.  Our 
earlier finding that mutation of sigS leads to increased clumping of the cells is also 
supported by our proteomic analysis.  Specifically, we identify the adhesion protein, 
SdrC as being increased in the sigS mutant background, confirming our microarray 
analysis, which also identified sdrC as being increased.  
 
Of those proteins decreased in the sigS mutant, a number are involved in cell wall 
metabolism.  The first of these is DdlA, or the D-alanine – D-alanine ligase, which 
produces the cell wall peptidoglycan precursor, D-alanine – D-alanine, and is vital for 
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cell wall biosynthesis (Walsh, 1989).  Additionally, the product of the gene co-
transcribed with DdlA, MurF, was also identified as being decreased in a sigS mutant.  
This protein is involved in cell wall biosynthesis, and functions by attaching the D-
alanine – D-alanine motif to the UDP-N-acetylmuramic acid tripeptide (Sobral et al., 
2006).  Both DdlA and MurF are involved in resistance to certain cell wall targeting 
antimicrobials (Sobral et al., 2003).  Specifically, previous reports demonstrate that 
increased susceptibility of S. aureus to β-lactam antibiotics is directly related to 
impairment of DdlA (Meziane-Cherif et al., 2010).  Correlatively, we show an increase in 
expression of sigS post exposure to the β-lactam antibiotics ampicillin and oxacillin.  
Further to this, we show increased susceptibility of the sigS mutant during coculture 
analysis to the presence of penicillin G, another β-lactam, which may also be explained 
by this decrease in DdlA and MurF in the sigS mutant.  The observed sigS expression and 
sigS mutant sensitivity to cell wall targeting antibiotics may also be a result of a decrease 
in the UDP-N-acetylmuramic acid:L-alanine ligase, MurC (Kurokawa et al., 2008), and 
the peptidyltransferase, FemX, important for catalyzing the formation of the interpeptide 
bridge (Schneider et al., 2004).  This decrease in FemX in the sigS mutant correlates well 
with our findings from our transposon analysis, which reveals an insertion in another 
peptidyltransferase, FemB, leads to increased expression of sigS.  Collectively, this 
supports our transcriptional and phenotypic studies and suggests a role for σS in the 
response to extracytoplasmic stimuli.  Indeed, preliminary analysis in our laboratory 
reveals increased sensitivity of the sigS mutant to cell wall targeting antimicrobial agents 
(Burda and Shaw unpublished observations). 
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Importantly, a decrease was observed in the proteomics studies for proteins involved in 
DNA metabolism, replication, recombination and repair; including the DNA mismatch 
repair proteins MutS and MutS2.  MutS was also identified in our transposon screen, 
disruption of which leads to increased expression of sigS, and also a mutator phenotype 
in S. aureus (O'Neill, 2010), meaning that strains acquire random SNPs at a higher 
frequency.  In E. coli, MutS has a role in preventing homologous recombination; 
however, in S. aureus it appears to only have a minor role in this process (Matic et al., 
1994; Prunier and Leclercq, 2005; Rayssiguier et al., 1989).  Further to this, we identified 
a decrease in the levels of the bicomponent exonuclease SbcDC.  As stated previously, in 
E. coli, this exonuclease functions to repair DNA and maintain genome stability through 
cleavage of DNA hairpins caused by intrastrand base pairing of palindromic DNA 
(Chalker et al., 1988; Connelly et al., 1998; Connelly et al., 1999; Leach and Stahl, 
1983).  Its function in S. aureus is not completely understood; however, it has been 
documented to be induced by the SOS response, and has a role in protection against DNA 
damage created by UV irradiation (Chen et al., 2007).  SACOL1479, which encodes 
another 5’-3’ exonuclease was also decreased in the sigS mutant.  While little is known 
about this protein, it has been demonstrated that E.coli deficient in 5’-3’ exonucleases are 
more susceptible to DNA damage induced by UV exposure (Chase and Masker, 1977).  
Therefore, it is plausible that this 5’-3’ exonuclease and SbcC may be necessary to repair 
DNA in S. aureus that has been damaged by UV irradiation.  This further corroborates 
our finding that sigS mutants are sensitive to damage by UV light; and we have 
previously identified disruptions in sbcC, and the 5’-3’ exonuclease, as leading to 
increased expression of sigS.  This increase in expression of sigS in exonuclease mutants, 
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as described during our previous transposon analysis, may be explained by an increased 
need for purines, as some exonucleases play a role in DNA and mRNA recycling as a 
part of purine salvage pathways that are induced following de novo inhibition (Datta and 
Niyogi, 1975; Wakamatsu et al., 2011).  This suggests that in addition to the purine 
biosynthesis genes, the sbcDC operon may be controlled by σS, further supporting a role 
for it in both DNA damage repair and de novo purine synthesis.   
 
Of major significance, we observed a decrease in the levels of proteins involved in purine 
biosynthesis upon proteomic analysis.  These findings are unsurprising as we have shown 
transcription of these genes to be decreased in the sigS mutant.  Further to this, we have 
also performed enzyme activity assays that corroborate both of these findings.  The levels 
of nucleotides in the cells were also tested, and found to be deficient in the pools of ADP 
and GDP in the sigS mutant.  Collectively, this affirms the role we have established 
herein for σS in de novo synthesis of purines. 
 
Phenotypically, we show that σS is important for survival during growth in whole human 
blood, and following phagocytosis.  This supports our earlier work, which shows strong 
upregulation of sigS expression (regardless of background) under these same conditions, 
and reveals a major requirement for σS during virulence (Shaw et al., 2008).  Previous 
reports demonstrate an increase in the purine biosynthesis genes during growth of S. 
aureus in both human serum and blood (Malachowa and DeLeo, 2011).  As we 
demonstrate a requirement for σS for full activity of the purine biosynthesis genes, this 
may explain our expression analysis during growth in serum, as well as our observation 
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that sigS mutants display decreased survival during growth in human blood.  
Furthermore, studies have shown that adenosine synthesis is utilized by S. aureus as a 
method for evading host immune responses (Thammavongsa et al., 2009).  Reports also 
demonstrate the importance of a functional purine biosynthesis pathway for full virulence 
in S. aureus, as well as a number of other pathogenic organisms, including Bacillus 
anthracis, Mycobacterium tuberculosis, Brucella abortus and Salmonella typhimurium 
(Alcantara et al., 2004; Crawford et al., 1996; Jackson et al., 1999; Jenkins et al., 2011; 
Lan et al., 2010; McFarland and Stocker, 1987; O'Callaghan et al., 1988; Samant et al., 
2008).  Moreover, it has been observed that pathogenic organisms such as Burkholderia 
spp., B. abortus and Vibrio cholerae defective in DNA damage repair pathways are 
attenuated in virulence, underscoring that pathogenic bacteria are bombarded by DNA 
damaging conditions during infection (Cuccui et al., 2007; Davies et al., 2011; Rolfe et 
al., 2012; Yeager et al., 2001).  Together this suggests that, upon entry into the host, 
bacterial pathogens are faced with an array of DNA damaging conditions, which requires 
extensive use of repair pathways, and an increased need for nucleotide building blocks.  
As free nucleotide pools are very low within the human host, de novo synthesis becomes 
of paramount importance.  Given that, at least in the case of purines, this is under the 
control of σS in S. aureus, this likely goes some way to explaining the avirulence of sigS 
mutants.  
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CHAPTER 6: 
FINAL DISCUSSION 
 
Discussion.  Herein we present characterization of the lone extracytoplasmic function 
(ECF) sigma factor, σS, of Staphylococcus aureus.  Specifically, we demonstrate 
conditions under which sigS is expressed and we have identified potential members of the 
σS regulatory cascade; as well as potential members of the σS regulon.  Promoter mapping 
of the sigS locus reveals four discrete transcriptional start sites.  Promoters, P1, P3 and P4 
appear to be under the control of the housekeeping σ factor, σA (Figure 54A) while P2 is 
autoregulated by σS (Figure 54B).  Through transcriptional analysis, we demonstrate that 
expression of sigS is minimal under standard conditions in the majority of S. aureus 
strains. This likely results in baseline expression from one or a combination of promoters, 
as we are able to detect transcript in the SH1000 background under standard conditions 
during our initial 5’ RACE analysis.  As is typical of many members of the ECF 
subfamily, any σS protein produced under these conditions is likely sequestered by an 
anti-sigma factor and held inactive.  Upon the introduction of a stress, such as cell wall 
disruption or DNA damage, σS would be freed from the anti-sigma factor and allowed to 
upregulated the genes in its regulon, including its own P2 promoter.  We have identified 
herein a numbers of stressors that bring about increased expression of sigS, which fall 
under two major classes.  The first of which are considered a typical response of ECF  
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Figure 54. Depiction of sigS Promoter Recognition.  (A) The sigS promoters P1, P3 
and P4 are under the control of σA. (B) The sigS promoter P2 is under the control of σS. 
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sigma factors, and include those chemicals that lead to cell wall destabilization such as 
oxacillin, ampicillin, cefotaxime, SDS and phosphomycin.  The second group is distinct 
from that of classical ECF sigma factor responses, and is made up of compounds that 
induce DNA damage stress, including MMS, EMS, ciprofloxacin and hydrogen peroxide.  
Furthermore, we were able to establish that expression of sigS is strongly induced during 
challenge by components of the innate immune system, likely as a result of exposure to a 
combination of cell wall destabilizing conditions and DNA damage stress.   
 
Although the specific pathways for σS regulation are still unclear, we suggest that at least 
two signal transduction mechanisms may exist, as σS responds to both extracytoplasmic 
stress (cell wall targeting antibiotics) and cytoplasmic stress (DNA damage); which are 
typically signaled in different ways.  Interestingly, this is true for RpoE of E. coli, which 
was originally identified as being triggered by misfolded proteins in the periplasm or 
outer membrane through regulation by RseA, a transmembrane anti-sigma factor 
(Dartigalongue et al., 2001).  Evidence exists to suggest that RpoE also responds to 
nutritional stress in response to ppGpp in a RseA-independent manner (Costanzo and 
Ades, 2006).  The signaling mechanisms employed by ECF sigma factors that respond to 
extracytoplasmic stress involve negative regulation by a membrane bound anti-sigma 
factor, while those responding to cytoplasmic stresses function via soluble, 
cytoplasmically located anti-sigma factors.  Upon examination of the sigS locus, two 
candidate anti-sigma factors were identified.  The σS locus, displayed in Figure 55, 
contains a downstream gene ecfX located 112bp away, as well as a transcriptionally 
divergent gene, ecfY.  This gene clustering is conserved across all sequenced strains of  
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Figure 55. Hydrophobicity Plots of the Putative Anti-Sigma Factors in the sigS 
Locus.  (A) Depicted is the sigS locus, detailing the downstream genes ecfX and ecfY, 
which present candidate anti-sigma factors.  Transmembrane domains were determined 
from protein sequence utilizing a Kyte-Doolittle hydrophobicity plot (B) EcfX or a 
SOSUI membrane topology map (C) EcfY; however, only EcfY displays a 
transmembrane domain.  
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the Staphylococci.  Hydrophobicity plots indicate a membrane spanning region within 
EcfY; however, no such region exists in EcfX (Figure 55).  While neither EcfY nor EcfX 
fit the classic model, individually they each have characteristics of membrane bound and 
cytoplasmic anti-σ factors, respectively.  To investigate this, we began by examining 
whether ecfX was cotranscribed with sigS.  Our data shows potential transcriptional 
linkage of ecfX with sigS; thus if it functions as an anti-σ factor, then its inactivation 
should result in free σS protein, and upregulation of the sigS gene via autoregulation.  Our 
data herein actually demonstrates a requirement for a functional EcfX for expression of 
sigS, suggesting that this gene acts as a positive activator.  These findings appear 
counterintuitive as the general mechanism previously established for ECF σ factors 
include negative regulation by a downstream co-transcribed gene (Helmann, 2002).  We 
sought to further corroborate these findings through phenotypic analysis, with the 
hypothesis that if ecfX fulfills such a function, then any phenotypes observed for the sigS 
mutant should be reproducible in the ecfX mutant strain as well.  Indeed, strains bearing 
mutation of ecfX displayed a decreased ability to survive compared to the wild-type; 
however, this decrease was not as substantial as that observed for sigS alone.  In addition 
to providing validation of our earlier findings, this also confirms that the sensitivity 
observed for the sigS mutant strains is not a result of polar effects on the downstream 
gene, ecfX.  If this were the case, the sigS mutant phenotypes would be mirrored in the 
ecfX mutant strains.  Further to this, our initial transcriptional analysis suggests stronger 
activity of the internal promoter, which likely generates ecfX transcript.  One might 
suggest that response of the internal promoter to DNA damage and cell wall destabilizing 
conditions leads to the upregulation of ecfX to circumvent the stress.  However, if this 
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were indeed true, a mutation in ecfX alone would lead to decreased survival during 
exposure to these stress conditions, which, as we demonstrate herein, is not the case.  As 
mutations in ecfX do not demonstrate phenotypes to the full extent as that seen with sigS 
mutants, this suggests that activity of σS is diminished only slightly in the absence of 
ecfX.  Bioinformatic analysis of EcfX reveals a ComK-like domain located in its C-
terminus (Figure 56).  In B. subtilis, ComK acts as a DNA-binding protein involved in the 
upregulation of itself and other competence genes (van Sinderen et al., 1995).  Therefore, 
EcfX may act as a DNA-binding protein in a manner akin to that of ComK, which would 
suggest novel control of σS.  Further to this, ComK of B. subtilis associates with ClpC 
and MecA in a complex, indicating that it also possesses protein-binding ability (Dubnau 
et al., 2002; Nakano et al., 2002; Turgay et al., 1997; Turgay et al., 1998).  As the exact 
residues required for DNA-binding and protein-protein interaction are still unknown for 
ComK, it is not clear whether EcfX possess homology to the DNA binding domain or the 
protein-protein interaction domain.  This suggests that EcfX may interact with σS at the 
protein level, possibly through stabilization of the σS-RNAP complex.  This is supported 
by the fact that in the ancient Staphylococcal species, S. carnosus, σS and EcfX are 
actually a single gene/protein, suggesting that they function together in the cell towards a 
common goal (Figure 57).   
 
As we have shown that EcfX is not acting as an anti-sigma factor, we currently believe 
that the membrane associated protein, EcfY, may serve as the σS anti-sigma factor.  Of 
note, examples exist that demonstrate mutation in the anti-sigma factor of ECF-sigma 
factors can have a toxic affect on the cell, due to hyperactivity of the σ factor.  For  
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Figure 56. Bioinformatic Analysis of EcfX Reveals a ComK-like Domain.  A domain 
search was performed on EcfX through analysis with InterPro Scan, revealing a ComK-
like domain.  
 
 
 
 
Figure 57. Bioinformatic Analysis of σS in S. carnosus Reveals a Single Gene/Protein 
Containing Both σS and EcfX.  BLAST analysis was performed on σS through InterPro. 
(A) S. carnosus reveals a single protein containing both σS and EcfX, while (B) σS and 
EcfX are individual proteins in S. aureus.  
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example, the anti-sigma factor of RpoE2 in Sinorhizobium meliloti can only be mutated if 
RpoE2 is mutated as well; this was confirmed via introduction of a multicopy plasmid 
containing rpoE2, which produced only slow-growing colonies (Sauviac et al., 2007).  
This is further corroborated by the inability to overexpress the ECF sigma factor RpoE 
from E. coli, or its Pseudomonas aeruginosa homologue AlgU, due to toxicity (Nitta et 
al., 2000; Rezuchova and Kormanec, 2001; Schurr et al., 1996).  This may, therefore, 
explain why we did not identify any insertion in ecfY during our transposon screen. This 
contention is further corroborated by the observation that, no transposon insertions were 
obtained for ecfY in a recently generated ordered transposon library for S. aureus strain 
USA300 (The Nebraska Center for Staphylococcal Research).  Indeed, preliminary 
analysis in our laboratory suggests that S. aureus cells are remarkably recalcitrant to 
overexpression of sigS. 
 
We have demonstrated that expression of sigS under standard conditions can be achieved 
by random mutation throughout the genome, as observed for the laboratory strain 
RN4220, and our NTG generated SH1000 strains.  Additionally, this can be 
accomplished by individual transposon mutation in select genes, which led to the 
identification of a number of candidate σS regulators, including a potential anti-sigma 
factor and a site-1-protease.  The former is Msa, which was previously determined to play 
a role in modulating expression of SarA, a global regulatory protein involved in virulence 
determinant expression (Sambanthamoorthy et al., 2006).  Msa contains three membrane 
spanning regions, and, when mutated, leads to increased expression of sigS.  As such, this 
protein may serve as a potential anti-sigma factor for σS, whereby disruption of it would 
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lead to an increase in free σS within the cell, and subsequently an increase in its 
expression through autoregulation.  A membrane spanning, C-terminal protease, CtpA, 
was also identified in our screen as potentially regulating sigS expression.  This serine 
protease demonstrates homology to DegS of E. coli, which initiates the proteolytic 
cascade to free the ECF sigma factor RpoE during the response to heat shock (Grigorova 
et al., 2004).  Like DegS, CtpA contains one transmembrane domain, a prc or c-terminal 
peptidase domain, and a PDZ signaling/protein-interaction domain.  Of note, an 
additional putative site-1-protease denoted PrsW has been identified via in silico analysis 
by our group.  This putative protease demonstrates homology to PrsW of B. subtilis, 
which acts to cleave the σW anti-sigma factor, RsiW, in response to antimicrobial 
peptides and cell envelope stress (Ellermeier and Losick, 2006).  Current work suggests 
that the PrsW homologue is the σS site-1-protease, as a number of phenotypes are 
conserved between the prsW and sigS mutants (Krute and Shaw, unpublished 
observations).  Therefore, one might suggest activation of σS can occur via multiple site-
1-proteases, including both CtpA and PrsW, as depicted in Figure 58.  An example of 
such a scenario comes from CtpB of B. subtilis, which acts alongside a second protease, 
SpoIV, to bring about activation of the sporulation sigma factor, σK (Pan et al., 2003). 
Typically, ECF-sigma factor activation proceeds, following site-1- cleavage, by site-2-
proteolysis of the anti-sigma factor.  In the case of σS, we have identified a candidate 
S2P, the zinc metalloprotease, RseP, which was increased in the sigS mutant during our 
proteomic analysis.  RseP is an intramembrane protease demonstrating homology to RseP 
of E. coli and B. subtilis, both of which act as the site-2-protease involved in the cleavage 
of the RpoE and σW anti-sigma factors, respectively (Akiyama et al., 2004).  Similar to  
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Figure 58. The Putative Proteolytic Cascade Leading to σS Activation.  (A) During 
times of noninduction, σS is sequestered by an anti-sigma factor; putatively either Msa or 
EcfY. (B) Upon the introduction of stress (DNA damage or cell wall destabilization), the 
site-1-protease (S1P) cleaves the anti-sigma factor at the C-terminus.  Candidate 
proteases involved in this cleavage event include PrsW and CtpA.  Additionally, the 
signals that PrsW and CtpA receive to activate σS may be different; however, this also 
has yet to be confirmed.  (C) The putative site-2-protease (S2P) RseP then cleaves the 
anti-sigma factor at the N-terminus, releasing σS.   
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that observed for EcfY, RseP is also considered a putative essential gene, as it too was 
not identified in the ordered transposon library; which is confirmed by preliminary work 
in our laboratory (Krute and Shaw, unpublished observations).  As such, our findings 
suggest that RseP of S. aureus may serve in the σS regulatory cascade as depicted in 
Figure 58). 
 
Transcriptomic and proteomic analysis of the sigS mutant has revealed potential genes 
under its control.  These include the cell wall metabolism genes, femX and ddlA, which 
may go some way to explaining the increase in sigS expression observed during exposure 
to cell wall destabilizing conditions.  Importantly, preliminary analysis in our laboratory 
also reveals increased sensitivity of the sigS mutant to cell wall targeting antimicrobial 
agents (Burda and Shaw, unpublished observations).  Further to this, we identify the 
purine biosynthesis genes purA, purB, guaBA and purEKCSQLFMNHD, as well as the 
exonucleases sbcDC and SACOL1479, as targets for σS activity.  These genes are 
believed to aid in the response to DNA damage, which may explain why sigS expression 
is increased under such conditions.  Analysis of the region 5’ of the start codon for these 
genes led to the identification of putative sigS recognized promoters, displaying the 
consensus cAAAgt -12 bp- taTCA, as displayed in Table 16.  Interestingly, the putative 
recognition sites appear to differ slightly from the consensus identified in the sigS operon, 
which may be explained by the observation that σE of E. coli will recognize promoter 
sequences from the genes under its control that are far more divergent than its general 
consensus (Dartigalongue et al., 2001).  It has been suggested that this organism can 
afford these deviations as it only encodes two ECF σ factors; whereas other organisms  
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Table 16. Putative Promoter Elements of σS Regulon Genes. 
Genea ORF ID Operon size Function -35
 -10 Spacingb 5’UTRc 
sigS SACOL1827 2 Sigma Factor CAAAGT TATCA 12 134 
sbcD SACOL1381 2 Exonuclease aAAAGg TATtA 11 38 
 
SACOL1479 1 5’-3’ Exonuclease gAAAGT atTCA 12 116 
purA SACOL0018 1 Purine Biosynthesis gAAAGT TgTCA 13 161 
purB SACOL1969 1 Purine Biosynthesis tAAAGT TtaCA 11 207 
guaB SACOL0460 2 Purine Biosynthesis CAAAcg TgTgA 10 43 
purE SACOL1073 11 Purine Biosynthesis aAAAGa aAaCA 9 109 
femX SACOL2253 1 Cell Wall 
Biosynthesis 
gAAAca atTCA 13 158 
ddlA SACOL2074 2 Cell Wall 
Biosynthesis 
CAAAGa TAaCA 15 68 
a The first gene in the operon is listed. 
b The spacing listed represents the nucleotides located between the -10 and -35 elements. 
c The 5’ UTR is the distance from the -10 element to the start codon. 
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such as B. subtilis encoding a number of ECF σ factors, require highly conserved 
promoters in order to differentiate unique ECF regulons (Helmann, 2002).  As σS is the 
only ECF σ factor encoded by S. aureus, it is possible that it can tolerate significant 
divergence from consensus in a manner similar to that of σE of E. coli.   
 
We demonstrate here that sigS activity is increased when S. aureus is challenged by 
complement during growth in pig serum.  Further to this, we also present evidence for 
sigS upregulation during ex vivo infection, as we demonstrate a strong upregulation 
(regardless of background) upon phagocytosis by murine macrophage-like cells.  
Phenotypically, we show that σS is important for survival during growth in whole human 
blood, and following phagocytosis.  This supports our previous work, which reveals a 
major requirement for σS during virulence in septic infections (Shaw et al., 2008).  
Furthermore, we provide evidence herein that σS is also important for virulence in 
localized infections as well.  As stated earlier, our transcriptional analysis reveals 
expression of sigS during exposure to DNA damage stress; however, we show the σS 
regulon to potentially include purine biosynthesis genes.  In support of this, it has been 
observed that pathogenic organisms such as Burkholderia spp., B. abortus and Vibrio 
cholerae defective in DNA damage repair pathways are attenuated in virulence, 
underscoring that pathogenic bacteria are bombarded by DNA damaging conditions 
during infection (Cuccui et al., 2007; Davies et al., 2011; Roux et al., 2006; Yeager et al., 
2001).  Following challenge by DNA damage agents, there may be increased pressure for 
the cell to synthesize purines as the nucleotide pool is being depleted by activated repair 
pathways. This is supported by the fact that previous reports demonstrate an increase in 
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purine biosynthesis gene expression during growth of S. aureus in both human serum and 
blood (Malachowa and DeLeo, 2011).  As de novo purine biosynthesis appears to be σS 
dependent, this would explain why sigS is induced following DNA-damage, and why 
sigS mutants have impaired survival during infection.  Furthermore, studies have shown 
that adenosine synthesis is utilized by S. aureus as a method for evading host immune 
responses (Thammavongsa et al., 2009).  Reports also demonstrate the importance of a 
functional purine biosynthesis pathway for full virulence in S. aureus, as well as a 
number of other pathogenic organisms, including Bacillus anthracis, Mycobacterium 
tuberculosis, Brucella abortus and Salmonella typhimurium (Alcantara et al., 2004; 
Crawford et al., 1996; Jackson et al., 1999; Jenkins et al., 2011; Lan et al., 2010; 
McFarland and Stocker, 1987; O'Callaghan et al., 1988; Samant et al., 2008).  Together 
this suggests that, upon entry into the host, bacterial pathogens are faced with an array of 
DNA damaging conditions, which requires extensive use of repair pathways, and an 
increased need for nucleotide building blocks.  As free nucleotide pools are very low 
within the human host, de novo synthesis becomes of paramount importance.  Given that, 
at least in the case of purines, this is under the control of σS in S. aureus, this likely goes 
some way to explaining the avirulence of sigS mutants.  
 
Future Directions.  Our analysis of σS thus far has led to the identification of 4 unique 
promoters; however, it is unclear what transcript is generated from each.  As such, a 
major future direction should be in defining the sigS and ecfX transcripts through the use 
of RNAseq or 3’ RACE analysis.  Due to the low level of expression of this locus, even 
under inducing conditions, the sensitivity of northern blot analysis has thus far proven too 
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weak to detect sigS transcript, and as such is perhaps not the method of choice for these 
purposes.  Furthermore, the specific conditions under which each individual promoter 
responds is still unknown.  Future work may involve determining which promoter(s) 
is/are responsible for the increase in expression observed during exposure to cell wall 
destabilization or DNA damage.  As we have shown this to be difficult herein due to low 
levels of transcript generated from the individual promoters, the method of choice would 
likely be qRT-PCR, with various primers located 3’ of each promoter.  Preliminary 
analysis in our laboratory reveals a number of potential DNA-binding proteins that 
recognize the upstream sigS promoter region (Burda and Shaw, unpublished 
observations).  These regulatory factors putatively influence the activity of the different 
sigS promoters, and as such their identification would provide novel insight into the 
regulation of σS.  This identification could be accomplished through the use of pull down 
assays utilizing biotin tagged sigS promoter DNA and protein lysates.  These lysates 
could be generated from cells expressing sigS so as to identify positive regulators, or cells 
harvested during periods of minimal sigS expression to identify negative regulators.  The 
resulting proteins could then be studied via LC-MS analysis.  We have also identified 
here potential members of the σS regulatory cascade, and as such a major focus moving 
forward should be to identify the roles for EcfX and EcfY.  We show herein a role for 
EcfX in the positive activation of sigS; however, we have yet to elucidate whether this 
occurs through DNA-binding activity or protein-protein interactions.  As such, protein-
protein pull-down assays using purified σS and EcfX would be an ideal method for initial 
analysis.  To begin to evaluate a role for EcfY in the regulation of σS, one may suggest 
performing qRT-PCR analysis of this gene in the presence of a mutation in sigS.  The 
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idea behind this being that, as sigS and ecfY are not transcriptionally linked, transcription 
of the σS anti-sigma factor may be decreased to compensate for the mutation in sigS if it 
is acting as a negative regulator.  Further, if EcfY is truly an essential gene due to the 
necessity to negatively regulate σS, then mutation of EcfY should be possible in a sigS 
mutant background.  If a double knockout strain is possible, insertion of a plasmid 
containing a functional sigS gene under the control of an inducible promoter would verify 
this hypothesis, as induction should be lethal to the cell.  Elucidation of the regulatory 
cascade controlling σS activity, including further evaluation of the potential S1P and S2P, 
PrsW, CtpA and RseP, becomes important for a complete understanding of σS function.  
An important initial analysis of these genes would include qRT-PCR of sigS in the 
presence of mutations in each potential regulator during induction conditions.  
Specifically, if these proteins participate in the proteolytic cascade leading to σS 
activation, and subsequent autoregulation, then in the absence of these proteins, sigS 
expression should be decreased.   
 
Thus far our research has focused on identifying those regulators that positively affect 
sigS expression. As such, an additional area of study could be the utilization of a reverse 
transposon screen to identify regulators that negatively affect sigS expression.  This 
would be accomplished by plating the existing 8325-4 sigS-lacZ transposon library on 
TSA containing 2.5 mM MMS and X-gal, which will result in the production of blue 
colonies due to sigS upregulation.  However, any transposon insertions resulting in 
disruption of the activation of σS would be no longer blue, and could then be selected for 
insertion site identification.  Herein we also identify potential σS target genes, including 
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the purine biosynthesis genes purA, purB, guaBA and purEKCSQLFMNHD; however, it 
is still unclear whether their observed decreases in transcription are a direct result of σS 
activity.  Therefore, one could use transcription run off analysis as a means of 
investigating whether σS complexed with RNAP can direct transcription of these genes. 
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which is encoded by a four-gene locus that regulates pathogenesis,
and the shift from localized to invasive phenotypes [19–21].
Further regulators exist, including the 12 members of the SarA
family of DNA binding proteins [22], several of which have been
shown to be important in virulence factor synthesis (SarA, Rot,
SarT) [23–25]. There are also three metal-dependent DNA
binding proteins encoded within the S. aureus genome, two of
which (Fur and PerR) are required for the survival of S. aureus in
animal models of infection [26].
S. aureus also has 3 known sigma factors: a housekeeping sigma
factor, sA, originally described by Deora and Misra [27], and two
alternative sigma factors, sB and sH [28,29]. Of these three, sB is
by far the most widely studied, the effects of which are apparent in a
variety of cellular processes, including oxidative stress resistance,
pigmentation, protein secretion, biofilm formation, drug resistance,
adaptation to stress and the progression of disease [30–32]. Indeed,
strains of S. aureus lacking a functional sB are pleiotropically altered
at the phenotypic level, and demonstrate reduced virulence in in vivo
models of animal infection [30,33]. sA, encoded by the plaC gene,
was first identified over a decade ago based on its homology with sA
from B. subtilis [27]. It is analogous to other primary sigma factors in
that it is essential for growth, and controls much of the day-to-day
house-keeping transcription. Documentation of a third sigma factor,
sH, in S. aureus recently appeared in a study by Morikawa et al. [28].
Here it was shown that S. aureus possesses a homologue of the genetic
competence sigma factor, sH, from B. subtilis.
While the primary sigma factor directs much of the transcrip-
tion during growth, most organisms possess alternative sigma
factors that direct the transcription of specific regulons during
unusual physiological conditions. ECF, or extra-cytoplasmic
function, sigma factors form a distinct and diverse subfamily
within this class of regulators that often share distant or divergent
identity with other known s factors. As a group, they are by far the
most numerate of the sigma factor families [34,35], with
Streptomyces coelicolor possessing more than 50 such elements within
its genome. Other organisms, including Mycobacterium tuberculosis,
Pseudomonas aeruginosa and Bacillus anthracis encode 10 or more such
factors [34]. They have been identified in a variety of Gram-
negative and Gram-positive organisms, and have been shown to
have wide-ranging and varied roles in cellular physiology. These
include the adaptation to: antimicrobial compounds, salt stress,
elevated or reduced growth temperatures, acidic pH, detergents,
oxidative stress, disulphide stress, iron starvation, osmotic stress,
carbon and nitrogen stress, high pressure and light [36–45]. More
importantly however, as the number of ECF-sigma factors
identified grows, attention is turning to their often considerable
roles in the virulence of pathogenic organisms [46].
Unusually, S. aureus seemingly achieves its versatile and adaptive
nature with only a limited selection of sigma factors. So far only
three have been documented, and only one of these (sB) has been
shown to have a role in cellular adaptation and virulence. In this
work we describe the characterization of a fourth S. aureus sigma
factor, an apparent ECF-sigma factor, which is seemingly involved
in cellular fitness and the adaptation to stress. Additionally it
appears to have a significant role in the pathogenic nature of S.
aureus, and likely represents an additional, key component in the
regulatory network of this organism.
Results
Identification of SACOL1827 as a putative ECF-sigma
factor
During work in our laboratory on the membrane proteases of S.
aureus, we generated a mutation in RseP. Multiple publications on
RseP proteases in E. coli, B. subtilis and Pseudomonas aeruginosa
demonstrate that they commonly serve to cleave the anti-sigma
factors of extra-cytoplasmic function (ECF)-sigma factors [47–53].
As it has previously been proposed by Helmann that the genome
of S. aureus likely contains an ECF-sigma factor [34], we undertook
an exploration of the S. aureus genome so as to determine whether
an as yet unidentified ECF sigma factor was present. Using the
protein sequence of the 7 known B. subtilis ECF-sigma factors, a
novel protein (SACOL1827) bearing homology to the ECF-sigma
factors sM and sYlaC was discovered in the S. aureus genome
(Table 1). BLAST analysis with this protein sequence revealed
homology with other ECF-sigma factors from a variety of
organisms (Table 1). The gene coding this protein is present in
the genome of all of the sequenced strains of S. aureus. Equally, it is
present in the four other sequenced Staphylococcal genomes: S.
epidermidis ATCC 12228 and RP62A, as well as S. haemolyticus and
S. saprophyticus. Our initial investigations of SACOL1827, using in
silico protein analysis, demonstrated the presence of both regions 2
and region 4 of s70. Further, in silico protein folding analysis (using
the 3D-JIGSAW, FUGUE and PHYRE databases) generated
strong homology scores for both of these regions (between 95–
100% certainty for region 2, and 90–95% certainty for region 4).
Overall our predictive protein folding and modeling analyses
returned a probability value of p =,0.001 for sS against the
founding-member of the ECF-sigma factors, sE of E. coli.
A common observance of ECF-family proteins is that the genes
encoding the sigma factors are contiguous to a coding region
specifying an anti-sigma factor. Analysis of the SACOL1827 locus
revealed a putatively transcriptionally-linked downstream gene
(SACOL1828) that is separated from SACOL1827 by 112 bp.
SACOL1828 is a conserved hypothetical protein with no
discernable homology to other proteins within the databases,
other than its direct homologues in staphylococci. In silico analysis
determined that these two genes are found clustered in this
arrangement in all of the sequenced S. aureus genomes (including
the RF122 bovine mastitis strain); in S. epidermidis ATCC 12228
and RP62A; and in S. haemolyticus and S. saprophyticus. Commonly
the anti-sigma factors of ECF-sigma factors possess membrane
associated domains, however analysis of SACOL1828 using a
Kyte-Doolittle hydrophobicity plot revealed no such region.
Interestingly, some ECF anti-sigma factors possess an
H(XXX)C(XX)C motif, as is the case in Streptomyces coelicolor and
Mycobacterium tuberculosis [54–56]. SACOL1828 bears a similar
sequence of H(LETN)C(VFH)C, which correlates well with that
found in other organisms.
Biochemical characterization of SACOL1827 reveals it to
be a sigma factor
Sigma factors bind to core RNAP in a reversible way in order to
induce transcription. To test the ability of S. aureus SACOL1827 to
bind to core-RNAP we generated recombinant protein using
standard E. coli overexpression techniques, and the 6HIS-tagging
vector pET24d (Novagen), as described previously [57]. Pulldown
assays were then performed using the purified protein and E. coli
core-RNAP (Epicentre). Recombinant SACOL1827 was coupled
to Ni-NTA agarose beads (via the HIS tag), followed by the
addition of core RNAP. Beads were then washed, resuspended in
sample buffer and loaded onto a SDS-PAGE gel. As a control, this
analysis was repeated in parallel omitting purified SACOL1827.
We determined that in the absence of SACOL1827, core-RNAP
was unable to bind the Ni-NTA beads, whilst in the presence of
SACOL1827 core-RNAP copurified upon elution (Fig. 1A).
Another common feature of ECF-sigma factors is that they have
a role in the autoregulation of their own expression. With this in
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mind we decided to test the ability of SACOL1827 to initiate
transcription from its own locus by transcriptional run off analysis.
Core-RNAP was preincubated with purified SACOL1827 protein
for 15 mins at 4uC, before the addition of an 1168 bp DNA-
fragment containing the sigS coding region and 945 bp of
upstream sequence. After further incubation (at 37uC for 15mins)
transcription was initiated by the addition of rNTPs, and allowed
to proceed for 30 mins. The mixture was then cleaned via two
acid-phenolchloroform extractions (to remove DNA contamina-
tion), and an isopropanol precipitation. The purified mRNA
transcript was then subject to a 1-step RT-PCR reaction with
primers internal to the SACOL1827 coding region (104 bp from
the initiation codon to 137 bp from the termination codon). This
experiment was repeated with controls, where either purified
SACOL1827 protein or core-RNAP was omitted from the
reaction mixture. The RT-PCR reactions were then resolved on
a 2% agarose gel (Fig. 1B), and revealed that only the
SACOL1827-core-RNAP complex lane yielded the expected
DNA fragment of 274 bp. The 2 control lanes demonstrated an
absence of bands, indicating that the acid-phenolchloroform
extractions effectively removed the template DNA. As the
SACOL1827-core-RNAP complex is capable of specifically
initiating transcription, we termed the SACOL1827 gene sigS,
and its resultant protein sS.
Analysis of a sigS mutant reveals a role for sS in the S.
aureus stress response
A common role of ECF-sigma factors is to protect bacterial cells
against external stress. In order to investigate if sigS has such a
purpose in S. aureus we created a SH1000 sigS::tet insertionally
inactivated mutant strain. Growth of the mutant was compared to
the wild-type and found to be indistinguishable in TSB media
under standard conditions (data not shown). However when long
term survival experiments were conducted (11 days, aerobic
growth, standard conditions) the sigS mutant showed a more
pronounced decrease in viability than the parental strain (Fig. 2A).
Table 1. Blast analysis for proteins homologous to SACOL1827 from Staphylococcus aureus.
Organism Assignment Identities Positives
No. of identical residues/total
no. of aligned residues
No. of similar residues/total
no. of aligned residues
B. subtilis sM ECF s factor 33/164 (20%) 73/164 (44%)
B. subtilis sYlaC ECF s factor 29/143 (20%) 69/143 (48%)
Idiomarina loihiensis ECF s factor 36/128 (28%) 69/128 (53%)
B. thetaiotaomicron ECF s factor 36/134 (26%) 72/134 (53%)
Pseudoalteromonas atlantica ECF s factor 35/121 (28%) 62/121 (51%)
B. cereus sM ECF s factor 31/108 (28%) 55/108 (50%)
V. parahaemolyticus ECF s factor 37/140 (26%) 70/140 (50%)
Oceanobacillus iheyensis ECF s factor 35/121 (28%) 59/121 (48%)
C. botulinum BotR/A s70 family 33/147 (22%) 78/147 (53%)
doi:10.1371/journal.pone.0003844.t001
Figure 1. Biochemical characterization of the SACOL1827 protein. (A) Pulldown Assay showing association of SACOL1827 with core-RNAP.
Lane order: L1, LMW Markers; L2, Monoclonal Anti-poly Histidine–Agarose antibody (with beads); L3, SACOL1827; L4, SACOL1827 (with beads); L5,
core-RNAP; L6, SACOL1827 + core-RNAP (with beads); L7, core-RNAP (with beads); L8, HMW Markers. (B) Transcription run-off assay. Lane order: L1,
DNA size markers; L2, transcription run-off conducted with core-RNAP + purified SACOL1827; L3, transcription run-off conducted with core-RNAP
only; L4, transcription run-off conducted with purified SACOL1827 only.
doi:10.1371/journal.pone.0003844.g001
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The sigS mutant strain lost viability at a consistently greater rate
than that of the parental strain, an effect that became more
pronounced as the experiment was prolonged. In order to assess
the long term implications of this, the mutant and parental strain
were subjected to starvation survival experiments over a period of
3 weeks (Fig. 2B). As with the 11 day experiment, the mutant
strain had a decreased viability during long term starvation when
compared to the parental strain.
ECF-sigma factors in a number of organisms have been shown
to be important in the response to elevated temperature stress
[38,44,58]. Therefore we tested the ability of the sigS mutant to
grow at elevated temperatures (40uC and 45uC), and to survive
heat shock (exponential cultures placed at 55uC for 15 mins before
being returned to growth at standard conditions). In each case the
sigS mutant strain responded to alterations in heat in a manner
akin to that of the parental strain (data not shown). However,
when we tested the viability of exponentially growing cultures
subjected to growth at 55uC, it was found that over a 2 hour
period the sigS mutant was more sensitive to killing by the elevated
temperature (Fig 3A). Following this, further death curves were
performed using the sigS mutant and its parental strain, in the
presence of 0.4 mg ml21 penicillin G, 50 mg ml21 lysostaphin and
0.05% Triton X-100. In the case of lysostaphin and penicillin G
no obvious difference was determined between the sigS mutant and
its parental strain. However, when Triton X-100 was used as a
lytic agent, the sigS mutant lysed at a quicker initial rate than that
of the parental strain (Fig. 3B). This early variations in lysis was not
borne out through the entire experimental time course, as the
parent and mutant strain reached equivalent levels of survival after
approximately 2 h.
Further to these experiments we set out to explore the role of
sigS in S. aureus physiology by subjecting the mutant strain to
growth analysis under a variety of different stress conditions. Disk
diffusions assays were conducted with SH1000 and the sigS mutant
in the presence of oxidative stress inducing compounds (30%
H202, 80% cumene hydroperoxide, 500mM diamide, 2M methyl
viologen, 1% menadione, 100mM plumbagin, 400 mg ml21
pyrogallol), nitric oxide stress inducing compounds (100mM
sodium nitroprusside), detergent stress (10% SDS, 10% Triton
X-100), acid (12M HCl) and alkali stress (6M NaOH), alcohol
stress (95% ethanol) and the antibiotics bacitracin (2 mg ml21),
vancomycin (2 mg ml21), penicillin G (5 mg ml21) and puromycin
(20 mg ml21). In each case no alteration in the zones of growth
inhibition were observed (data not shown). The mutant and
parental strain were tested further by growing them separately in
liquid media containing 1 M and 2.5 M NaCl, 20 mM Glucose,
and acidic and alkaline adjusted media (pH 5, with HCl; and
pH 9, with NaOH). Again no alterations in growth were detected
between the wild-type and mutant strain (data not shown).
Competitive growth analysis reveals the sS mutant has a
decreased fitness for survival
Competitive growth experiments were undertaken to assess the
viability of the SH1000 sS mutant when grown in coculture
Figure 2. Long term survival of the sigSmutant. The SH1000 sigS (&) mutant, along with its parental strain (X), were grown in TSB for 11 (A) or
21 (B) days. CFU/ml were determined at the specified intervals and are expressed as percentage survival.
doi:10.1371/journal.pone.0003844.g002
Figure 3. (A) Death curves of the sigS mutant and parental strain. (A), The effect of elevated temperature (55uC) on cellular viability.
Exponentially growing SH1000 (X) and the sigS mutant (&) were shifted from growth at 37uC to growth at 55uC, and viabilities were determine by
CFU/ml at the time intervals specified. The standard deviation of five replicate cultures is shown in the form of error bars. (B) Triton X-100 induced
lysis of the sigS mutant and its parental strain. SH1000 (X) and the sigS mutant (&) were lysed using 0.05% Triton X-100 and the CFU/ml determined
at the time intervals specified.
doi:10.1371/journal.pone.0003844.g003
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experiments with its parental strain SH1000. These experiments
are facilitated by the fact that the sS mutant is marked with a
tetracycline resistance cassette; thus plating dilutions of the
coculture on both TSA (Tryptic Soy Agar) and TSA containing
tetracycline, allows derivation of exact colony counts for each
strain, and thus calculation of the competitive index (CI). What
was found was that SH1000 inoculated with the sS mutant in a
1:1 ratio resulted in a 1:0.28 ratio after 24 hours growth (Fig. 4).
The mutant was even further impaired in its competitive abilities
against the parental strain after 7 days of growth, resulting in a
growth ratio of 1:0.04. As ECF-sigma factors commonly serve to
protect the cell during times of stress we hypothesized that sigS
mutant would show additional decline in coculture experiments
with the parent when grown in the presence of sub-inhibitory
concentrations of stress-inducing compounds. Indeed, whilst little
variation from non-stressed conditions was observed after
24 hours growth, significant differences were observed after 7 days
growth. When the experiments were repeated using the oxidative
stress inducing chemicals hydrogen peroxide (1 mM) and diamide
(1.5 mM) 7 day ratios were found to be 1:0.02 and 1:0.01,
respectively. Additionally when the pH was altered in coculture
flasks using HCl (10 mM) or NaOH (10 mM) further declines
were seen, yielding 7 day ratios of 1:0.005 and 1:0.0006,
respectively. Similarly coculture experiments using the metal ion
chelator EDTA (0.1 mM) produced 7 day ratios of 1:0.003.
Finally, and most dramatically, experiments using penicillin G
(0.01 mg ml21) and ethanol (5%) yielded no detectable sigS mutant
colonies after 7 days of growth with the parental strain.
Transcription profiling analysis of sigS expression
In order to determine the timing and levels of sigS expression in
S. aureus we created a lacZ reporter-fusion strain of SH1000. We
cloned a 1405 bp fragment into the suicide vector pAZ106, which
bears a promoterless lacZ cassette. This 1405 bp fragment runs
from 945 basepairs upstream to 354 basepairs downstream of the
sigS initiation codon. The possibility of additional promoter
elements being present in this fragment was excluded by analysis
of the sigS locus, revealing that SACOL1826 is located 199 bp
from the sigS initiation codon, and is transcribed in a divergent
orientation. This plasmid was first introduced into RN4220 before
being transferred to SH1000. Analysis of this strain on TSA
containing X-Gal revealed no blue coloration, even after
incubation of up to 1 week. We then grew the SH1000 sigS-lacZ
strain in liquid media for 3 days, removing aliquots at 1 hour
intervals in order to assay for specific sigS expression. We found
that even after 3 full days of growth, we could determine no
expression of lacZ from the sigS reporter strain (Fig 5; maximum
miller units were 19 at 52 h). The construct and mutant were
Figure 4. Competitive growth analysis of the sigSmutant and its parental strain. SH1000 and its sigS mutant derivative were cocultured in
TSB or TSB containing subinhibitory concentrations of: hydrogen peroxide (1 mM), diamide (1.5 mM), HCl (10 mM), NaOH (10 mM), EDTA (0.1 mM),
penicillin G (0.01 mg ml21) or ethanol (5%). The competitive index (CI) was determined for each strain after the respective growth periods and
represents the relative proportion of the two strains after inoculation at a 1:1 ratio. Data is representative of at least 3 independent cultures.
doi:10.1371/journal.pone.0003844.g004
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independently regenerated 2 additional times to ensure that no
unwanted genetic rearrangements had occurred with the plasmid,
or plasmid bearing strains; yet in each case no sigS expression, as
determined by b-Galactosidase activity, was detectable.
Studies of ECF-sigma factors in other organisms have
demonstrated the induction of ECF-sigma factor expression in
response to stress inducing compounds. Specifically, in one such
study by Cao et al [59], an elegant disc-diffusion reporter-gene
fusion method was employed to define conditions conducive to the
expression of sW in B. subtilis. Thus we employed a similar
technique using our sigS-lacZ fusion strain. TSA plates were
overlayed with TSB top agar (0.7% w/v) seeded with exponen-
tially growing SH1000 sigS-lacZ cells, and containing 40 mg ml21
X-GAL. Sterile filter discs were overlayed onto these plates (3 per
plate), before being inoculated with 10 ml of the following stress
inducing chemicals: 30% H202, 80% cumene hydroperoxide,
500mM diamide, 2M methyl viologen, 1% menadione, 100mM
plumbagin, 400 mg ml21 pyrogallol, 100mM sodium nitroprus-
side, 10% SDS, 10% Triton X-100, 12M HCl, 6M NaOH, 95%
ethanol, 2 mg ml21 bacitracin, 2 mg ml21 vancomycin, 5 mg
ml21 penicillin G and 20 mg ml21 puromycin. Plates were
incubated for 24 h at 37uC and screened for conditions conducive
to sS expression as determined by a blue halo around the edge of
the filter discs. Upon analysis we found that none of the chemicals
tested resulted in the induction of sS expression, as determined by
a lack of blue coloration on any of the test plates (data not shown).
Investigating the effect of SACOL1828 on sigS expression
As referred to above, ECF-sigma factors are often encoded
upstream of an ORF that specifies an anti-sigma factor. Whilst
SACOL1828 would be an unusual anti-sigma factor, as it lacks
any obviously membrane associated domains, we decided to assess
its role on sigS expression. As sS seems to have a role in
autoinducing its own transcription, it follows that if SACOL1828
were to inhibit the activity of the sS protein, then a SACOL1828
mutant would have higher sigS expression, as a result of an
increase in free sS protein. Thus we generated a SACOL1828::tet
mutant in SH1000, before transducing it with the sigS-lacZ
reporter-gene fusion. The presence of both mutation and
reporter-fusion were confirmed by PCR analysis, and the strain
was assayed for b-Galactosidase activity. Much like that seen with
the SH1000 sigS-lacZ fusion alone, we found that the inactivation
of SACOL1828 had no effect on sigS expression. Indeed no b-
Galactosidase activity was detectable in this strain even after
1 week of growth on TSA containing X-GAL. Because of the close
proximity of the integration sites for the sigS-lacZ and SACOL1828
mutation we regenerated this strain via an alternative manner.
Electrocompetent RN4220 SACOL1828::tet cells were prepared,
and used as recipients for electroporation with the sigS-lacZ
construct. Clones were analyzed for the presence of both the
mutation and reporter-fusion by PCR analysis, before 2
representative clones were used to generate phage lysate using
w11. These lysates was then used to transduce SH1000, with
transductants selected for on the basis of the resistances of either
the mutation (tetracycline) or the reporter-fusion (erythromycin).
Clones were screened by PCR to confirm the efficient con-
stransduction of each marker. Again as with the sigS-lacZ reporter-
fusion strain, the regeneration of this strain did not result in
detectable b-Galactosidase activity.
sS is required for the full virulence of Staphylococcus
aureus
As the number of ECF-sigma factors identified grows, attention
is turning to their often considerable roles in bacterial virulence
[46]. Therefore we studied the impact of sS on the virulence of S.
aureus infection in a murine model of septic arthritis. Mice were
intravenously inoculated with either the parental strain (SH1000)
or its sigS mutant derivative. In initial experiments using higher
doses of bacteria, ranging from 4.56106 to 86106 bacteria per
mouse, infection with the sigS mutant gave rise to significantly less
mortality when compared to animals infected with SH1000
(Fig. 6A). Data from 3 pooled experiments showed that only 3 out
of 30 mice infected with the sigS mutant died during the 14 day
experimental period, compared with 10 out of 30 mice infected
with SH1000 (p,0.05). In addition, mice infected with the sigS
mutant lost significantly less weight than mice infected with
SH1000. At day 5 post-inoculation, mice infected with the sigS
mutant had lost on average only 4.4% (213.3% to +2.2%, IQR)
of their body weight, whereas SH1000 infected mice had a median
weight loss of 10.4% (220.2% to 25%, IQR) (p,0.05, Fig. 6B).
At later time points the weight changes in surviving animals were
similar in the two groups, probably due to the markedly higher
mortality of mice infected with SH1000. The development of
clinical arthritis was significantly less frequent in mice infected with
Figure 5. Expression analysis of sigS using a lacZ reporter-fusion strain. An SH1000 sigS-lacZ strain was grown for 72 hours, with samples
withdrawn every hour to quantify the relative amount of sigS expression (N). The OD600 of the strain was also measured at each time point, and is
shown (#).
doi:10.1371/journal.pone.0003844.g005
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the sigS mutant, than in mice given the same dose of SH1000
(Fig. 6C). At 7 days post-inoculation with the sigS mutant only 2
out of 17 mice (12%) had clinically overt arthritis, as compared to
10 out of 17 mice (59%) infected with SH1000 (p,0.05). In
addition, the severity of clinical arthritis at this time point was
significantly reduced in the sigS mutant-infected mice, as
compared to SH1000-infected mice (p,0.05, fig. 6D).
Fourteen days after inoculation all limbs from the mice
inoculated with 36106 to 46106 bacteria per mouse were
subjected to histopathological evaluation. As shown in figure 7A,
infection with the sigS mutant induced much less erosion of bone
and cartilage as compared to infection with the parental strain
(p,0.05). In addition, infection with the sigS mutant also induced
somewhat milder joint inflammation than SH1000 (Fig 7A),
although these results were not found to be statistically significant.
The systemic immune responses of mice infected with the sigS
mutant and SH1000 were also compared by analyzing the levels of
the proinflammatory cytokine interleukin (IL)-6 in serum 14 days
post-inoculation. Mice infected with 36106 bacteria of the sigS
mutant had a median serum IL-6 concentration of 147 pg/ml
(IQR 130–202 pg/ml; n= 10), which was markedly lower than the
IL-6 concentration found in mice infected with SH1000, which
had a median of 358 pg/ml (IQR 219–729 pg/ml; n= 10)
(p,0.001, Fig 7B). Finally we investigated the ability of the strains
to persist in host tissues, by determining the CFU/ml in kidney
tissue homogenates. For this purpose, samples were taken from the
kidneys 14 days after inoculation with 36106–46106 staphylococ-
ci per mouse. The sigS mutant clearly showed a reduced capacity
to colonize host tissues, as it could not be detected in the kidneys of
6 out of 17 mice (35.3%). In contrast, growth of SH1000 was seen
in the majority of infected animals, with only 2 out of 17 mice
having negative kidney cultures (11.8%). The median number of
staphylococci in the kidneys was 56104 (IQR 0–3.46107) bacteria
after inoculation with the sigS mutant, as compared to 3.26107
(IQR 2.56105–1.36108) after inoculation with SH1000. Similar
results were obtained after inoculation with higher doses of
bacteria (data not shown).
Discussion
S. aureus is a complex and versatile pathogen, which employs
many different strategies in order to bring about its pathogenic
response. It possess a diverse and wide-reaching network of
regulatory elements that serve to fine-tune the coordinated
expression of virulence determinants [13,15,20,23,24], so as to
specifically bring about infection in a targeted manner. Addition-
ally, there are a number of regulatory elements that contribute to
the S. aureus virulence process, by controlling cellular physiology,
and the adaptation to external conditions. The presumably
facilitate both adaptation and proliferation in the harsh environ-
ment of the host [17,18,26,31]. Such loci, whilst not always
directly controlling virulence determinant production, are no less
important to the virulence process, as they facilitate the rapid
physiological switching that is a hallmark of S. aureus. This kind of
Figure 6. sS is required for the full virulence of S. aureus in a murine model of septic arthritis. (A), The cumulative mortality of mice
(assessed by a log rank test, p,0.05). N = 30 per group. (B), Changes of body weight in the same mice as in A (*p,0.05 as compared using a Mann-
Whitney U test.). (C), Frequency of clinical arthritis in mice inoculated with either wild-type S. aureus (SH1000) or its isogenic sigS mutant. The data
from 2 separate experiments were pooled, n = 25 per group at day 3, n = 18 per group at days 5–10, and n= 10 per group at day 14. Statistical
comparisons were performed using a chi-square test with Yates correction (*p,0.05). (D), Severity of clinical arthritis in the same mice as in C. Data is
presented as medians (horizontal lines); inter-quartile ranges (bars) and ranges (error bars). An arthritic index was calculated by scoring all four limbs
of each animal. Statistical comparisons were performed using a Mann-Whitney U test (*p,0.05).
doi:10.1371/journal.pone.0003844.g006
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responsiveness is commonly induced in other organisms by sigma
factors, as they present a rapid and direct way of modulating
stimulons in response to change. Rather unusually, S. aureus
seemingly achieves its versatile and adaptive nature with only a
limited selection of sigma factors. So far only three have been
documented [27,28,29], and only one of these (sB) has been
shown to have a role in cellular adaptation and virulence
[30,31,33]. The work presented in this current study demonstrates
that an additional, and as yet uncharacterized, 4th sigma factor
(sS) exists in S. aureus. sS appears to be a member of the ECF-
family of sigma factors, and likely represents an important
component of the stress and pathogenic responses of this organism.
Using biochemical approaches we have shown that sS is able to
associates with core-RNAP, and initiate transcription from its own
coding region. The autoregulation of ECF-sigma factor expression
is a common hallmark of this family of regulators, and has been
observed amongst a great many of their number [34]. Addition-
ally, using a sigS mutant of S. aureus, we have shown that sS
contributes to the protection against external stress, and plays a
role in cellular fitness and survival. This is not unexpected, as the
majority of ECF-sigma factors studied have been shown to
function in the adaptation to stressful conditions [36–45]. In this
study we present that sS is important for S. aureus cellular survival
when faced with prolonged starvation, and extended exposure to
elevated growth temperatures. Additionally a sigS mutant is
seemingly less able to survive, at least initially, the attack on cell
wall stability posed by Triton X-100. The observation of these
phenotypes for sS is not out of keeping with other ECF-sigma
factors, as a number are known to contribute to either heat shock
responses and/or modulate cell wall stability [34].
On the other hand, using disc diffusion analysis, we were unable
to find any increased sensitivity of the sigS mutant to a variety of
chemical stresses, including those generating oxidative stress
(H202, cumene hydroperoxide, diamide, methyl viologen, mena-
dione, plumbagin, pyrogallol), nitric oxide stress (sodium nitro-
prusside), detergent stress (SDS, Triton X-100), acid and alkali
stress (HCl, NaOH), alcohol stress (ethanol) and antibiotic stress
(vancomycin, penicillin G, puromycin). Whilst this may appear
unusual, given that a number of ECF-sigma factors in other
organisms respond to these conditions, it is not entirely
inexplicable. ECF-sigma factors are selectively induced in response
to the specific stress that they are intended to combat. Thus it is
likely the case that in S. aureus, sS is not the primary arbiter of
adaptation to the stresses listed above. This is particularly
pertinent to oxidative and antibiotic stress, as S. aureus has a
variety of mechanisms by which to circumnavigate and survive
these threats [60–69]. Therefore it is probably that the efforts
exerted in the present study have yet to hit upon the specific
condition to which sS is required to respond. Indeed it possible,
given the data generated by our animal studies, that the specific
stress(es) sS responds to are not ones that can be simulated in vitro,
but are uniquely associated with the in vivo lifestyle of S. aureus.
With that said, it is apparent that sigS does present some benefit
to the cell during in vitro growth. In our coculture studies, where
the parent and mutant strain were grown together under a variety
of conditions, it was clear that sS was a significant aid to the
survival and fitness of S. aureus. When the SH1000 sigS mutant was
forced to compete with its parental strain, it displayed significantly
reduced abilities for growth and survival. This phenotype was only
exacerbated during prolonged growth periods (7 days), or in the
presence of external stressor compounds. This would tend to
suggest that sigS presents a selective advantage to S. aureus cells
both during standard growth conditions, as well as during times of
starvation and/or stress. Therefore it would seem logical that sS is
a valuable component for maintaining cellular harmony and
stability, and as such likely represents an important mechanism by
which S. aureus protects itself against the harsh environments
encountered during growth.
Our transcription profiling studies of sigS turned up some
interesting information regarding its expression. It appears that
during growth under standard conditions, S. aureus SH1000 cells
do not initiate expression from the sigS locus. Our studies, which
were sampled every hour for 3 days, consistently revealed
expression in the typically background range of 0–1 Miller units.
Only in 2 instances during growth did we detect anything higher
than these values (32–36 h, and 48–52 h), and even then maximal
expression was only 19 Miller units. We have generated a number
of lacZ reporter-fusion strains in a variety of S. aureus backgrounds
Figure 7. Analysis of the requirement for sS in S. aureus infection as measured via histopathological evaluation and mounted
immune response analysis. (A), Histopathological evaluation of all limbs from mice 14 days post infection. The levels of synovitis and erosion
(*p,0.05) were measured and mean scores are represented by vertical bars. (B), Serum IL-6 concentrations were determined for infected mice. All
samples were run in triplicate. ***p,0.001.
doi:10.1371/journal.pone.0003844.g007
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[30,70–72] (unpublished data), and have never seen a strain that
displays such limited expression under specific analysis. Even upon
the analysis of apparently very lowly expressed genes (e.g. SH1000
ssp-lacZ fusion), which display little to no blueness on TSA X-gal
plates, we routinely observe expression units in the hundreds [30].
With this in mind, and given the length of our transcription
experiment, it is likely that even these 2 windows of minor
expression may be the result of something other than actual
induction of the sigS operon (e.g. cellular lysis). Therefore, as
asserted above, this would tend to suggest that sigS is not expressed
in SH1000 during growth under standard conditions.
This is certainly an unusual observation, but as ECF-sigma
factors are commonly inducibley expressed in response to stress
conditions, it perhaps not surprising. Indeed, analysis of the ECF-
sigma factors of B. subtilis provides similar examples of transcrip-
tional regulation. For example it has been reported that
transcription of the ECF-sigma factor sZ from B. subtilis is
undetectable during growth in rich and minimal media [73].
Further, specific analysis of B. subtilis ECF-sigma factor expression,
conducted by Asai et al [74], revealed that the expression of sV,
sY and sYlaC, in addition to sZ, were all equally low, and barely
detectable during growth under standard conditions. In a study
aimed at defining conditions conducive to sW expression in B.
subtilis, by Cao et al [59], an elegant disc-diffusion reporter-gene
fusion method was employed. Cells bearing a sigW-lacZ fusion
were grown on LB agar containing X-GAL, and overlayed with
filter discs containing a variety of antibiotics. Using this approach,
chemicals conducive to sW expression yielded a halo of blue
around the edge of the filter disc. We employed just such an
approach with our SH1000 sigS-lacZ fusion, using the chemicals
previously tested in sensitivity assays with the SH1000 sigS mutant.
Perhaps unsurprisingly, we found none of the chemicals tested
resulted in an increase in sS expression. This would tend to add
further weight to our assertion that in the present study have yet to
hit upon the specific condition to which sS is induced in S. aureus.
Further transcriptional analysis focused on the role of
SACOL1828 on sS expression. As referred to above, ECF-sigma
factors are often encoded upstream of an ORF that specifies an
anti-sigma factor. As sS seems to have a role in autoinducing its
own transcription, it follows that if SACOL1828 were to inhibit
the activity of the sS protein, then a mutation in SACOL1828
would have higher sigS expression as a result of more free and
active sS protein. Indeed similar approaches have been used to
analyze the putative anti-sigma factors of B. subtilis ECF-sigma
factors, including sYlaC and sX [75,76]. Our analysis found that
inactivating SACOL1828 did not result in an increase in sigS
expression, as would have been predicted if SACOL1828 were to
function as an anti-sigma factor. We suggest, however that this
observation may be explained by the apparent lack of sigS
expression in SH1000. If, as we find, there is little to no sigS
expression in SH1000 during growth under standard conditions,
then it follows that there is little to no sS protein present in the
cell. Therefore the inactivation of a sS anti-sigma factor would not
bring about the predicted snowballing of sigS expression, resulting
from free sS protein being able to auto-stimulate its own
transcription. Thus it appears that further investigation is required
before we can specifically determine whether SACOL1828 plays
any role in the regulation of sS activity.
The most striking, and indeed important, role we have defined
for sS is its role in the virulence of S. aureus. Using our murine
model of septic arthritis infection we have demonstrated that in
each of the tests applied, to determine the extent and severity of
disease, S. aureus cells lacking a functional sigS gene were
significantly impaired in their ability to establish and maintain
infection. Mice infected with S. aureus in this model lose weight,
undergo extreme destruction of joints, bone and cartilage, and
ultimately die. However those mice infected with the sigS mutant
lost significantly less weight, developed septic arthritis at
considerably lower levels, and most tellingly, had considerably
increased survival rates. In addition, our studies of mounted
immune responses by infected mice reveal that those animals
infected with the sigS mutant had significantly lower levels of IL-6,
indicating only a very weak immune response to the invading
pathogens. Finally, a major hallmark of septic arthritis is systemic
dissemination, moving from the site of infection into the kidneys.
Our analysis reveals that mice infected with the parental strain
possessed large numbers of S. aureus cells in the kidneys of infected
mice. However when the same analysis was conducted with the
sigS mutant it was apparent that strains of S. aureus lacking a
functional sigS gene were far less able to undergo systemic
dissemination. Collectively, the virulence data that we present
speaks very strongly to the importance of sS in the ability of S.
aureus to cause disease, a fundamental cornerstone of its innate
behavior.
From our investigations presented here we have demonstrated
that sS is important for the S. aureus stress response, aiding in the
protection against unfavorable conditions. In addition we have
shown that it is vital for the infectious nature of S. aureus, as a sigS
mutant is attenuated in virulence in a murine model of septic
arthritis infection. However the specific and mechanistic role of sS
in S. aureus biology remains unknown. It is unlikely; thought not
impossible, that sS wields its role via direct regulation of virulence
determinant expression. A more probable scenario is that sS, as
with other ECF-sigma factors, is responsible for sensing and
responding to discrete external cue(s); and changing S. aureus gene
expression profiles so as to protect the cell. It is the current and
future purpose of our laboratory to explore and develop an
understanding of the role of sS, which will doubtlessly further our
knowledge of this important human pathogen and its disease
causing abilities.
Materials and Methods
Bacterial strains, plasmids and growth conditions
The S. aureus and E. coli strains, along with the plasmids used in
this study are listed in Table 2. E. coli was grown in Luria-Bertani
(LB) medium at 37uC. S. aureus was grown in 100 ml TSB (1:2.5
flask/volume ratio) at 37uC with shaking at 250 rpm, unless
otherwise indicated. For growth analysis experiments, overnight
cultures were inoculated into fresh media to an OD600 of 1.0 and
allowed to grow for 3 hours. These cultures were then in turn used
to inoculate fresh TSB to an OD600 of 0.01, and these were used as
test cultures. CFU/ml counts were determined by the serial
dilution of test-cultures onto TSA, followed by enumeration after
overnight growth. All CFU/ml values represent the mean from
three independent experiments. When required antibiotics were
added at the following concentrations: ampicillin 100 mg ml21 and
tetracycline 12.5 mg ml21 (E. coli); tetracycline 5 mg ml21,
erythromycin 5 mg ml21and lincomycin 25 mg ml21 (S. aureus).
Where appropriate, X-GAL was added to media at a concentra-
tion of 40 mg ml21.
Overexpression and Purification of sS
The 470bp sigS coding region was PCR generated using primer
pair OL-389/OL-390 and cloned into the E. coli overexpression
vector pET24d (Novagen) to create pLES200. The plasmid was
subjected to DNA sequence analysis (UGA core facility) to ensure
that the coding region was generated without mistake. This
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plasmid was purified from E. coli DH5a and transferred to the E.
coli expression host Tuner (Novagen). Cells were grown at 37uC (in
LB supplemented with 34 mg/l chloramphenicol and 30 mg/l
kanamycin) before the induction of protein expression with
100 mM IPTG at an OD600 of 0.5. The culture temperature
was then reduced to 30uC and growth was permitted for a further
4–5 h with vigorous agitation. Cells were harvested by centrifu-
gation (10 min, 4,500 g), resuspended (Buffer A: 50 mM Tris-HCl
pH 8.0, 100 mM NaCl, 50 mM imidazole) and disrupted by
sonication. Soluble protein fractions, collected by centrifugation
(30 min, 14,000g, 4uC), were applied to a Chelating Sepharose
(Amersham) Ni2+ affinity column (1.5cm61.6cm). To ensure
saturated binding of the recombinant sS to the matrix, samples
were circulated through the column for 2.5 h using the Akta
Explorer system (Amersham), and then washed extensively with
Buffer A until the OD280 of the eluate dropped to a baseline
reading. Recombinant sS was eluted from the column in a
stepwise manner with buffer A containing imidazole at 140, 320
and 500 mM concentrations. Fractions eluted at 320 mM were
pooled and lyophilized in order to concentrate the purified
recombinant protein. This was then resuspended in water,
desalted (HiTrap desalting column, Amersham) by buffer
exchange (20 mM Tris-HCl pH 8.0, 20 mM NaCl) and re-
lyophilized. Protein purity was assayed by SDS-PAGE, yielding a
Table 2. Strains, plasmids and primers used in this study. Where applicable restriction sites are underlined.
Strain, Plasmid or Primer Genotype or Description Reference/Source
E. coli
DH5a w80 D( (lacZ)M15 D( (argF-lac)U169 endA1 recA1 hsdR17 (rK
2mK
+) deoR thi-1
supE44 gyrA96 relA1
78
Tuner F2 ompT hsdSB (rB
2 mB
2) gal dcm lacY1(DE3) pLysS (CamR) Novagen
S. aureus
RN4220 Restriction deficient transformation recipient Lab Stocks
SH1000 Functional rsbU derivative of 8325-4 rsbU+ 30
LES55 SH1000 sigS::tet sigS2 This Study
LES56 SH1000 SACOL1828::tet SACOL18282 This Study
LES57 SH1000 pAZ106::sigS-lacZ sigS+ This Study
LES58 RN4220 SACOL1828::tet SACOL18282 This Study
LES59 RN4220 SACOL1828::tet pAZ106::sigS-lacZ sigS+ SACOL18282 This Study
Plasmids
pAZ106 Promoterless lacZ erm insertion vector 77
pET24d 6His-tag overexpression vector Novagen
pLES200 pET24d containing a 470bp sigS fragment This Study
pLES201 pAZ106 containing a 2.3kb sigS fragment This Study
pLES202 pAZ106 containing a 2.2kb SACOL1828 fragment This Study
pLES203 pLES201 containing a tetracycline cassette within sigS This Study
pLES204 pLES202 containing a tetracycline cassette within SACOL1828 This Study
pLES205 pAZ106 containing a 1.4kb sigS fragment This Study
Primers
OL-281 ACTGGATCCCAGTTGCAGATGCATCTCTCC
OL-282 AGCTAGGCATGCCAAGTCTATCTGGCGTAC
OL-285 ACTGGATCCGACCATCACGATACATCA
OL-286 CTTCACTGACAACTATGCCG
OL-287 GCGATTACATTCTAGAAGTTCC
OL-288 GGAACTTCTAGAATGTAATCGC
OL-293 ATGGAATTCGTTTGAGCCATAGTCTTTCTC
OL-297 ATGGAATTCCTAATTAAAATTATGTTGGCATTTA
OL-387 GATGAGTATTATCAACTACTCTTG
OL-389 ATGACCATGGTGAAATTTAATGACGTATAC
OL-390 ATGACTCGAGATTAAAATTATGTTGGATTTTACGC
OL-429 TATCAACTACTCTAGATAAAAATGTGGC
OL-430 GCCACATTTTTATCTAGAGTAGTTGATA
OL-522 ATGTCTAGAGAGTAATGCTAACATAGC
OL-523 ATGTCTAGACCCAAAGTTGATCCCTTAACG
doi:10.1371/journal.pone.0003844.t002
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single band with a molecular mass of 19 kDa. The presence of the
6His-Tag in recombinant sS was confirmed by Western Blot with
anti-HisTag antibodies (Roche).
sS-Core RNAP Association Experiments
200 ml of anti-His-tag antibodies conjugated to agarose beads
(Sigma) were washed thoroughly (20 mM Tris-HCl pH 8.0,
10 mM NaCl) and incubated with 250 ml of 0.2 mg/ml
recombinant sS at room temperature for 3 h. The resin was
washed thoroughly with 20 mM Tris-HCl pH 8.0, 10 mM NaCl
and TBS-Tween, before adding 20 ml of core-RNAP at 1U ml21
(Epicentre). Samples were then incubated for 2(h at room
temperature followed by extensive washing. After adding SDS-
PAGE sample buffer, samples were boiled and centrifuged
(10(min, 16 000(g), and the supernatant subjected to SDS-PAGE.
Transcription Run-Off Experiments
0.25 mg of core-RNAP (Epicentre) was preincubated with 1 mg of
sS in transcription buffer [30mM Tris-HCl (pH 8.0), 10mM
MgCl2, 100mM KCl, 1mM DTT], at 4uC for 15mins. After this
time, 1 mg of a 1168 bp DNA-fragment (PCR generated using
primer OL-281/OL-297), containing the sigS coding region and
945 bp of upstream sequence, was added to the sS-core-RNAP
complex, and further incubated at 37uC for 15mins. Transcription
was initiated by the addition of 2.5 mM rNTPs, and transcription
was allowed to proceed for 30 mins at 37uC. After this time the
mixture was cleaned via 2 acid-phenolchloroform extractions (to
remove DNA contamination), followed by isopropanol precipita-
tion. The purified mRNA transcript was then subjected to a 1-step
RT-PCR reaction using primer pair OL-387/OL-293 (104 bp from
the initiation codon to 137bp from the termination codon, with a
target fragment size of 274bp) and the Superscript III enzyme
(Invitrogen). This experiment was repeated, omitting either purified
sS or core-RNAP as controls. RT-PCR reactions were resolved on
a 2% agarose gel and visualized using a BioDocIt Device (UVP).
Construction of the sigS and SACOL1828 mutant strains
A plasmid for the mutagenesis of sigS was constructed by PCR
amplification. Two approximately 1kb fragments were PCR
generated surrounding the sigS coding region (1 located upstream,
primer pairs OL-281/OL-430; and 1 located downstream, primer
pairs OL-282/OL-429). Primers OL-429 and OL-430 are
identical, but divergent to each other, and each contain base pair
mismatching, converting the wild type sequence of TCAAGC
(,100bp from the sigS Met) to TCTAGA, an XbaI restriction
recognition site. These fragments were purified and used together
as the template for a further round of PCR with primer pair OL-
281/OL-282. The resultant 2.3 kb DNA fragment was digested
with BamHI and SphI, and cloned into the suicide vector pAZ106
[77] to generate pLES201, using standard cloning techniques [78].
A plasmid for the mutagenesis of SACOL1828 was constructed in
a similar manner with the following exceptions. The two approxi-
mately 1kb fragments were generated using primer pairs OL-285/
OL-288, and OL-286/OL-287. Primers OL-287 and OL-288 are
identical, but divergent to each other, and contain mismatching that
converts the wild type sequence of TCTTAA (,100bp from the
SACOL1828 Met) to a TCTAGA XbaI site. These fragments were
used as the template for further PCR using primer pair OL-285/OL-
286. This 2.2 kb DNA fragment was digested with BamHI and SphI
and cloned into pAZ106 to generate pLES202 .
The novel XbaI sites in pLES201 and pLES202 were then used
as a target sites for the insertion of a tetracycline resistance
cassette, generated from pDG1515 [79] using primer pair OL-
522/OL-523. The XbaI digested cassette was cloned into
pLES201 and pLES202, yielding pLES203 (sigS) and pLES204
(SACOL1828). These were then used to transform electrocompe-
tent S. aureus RN4220, according to the method of Schenk and
Ladagga [80], with clones selected for on the basis of tetracycline
and erythromycin resistance. Integrants were confirmed by PCR
analysis (data not shown) and used as donors for the transduction
of S. aureus strain SH1000 using phage w11. Transductants were
selected for their resistance to tetracycline (indicating the presence
of the cassette) and sensitivity to erythromycin (indicating loss of
the plasmid and associated functional copy of sigS or SA-
COL1828), before being confirmed by PCR analysis. This created
strains LES55 (sigS) and LES56 (SACOL1828).
Construction of a sigS-lacZ reporter-fusion strain
The putative promoter region of sigS was amplified as a 1.4 kb
PCR fragment using primer pair OL-281/OL-293 (Table 2). The
purified DNA fragment was digested with BamH1 and EcoRI and
cloned into similarly digested pAZ106. S. aureus RN4220 was
transformed with the resulting plasmid, pLES205, and integrants
were confirmed by PCR analysis. A representative clone was then
used to transduce S. aureus SH1000 using w11, with clones again
confirmed by PCR analysis. This created strain LES57 (sigS-lacZ).
b-Galactosidase assays
Levels of b-Galactosidase activity were measured as described
previously [71]. Fluorescence was measured using a Bio-Tek
Synergy II plate reader, with a 0.1 sec count time, and calibrated
with standard concentrations of MU (4-methyl umbelliferone).
One unit of b-Galactosidase activity was defined as the amount of
enzyme that catalyzed the production of 1 pmol MU min21
OD600 unit
21. Assays were performed on duplicate samples and
the values averaged. The results presented here were representa-
tive of three independent experiments that showed less than 10%
variability.
Disc-Diffusion Assays
Disk diffusion sensitivity assays were performed as follows: 5 ml
of TSB top agar (0.7%, wt/vol) was seeded with 5 ml of
exponentially growing strains of S. aureus, and used to overlay
TSA plates. Sterile filter disks were placed in the centre of the
overlayed plates, and 10 ml of the test chemicals was applied at the
following concentrations: 30% H202, 80% cumene hydroperoxide,
500mM diamide, 2M methyl viologen, 1% menadione, 100mM
plumbagin, 400 mg ml21 pyrogallol, 100mM sodium nitroprus-
side, 10% SDS, 10% Triton X-100, 12M HCl, 6M NaOH, 95%
ethanol, 2 mg ml21 bacitracin, 2 mg ml21 vancomycin, 5 mg
ml21 penicillin G and 20 mg ml21 puromycin. This technique was
also adapted for transcription profiling using the SH1000 sigS-lacZ
strain. In this situation 5 ml of exponentially growing sigS-lacZ cells
was seeded into 5 ml of TSB top agar (0.7%, wt/vol) containing
X-GAL (40 mg ml21). This was then used to overlay TSA plates
before sterile filter discs (3 per plate) were placed on top of the agar
overlay. Filter discs were then seeded with 10 ml of the same stress
inducing chemicals listed above.
Cell Wall Lysis Experiments
Lysis kinetics using lysostaphin and Triton X-100 were
performed as described previously [81]. Penicillin G lysis was
performed as described by Fujimoto & Bayles [82].
Coculture experiments
SH1000 and the SH1000 sigS mutant were grown in
competitive culture experiments as described previously by
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Doherty et al [83]. Briefly, both strains were grown separately for
18h in TSB under standard conditions. Cells were harvested by
centrifugation, washed with PBS and used to inoculate fresh TSB
with an inoculation ratio of 1:1. These ratios were confirmed by
retrospective viable counts of the starting inoculum in triplicate.
Cultures were incubated at 37uC for the times specified and viable
counts were again determined in triplicate. These experiments are
facilitated by the tetracycline resistance cassette used to mark the
sigS mutant. Therefore plating dilutions of the coculture on both
TSA, and TSA containing tetracycline, allows derivation of exact
colony counts for each strain, and thus calculation of the
competitive index (CI).
Experimental models of S. aureus sepsis and arthritis
Female NRMI mice, 6 to 8 weeks old, were purchased from B
& K Universal AB (Sollentuna, Sweden) and kept in the animal
facility of the Department of Rheumatology and Inflammation
Research, Go¨teborg University. S. aureus strain SH1000 and its
isogenic sigS mutant were cultured on horse-blood agar plates at
37uC for 24 hours, harvested, washed in PBS and resuspended in
PBS supplemented with 10% dimethyl sulfoxide and 5% bovine
serum albumin. Aliquots of bacterial suspensions with a known
CFU/ml, as determined by viable counts, were stored at 220uC.
Before inoculation, bacterial cultures were thawed, washed once
with PBS and diluted in PBS to the desired concentration. In five
independent experiments mice were inoculated intravenously with
200 ml of bacterial suspension in declining bacterial doses (86106,
66106, 4.56106, 46106, and 36106 CFU/mouse). Viable counts
of the inoculum were performed in each experiment to confirm
the accuracy of each dose. Mice were individually monitored for
up to 14 days by an observer (CL) blinded to the identity of the
experimental groups for general appearance, weight change,
mortality, and the development of arthritis, before being sacrificed.
Clinical arthritis, defined by visible erythema and/or swelling of at
least one joint, was scored from 0 to 3 for each limb (1, mild
swelling and/or erythema; 2, moderate swelling and erythema; 3,
marked swelling and erythema). An arthritic index was generated
by adding the scores for each limb of a given animal.
Histopathological evaluations of the limbs were performed after
routine paraformaldehyde fixation, decalcification, paraffin em-
bedding, and hematoxylin and eosin staining. Tissue sections were
evaluated for synovitis and joint destruction by an observer (CL)
blinded to the identity of the groups. Synovitis and cartilage/bone
destruction were scored separately as 0, none; 1, mild; 2,
moderate; and 3, for severe synovial hypertrophy and joint
damage. The sum of all of the limbs was used to calculate a
histopathology score.
Bacterial persistence in host tissues was evaluated by aseptically
removing the kidneys, homogenizing them and performing viable
counts after serial dilution in PBS. The CFU/ml were determined
after 24 hours of cultivation on horse blood agar plates. Serum IL-
6 concentrations were determined as previously described, using a
bioassay in which the murine hybridoma cell line B9 is dependent
on IL-6 for growth, [84]. All samples were run in triplicate, and
the statistical evaluations of weight change and severity of clinical
and histopathological arthritis between groups was performed
using a Mann-Whitney U test. A chi-square test was used for
comparison of frequency of clinical arthritis between groups, whilst
the comparison of mortality was done by a log rank test. A p-value
,0.05 (after Bonferroni correction for multiple comparisons) was
deemed to indicate statistically significant differences.
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Staphylococcus aureus possesses 16 two-component systems (TCSs), two of which (GraRS and
NsaRS) belong to the intramembrane-sensing histidine kinase (IM-HK) family, which is conserved
within the firmicutes. NsaRS has recently been documented as being important for nisin resistance
in S. aureus. In this study, we present a characterization of NsaRS and reveal that, as with other IM-
HK TCSs, it responds to disruptions in the cell envelope. Analysis using a lacZ reporter–gene
fusion demonstrated that nsaRS expression is upregulated by a variety of
cell-envelope-damaging antibiotics, including phosphomycin, ampicillin, nisin, gramicidin, carbonyl
cyanide m-chlorophenylhydrazone and penicillin G. Additionally, we reveal that NsaRS regulates a
downstream transporter NsaAB during nisin-induced stress.NsaSmutants also display a 200-fold
decreased ability to develop resistance to the cell-wall-targeting antibiotic bacitracin. Microarray
analysis reveals that the transcription of 245 genes is altered in an nsaS mutant, with the vast
majority being downregulated. Included within this list are genes involved in transport, drug
resistance, cell envelope synthesis, transcriptional regulation, amino acid metabolism and
virulence. Using inductively coupled plasma-MS we observed a decrease in intracellular divalent
metal ions in an nsaS mutant when grown under low abundance conditions. Characterization of
cells using electron microscopy reveals that nsaS mutants have alterations in cell envelope
structure. Finally, a variety of virulence-related phenotypes are impaired in nsaS mutants, including
biofilm formation, resistance to killing by human macrophages and survival in whole human blood.
Thus, NsaRS is important in sensing cell damage in S. aureus and functions to reprogram gene
expression to modify cell envelope architecture, facilitating adaptation and survival.
INTRODUCTION
Staphylococcus aureus is a highly successful and dangerous
human pathogen that is a leading agent of both nosocomial
and community-associated infections. It has an extremely
diverse pathogenesis, causing infection in a plethora of
ecological niches within the host. Typically these proceed
from a localized site of infection (e.g. wound infection),
through to systemic dissemination (bacteraemia) leading
to metastatic disease (e.g. osteomyelitis, endocarditis and
septic arthritis). The pathogenic success of S. aureus is
Abbreviations: CCCP, carbonyl cyanide m-chlorophenylhydrazone;
ICP-MS, inductively coupled plasma-MS; IM-HK, intramembrane-sensing
histidine kinases; MU, 4-methyl umbelliferone; TCS, two-component
system; TEM, transmission electron microscopy.
The dataset for the microarray carried out in this study has been
deposited in the NCBI GEO database under accession number
GSE27061.
Two supplementary tables are available with the online version of this
paper.
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largely the result of its arsenal of virulence determinants,
which include haemolysins, toxins, adhesins and other
exoproteins, such as proteases, staphylokinase and protein
A (Lowy 1998; Novick, 2006). These damaging virulence
factors are subject to multi-level and multi-factorial
regulation, both temporally and spatially, in response to
the environments encountered during growth. Accordingly,
S. aureus has a diverse and wide-reaching network of
regulatory elements that serve to modulate gene expression
(Cheung et al., 1992; Fournier et al., 2001; Giraudo et al.,
1994; McNamara et al., 2000; Novick et al., 1995) and bring
about infection. These include all of the classical regulators
of microbial gene expression, including DNA-binding
proteins, regulatory RNAs, alternative sigma factors and
two-component systems (TCSs). This latter class is an
elegant mechanism of modulating gene expression in
response to external conditions. As the name suggests, they
are composed of two elements: a membrane-associated
histidine kinase and a cytoplasmically located response
regulator. These systems function to sense change in the
external environment and reprogram gene expression
accordingly, to circumnavigate stress.
In S. aureus, there are 16 conserved two-component
regulators encoded within the various genomes sequenced
thus far. Of this number, there are those that control
autolysis (ArlRS, LytRS), virulence (SaeRS, AgrCA) and cell
wall synthesis/drug resistance (WalKR, GraRS, VraSR)
(Brunskill & Bayles, 1996; Delaune et al., 2011; Fournier
et al., 2001; Giraudo et al., 1994; Kuroda et al., 2003; Meehl
et al., 2007; Novick et al., 1995). There are yet others that
sense external iron (HssRS), nitrogen (NreBC) or oxygen
(SrrRS) conditions (Schlag et al., 2008; Torres et al., 2007;
Yarwood et al., 2001). Recent phylogenetic analysis of
bacterial TCSs revealed a conserved group of regulators
termed intramembrane-sensing histidine kinases (IM-
HKs), which are largely confined to the firmicutes
(Joseph et al., 2002; Mascher, 2006). These unique TCSs
are characterized as having very small histidine kinase
proteins (less than 400 aa) with limited extracellular
spanning domains (no more than 25 aa). The IM-HKs
can be further divided into two major classes, those that are
encoded upstream of a two-component ABC-type trans-
port system, and those that are genetically linked to a
conserved membrane protein. The latter class is only found
in the low G+C Gram-positive bacteria and bears a HPK7
subfamily protein with multiple membrane-spanning
domains. The best studied example of this class of
regulators is VraRS from S. aureus, which is involved in
resistance to cell-wall-targeting agents, and has been shown
to protect against cell damage by modulating components
of the peptidoglycan biosynthesis pathway (Gardete et al.,
2006; Kuroda et al., 2003).
Quite distinct from the VraRS family is the second, and by
far the most numerate, class of IM-HKs, which are defined
by an HPK3i subfamily protein, containing only two
membrane-spanning domains (Mascher, 2006). This
family of regulators functions by sensing cell envelope
damage, and upregulating adaptation and survival path-
ways. This is mediated by a variety of processes, including
remodelling of cell architecture, and detoxification via
transport systems (Mascher, 2006). In S. aureus there are
two members of this latter family, the relatively well-
studied GraRS, and the recently named NsaRS (Blake et al.,
2011). GraRS has been described as being important in the
resistance of S. aureus to antimicrobial peptides by a variety
of mechanisms which remodel the cell wall (Herbert et al.,
2007; Li et al., 2007). Reference to NsaRS has only recently
appeared in the literature, where it was demonstrated to be
important for nisin resistance in S. aureus (Blake et al.,
2011). In this study we present a characterization of the
NsaRS system and reveal that, as with other IM-HK TCSs,
it responds to disruption of the cell envelope and redirects
gene expression to mediate resistance. Additionally, we
demonstrate that NsaRS is required for full biofilm for-
mation across a variety of S. aureus strains, and contributes
to survival during challenge by components of the human
innate immune system.
METHODS
Bacterial strains, plasmids and growth conditions. S. aureus and
Escherichia coli strains, along with the plasmids used in this study, are
listed in Table 1. The strains were grown as described previously
(Shaw et al., 2008). Cultures for growth experiments were obtained by
using the following protocol. Overnight S. aureus cultures (1 ml) were
used to inoculate fresh medium and allowed to grow for 3 h. These
exponentially growing cultures were used to seed new medium at
OD600 0.05. Test cultures were allowed to grow for the time period
required for the experiment. Where used, CLR medium consisted of
CL (containing 400 mM magnesium) with the following metals at a
final concentration of 0.2 mM: calcium chloride, copper sulfate,
ferrous sulfate, manganese chloride, nickel sulfate and zinc sulfate. We
deviated from published protocols (Horsburgh et al., 2001a) by
omitting molybdenum sulfate and including 0.2 mM cobalt sulfate.
Construction of an nsaRS reporter fusion strain. The putative
promoter region of the nsaRS locus was amplified as a ~1.5 kb
fragment (OL802/OL803) from S. aureus SH1000 genomic DNA. The
reporter fusion was then constructed as described previously (Shaw
et al., 2004). Briefly, the PCR fragment was cloned into the Gram-
positive suicide vector pAZ106 creating plasmid pSLK1. S. aureus
RN4220 was transformed with the resulting plasmid, and clones were
selected for using TSA containing erythromycin (plasmid-encoded).
The resulting strains were confirmed by genomic DNA extraction and
PCR analysis. Transformants were used to generate 80a phage lysates
for transduction of S. aureus SH1000, with clones again confirmed by
PCR analysis. This created strain SLK1.
Construction of the nsaS mutant strain. We generated an nsaS
histidine kinase mutation to probe the role of this system as described
previously (Shaw et al., 2004). An 800 bp PCR fragment within the
nsaRS locus was amplified (primers OL837/OL838) and cloned into
the pAZ106 suicide vector, generating pSLK2, which was used to
transform S. aureus RN4220 cells. A representative clone was used to
generate a phage lysate for transduction of S. aureus SH1000,
Newman and UAMS-1790 [USA300-HOU-MRSA (Highlander et al.,
2007) cured of pUSA300-HOU-MRSA, a gift from Dr Mark Smeltzer]
using 80a. This created strains SLK2, SLK3 and SLK4, respectively. In
this mutation, the forward primer (OL837) is located 191 nt
downstream of the ATG of nsaR, whilst the reverse primer (OL838)
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is located approximately one-third of the way into the nsaS coding
region (~350 nt into the 942 nt gene). Accordingly, the recombina-
tion event results in a full-length nsaR along with approximately
350 nt of nsaS connected to the natural promoter. The remainder of
the nsaS gene, including the histidine kinase region, is disrupted by
the insertion event. To further verify the mutation, we conducted
reverse-transcription studies, which confirmed, as predicted, that only
~350 bp of nsaS is transcribed with nsaR, and that no mRNA
containing the last two-thirds of nsaS (including the histidine kinase
domain) is produced (data not shown). To determine if mutation of
nsaS affected nsaR, we conducted real-time PCR analysis for nsaR in
both the SH1000 wild-type and its nsaS mutant. We observed no
alteration in expression of nsaR between the two strains (data not
shown), indicating that nsaS mutation produced no unintended
effects, such as compensatory nsaR overexpression.
Construction of nsaRS complemented strains. In order to
construct a complementation vector the entire nsaRS locus was
amplified (OL802/OL931) as a 2.5 kb fragment. In silico analysis
reveals an additional gene (SACOL2647) upstream of nsaR that likely
forms the first coding unit of this operon. Accordingly, the forward
primer is located 703 nt upstream of SACOL2647, and the reverse
Table 1. Strains, plasmids and primers used in this study
Restriction sites are underlined. Primers are given in 59–39 orientation.
Strain, plasmid
or primer
Genotype or description Reference or source
Strains
E. coli
DH5a w80 D(lacZ)M15 D(argF-lac)U169 endA1 recA1 hsdR17 (r2K m
2
K ) deoR thi-1
?<?show=sr]supE44 gyrA96 relA1
Lab stocks
S. aureus
RN4220 Restriction-deficient transformation recipient Lab stocks
8325-4 Wild-type laboratory strain rsbU mutant Lab stocks
SH1000 Wild-type laboratory strain rsbU functional Horsburgh et al. (2002)
Newman Wild-type laboratory strain Lab stocks
UAMS-1790 Sequenced USA300-HOU-MRSA isolate cured of pUSA300-HOU-MRSA Highlander et al. (2007); from M. Smeltzer
SLK1 SH1000 nsaRS–lacZ fusion This study
SLK2 SH1000 nsaS mutant This study
SLK3 Newman nsaS mutant This study
SLK4 USA300 nsaS mutant This study
SLK5 SH1000 nsaS mutant complemented with pSLK3 This study
SLK6 Newman nsaS mutant complemented with pSLK3 This study
SLK7 USA300 nsaS mutant complemented with pSLK3 This study
Plasmids
pAZ106 Promoterless lacZ erm insertion vector Kemp et al. (1991)
pMK4 cm shuttle vector Sullivan et al. (1984)
pSLK1 pAZ106 containing a 1.5 kb nsaRS promoter fragment This study
pSLK2 pAZ106 containing an 800 bp mutagenic nsaS fragment This study
pSLK3 pMK4 containing a 2.5 kb nsaRS complementation fragment This study
Primers
OL802 ATGGGATCCGTCACGTGTGCAGCATATGC
OL803 ATGGAATTCCAGGCGCGTCATGTTAACAGC
OL837 ATGGGATCCCATTGGTGTCAAGAAATCCGAA
OL838 ATGGAATTCCAGTTGTGCTGCAGTAATGGGTG
OL931 ATGGAATTCGTGCTGTCGTAGCATTCAAAC
OL1036 CCGCGCACATTTCCCCGAAA
OL1180 TGGTTACGCAAGGTGTTG
OL1181 TCAACTGGTGAAGGACTG
OL1222 GAAGCACAACATGGTGGT
OL1223 TTGCTGCTACTCCACCA
OL1224 AGATGAACTCGTCCA
OL1225 GCACATCTGAAGGCG
OL1226 CGTCATTGATGAGTGGTG
OL1227 GGTACACTCCAAACATGC
OL1333 CGGTGTTATTGTCGTTG
OL1334 ACCATT0TAACGTTGGCA
OL1335 TGCATGCCATGTTGCT
OL1336 TTCACCAGCTCCAACT
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primer terminates downstream of nsaS. This fragment was cloned
into the Gram-positive shuttle vector pMK4, creating pSLK3. S.
aureus RN4220 was transformed with this construct, and clones were
confirmed by genomic DNA extraction and PCR analysis, using a
combination of gene- and vector-specific primers (OL802/OL1036).
A representative isolate was selected to generate an 80a phage lysate,
to transduce the SH1000, Newman and UAMS-1790 nsaS mutants.
Clones were again confirmed by PCR analysis, creating strains SLK5,
SLK6 and SLK7, respectively.
Plate-based assay to determine alterations in transcription
resulting from external stress. This assay was performed as
described previously (Shaw et al., 2008). Briefly, TSA plates were
overlaid with TSB top agar (0.7% w/v) containing X-Gal, and seeded
with exponentially growing SH1000 nsaRS–lacZ reporter-fusion cells.
Sterile filter discs were overlaid onto these plates (three per plate)
which were then inoculated with 10 ml of the following stress
inducing chemicals: 6 M HCl, 85% phosphoric acid, 100% TCA,
88% formic acid, 0.2 M acetic acid, 6 M sulphuric acid, 6 M nitric
acid, 6 M sodium hydroxide, 2 M NaCl, 1 M glucose, 95% ethanol,
100% methanol, 100% 2-propanol, 10% SDS, 10% Triton X-100,
10% Tween-20, 1 M N-lauroyl sarcosine, 30% hydrogen peroxide,
1 M methyl viologen, 1% menadione, 2 mg pyrogallol ml21, 1 M
sodium nitroprusside, 1 M methyl-methane sulfonate, 5 mg penicil-
lin G ml21, 5 mg vancomycin ml21, 2 mg phosphomycin ml21, 5 mg
spectinomycin ml21, 100 mg ampicillin ml21, 5 mg nisin ml21, 5 mg
gramicidin ml21, 5 mg tetracycline ml21, 50 mg kanamycin ml21,
50 mg neomycin ml21, 10 mg chloramphenicol ml21, 20 mg
puromycin ml21, 2 mg bacitracin ml21, 1 mg oxacillin ml21, 1 mg
cefotaxime ml21, 5 mg D-cycloserine ml21, 1 mg teicoplanin ml21,
5 mg polymyxin B ml21, 5 mg chlorpromazine ml21, 0.1 mg
carbonyl cyanide m-chlorophenylhydrazone (CCCP) ml21, 1 mg
valinomycin ml21, 2 mg mupirocin ml21, 500 mM diamide, 12.8 mg
berberine chloride ml21, 4.21 M peracetic acid, 0.1 M EDTA, 1 M
DTT. Plates were incubated for 24 h at 37 uC and screened for a blue
halo around the perimeter of the filter discs, indicating expression.
Kirby–Bauer sensitivity profiling of cell-wall-damaging agents.
Overnight broth cultures of the SH1000 wild-type and its nsaS
mutant were diluted 1 : 1000 and added to 5 ml top agar; this was
mixed and used to overlay TSA plates. Lawns were allowed to dry for
15 min and sterile filter disks were added to each plate. Penicillin G,
oxacillin, ampicillin, cefotaxime, D-cycloserine, phosphomycin, gra-
micidin, teicoplanin, bacitracin or polymyxin B (all 10 ml) was added
to the filter disks from a 5 mg ml21 stock solution. Plates were
incubated at 37 uC overnight and zones of inhibition were recorded.
b-Galactosidase assays. Levels of b-galactosidase activity were
measured as described previously (Shaw et al., 2006, 2007).
Fluorescence was measured using a BioTek Synergy 2 plate reader
and calibrated with standard concentrations of 4-methyl umbellifer-
one (MU). One unit of b-galactosidase activity was defined as the
amount of enzyme that catalysed the production of 1 pmol MU
min21 (OD600 unit)
21. Assays were performed on duplicate samples
and the mean value was determined. The results presented here are
representative of three independent experiments that showed less
than 10% variability.
Transcriptomic studies. The SH1000 wild-type and nsaS mutant
were grown for 3 h, which corresponds to a window of maximal
nsaRS expression. After this time RNA was extracted, converted to
fluorescently labelled cDNA and hybridized to S. aureus COL genome
microarrays version 6.0, as described previously (Delgado et al.,
2008). Four hybridizations were performed for this study, including a
biological replicate and a dye-swap experiment for each replicate to
account for dye bias. Spots flagged as empty or bad were excluded and
the raw data from each slide were normalized using the LOWESS
method, with background correction. Data from the replicates were
combined (using the median value) and a one-sample t-test was
performed. A volcano plot was used with a fold change cut-off of¢2
and a P-value of ,0.05 to filter the genes that were differentially
expressed. ORF IDs in the list of differentially expressed genes were
then mapped to S. aureus COL IDs where possible. The entire dataset
for this study has been deposited in the NCBI GEO database under
accession number GSE27061.
Real-time PCR. Quantitative real-time PCR analysis was conducted
as described previously (Livak & Schmittgen, 2001; Riordan et al.,
2010) using primers specific for alanine dehydrogenase (OL1222/
OL1223), Rex (OL1224/OL1225), NarI (OL1226/OL1227), L-lactate
dehydrogenase (OL1180/OL1181), nsaR (OL1333/OL1334) and nsaA
(OL1335/OL1336). The control primers were for the 16s rRNA gene,
as described previously (Koprivnjak et al., 2006).
Thin-section electron microscopy. Aliquots of bacteria grown in
TSB or 10% NaCl for 3 and 6 h were processed and fixed as described
previously (Shaw et al., 2005). Samples were observed and photo-
graphed in an FEI Morgagni 268D (FEI)transmission electron
microscope with an Olympus SIS MegaView III (ResAlta Research
Technologies) camera at the Integrative Biology Electron Microscopy
Core Facility at the University of South Florida.
Negative staining electron microscopy. A method of fixing
bacteria in osmium tetroxide prior to pelleting was employed to
stabilize cell walls. Osmium does not cross-link any protein in culture
medium to bacterial cells, and allows preservation of the cell wall
structure throughout centrifugation. This permits rinsing to remove
culture media proteins prior to preparing cells for negative stain
preparation and transmission electron microscopy (TEM) analysis.
This method imparts electron density similar to that of uranyl acetate
or other similar negative stains commonly used to observe bacteria
via electron microscopy. Aliquots of cells grown in TSB for 3 and 6 h
were initially fixed in an equal volume of 2% osmium tetroxide in
distilled water for 1 h at 4 uC. Following fixation, cells were rinsed in
distilled water and pelleted three times at 5000 r.p.m. for 10 min.
Dilutions were performed to obtain approximately 2000–3000 cells
per drop, before one drop of each sample was applied to a carbon–
Formvar-coated copper grid. Grids were allowed to air dry and were
visualized by electron microscopy.
Biofilm formation assay. Biofilm formation assays were performed
as described previously (Beenken et al., 2003). The absorbance of
samples was read using a BioTek Synergy 2 plate reader.
Metal ion profiling using inductively coupled plasma (ICP)-MS.
The SH1000 parental strain, its nsaS mutant and the complemented
strain were grown in TSB and metal-limiting media for 4 h at 37 uC.
Cells were harvested and their pellets were weighed and dried at 80 uC
for 12 h. For hot acid digestion, filter pipette tips were rinsed with
2% nitric acid in ultrapure water. Dried pellets were allowed to
incubate for 1 h at room temperature in 500 ml ultrapure nitric acid
OPTIMA. Each sample was then transferred to a borosilicate tube and
placed in a silicone oil bath at 140–150 uC until ~200–250 ml each
sample remained. To each sample, 250 ml of 30% hydrogen peroxide
ULTREX II was added and incubated at room temperature for 5–
10 min. Tubes were placed back into the oil bath at 120 uC and the
hydrogen peroxide was allowed to evaporate until ~200–250 ml
remained. Tubes were removed from the water bath and ultrapure
water was added to each sample up to 5 ml. For ICP-MS analysis,
standards of the desired elements (1, 5, 10, 25, 100, 250 and
1000 p.p.b.) in 2% nitric acid were made to create a standard curve.
The ICP mass-spectrometer was tuned with 10 p.p.b. of elements
¢Li for optimization of lenses, and the internal standard used was
10 p.p.b. Indium. A blank (2% nitric acid) standard curve and the
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samples were loaded and processed using the Thermo PlasmaLab
software. The amount of each metal was determined based on p.p.b.
given and the dried cell weights. The data presented are derived from
at least five independent cultures.
Macrophage culture and S. aureus intracellular survival assay.
The Newman wild-type and its nsaS mutant were analysed using a
human macrophage model of survival and clearance, as described
previously (Kubica et al., 2008). The data presented were generated
from six independent experiments. The data were analysed using
Student’s t-test with a 5% confidence limit to determine statistical
significance.
Whole human blood survival assay. Exponentially growing
cultures of the SH1000 wild-type, nsaS mutant and the complemented
strain were washed three times with PBS and resuspended in 1 ml
whole human blood. The initial inoculum of each strain was also
determined at this time by serial dilution and plating on TSA. Blood
cultures were incubated at 37 uC with shaking for 3 h, before the c.f.u.
ml21 of each strain was determined, again by serial dilution and
plating. Data are presented as percentage survival of each strain
compared with initial inocula. These experiments were performed with
two separate blood samples and represent five independent replicates.
RESULTS
Transcriptional profiling of the nsaRS TCS
We initially set out to investigate the role of nsaRS by
analysing its transcription in the laboratory strain SH1000.
A reporter–gene fusion, using a promoterless lacZ cassette,
was created and monitored for transcription during
growth. Analysis revealed that maximal transcription of
nsaRS occurs during the exponential and post-exponential
phases of growth (2–5h) and declines into stationary phase
(Fig. 1a). Given that TCSs function by sensing external
stimuli, we sought to determine if the transcription of
nsaRS could be modulated by the presence of chemical
stressor compounds. As such, a plate-based assay was
employed, as described by Cao et al. (2002) and Shaw et al.
(2008), containing a variety of stress-inducing compounds
(see Methods) to mimic natural external conditions. What
we found was that a variety of cell-envelope-targeting
antibiotics upregulated transcription of nsaRS, includ-
ing ampicillin, phosphomycin, D-cycloserine, gramicidin,
nisin, CCCP and penicillin G (data not shown). To quan-
titatively confirm these observations, we conducted real-
time PCR on S. aureus SH1000 grown in either TSB or TSB
containing subinhibitory concentrations of ampicillin,
phosphomycin, penicillin G and nisin (Fig. 1b). When
analysed during a window of peak nsaRS expression (3 h)
we found that phosphomycin had the most dramatic effect,
increasing expression by approximately fivefold compared
with standard conditions. Further to this, analysis using
nisin revealed a 3.3-fold upregulation, whilst studies with
ampicillin revealed a twofold increase in transcription.
Finally, subinhibitory concentrations of penicillin G
revealed no alteration in nsaRS expression, perhaps
suggesting that greater concentrations of this agent, as
used in the plate-based assay, are required to induce
expression of this TCS.
NsaRS regulates transcription of the downstream
transporter NsaAB in response to nisin stress
As with other members of the IM-HK TCS family, NsaRS is
encoded upstream of a transcriptionally distinct locus that
specifies an ABC type transporter (termed NsaAB). The
existing paradigm of this arrangement is that the trans-
porter aids in detoxification of the cell in response to cell-
envelope-damaging agents, and is commonly regulated by
its cognate TCS (Staron´ et al., 2011). In order to ascertain if
NsaRS regulates NsaAB, we conducted real-time PCR
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Fig. 1. Transcriptional profiling of nsaRS. (a) A reporter lacZ fusion was created for nsaRS in the SH1000 background, and
analysed using 4-MU. Cultures were grown in TSB and OD600 (h) and b-galactosidase activity (&) was measured every hour
throughout growth. Data shown are from at least three independent cultures that demonstrated less than 10% variability.
(b) qRT-PCR was performed for nsaRS under standard conditions (3 and 5 h), and also following the addition of subinhibitory
concentrations of cell-wall-damaging chemicals (3 h). The data presented are from at least three independent experiments;
error bars, SEM.
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analysis on nsaAB in both the SH1000 wild-type and its
nsaS mutant during a window of high NsaRS expression
(3 h). Interestingly, we saw no alteration in nsaAB
transcription between these two strains under standard
conditions (Fig. 2). Given that these ABC transporters
commonly function as detoxification units, we repeated
nsaAB qRT-PCR analysis with cells grown under condi-
tions shown to induce nsaRS expression. Accordingly,
SH1000 was grown for 3 h in the presence of subinhibitory
concentrations of phosphomycin, ampicillin and nisin, and
analysed for nsaAB expression. Interestingly, whilst phos-
phomycin and ampicillin did not affect transcription of
nsaAB, nisin resulted in an approximately tenfold upregu-
lation of the transporter. To determine if the nisin-
dependent stimulation of nsaAB expression was mediated
via NsaRS, we repeated these analyses with the nsaS
mutant. Compared with the wild-type strain we observed a
twofold reduction in nsaAB expression in the nsaS mutant
when grown in a subinhibitory concentration of nisin.
Interestingly, the expression levels of nsaAB were still
increased fivefold above that of the wild-type grown under
standard conditions. This suggests that NsaRS plays a
major role in regulating nsaAB in response to nisin stress
but that other factors may also contribute to this process.
These findings are consistent with existing literature on
similar systems, which reveals that there is often discrep-
ancy between IM-HK TCS induction and downstream
transporter regulation (Staron´ et al., 2011).
NsaRS has a significant role in the ability of S.
aureus to develop resistance to bacitracin
In this study, we show that a number of cell-envelope-
targeting antimicrobials upregulate nsaRS transcription.
Additionally, others have shown the importance of NsaS in
the development of resistance to nisin (Blake et al., 2011).
Finally, a previous study revealed that an nsaS mutant had
a fourfold increase in sensitivity to bacitracin (Matsuo
et al., 2010). As such, we set out to assess the sensitivity of
the nsaS mutant to a variety of cell-envelope-targeting
antimicrobial compounds. Using a modified Kirby–Bauer
disk-diffusion approach we were unable to identify any
increase in sensitivity of the mutant compared with the
wild-type strain (see Methods for list; data not shown).
Further qualification of this observation by determining
minimum bactericidal concentration (MBC) also revealed
no alteration between SH1000 and its nsaS mutant (data
not shown). We suggest that these findings are consistent
with the existing literature, which demonstrates that
mutants of IM-HKs are themselves typically not sensitive
to the antibiotics they sense (Staron´ et al., 2011). More-
over, it is mutants of the transporters they regulate that
demonstrate this type of sensitivity (Staron´ et al., 2011).
This observation is somewhat surprising, however, given
that an nsaS mutant was previously reported as being more
sensitive to bacitracin (Matsuo et al., 2010). When per-
forming MIC analyses, we found that the nsaS mutant was
not altered for bacitracin in the SH1000 and USA300
backgrounds. The disparity between our findings, and
those of Matsuo et al. (2010) is probably explained by
bacitracin MICs of the strains chosen; our study used
SH1000 and USA300, whilst the previous study used MW2.
SH1000 and USA300 have an MIC of 16 mg ml21 for
bacitracin, whilst MW2 has an MIC of 64 mg ml21. The fact
that Matsuo and colleagues reported an MIC of 16 mg ml21
for the nsaS mutant in MW2, which is that observed for
our wild-types, suggests that intrinsic drug resistance
mechanisms of MW2 may have some impact on this effect.
Given the recent documentation of the role of NsaS in
mediating resistance to nisin, we next determined if the
nsaS mutant was impaired in its ability to mediate
resistance to other cell-wall-targeting compounds. As such,
we analysed spontaneous mutation frequencies for D-
cycloserine, phosphomycin, vancomycin, cefotaxime and
bacitracin. When performing 13 replicates from five
separate cultures, we were unable to find alterations in
the spontaneous mutation frequency for D-cycloserine,
phosphomycin, vancomycin or cefotaxime. We did, how-
ever, find a major discrepancy between the wild-type strain
and nsaS mutant for bacitracin. Specifically, we obtained
886 mutants from a combined inocula of 5.7761010 for
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Fig. 2. Role of NsaRS in regulating the
transporter nsaAB. Transcription of nsaAB
was initially determined under standard condi-
tions in SH1000 (WT) and its nsaS mutant
grown for 3 h. These analyses were repeated
using TSB containing subinhibitory concentra-
tions of phosphomycin, ampicillin and nisin in
SH1000 and its nsaS mutant (no change
observed for phosphomycin and ampicillin,
data not shown). The data presented are from
at least three independent experiments; error
bars, SEM.
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SH1000 when plated on bacitracin agar plates containing
36 MIC. In contrast, we were only able to obtain three
mutants from a combined inocula of 3.8461010 for the
nsaS mutant strain. This results in a spontaneous mutation
frequency of 1.5361028 for SH1000 and 7.81610211 for
the nsaS mutant, representing a 196-fold decrease in
spontaneous mutation frequency for the mutant strain.
Profiling the NsaRS transcriptome
Given that TCSs function via modulation of gene expres-
sion, we set out to analyse those genes that fall either
directly or indirectly under the control of NsaRS. As such,
we analysed an nsaS histidine kinase mutant via microarray
analysis. Cultures of both SH1000 and its nsaSmutant were
grown in TSB for 3 h, which corresponds to a window of
maximal nsaRS expression. Total RNA was converted
to cDNA and analysed using S. aureus COL genome
microarrays v. 6.0 as described previously (Delgado et al.,
2008). A total of 245 genes were found to be altered in
transcription at a level of twofold or greater. Of these
genes, 34 are negatively controlled by NsaRS (see Supple-
mentary Table S1, available with the online version of this
paper), whilst 211 are positively regulated (Supplementary
Table S2), indicating that this TCS functions overwhel-
mingly as a positive regulator of gene expression. Of those
genes found to be repressed, a large number were com-
ponents that had been previously implicated in virulence,
including b-haemolysin, hyaluronate lyase, fibronectin
binding protein A, seven of the genes required for capsule
formation and six of the ten extracellular proteases. This
last category of enzymes was amongst the most upregulated
in the nsaS mutant, with members of the spl operon
transcribed at levels more than sixfold higher than in the
parental strain. Perhaps unsurprisingly, of the 211 genes
positively controlled by NsaRS, a large number specify
proteins whose function is associated with the cell enve-
lope. These include components involved in cell wall
biosynthesis, surface proteins, cell-wall-anchoring enzymes
and, most extensively, those classified as encoding trans-
porters. Indeed, 55 such elements were identified of this
latter class, encompassing those either previously shown or
implicated in the transport of metal ions, amino acids,
peptides, sugars and antimicrobial compounds. In addition
to this, there were alterations in genes that function in the
biosynthesis and metabolism of amino acids, including
arginine, lysine, threonine, glutamate, aspartate, phenyla-
lanine and methionine. Another major class of genes with
altered expression included those involved in transcrip-
tional regulation, with 14 such elements identified,
including SarS and Rex. Other ontologies of function
identified included metabolic enzymes, DNA-damage-
repair-encoding genes and elements involved in nucleotide
biosynthesis. Interestingly, there were also a large number
of genes contained within the transcriptome that have
previously been shown to function in anaerobic growth,
including acetoin reductase, L-lactate dehydrogenase and
D-lactate dehydrogenase (Pagels et al., 2010).
Confirmation of transcriptome data was performed using
qRT-PCR analysis for selected genes identified in the
dataset. Specifically, this was performed for alanine
dehydrogenase, Rex, narI and L-lactate dehydrogenase,
revealing 12.56-, 2.69-, 3.83- and 2.12-fold changes,
respectively, in the nsaS mutant compared with the wild-
type, akin to that seen in the transcriptome.
ICP-MS profiling reveals that NsaRS is required
for metal ion transport under limiting growth
conditions
Transcriptomic analysis revealed a total of 55 transporters
displaying decreased expression in the nsaS mutant. Of
these elements, at least 20 appear to be specific to metal
transportation, particularly with respect to divalent metal
ions. Accordingly, we set out to analyse by ICP-MS the
ability of the wild-type, nsaS mutant and complemented
strains to import a variety of these ions. Quintuplet
samples of each strain were grown in either TSB or metal-
ion-limited media (CLR) supplemented with 400 mM
magnesium sulfate and 0.2 mM calcium chloride, copper
sulfate, ferrous sulfate, manganese chloride, nickel sulfate,
zinc sulfate or cobalt sulfate. Samples were then analysed
for the presence of the eight specific ions: Mg, Ca, Fe, Zn,
Co, Ni, Cu, and Mn. We found that whilst little variation
was observed during growth in replete media, the mutant
strain displayed a marked decrease in its ability to import
six of the eight metal ions tested when grown in limiting
media (Fig. 3). Specifically, we determined a 2-fold
decrease in cobalt, a 2.5-fold decrease in iron and calcium,
a 3.5-fold decrease in copper and an approximately 5-fold
decrease in both zinc and magnesium ions in the nsaS
mutant strain. These findings suggest a role for NsaRS in
metal ion import, particularly with respect to low-
abundance growth conditions.
Electron microscopy reveals alterations in the cell
envelope of nsaS mutant cells
Given that our data thus far suggest a role for the NsaRS
TCS in sensing cell envelope stress, we performed TEM
analysis of the wild-type, mutant and complemented
strains. When cells were grown in TSB for 3 h, we observed
that the nsaS mutant had a diffuse and less defined/smooth
cell wall compared with the parental and complemented
strains (Fig. 4). Additionally, negative stain analysis
revealed markedly increased encapsulation of the nsaS
mutant after 3 h of growth, which became even more
striking at later time points (data shown from 6 h). This
finding is perhaps explained by the observed greater than
twofold increase in transcription of seven of the ten genes
required for capsule biosynthesis in the nsaS mutant.
Finally, we also observed decreased transcription of a
number of osmoprotectants (cudT and opuCA) in the nsaS
mutant, along with a number of solute importers and
general permeases. Accordingly, we grew the strains in TSB
containing 10% NaCl to assess whether the nsaS mutant
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displayed impaired growth. Upon analysis we observed
only minor defects in the nsaS mutant when compared
with the wild-type strain (1.5-fold maximal decrease in
viability at 6 h growth). However when these same cultures
(6 h) were analysed by TEM we observed dramatic
alterations in cellular appearance. Following the trend of
TSB-grown cultures, mutant cells incubated with 10%
NaCl showed highly irregular and diffuse cell walls
compared with similarly grown wild-type and comple-
mented cells. Taken together, these data suggest that NsaRS
influences cell envelope architecture, particularly during
times of stress.
NsaRS contributes to biofilm formation in a
variety of diverse S. aureus strains
NsaRS is an orthologue of GraRS in S. aureus, another IM-
HK TCS involved in sensing disruption and instability of
the cell wall (Li et al., 2007; Kraus et al., 2008). Previous
work by other groups has revealed that GraRS mutants are
impaired in their ability to form a biofilm (Boles et al.,
2010; Herbert et al., 2007). In addition to this, we observed
that a number of proteins required for biofilm formation
display altered transcription in the nsaS mutant strain.
Specifically, proteases are strongly upregulated in the nsaS
mutant strain, which, as demonstrated by the recent work
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Fig. 3. The transport of divalent metal ions under low-abundance conditions requires a functional NsaRS. The SH1000 wild-
type (black), its nsaS mutant (light grey) and the complemented strain (dark grey) were grown for 4 h in metal-ion-limiting media
(CLR) containing 400 mM magnesium sulfate and 0.2 mM calcium chloride, copper sulfate, ferrous sulfate, manganese chloride,
nickel sulfate, zinc sulfate and cobalt sulfate. Cells were harvested and analysed for the presence of the supplementary metal
ions using ICP-MS. The data presented are from five independent cultures; error bars, SEM. Two graphs are presented because
of the widely differing y-axis scales.
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Fig. 4. NsaRS mediates remodelling of cell
envelope architecture. SH1000, its nsaS
mutant and the complemented strain were
grown in TSB for thin section (3 h cultures)
and negative stain (6 h cultures) analyses.
Additionally, thin section images were cap-
tured for strains grown in TSB containing 10%
NaCl (6 h). WT, Wild-type; M, nsaS mutant;
C, nsaS mutant strain complemented in trans
within nsaRS. The images presented are
representative of more than 10 frames from
three independent cultures. Bars, 0.2 mm.
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by ourselves and others, would be counterproductive to
biofilm formation (Beenken et al., 2010; Boles & Horswill,
2008; Tsang et al., 2008). Additionally, the nsaS mutant has
reduced expression of a number of anaerobiosis genes,
which should also negatively impact biofilm formation
(Beenken et al., 2004). Finally, the synthesis of the surface
proteins SasG and surface protein A, which have previously
been shown to be required for biofilm formation, are also
reduced in the mutant (Corrigan et al., 2007; Merino et al.,
2009). Analysis of the SH1000 nsaS mutant for biofilm
formation (Beenken et al., 2003) revealed a 3.7-fold
reduction for the mutant strain compared with the wild-
type (Fig. 5). This phenotype was reversed when the nsaRS
locus was introduced into the mutant strain in trans. Given
the importance of biofilm formation to S. aureus disease
progression, we assessed whether this phenotype was
reproducible in other strains. Accordingly, we tested nsaS
mutants in strain Newman and a community-acquired
MRSA USA300 isolate. Again, in each case we were able to
demonstrate a decrease in biofilm formation (Newman, 2.7-
fold; USA300, 3.9-fold) for nsaS mutant strains, which was
restored to wild-type levels upon complementation. Thus, it
would appear that NsaRS contributes to biofilm formation
across diverse and clonally distinct S. aureus strains.
NsaRS functions in protecting S. aureus cells
during interaction with components of the innate
immune system
In order to determine the impact of NsaRS on S. aureus
virulence, we examined interaction of the nsaS mutant with
components of the innate immune system. This was
performed using a human macrophage model of survival
and clearance previously described by us (Koziel et al., 2009;
Kubica et al., 2008). As such, the Newman wild-type and
nsaS mutant were challenged with human monocyte-
derived macrophages (hMdMs) at an m.o.i. of 1 : 50, and
monitored for up to 5 days. Our use of Newman in these
studies rather than SH1000, as in other studies, stems from
the observation that SH1000 produces variable and
inconsistent results in this model, whilst our experience
reveals that Newman generates far more reproducible data
(Koziel et al., 2009; Kubica et al., 2008). As such, we
observed a consistent and significant reduction in the
number of nsaS mutant cells recovered from infected
hMdMs over the course of the infection period (Fig. 6a).
Specifically, we observed a 25-fold reduction in mutant cells
after 24 h compared with the parental strain (P50.060).
Furthermore, by the second day post-infection we observed
a further 70-fold reduction in nsaS mutant cells (P50.036),
and by the third day we were unable to recover any cells
from nsaS-infected hMdM cells, whilst the parental strain
still returned 100–1000 c.f.u. ml21 at this time.
Further to this, we also used a whole human blood survival
assay to examine the pathogenic fitness of the nsaS mutant.
Accordingly, SH1000, its nsaS mutant and complemented
strain were grown to exponential phase in TSB, before
being inoculated into whole human blood. Cells were
incubated for 3 h, and the survivability of each strain was
determined and converted to per cent survival of the
inoculum. An analysis with two different blood samples
and five different replicates revealed that the wild-type and
complemented strains not only were able to survive
incubation in whole human blood but also continued to
grow. Specifically, we were able to recover 324±43.29%
(SEM) and 290±31.29% of the wild-type and complemen-
ted strain inocula, respectively, after 3 h incubation (Fig.
6b). In contrast, the nsaS mutant demonstrated a 2.4-fold
decrease in bacterial load compared with the parental
strain, returning only 136±48.88% of the inoculum upon
incubation. Thus it would appear that the nsaS mutant
strain is not only more rapidly cleared by hMdMs than the
wild-type but also impaired in its ability to proliferate in
human blood. As such, the NsaRS system seemingly has a
significant role during interaction with components of the
human innate immune system.
DISCUSSION
In this study, we present a characterization of the TCS
NsaRS from S. aureus. This TCS belongs to the IM-HK
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Fig. 5. The NsaRS TCS contributes to biofilm
formation in S. aureus. nsaS mutants in the
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were assayed for biofilm formation. WT, Wild-
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family of regulators which commonly modulate cell
envelope stability by sensing disruption of the cell wall
and membrane (Joseph et al., 2002; Mascher, 2006; Staron´
et al., 2011). We present evidence here that NsaRS fulfils a
similar function in S. aureus, responding to cell envelope
damage mediated by a variety of antimicrobial agents. A
recent study demonstrated that development of spontan-
eous resistance to nisin in S. aureus is primarily mediated
by NsaS (Blake et al., 2011). Nisin is a polycyclic
antibacterial peptide produced by Lactococcus lactis and is
particularly effective against other Gram-positive bacteria.
It functions by binding to the carbohydrate–phosphate
moiety of the cell wall biosynthesis component lipid II (de
Kruijff et al., 2008; Schneider & Sahl, 2010). By binding and
sequestering lipid II, nisin blocks cell wall biosynthesis and
can lead to delocalization of biosynthetic components and
aberrant septum formation (Hasper et al., 2006; Hyde
et al., 2006). Additionally, nisin is also believed to use this
docking event with lipid II to engineer pore formation in
the membranes of target cells. In this study we provide
corroborative evidence for the observations of Blake et al.
(2011) by demonstrating that nisin results in elevated
nsaRS expression and upregulation of the downstream
NsaAB transporter, which is, at least in part, dependent on
NsaRS.
Interestingly, in this study we demonstrate that a number
of other antimicrobial agents that target the cell wall also
upregulate nsaRS expression. Specifically, both phospho-
mycin and D-cycloserine, which affect enzymes involved in
intracellular peptidoglycan assembly, upregulate expression
of nsaRS. The observation with regard to phosphomycin
supports that of a previous study, which demonstrates that
both nsaR and nsaS are upregulated in S. aureus following
phosphomycin challenge (Petek et al., 2010). Furthermore,
microarray analysis in this study reveals that NsaRS is
responsible for regulation of another TCS, yhcSR. Previous
studies with cells depleted for yhcSR reveal elevated
sensitivity to this antibiotic (Sun et al., 2005), suggesting
interplay between these two systems when sensing
phosphomycin-mediated damage. Further to this, using a
plate-based screening assay, we demonstrate that ampicillin
and penicillin G, both of which are involved in extracellular
peptidoglycan cross-linking, results in increased nsaRS
expression. This information, in the context of our finding
that nsaS mutants have an almost 200-fold decreased
capacity for spontaneous bacitracin resistance, which
blocks dephosphorylation and recycling of undecaprenyl-
pyrophosphate, suggests a major role for NsaRS in sensing
and responding to alterations in the cell wall. Indeed this
latter finding corroborates a recent study which demon-
strates that an NsaS mutant of MW2 has a fourfold
increase in sensitivity to bacitracin (Matsuo et al., 2010).
Thus it appears that NsaRS has a role in sensing and
responding to perturbation of the cell wall biosynthesis
pathway at each step in the cycle, from early, intracellular
peptidoglycan subunit assembly (phosphomycin and D-
cycloserine), to the transport and anchoring of these
moieties via lipid II (nisin), followed by extracellular cross-
linking of the peptidoglycan subunits (ampicillin and
penicillin G), and finally re-entry of the bactoprenol carrier
to continue the cycle (bacitracin). Interestingly, nsaRS does
not appear to respond to every cell-wall-targeting anti-
biotic, as we observe no upregulation of nsaRS or
sensitivity of the nsaS mutant to other drugs, including
vancomycin. Additionally, we find no upregulation of
nsaRS by, or sensitivity of the nsaS mutant to, a variety of
antimicrobial peptides (data not shown). We do, however,
show that certain cell-membrane-damaging agents, such as
gramicidin, nisin and CCCP, upregulate expression of
nsaRS. Furthermore, a previous study by Muthaiyan et al.
(2008) reveals upregulation of nsaR in response to
daptomycin. This indicates that this system responds to
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Fig. 6. NsaRS plays an important role during the interaction of S. aureus with components of the human innate immune system.
(a) Phagocytosis assays were carried out for the Newman strain ($) and nsaS mutant (#) at an m.o.i. of 1 : 50 (hMdMs). After
challenge, cultures were maintained for the desired time before infected cells were lysed by treatment with ice-cold water.
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recovery of SH1000 (WT), its nsaS mutant (M) and complemented strain (C) in whole human blood. Data presented are from
two separate blood samples and five individual replicates; error bars, SEM.
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perturbation of not only the cell wall but also the cell
membrane. Thus, it appears that NsaRS has a general role
in sensing and responding to disruption of the cell
envelope in S. aureus. The fact that it does not respond
to every cell-envelope-targeting compound is consistent
with the literature from other IM-HK studies (Staron´ et al.,
2011) and is perhaps explained in S. aureus by a number of
other cell membrane or cell wall stress-responding TCSs,
such as GraRS, VraRS and WalKR (Li et al., 2007; Kraus
et al., 2008; Pietia¨inen et al., 2009; Delaune et al., 2011).
In addition to findings focused on cell-envelope-targeting
antibiotics, we also present electron microscopy data
revealing that nsaS mutants have a more diffuse and less
defined/smooth cell wall. This disparity from the parental
and complemented strains is even further enhanced when
cells are subject to salt stress, with nsaS mutant cells
displaying striking and irregular cell wall appearances. This
is perhaps explained by the observation that transcription
of a number of osmoprotectants (cudT and opuCA) is
repressed in the nsaS mutant, along with a number of
solute importers and general permeases. These alterations
in cell wall structure can perhaps be further explained by
diminished expression in the nsaS mutant strain of genes
previously shown to function in cell wall biosynthesis (e.g.
tagB, fmhA or scdA). Additionally, we observed decreased
expression of glpQ in the nsaS mutant, which is part of the
glycerol utilization pathway (Nilsson et al., 1994). Analysis
of S. aureus cells that are deprived of their ability to utilize
glycerol reveals major remodelling of the cell envelope and
an accumulation of fatty acids in the cell resulting from a
failure to incorporate them into the phospholipid mem-
brane (Ray et al., 1972). Pilot metabolic profiling con-
ducted in our laboratory reveals that a large number of
saturated fatty acids do indeed accumulate in nsaS mutant
cells (S. L. Kolar and L. N. Shaw, unpublished observation).
Further electron microscopy studies using negative staining
techniques reveal a significant alteration in encapsulation
of the nsaS mutant compared with the wild-type and
complemented strains. During growth in TSB and high salt
concentrations (data not shown) we observed in the
mutant strain a significantly increased association of cells
in what appears to be an extracellular capsule. This is
perhaps explained by microarray analysis, which reveals
that nsaS mutant cells demonstrate a greater than twofold
increase in transcription of seven of the ten capsule-
encoding genes. In addition to this, we also noted a
number of other genes in the transcriptome that have
functions connected with cell envelope formation and
architecture. These include membrane proteins, transpor-
ters, cell-wall-anchoring proteins and cell-wall-associated
proteins. Thus, it is clear that, in addition to its role in
sensing perturbation of the cell wall and membrane, NsaRS
has a significant effect on remodelling cell envelope
architecture during growth of S. aureus. This is perhaps
not surprising given that many other IM-HK TCSs,
including the NsaRS orthologue GraRS, have similar roles
(Joseph et al., 2002; Mascher, 2006; Li et al., 2007).
In addition to this, and perhaps equally intriguing, is the
number of elements identified in the transcriptome that
have a role in transport. We identified that 55 such genes
have a known or implied role in the import/export of
sugars, metal ions, amino acids and antimicrobial com-
pounds. Given this, it is perhaps not surprising that we
demonstrate a role for NsaRS in the process of cellular
import. When grown during metal-ion-limiting condi-
tions, the levels of intracellular divalent metal ions in the
nsaS mutant were significantly reduced. This is in contrast
with our finding that the same strain grown in replete
media has no such defect. As we have shown that there are
alterations in the cell surface of the nsaS mutant, it is
possible that these findings result from a decreased
association of metal ions with the surface of mutant cells.
However, this is perhaps unlikely given that under metal
replete conditions we do not observe similar decreases in
internal metal concentrations. Thus it would appear that
NsaRS mediates internal metal ion pools, not during
conditions of abundance but more specifically during times
of scarcity. As such, S. aureus cells may utilize NsaRS as a
modulator of low abundance metal ion import during
times of starvation. It could be speculated that this would
be of particular importance during life within the host,
which is known to be an environment of famine for metal
ion availability. Indeed, such a mechanism might perhaps
contribute to the diminished virulence phenotype we
observed during ex vivo testing with the nsaS mutant.
Of interest from the microarray studies was the observation
that other TCSs are controlled by NsaRS. The positive
regulation of SACOL0201/0202 by NsaRS is intriguing
because, whilst this regulatory element has not formally
been studied thus far, it has been suggested to play a role in
the anaerobic response of S. aureus (Fuchs et al., 2007). As
such, the finding that a number of components involved in
anaerobiosis have reduced expression in the nsaS mutant
strain (such as idhA, idh2, acetoin reductase, fdhD and
ald1) is reasonable, and could perhaps be mediated, at least
in part, via control of SACOL0201/0202 by NsaRS. Further
to this, we also identified decreased expression of the
anaerobiosis repressor Rex in the nsaSmutant. This finding
is somewhat at odds with our other data, as it could be
predicted that a strain displaying reduced Rex expression
would also demonstrate increased transcription of anaero-
bically involved loci (Fuchs et al., 2007; Pagels et al., 2010).
However, it is tempting to speculate that SACOL0201/0202
and Rex have antagonizing roles in the process of
controlling the anaerobic response, and that NsaRS
mediates their interaction via regulatory control. It is also
equally possible that NsaRS participates in upregulation of
the anaerobic response directly, thus proving dominant to
the inhibitory capacity of Rex.
We demonstrate that nsaS mutants are impaired in their
ability to form biofilms across a variety of S. aureus strains.
There are a number of regulatory elements that have been
suggested as having roles in this process in S. aureus,
including other TCSs and global regulatory loci such as agr,
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sarA and sB (Beenken et al., 2004). Recent work conducted
by ourselves and others (Beenken et al., 2010; Boles &
Horswill, 2008; Tsang et al., 2008) has focused not on these
regulatory elements but rather on the physiological con-
ditions that facilitate or prevent this aggregate lifestyle. As
such, when the NsaRS regulon is analysed, it is perhaps no
surprise that a mutant in this system would be impaired in
forming and/or maintaining a biofilm. Specifically, the
expression of a variety of extracellular proteases (including
the V8 protease, staphopain B and a number of Spls), all
of which have an important role in the breakdown of
extracellular components required for biofilm formation,
are increased in the nsaS mutant (Beenken et al., 2010;
Boles & Horswill, 2008; Tsang et al., 2008). Further to this,
the nsaS mutant has reduced expression of a number of
anaerobiosis genes, which would again be counterproduc-
tive to this process (Beenken et al., 2004). Finally, the nsaS
mutant has diminished synthesis of the surface proteins
SasG and surface protein A, which have been shown to be
required for biofilm formation (Corrigan et al., 2007;
Merino et al., 2009). Collectively, these observations pro-
bably explain the role of nsaRS in biofilm formation, a
phenotype which is broadly maintained across a number of
distinct S. aureus lineages.
Finally, we present data evaluating the role of nsaRS in the
virulence of S. aureus. Using a human model of macro-
phage clearance and survival we observed a 25-fold
reduction of mutant cells after 24 h, a 70-fold reduction
after 2 days and a lack of mutant cells after this time. Thus
it would appear the nsaS mutant is more rapidly cleared
than the wild-type upon interaction with human macro-
phages. Additionally, when performing survival experi-
ments using whole human blood, we observed a reduction
in the capacity of the nsaS mutant to proliferate. Whilst the
wild-type and complemented strains are able to survive and
rapidly proliferate upon challenge, nsaS mutant growth
seemingly stalls when faced with these hostile conditions.
Human blood is replete with a variety of antimicrobial
agents, including leukocytes, antimicrobial peptides/pro-
teins and factors of the complement system (Levy, 2000).
As such, whole blood survival assays corroborate the ex
vivo macrophage survival and clearance data, and suggest
an important role for NsaRS in mediating resistance of S.
aureus to the human immune system. Additionally,
transcriptome analysis reveals that the expression of a
number of elements known to be involved in virulence
(such as essABC, sarS, spa, srtB, htrA, clpB and isaB) is
decreased in the nsaS mutant. Conversely a number of
known virulence factors were also elevated in the trans-
criptome (such as the V8 protease, staphopain B, FnpB,
Hlb, HysA). It is entirely possible that these increases in
transcription present a situation akin to that of a sarA
mutant, which overexpresses extracellular proteases and
has attenuated virulence. Accordingly, this imbalance of
virulence determinant expression would likely destabilize
the pathogenic response of nsaS mutant cells and perhaps
explains the phenotypes observed.
In summary, we present a characterization of the IM-HK
family member and GraRS orthologue, NsaRS. NsaRS
appears to have parallel roles to its better studied counterpart
in a number of processes, including biofilm formation and
impaired interaction with components of the innate immune
system (Li et al., 2007; Kraus et al., 2008; Boles et al., 2010;
Cheung et al., 2010). This is probably explained, in part, by
the relatedness of these two systems, and the observation that
nsaR has previously been shown to be subject to twofold
repression by GraRS (Herbert et al., 2007). Additionally,
we demonstrate a number of unique NsaRS phenotypes,
indicating its independent contribution to, and role in,
sensing and adapting to cell-envelope-mediated stress. We
also show that the NsaRS regulatory system appears to have
an important role in the transport of metal ions, and is
required for full biofilm formation across a number of
genetically diverse S. aureus strains. Finally, the defects we
present for the nsaS mutant when interacting with compo-
nents of the innate immune system strongly argue for the
importance of this TCS in the in vivo lifestyle of S. aureus.
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Staphylococcus aureus is a leading human pathogen of both hospital and community-asso-
ciated diseases worldwide. This organism causes a wealth of infections within the human
host as a result of the vast arsenal of toxins encoded within its genome. Previous tran-
scriptomic studies have shown that toxin production in S. aureus can be strongly impacted by
the negative regulator CodY. CodY acts by directly, and indirectly (via Agr), repressing toxin
production during times of plentiful nutrition. In this study, we use iTRAQ-based proteomics
for the first time to study virulence determinant production in S. aureus, so as to correlate
transcriptional observations with actual changes in protein synthesis. Using a codY mutant in
the epidemic CA-MRSA clone USA300 we demonstrate that deletion of this transcription
factor results in a major upregulation of toxin synthesis in both post-exponential and
stationary growth. Specifically, we observe hyper-production of secreted proteases, leukoci-
dins and hemolysins in both growth phases in the USA300 codY mutant. Our findings
demonstrate the power of mass spectrometry-based quantitative proteomics for studying
toxin production in S. aureus, and the importance of CodY to this central process in disease
causation and infection.
Keywords:
Microbiology / Regulation / Staphylococcus aureus / Toxins / Virulence determinants
The transcription factor CodY is well conserved within the
low G1C Gram-positive bacteria, where it has been shown
to be an important regulator of metabolism and virulence
[1]. It functions by sensing intracellular levels of branched-
chain amino acids (BCAAs) and GTP during growth, and
responds by repressing genes involved in starvation beha-
viors in nutrient-rich conditions, such as amino acid trans-
port, sporulation, and competence [2–5]. As BCAA and GTP
levels decline, CodY loses its affinity for DNA binding,
bringing about de-repression of target genes [1]. This results
in a physiological transition from growth and division to
amino acid metabolism and stress tolerance. In this study,
we focus on the impact of CodY on toxin production in the
major human pathogen Staphylococcus aureus. Previous
reports have shown that, in addition to its role in nutritional
regulation, CodY impacts toxin gene expression in S. aureus
by repressing transcription of another regulator, agr. Agr is a
quorum-sensing, two-component system that is maximally
expressed during post-exponential growth, where it repres-
ses surface proteins and induces transcription of toxins [6].
As such, CodY functions to couple toxin gene regulation in
S. aureus to the nutritional status of the cell. Thus far, a
variety of studies have documented the effects of CodY on S.
aureus toxin gene transcription [7–9], but, to date, a study of
how these changes affect toxin synthesis is lacking.
Accordingly, we have employed iTRAQ to assess the
impact of CodY on toxin synthesis in the human clinical
isolate, CA-MRSA USA300. A codYmutant was generated in
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strain USA300-HOU-MRSA [10] using techniques described
previously [11]. Post-exponential phase (5 h) or stationary
phase (15 h) cultures of wild-type and mutant strains
(Supporting Information Fig. 1) were prepared in TSB as
described previously [10, 11]. Secretomes were harvested by
centrifugation, sterilized by filtration, and concentrated
using Millipore Centricon Plus-70 filter units with a 3 kDa
cutoff. Proteins were precipitated overnight at 41C using
10% trichloroacetic acid. Precipitates were collected by
centrifugation and pellets washed thrice with 100% ice-cold
ethanol, before being air-dried. Samples were resuspended
in iTRAQ dissolution buffer at 100mg/mL, in a volume of
20mL. One mL of denaturant and 2mL of reducing reagent
were added to each sample, and incubated at 601C for 1 h.
Next, 1 mL of cysteine blocking reagent was added and
incubated for 10min at room temperature. Trypsin was
added in a ratio of 1:30, and samples digested for 12–16 h at
371C. Labeling with iTRAQ reagents was completed
according to manufacturer’s instructions. Briefly, peptide
samples were individually labeled with iTRAQ reagents
(USA300-116, USA300-codY-117) for 1 h at room tempera-
ture. After incubation, samples were combined and dried
using a SpeedVac centrifuge, and resuspended in 1mL of
0.1% formic acid in water. A C-18 Vydac column was used to
desalt samples, with peptides eluted using 0.1% formic acid
in ACN. After peptide elution, iTRAQ-labeled samples
were dried using a SpeedVac centrifuge, resuspended in
0.1% formic acid in water, and analyzed using a hybrid
linear ion trap-Orbitrap instrument mass spectrometer
(LTQ Orbitrap XL, Thermo) operated with Xcalibur (v2.0.7)
data acquisition software. Five mL of protein digest was
loaded onto a 75mm id 2 cm ProteoPep II C18 trap (New
Objective, Woburn, MA, USA) and desalted online before
injection onto a 75 mm id 10 cm Proteopep II C18 analy-
tical column, where a linear gradient was carried out to 40%
acetonitrile in 90min at 250 nL/min, using a NanoUltra 2D-
HPLC system (Eksigent, Dublin, CA, USA). Data-dependent
acquisition consisted of MS/MS analysis in the LTQ linear
ion trap of the top three most intense precursor ions from
initial high-resolution (30 000 at m/z 400) survey scans,
followed by high-energy collision dissociation (HCD) and
Orbitrap fragment ion detection (7500 at m/z 400) of the
same three ions.
MS/MS spectra generated from data-dependent acquisi-
tion via the LTQ Orbitrap XL were extracted by extra-
ctMSN.exe (BioWorks v.3.3, Thermo), and searched against
a concatenated subset database containing both normal and
randomized sequences of S. aureus USA300_FPR3757
obtained from Uniprot.org (downloaded 07-27-2010, 5214
entries) using the MASCOT search algorithm (v2.2.2).
MASCOT was searched with a fragment ion mass tolerance
of 0.60Da, and a parent ion tolerance of 10 ppm, assuming
full trypsin specificity with 1 possible missed cleavage.
Oxidation of methionine, as well as iTRAQ labeling of
peptide N-terminus, lysine, and tyrosine, were included as
variable modifications in MASCOT. Fixed modifications
included MMTS modification of cysteine. MASCOT results
were compiled in ProteoIQ (v2.1.11, Nusep) for final iden-
tification and relative quantitation. The MASCOT database
search score cutoff was adjusted within ProteoIQ to achieve
a 1% false discovery rate at the protein level. Relative
quantitation of iTRAQ reporter ions was performed by
ProteoIQ followed by normalization to the dataset median
(assuming a global median ratio of 1) using Microsoft Excel.
The ratios are reported as 117 reporter ion intensity
(USA300-codY)/116 reporter ion intensity (USA300), and
considered significant if the ratio was at least 71 standard
deviation away from the median. Quantitative proteomic
analysis using iTRAQ was performed using three biological
replicates. All MASCOT identification data are deposited in
the PRIDE proteomics identification database (http://
www.ebi.ac.uk/pride) under accession numbers 17700–
17705 [12]. The data were converted using the PRIDE
Converter [13].
Tables 1 and 2 show iTRAQ-based relative quantitation
for proteins that are known or putative secreted virulence
factors of S. aureus; however, all proteins and corresponding
iTRAQ ratios are reported in Supporting Information Tables
1 and 2. It should be noted that the complete data sets in
Supplementary Information contain a number of intracel-
lular proteins within the secretomes of both strains. It has
been our experience, and that of others [14], that sub-
proteome contamination is common, and can be the result
of a number of factors, including natural cell lysis during
growth. Additionally, there is growing evidence to suggest
that intracellular proteins are intentionally exported, and
have novel functions outside the cell [14]. For the data
presented herein, we analyzed only those proteins that were
significantly altered between the two strains based on our
filtering criteria, and are either known secreted proteins, or
contained signal peptides, as determined by the SignalP
algorithm.
Post-exponential secretomes of the codY mutant
compared with the wild-type (Table 1) demonstrate a
dramatic increase in several agr-regulated proteases, such as
aureolysin (14.1-fold), Spl proteases (SplE5 7.3-fold,
SplB5 6.6-fold), and Staphopain B (4.4-fold). Most
pronounced, however, was V8 protease, which was produced
at levels 16.8-fold higher in the mutant. Furthermore,
synthesis of multiple leukocidins, including LukD (3.5-fold)
and LukE (5.1-fold), along with the Panton-Valentine
leukocidins, LukF-PV (4.9-fold) and LukS-PV (6.9-fold), were
increased in the mutant during post-exponential growth.
Additionally, subunits of the g-hemolysin were found in
greater abundance in the codY-null strain (HlgB5 3.0-fold,
HlgC5 6.7-fold). Interestingly, during post-exponential
growth in the mutant, we observed decreased levels of two
phenol soluble modulins: d-hemolysin and Psmb1 (4.8-
fold and 5.0-fold, respectively). It is possible that this
unexpected downregulation may result from overproduction
of proteases in the codY mutant. Indeed, it has previously
been suggested that the V8 protease may modulate self-
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Table 1. Quantitative proteomic profiling of virulence determinant production in CA-MRSA USA300 and its codY mutant during
post-exponential growth
Accession number Gene Protein name CodY ratioa) Standard deviationb)
Upregulated
SAUSA300_0951 sspA V8 protease 4.07 (16.8) 2.28
SAUSA300_2572 aur Zinc metalloproteinase aureolysin 3.82 (14.1) 2.71
SAUSA300_1754 splE Serine protease 2.86 (7.3) 0.46
SAUSA300_1382 lukS-PV Panton-Valentine leukocidin 2.79 (6.9) 1.73
SAUSA300_1759 Putative uncharacterized protein 2.76 (6.8) 2.06
SAUSA300_2366 hlgC Gamma-hemolysin component C 2.75 (6.7) 2.1
SAUSA300_1757 splB Serine protease 2.72 (6.6) 2.29
SAUSA300_1769 lukE Leukocidin 2.34 (5.1) 2.18
SAUSA300_1381 lukF-PV Panton-Valentine leukocidin 2.29 (4.9) 2
SAUSA300_0950 sspB Cysteine protease 2.15 (4.4) 2.13
SAUSA300_0409 Putative uncharacterized protein 1.86 (3.6) 0.58
SAUSA300_1768 lukD Leukocidin 1.79 (3.5) 1.89
SAUSA300_2367 hlgB Gamma-hemolysin component B 1.61 (3.0) 1.91
Downregulated
SAUSA300_1067 psmb1 Antibacterial protein 2.23 (4.8) 1.02
SAUSA300_1988 hld Delta-hemolysin 2.31 (5.0) 1.48
 Indicates ratio value that is Z2 standard deviations away from median.
a) Ratio values are Log2 transformed; number in parenthesis represents fold change.
b) Standard deviation (SD) values are calculated based on ratio values obtained from all peptides across all replicates (n5 3); SD values
are Log2 transformed.
Table 2. Quantitative proteomic profiling of virulence determinant production in CA-MRSA USA300 and its codY mutant during stationary
growth
Accession number Gene Protein name CodY ratioa) Standard deviationb)
Upregulated
SAUSA300_1758 splA Serine protease 4.06 (16.6) 0.96
SAUSA300_2572 aur Zinc metalloproteinase aureolysin 3.78 (13.7) 2
SAUSA300_1754 splE Serine protease 3.70 (13.0) 2.03
SAUSA300_2366 hlgC Gamma-hemolysin component C 3.54 (11.6) 2.24
SAUSA300_1382 lukS-PV Panton-Valentine leukocidin 3.50 (11.3) 1.94
SAUSA300_0274 Putative uncharacterized protein 3.38 (10.4) 1.92
SAUSA300_1753 splF Serine protease 3.12 (8.7) 1.46
SAUSA300_1755 splD Serine protease 3.12 (8.7) 1.8
SAUSA300_1757 splB Serine protease 3.08 (8.5) 2.01
SAUSA300_1381 lukF-PV Panton-Valentine leukocidin 3.04 (8.2) 1.61
SAUSA300_0815 ear Ear protein 3.04 (8.2) 2.21
SAUSA300_0951 sspA V8 protease 2.86 (7.3) 2.51
SAUSA300_1759 Putative uncharacterized protein 2.76 (6.8) 2.28
SAUSA300_2365 hlgA Gamma-hemolysin component A 2.38 (5.2) 2.42
SAUSA300_0950 sspB Cysteine protease 2.34 (5.0) 2.11
SAUSA300_1058 hla Alpha-hemolysin 2.24 (4.7) 1.47
SAUSA300_0883 Putative surface protein 2.10 (4.3) 1.93
SAUSA300_1890 scpA Staphopain A 1.76 (3.4) 1.75
SAUSA300_2164 Hypothetical protein 1.58 (3.0) 1.25
SAUSA300_1768 lukD Leukocidin 1.44 (2.7) 2.13
SAUSA300_0955 atl Bifunctional autolysin 1.38 (2.6) 2.36
SAUSA300_1988 hld Delta-hemolysin 1.28 (2.4) 1.89
 Indicates ratio value that is Z2 standard deviations away from median.
a) Ratio values are Log2 transformed; number in parenthesis represents fold change.
b) Standard deviation (SD) values are calculated based on ratio values obtained from all peptides across all replicates (n5 3); SD values
are Log2 transformed.
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derived toxin stability [15]; whilst more recently our group
has shown that aureolysin degrades both Hla and the PSMs
[16]. This observation might also explain why we did not
observe significant alteration in a-hemolysin protein levels
during post-exponential growth, despite our validation
assays detecting elevated hla (and hld) transcription in the
codY mutant (Supporting Information Fig. 2).
When exploring the effects of codY mutation on
stationary-phase toxin synthesis (Table 2), we observed
additional alterations when compared with the wild-type.
Specifically, the hyperactive agr phenotype of USA300 [17]
is more pronounced in the absence of CodY during
stationary phase, with significant overproduction of agr-
regulated proteins. As with our post-exponential findings,
the major class of proteins with increased synthesis was
again secreted proteases. Of the ten known enzymes, nine
are increased in stationary-phase cultures of the mutant,
with only SplC not shown to be significantly altered.
Specifically, Spl enzymes increased from 8.5-fold (SplB) to
16.6-fold (SplA). In addition, we observed upregulation of
both cysteine proteases (SspB5 5.0-fold, ScpA5 3.4-fold),
aureolysin (13.7-fold), and V8 protease (7.3-fold). These
findings are again consistent with our transcriptional vali-
dation work, which reveals strong upregulation from major
protease loci (aur, scp and ssp), throughout growth in the
codY mutant (Supporting Information Fig. 2). Leading on
from this, given that secreted proteases negatively impact S.
aureus biofilm formation [10, 16], one would predict that a
USA300 codY mutant would be impaired in this behavior.
As such, we analyzed biofilm formation in the codY mutant,
and found an approximately 3-fold reduction when
compared with the parental and complemented strains
(Fig. 1A).
We also observed accumulation of cytolytic toxins in
stationary phase cultures of the mutant, with both PVL
components increased (LukS-PV5 11.3-fold, LukF-PV5
8.2-fold), as was LukD (2.7-fold). There was also a global
increase in hemolysin production in the mutant, with a-
hemolysin (4.7-fold), g-hemolysin (HlgA5 5.2-fold, HlgC5
11.6-fold) and d-hemolysin (2.4-fold) all displaying greater
protein levels. This former finding is in strong agreement
with our validation assays, which reveal a 5.8-fold increase in
a-hemolysin activity in the codY mutant during this growth
phase (Fig. 1B). This latter finding is of interest as it is in
contrast to the post-exponential data, where we observed
decreased d-hemolysin. While protease levels remain high
during stationary phase, it is possible that they suffer a
decrease in enzymatic activity as cultures age, explaining the
increase in d-hemolysin accumulation. Furthermore, d-
hemolysin is transcribed at very high levels in the run up to
stationary phase (Supporting Information Fig. 2); therefore,
despite proteolytic degradation, its abundance is still detec-
tably increased.
Our findings with regards to the high levels and activity
of proteolytic enzymes raise an important technical point.
Owing to the high abundance of these enzymes in cultures
at both time points, the standard deviation values for ratios
determined may be elevated due to biological variability
associated with proteolytic degradation. This result would be
expected, giving variability at the peptide level within
biological replicates, and producing alterations in sequence
coverage obtained by MS analysis. Additionally, iTRAQ-
labeled peptides derived from the relatively complex secre-
tomes used in this study were not fractionated prior to LC-
MS/MS which may lead to iTRAQ ratio compression for
certain peptides and therefore, underestimation and/or
increased variability of relative changes determined at the
protein level [18]. In spite of this, we suggest that such
proteomic analyses are of significant value, and perhaps
provide more insight than those focused on transcriptional
changes. Specifically, changes in gene expression may not
directly lead to alterations in protein abundance; resulting
from the post-translational events described herein, and in
other works [15, 16]. Even though these findings are from in
vitro studies, one would predict that such events also occur
in vivo, and are thus physiologically relevant and important.
We also observed an increase in the production of a
number of uncharacterized secreted proteins in the codY
mutant. Specifically, SAUSA300_0409 and SAUSA300_0274
were upregulated in post-exponential and stationary phases,
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Figure 1. Deletion of codY in S. aureus USA300 results in
decreased biofilm formation and increased hemolytic activity. The
USA300 codY mutant, and its parental and complemented strains,
were assayed for biofilm formation (A) and hemolytic activity (B),
as described previously [10, 13]. 8325-4 (A) and a USA300 agr
mutant (B) were used as the negative controls. Hemolysis data are
derived from 15 h cultures. Data presented are from three biolo-
gical replicates. Error bars are shown as 7SEM.
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respectively. While no obvious domains or homology could
be detected for these proteins, the same is not true for
SAUSA300_1759, which was upregulated in the mutant
during both growth phases at the same level (6.8-fold).
SAUSA300_1759 has homology to the Ear protein, which
was also found to be upregulated in the codY mutant (8.2-
fold). The Ear protein currently has unknown function, but
has been labeled a putative toxin in strain MW2, and is
found on the cSa3 pathogenicity island [19, 20]. Other
putative toxins were also found to have altered levels, with
two Eap/Map domain proteins SAUSA300_0883 (4.3-fold)
and SAUSA300_2164 (3.0-fold) both showing increases in
the mutant. While these two proteins have yet to be studied,
they are part of a family of proteins in S. aureus that contain
such domains. Eap/Map proteins are both surface asso-
ciated and extracellular virulence determinants, with a
variety of roles in pathogenesis, including adherence and
immune-subversion [21, 22].
The present study is the first of its kind to use iTRAQ
proteomic techniques to map toxin production in the
major human pathogen S. aureus. It is apparent from our
studies that this approach can be an effective method
for relative protein quantitation in this bacterium, as a way
to corroborate transcriptional analyses. We show that a
variety of known and novel toxins encoded within the
genome of CA-MRSA USA300 are hyper-produced as a
result of codY inactivation. As such, this information
provides additional insight into the role of this important
regulator, and an understanding of its contribution to
disease causation.
All MASCOT identification data are available in the PRIDE
database (http://www.ebi.ac.uk/pride) under accession numbers
17700–17705.
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Abstract 24 
Previously we identified a novel component of the S. aureus regulatory network, an 25 
extracytoplasmic-function σ-factor, σS, involved in stress response and disease causation.  Here 26 
we present additional characterization of σS, demonstrating a role for it in protection against 27 
DNA damage, cell wall disruption and interaction with components of the innate immune 28 
system.  Promoter mapping reveals the existence of three unique sigS start sites, one of which 29 
appears to be subject to auto-regulation.  Transcriptional profiling revealed that sigS expression 30 
remains low in a number of S. aureus wild-types, but is upregulated in the highly mutated strain 31 
RN4220.  Further analysis demonstrates sigS expression is inducible upon exposure to a 32 
variety of chemical stressors that elicit DNA damage, including methyl methanesulfonate and 33 
ciprofloxacin, as well as those that disrupt cell wall stability, such as ampicillin and oxacillin.  34 
Significantly, expression of sigS is highly induced during growth in serum and upon 35 
phagocytosis by RAW 264.7 murine macrophage-like cells.  Phenotypically, σS mutants display 36 
sensitivity to a broad range of DNA damaging agents and cell wall targeting antibiotics.  Further 37 
to this, the survivability of σS mutants is strongly impacted during challenge by components of 38 
the innate immune system. Collectively, our data suggests that σS likely serves dual functions 39 
within the S. aureus cell, protecting against both cytoplasmic and extracytoplasmic stresses. 40 
This further argues for its important, and perhaps novel, role in the S. aureus stress and 41 
virulence responses. 42 
 43 
 44 
 45 
 46 
 47 
 48 
 49 
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Introduction 50 
Staphylococcus aureus is an exceedingly virulent and successful pathogen, capable of causing 51 
a wide range of infections, from relatively benign skin lesions to life threatening septicemia.  52 
With an overwhelming ability to adapt to its environment, S. aureus has become the most 53 
common cause of both hospital and community acquired infections, and is believed to be the 54 
leading cause of death by a single infectious agent in the United States (20, 34). The threat 55 
posed by this organism to human health is further heightened by the rapid and continued 56 
emergence of multi-drug resistant isolates (1, 20, 34, 43).  57 
 58 
Many components govern the adaptive nature of S. aureus, including complex regulatory 59 
networks, which allow it to respond to constantly changing environments via rapid shifts in gene 60 
expression. There are a number of different elements that mediate this fine-tuning, including 61 
DNA-binding proteins, two-component systems, regulatory RNAs and alternative σ factors (10, 62 
11, 18, 21, 22, 32, 44, 50, 51). This latter class acts by binding to core-RNA polymerase and 63 
redirecting promoter recognition to coordinate gene expression, bringing about expedient and 64 
wide-reaching alterations within the cell.  65 
 66 
From a classification perspective, σ factors are divided into five discrete subfamilies, with the 67 
essential housekeeping factors (σA or σ70), which are responsible for the majority of 68 
transcription, comprising group 1. The remaining families (2-5) contain alternative σ factors, 69 
which are important for niche-specific transcriptional regulation in response to environmental 70 
change (24, 27, 40, 41).  These elements provide the ability to readily adapt to an ever-71 
changing environment by discrete alterations in transcription profiles.  As such, bacteria typically 72 
encode a number of alternative σ factors within their genome that fulfill a wide range of 73 
functions.  Of the alternative families, group 4, comprising the ECF (extracytoplasmic function) σ 74 
factors, are by far the most numerate of all such elements (27); for example, Streptomyces 75 
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ceolicolor contains approximately 65 σ factors, around 50 of which are of the ECF subtype (27).  76 
Interestingly, S. aureus relies on only 4 σ factors to oversee the execution of its gene 77 
expression. In addition to a primary σ factor, σA, (16, 17), S. aureus, as with the majority of 78 
firmicutes, possesses a σB alternative σ factor, which controls the general stress response (18, 79 
28, 37, 54, 63).  A third σ factor, σH, has recently been reported, demonstrating homology to σH 80 
from Bacillus subtilis, and has been shown to regulate competence genes and the integration 81 
and excision of prophages (46, 69).  Finally, a recent discovery in our laboratory demonstrated 82 
the existence of a fourth σ factor, σS, belonging to the ECF-family (64).  Unlike many other 83 
organisms, which commonly possess multiple ECF σ factors, σS is the only such element 84 
discovered in this organism thus far (27, 64).   85 
 86 
Previous work by our group revealed a role for σS in the stress and virulence response of S. 87 
aureus (64).  Specifically, we showed that σS is important in extended survival during starvation 88 
and by lysis with Triton X-100.  Competitive growth analysis revealed a decreased ability of a 89 
sigS mutant to compete against its parental strain both under standard conditions, and in the 90 
presence of stress.  Interestingly, transcriptional analysis of sigS in the laboratory strain SH1000 91 
revealed only baseline expression during growth in rich media over a 72 h period.  Finally, using 92 
a murine model of septic arthritis, we demonstrated a role for σS in systemic infections, as mice 93 
infected with a sigS mutant displayed significantly decreased weight-loss, mortality, severity of 94 
infection, systemic dissemination and mounted immune response by the host.   95 
 96 
In this study we have further explored the role and regulation of σS, in an effort to understand 97 
the conditions under which S. aureus utilizes this transcriptional regulator. We show that not 98 
only is sigS transcription seemingly subject to genetic control in S. aureus cells, but it is highly 99 
inducible in response to a variety of stresses, including those that elicit DNA-damage and cell 100 
wall perturbations.  Additionally, we reveal that sigS is strongly upregulated upon exposure to 101 
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serum, and following phagocytosis by macrophage-like cells.  Finally, we present a role for σS in 102 
the response to DNA damage and cell wall stress, as well as a role in protection against 103 
components of the innate immune system.   104 
 105 
 106 
 107 
 108 
 109 
 110 
 111 
 112 
 113 
 114 
 115 
 116 
 117 
 118 
 119 
  120 
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Materials & Methods 121 
Bacterial strains, plasmids and growth conditions.  S. aureus and E. coli strains and 122 
plasmids are listed in Table 1.  E. coli was grown in Luria-Bertani (LB) medium at 37°C.  S. 123 
aureus was grown in 100 ml Tryptic Soy Broth (TSB) (1:2.5 flask/volume ratio) at 37°C with 124 
shaking at 250 rpm, unless otherwise indicated. Synchronized cultures were obtained as 125 
described previously (64).  When required, antibiotics were added at the following 126 
concentrations:  ampicillin 100 mg l-1 (E. coli), tetracycline 5 mg l-1 (S. aureus), erythromycin 5 127 
mg l-1 (S. aureus), lincomycin 25 mg l-1 (S. aureus), and chloramphenicol 5 mg l-1 (S. aureus).   128 
Where specified, chemically defined minimal media (CDM) and metal ion limiting media (CL), 129 
were prepared as described previously (29, 75). Porcine serum agar was created by adding 130 
filter sterilized porcine serum (Sigma) to preautoclaved and cooled 2% agar in dH20.   131 
 132 
Construction of the sigS mutant and sigS-lacZ fusion strains.  All strains used in this study, 133 
other than those described below, were created via φ11 mediated transduction from strains 134 
previously described (Table 1).  135 
 136 
Construction of sigS complement strains.  The complement construct generated contains 137 
approximately 1 kb of upstream and 710 bp of downstream DNA, relative to the sigS coding 138 
region. This was PCR amplified using primer pair OL281 and OL1715 (Table 1), and cloned into 139 
the Gram-positive shuttle vector pMK4, creating pHKM1.  S. aureus RN4220 was transformed 140 
with this construct, with clones confirmed by PCR analysis, using a combination of gene and 141 
vector specific primers (OL-281/OL-1036).  A representative clone was selected to transduce 142 
the RN4220 and USA300 sigS mutants. Clones were again confirmed by PCR analysis, 143 
creating strains HKM06 and HKM08. 144 
 145 
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β-Galactosidase assays.  Levels of β-galactosidase activity were measured as described 146 
previously (35).  The results presented herein are representative of three independent replicates 147 
that showed less than 10 % variability. 148 
 149 
Real-time PCR. Quantitative real-time PCR analysis was conducted as described previously 150 
(35) using primers listed in Table 1 specific for sigS (OL1275/OL1276).  Control primers were for 151 
the 16s rRNA gene, as described previously (36). Values were calculated from three 152 
independent replicates, and the data analyzed using a Student t test with a 5% confidence limit 153 
to determine statistical significance. 154 
 155 
Primer extension analysis. Primer extension analysis was carried out as described previously 156 
(62) using the AMV reverse transcriptase primer extension system (Promega) according to the 157 
manufacturer’s guidelines.  RNA for primer extension reactions was extracted using an RNeasy 158 
kit (Qiagen) as described previously (35).  For primer extension analysis 32 µg RNA was used 159 
with primer OL1528.  160 
 161 
Plate based assay to determine alterations in transcription resulting from external stress. 162 
These assays were performed using sigS-lacZ fusion strains as described previously (64), with 163 
the following stress chemicals: 6 M HCl, 85% phosphoric acid, 100% TCA, 88% formic acid, 0.2 164 
M acetic acid, 6 M sulphuric acid, 6 M nitric acid, 6 M sodium hydroxide, 2 M NaCl, 1 M glucose, 165 
95% ethanol, 100% methanol, 100% isopropanol, 10% SDS, 10% Triton X-100, 10% Tween-20, 166 
1 M N-lauroyl sarcosine, 30% hydrogen peroxide, 1 M methyl viologen, 1% menadione, 2 mg 167 
ml-1 pyrogallol, 1 M sodium nitroprusside, 1 M ethyl methane sulfonate, 1 M methyl methane 168 
sulfonate, 5 mg ml-1 penicillin G, 5 mg ml-1 ciprofloxacin, 5 mg ml-1 nalidixic acid, 5 mg ml-1 169 
cefotaxime, 5 mg ml-1 vancomycin, 2 mg ml-1 phosphomycin, 5 mg ml-1 spectinomycin, 100 mg 170 
ml-1 ampicillin, 100 mg ml-1 oxacillin, 5 mg ml-1 gramicidin, 5 mg ml-1 tetracycline, 50 mg ml-1 171 
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kanamycin, 50 mg ml-1 neomycin, 10 mg ml-1 chloramphenicol, 20 mg ml-1 puromycin, 2 mg ml-1 172 
bacitracin, 2 mg ml-1 mupirocin, 500 mM diamide, 12.8 mg ml-1 berberine chloride, 4.21 M 173 
peracetic acid, 0.1 M EDTA, 1 M DTT. Plates were incubated for 24 h at 37OC and screened for 174 
blue halos, indicating expression.   175 
 176 
Transcriptional analysis during growth in porcine serum. Synchronous cultures of the sigS-177 
lacZ fusion strains were standardized to an OD600 of 0.5, pelleted and washed twice in PBS 178 
before being resuspended in 1 ml of filter sterilized porcine serum (Sigma).  The suspension 179 
was then incubated at 37oC in a rotator device for a period of 1, 5 or 24 h.  At the appropriate 180 
time point 1 ml samples were pelleted and stored in -20oC for future analysis.  Concomitantly, 181 
the CFU per ml for each sample was determined via serial dilution and plating on TSA.  182 
Harvested bacterial cells were assayed for β-galactosidase production as described previously 183 
(35), with the following alterations.  Arbitrary expression units were calculated as a measure of 184 
substrate cleavage (4-MUG) by β-galactosidase into 4MU, which was evaluated by measuring 185 
the fluorescence of each sample at 355 / 460 nm, 0.1 sec, divided by the CFU ml-1.  Samples 186 
collected from the initial inocula were analyzed for β-galactosidase activity, and used as a 187 
measure of baseline expression to identify changes in transcription, as described previously (68, 188 
74).  The data presented was generated from 3 independent replicates and analyzed using a 189 
Student t test with a 5% confidence limit to determine statistical significance. 190 
 191 
Macrophage cell culture and S. aureus intracellular transcriptional analysis.  Assays were 192 
carried out using the RAW 264.7 murine leukaemic monocyte macrophage cell line (ATCC TIB-193 
71) as described previously (74). Cells were maintained in DMEM (Sigma) supplemented with 194 
10% fetal bovine serum (Invitrogen) and 1% penicillin/streptomycin solution (Sigma) until 195 
infection, at which time antibiotics were used as described below.  RAW 264.7 cells were 196 
seeded into 6-well plates and allowed to grow to a density of 2.5 x 106 cells per well. These 197 
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were then infected with S. aureus strains resuspended in cell culture medium at 2.5 x 108 CFU 198 
per well to give an MOI of 100. To synchronize infections and facilitate contact between bacteria 199 
and RAW 264.7 cells, plates were centrifuged at 1000 rpm for 10 min.  Cells were subsequently 200 
incubated for 1 h at 37oC in a humidified atmosphere containing 5% CO2 to allow phagocytosis.  201 
After this time, wells were washed twice with PBS and any remaining non-phagocytosed 202 
bacteria were killed by the addition of media containing 30 µg ml-1 gentamicin, for 1 h. This was 203 
then replaced with fresh DMEM containing 5 µg ml-1 gentamicin, and incubated for 24 h.  204 
Following this, RAW 264.7 cells were washed twice with PBS, and lysed using 500 μl PBS 205 
containing 0.5% Triton X-100. Samples were withdrawn to determine bacterial numbers and the 206 
remaining bacteria were pelleted by centrifugation. Harvested bacterial cells were assayed for 207 
β-galactosidase production as described previously (35), with the modifications described above 208 
for pig serum studies.  The data presented was generated from 6 independent replicates and 209 
analyzed using a Student t test with a 5% confidence limit to determine statistical significance. 210 
 211 
DNA damage sensitivity assays. Exponentially growing cultures were washed and 212 
resuspended in PBS before the addition of DNA damaging agents: 150 mM H2O2, 20 mM MMS 213 
or 2 mg ml-1 EtBr. These were placed at 37oC with shaking, and aliquots removed at the time 214 
intervals specified. Samples were then serially diluted, and CFU ml-1 determined alongside 215 
control samples that were removed prior to exposure.  Percent survival was calculated by 216 
comparing initial CFU ml-1 to final CFU ml-1 from three independent assays, and the data was 217 
analyzed using a Student t test with a 5% confidence limit to determine statistical significance. 218 
Data is presented as fold change of percent survival relative to that of the wild-type strain. 219 
 220 
Ultraviolet radiation survival assay. This assay was performed as previously described (9).  221 
Briefly, strains were synchronized to an OD600 of 0.05 and allowed to grow for 4 h.  Cultures 222 
were then serially diluted, and 10-2 through 10-6 dilutions plated on TSA.  Dilutions 10-2 and 10-3 223 
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were subjected to UV irradiation at 4,000 µJ/cm2 using a CL-1000 Ultraviolet Crosslinker (UVP).  224 
Dilutions 10-4 through 10-6 served as unexposed controls.  All plates were incubated in the dark 225 
at 37oC overnight.   Survival rates were calculated from three independent experiments, and the 226 
data analyzed using a Student t test with a 5% confidence limit to determine statistical 227 
significance. 228 
 229 
MIC determinations of cell wall targeting antibiotics.  These were performed using a variety 230 
of cell-wall targeting antibiotics, and a microbroth dilution assay, described previously (5).  231 
 232 
Whole Blood Survival Assay. The USA300 wild-type and its isogenic sigS mutant were 233 
subjected to analysis using a whole human blood model of survival as described previously 234 
(35). Pooled and deidentified whole human blood was purchased from Bioreclamation. Survival 235 
rates were calculated from three independent replicates, and the data analyzed using a Student 236 
t test with a 5% confidence limit to determine statistical significance. 237 
 238 
Macrophage cell culture and S. aureus intracellular survival assay.  Infections were carried 239 
out as described above for transcription studies, with the following alterations.  RAW 264.7 cells 240 
were infected with S. aureus strains resuspended in cell culture medium at 2.5 x 106 CFU per 241 
well to give an MOI of 1.  Samples were withdrawn 24 hours post phagocytosis and CFU ml-1 242 
determined via serial dilution and plating on TSA.  The data presented was generated from 3 243 
independent replicates and analyzed using a Student t test with a 5% confidence limit to 244 
determine statistical significance. 245 
  246 
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Results 247 
σS is differentially expressed in S. aureus wild-type strains.  An unusual finding from our 248 
previous study on σS was that no expression of the sigS gene was detected in SH1000 under 249 
standard conditions (64). To assess whether this is a conserved phenomenon, transcriptional 250 
analysis using a sigS-lacZ fusion was performed in a variety of laboratory strains, including 251 
RN4220, 8325-4, SH1000 and Newman, as well as the clinical isolate, USA300.  Expression of 252 
sigS again exhibited only baseline activity over a 24 h period in complex liquid media in every 253 
strain, apart from RN4220 (Figure 1A).  Surprisingly, in this latter strain we observed an 254 
approximate 5-fold increase in sigS expression when compared to other S. aureus isolates.  To 255 
ensure our findings were not an artifact of the fusion construct, we performed quantitative real-256 
time PCR on these wild-type strains during a window of maximal sigS expression (3 h). Using 257 
this approach we again observed robust expression of sigS in RN4220, with minimal 258 
transcription detected in the other isolates (Figure 1B).  Curiously, whilst low expression was 259 
observed for the other backgrounds, transcriptional activity in Newman was almost entirely 260 
negligible. To determine if nucleotide alterations in the promoter region contributed to this 261 
variable expression, we sequenced a 945 bp region immediately 5’ of the annotated sigS start 262 
codon for each of these strains. Interestingly, all sequences were identical to each other, and, 263 
where available, matched publicly available genome data for the requisite strains.  As such, the 264 
differential expression of sigS is seemingly not mediated by SNPs within the promoter or 265 
regulatory regions of the sigS gene.   266 
 267 
Mapping the sigS transcriptional start site.  We previously demonstrated that σS acts to 268 
upregulate itself from its own promoter region; therefore, in order to elucidate this promoter and 269 
any others, we set out to map the sigS promoters using RN4220 as a model.  To this end, we 270 
performed primer extension analysis on RNA extracted from strain RN4220 from exponentially 271 
growing cultures (3 h) using a primer located 12 nucleotides downstream of the sigS initiation 272 
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codon. We identified 3 unique transcription start sites (Figure 2), the longest of which bears an 273 
adenine +1 residue, located 150 bp upstream of the translation start site.  This is 7 nt away from 274 
a putative σA promoter, denoted as P1, with a sequence of aTtACA, followed by a 17bp spacer, 275 
and then TATtta.  Promoter P2 is located 126 nt upstream of the translational start site, 276 
beginning with a thymine residue, and appears to have no notable σA or σB promoter 277 
sequences; however, a possible σS consensus was identified as CAAAGT 12 bp upstream of 278 
TATCA, the putative -10 site.  The third transcription start site, positioned 107 nt upstream of the 279 
coding region, contains an adenine +1 residue and is 7 nucleotides away from a putative σA 280 
promoter, denoted as P3, with a sequence of aTcACA, followed by a 11bp spacer, and then 281 
acTtAT.    282 
 283 
sigS deletion results in a growth defect in strain RN4220.  We previously reported that the 284 
sigS mutant in the SH1000 background displayed no notable growth defect under standard 285 
conditions (Shaw 2008). Given the data presented above regarding differential expression of 286 
sigS in S. aureus wild-type strains, we next performed growth analysis of the sigS mutant in the 287 
RN4220, 8325-4, SH1000 and USA300 LAC backgrounds.  Interestingly, whilst mutation of σS 288 
led to no notable growth defects in these latter 3 strains, we observed a significant growth 289 
defect in strain RN4220 (Figure 3). Specifically, sigS deletion in this strain resulted in a 290 
significant defect upon exit from stationary phase, which continued through exponential growth.  291 
At hour 2 we noted a 4.4-fold decrease in optical density of the σS mutant compared to the wild-292 
type, which peaks at hour 3 with a fold change of 5.3.  This trend continues through hour 4 with 293 
a fold decrease of 3.  By hours 5 growth of the σS mutant is comparable to that of the parent 294 
strain. This observation is particularly interesting, as sigS expression peaks at hour 3 in 295 
RN4220, which corresponds to the time point at which we observe the highest fold decrease in 296 
growth for the mutant strain.   297 
 298 
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 299 
sigS expression is inducible in response to external stimuli. Given the differential nature of 300 
sigS expression amongst S. aureus strains, we next set out to explore whether transcription 301 
could be induced from this locus via external stress, as with other ECF-sigma factors (27, 55, 302 
67). This was performed using a disk diffusion assay previously described by us (35, 64), and 303 
builds on a pilot screen conducted with SH1000 (64).  As such, sigS-lacZ fusion strains in 8325-304 
4, Newman, SH1000 and USA300 were grown in the presence of a plethora of stress conditions 305 
(see materials and methods). Whilst we were unable to detect upregulation of sigS in most 306 
strains, we did observe significant inducibility in 8325-4. Specifically, we noted sigS expression 307 
in the presence of a variety of chemicals (Table 2), including a number of agents that induce cell 308 
wall stress, as well as compounds know to elicit DNA damage. We also noted sigS upregulation 309 
in amino acid limiting media, metal ion limiting media, and during growth on pig serum. These 310 
minimal media studies were of particular interest, as they correlate with our previous studies 311 
demonstrating a starvation survival defect for sigS mutant strains (64). Again to rule out artifacts 312 
of the screen, we sought to verify these findings during continuous growth in liquid media. This 313 
was performed with the 8325-4 sigS-lacZ fusion strain grown in TSB containing sub-lethal 314 
concentrations of select chemicals (MMS, H2O2 and NaOH) from Table 2, and revealed 315 
increased expression of sigS in each instance (Figure 4A-C). Specifically, in the presence of 316 
MMS, expression peaked at 5 h, with a 48.7-fold increase compared to standard conditions. 317 
Maximal expression with both NaOH and H2O2 occurred at 10 h, with fold increases of 10 and 318 
4.4 respectively, compared to unsupplemented media.  Additional qRT-PCR analysis was 319 
performed (Figure 4D) to verify this data, and again confirmed that the greatest fold increase in 320 
sigS expression was induced by exposure to MMS, resulting in a 102.6- fold increase in 321 
transcription.  Transcription of sigS upon exposure to NaOH and H2O2 was 63.3- and 57.2-fold 322 
higher, respectively.   323 
 324 
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To explore if this upregulation was conserved for other S. aureus strains, but perhaps below the 325 
limit of detection for our plate based assay, we performed experiments with MMS, NaOH and 326 
H2O2 using SH1000 and USA300 sigS-lacZ fusion strains. Interestingly, despite a lack of blue 327 
coloration in the plate based assay, we again detected upregulation of sigS during growth in 328 
liquid media with sub-lethal concentrations of MMS and H2O2 (Figure 5A-B).  Specifically, 329 
expression with MMS in both SH1000 and USA300 was highest at 2 h, with fold increases of 3.6 330 
and 8.1, respectively, compared to standard growth conditions. In the presence of H2O2, sigS 331 
expression in SH1000 increased by 2.6-fold (2 h), and by 2.3-fold in USA300, (7 h). Conversely, 332 
we observed no increase in expression for NaOH when grown in these conditions, suggesting 333 
that greater, and more lethal, concentrations of this agent may be required to induce 334 
expression. We again confirmed this data by qRT-PCR in SH1000 and USA300 grown in the 335 
presence of MMS and H2O2 (Figure 5C). We determined that SH1000 displays a 16.9-fold 336 
increase in sigS expression when cultured with MMS, and a 13.5-fold increase when cultured 337 
with H2O2.  Expression of sigS in USA300 grown with MMS or H2O2 displayed 4.6- and 2.8-fold 338 
increases in transcription, respectively. Collectively, these findings demonstrate a significant 339 
inducibility of sigS in response to external stimuli that is conserved across S. aureus strains. 340 
 341 
sigS is strongly upregulated during challenge by components of the innate immune 342 
system. Despite limited expression under standard laboratory growth conditions, we have 343 
previously demonstrated a role for σS in the virulence of S. aureus (64). Working on a 344 
hypothesis that sigS transcription would be increased during infection, we performed expression 345 
profiling of sigS-lacZ fusion strains upon ex vivo challenge by components of the innate immune 346 
system. Indeed, our plate based analysis already suggests that sigS expression is increased by 347 
exposure to pig serum (Table 2).  In order to confirm these findings, and quantify this increase 348 
across different strains, we performed transcriptional analysis using sigS-lacZ fusions strains 349 
grown in TSB, and then subcultured into pig serum.  We determined that after just 1h of growth 350 
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in serum, sigS expression increased by 3.4-fold in strain 8325-4, compared to TSB (Figure 6A). 351 
Expression continued to rise over time, with fold increases of 21.2 and 20.5 observed at hours 5 352 
and 24, respectively.  Additionally we observed a similar effect in strains SH1000 and USA300.  353 
Specifically, over the course of growth, we noted fold increases of 13.8, 36.2 and 44.0 in 354 
SH1000 for hours 1, 5 and 24, respectively.  Finally, in USA300, sigS expression increased 6.8-, 355 
15.6- and 26.3-fold at hours 1, 5 and 24, respectively.  We continued this line of investigation by 356 
assessing sigS expression upon phagocytosis by RAW 264.7 macrophage-like cells.  357 
Accordingly, macrophages were infected with strains 8325-4, SH1000 and USA300 bearing a 358 
sigS-lacZ fusion for a period of 24 h, before β-galactosidase activity was measured.  Expression 359 
of sigS was significantly increased after phagocytosis in all strains tested (Figure 6B), with the 360 
highest levels observed in 8325-4. In this strain we found a 286.6-fold increase in sigS 361 
expression compared to background levels.  Expression in SH1000 and USA300 increased by 362 
7.5- and 7.4-fold, respectively, compared to background levels. As such, these findings support 363 
our hypothesis, and suggest that σS is required during the interaction of S. aureus with its host.    364 
 365 
σS mutants are sensitive to DNA damage stress and cell-wall targeting antibiotics. Thus 366 
far we have demonstrated that chemicals known to induce DNA damage and cell wall stress 367 
strongly impact sigS transcription.  Accordingly, we next sought to perform death-curve kill 368 
studies to examine the viability of sigS mutants during exposure to lethal concentrations of 369 
these agents in strains 8325-4, SH1000 and USA300.  We found that when exponentially 370 
growing cultures were exposed to 5X the MIC of MMS for 30 min, a consistent decline in mutant 371 
cell viability was seen across all strains tested (the data for USA300, which is representative, is 372 
presented, (Figure 7A).  Specifically, we recovered 3.33-fold less sigS mutant cells compared to 373 
the wild-type, when exposed to this agent.  Complementation of the σS mutation reduced the 374 
observed growth impairment significantly, although not completely to wild-type levels. This lack 375 
of full complementation is likely attributed to plasmid instability in the presence of DNA 376 
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damaging conditions, as suggested by others previously (3, 26, 49, 59, 73, 76).  Further to this, 377 
in order to determine whether the role of σS was limited to protection against DNA alkylation (as 378 
induced by MMS), we next examined the ability of the USA300 σS mutant to survive exposure to 379 
agents that induce other types of DNA damage.  As such, analysis was carried out during 380 
exposure to oxidative stress resulting from the addition of H2O2.  Following a 5 min exposure to 381 
this agent, we observed a 3.9-fold decrease in sigS mutant viability compared to the parent 382 
strain, which was fully complementable (Figure 7B).  We next used the DNA intercalating agent 383 
ethidium bromide (EtBr), and found that the sigS mutant displayed a 2.1–fold decrease in 384 
viability compare to the wild-type strain after 15 min of exposure (Figure 7C). We again saw that 385 
complementation was able to abrogate these affects, but not completely to levels of the wild-386 
type strain. This is likely attributed to the ability of EtBr to cure plasmids upon exposure, as 387 
observed by others previously (3).  Finally, in order to determine if σS mediates protection 388 
against UV induced lesions and double strand breaks, we compared the survivability of the wild-389 
type strain and its sigS mutant.  Exponentially growing cultures were serially diluted on TSA and 390 
subjected to UV at a dosage of 4,000 µJ cm-2.  Exposure at this level resulted in a 2.1-fold 391 
decrease in viability for the mutant (Figure 7D).  Complementation in this assay is not possible 392 
because of plasmid instability, as we observed >83% loss upon exposure (data not shown). 393 
 394 
Following this, we next assessed the sensitivity of sigS mutants to a variety of cell wall targeting 395 
antibiotics (Figure 8). Analysis using bacitracin in the USA300 background revealed a 4.5-fold 396 
decrease in MIC for the mutant strain (30 μg ml-1) compared to the parent (135 μg ml-1). We 397 
observed a similar degree of sensitivity with ampicillin, resulting in a 4-fold decrease in MIC for 398 
the mutant (25 μg ml-1) compared to wild-type USA300 (100 μg ml-1). Finally, analysis performed 399 
using penicillin G yielded a striking 60-fold decrease in MIC for the sigS mutant (5 μg ml-1) 400 
compared to the parent (300 μg ml-1). 401 
 402 
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σS aids in protection of the S. aureus cell during interaction with components of the 403 
innate immune system. Previously we have shown a role for σS in virulence, using a murine 404 
model of septic arthritis. We have also demonstrated herein that sigS expression increases not 405 
only upon exposure to serum, but also during phagocytosis by macrophage-like cells. As such, 406 
we sought to determine the importance of σs during challenge by components of the innate 407 
immune system.  This was first performed using whole human blood and the USA300 wild-type, 408 
sigS mutant, and its complemented strain.  As such, exponentially growing cells were inoculated 409 
into whole human blood, and incubated for 4 hours. After this time we recovered 2.1-fold less 410 
viable cells of the sigS mutant, compared to the wild-type strain (Figure 9A). Complementation 411 
analysis restored viability to levels similar to that of the wild-type.  Following this, we also 412 
conducted macrophage survival assays, again in the USA300 background, to assess the ability 413 
of the sigS mutant to persist upon phagocytosis.  At 24 h post-phagocytosis by RAW 264.7 414 
cells, we observed a 4.5-fold decrease in survivability of the sigS mutant compared to the parent 415 
(Figure 9B). Complementation of this finding increases survivability of the mutant cells, but not 416 
completely to levels of the wild-type strain. This is likely explained by significantly instability of 417 
the plasmid during phagocytosis, which we routinely observe when performing this assay.   418 
Collectively, these findings support our earlier work, which indicates an important role for σs in 419 
the virulence of S. aureus, and confirms our expression analysis, demonstrating sigS 420 
upregulation during interaction with components of the innate immune system.  421 
  422 
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Discussion 423 
In this study, we provide new evidence for the role of σS, a novel ECF σ factor in S. aureus. In 424 
our previous works we have shown that σS is a functioning sigma factor that controls is own 425 
expression (64). Additionally, we have demonstrated a role for it in the stress and virulence 426 
responses of this organism. From a gene expression standpoint, we have previously shown that 427 
sigS expression is minimal during growth under standard laboratory conditions in SH1000 (64).  428 
In this study, we reveal that this phenomenon is conserved across a variety of S. aureus strains, 429 
including laboratory (8325-4, SH1000 and Newman) and clinical (USA300) isolates.  In each 430 
case, we observed low levels of expression of sigS during growth in rich media.  These results 431 
may not be entirely surprising, as the majority of ECF σ factors are employed to protect the cell 432 
during times of stress, and are often only transcribed when required (27, 55, 67).   433 
 434 
Interestingly, we did observe robust sigS expression in the highly mutated laboratory strain, 435 
RN4220.  Amongst the many mutations present in this strain are those that render the activity of 436 
other global regulators nonfunctional, including agr and sigB (15, 71).  As such, the regulatory 437 
circuits in place in this strain are likely to be highly disordered, potentially explaining sigS 438 
disregulation, and therefore upregulation.  Interestingly, these affects do not appear to be 439 
mediated directly through either Agr or σB, as mutations in these genes alone do not affect sigS 440 
expression in either SH1000 or USA300 (data not shown).  Recent sequencing of the RN4220 441 
genome has revealed a number of SNPs (single-nucleotide polymorphisms) and deletions 442 
relative to the parental strain NCTC 8325 (2, 48).  Of interest, a number of these are in genes 443 
involved in DNA metabolism, replication, recombination and repair.  Most notably, RN4220 444 
carries a SNP in UvrC, a component of the UvrABC exonuclease, which in Escherichia coli 445 
repairs DNA damage induced by a number of mechanisms, including UV light (60).  446 
Interestingly, our analysis herein demonstrates σS mutants are less able to survive exposure to 447 
UV stress.  Additionally, SNPs in RN4220 are located in a putative helicase, SAOUHSC_02790 448 
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as well as a truncated resolvase, SAOUHSC_02392.  Collectively, these observations suggest 449 
that RN4220 is perhaps more prone to DNA damage than other wild-type strains, as a result of 450 
mutated and non-functional repair pathways. This would then perhaps explain why this strain 451 
exhibits stronger sigS expression than other wild-types, as we implicate σS in influencing the 452 
response of S. aureus to DNA damage in this study. Indeed we have observed that the 453 
increasing levels of sigS transcription in different wild-type strains directly correlates with their 454 
sensitivity to DNA damaging agents, such as MMS (data not shown).   455 
 456 
Promoter mapping of the sigS locus reveals three discrete transcriptional start sties. Promoters, 457 
P1 and P2, both appear to be under the control of the housekeeping σ factor, σA, however both 458 
are severely corrupted from consensus sequences and/or spacing. Due to the relative 459 
weakness of these promoters it is likely that other regulatory elements must act to activate 460 
transcription from these sequences. This again likely explains the low levels of sigS expression 461 
observed in the majority of S. aureus strains, and argues for a genetic regulatory network that 462 
controls expression of this regulator.  Previously we demonstrated that sigS, as with other ECF-463 
sigma factors (27, 45, 65), controls its own expression via auto-regulation.  During promoter 464 
mapping in the present study we reveal a likely σS controlled transcript, P2 (CAAAGT -12 bp- 465 
TATCA).  Typically ECF sigma factor consensus sequences display a conserved AAC motif in 466 
the -35 region (27, 45); however, exceptions exist.  Specifically, the ECF sigma factor of 467 
Neisseria gonorrhoeae does not recognize an AAC motif (25), whilst σR of Streptomyces 468 
coelicolor recognizes an AAT motif (53).  More importantly, σX, an ECF sigma factor in several 469 
Psuedomonas spp, specifically recognizes an AAG motif, as seen here for σS (4), (39). ECF σ 470 
factors typically have significant divergence, and decreased homology within their region 2.4 471 
(41, 45), which specifically recognizes -10 promoter elements. Accordingly, such sites are often 472 
difficult to ascertain, however the identified putative -10 element is strikingly similar to the 473 
TCTGA recognized sequence of σE in E. coli (13).   474 
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In addition to examining expression in wild-type strains, we have also assessed the level to 475 
which sigS is upregulated in response to external stress. We show that a variety of stressors 476 
can induce expression of sigS, ranging from those that elicit alkali stress, to others that affect 477 
protein synthesis.  Interestingly, this is most pronounced in strain 8325-4, which, like RN4220, 478 
lacks natural σB activity. We are able to demonstrate that the conditions of sigS inducibility in 479 
8325-4 hold true for the σB functional strains SH1000 and USA300, although not always at the 480 
same levels. Of note, when we inactivate sigB in SH1000, we do not observe the same robust 481 
increases in sigS inducibility seen in 8325-4 (data not shown), despite these strains being very 482 
closely related. This observation is perhaps explained by the fact that 8325-4 is an rsbU mutant, 483 
which is an activator of σB activity, rather than a true sigB null-strain. Given recent findings 484 
showing a role for RsbU outside of its influence of σB activity (72), it is possible that these 485 
differences are mediated by RsbU, rather than σB, mechanisms. It has also recently been 486 
shown that 8325-4 and SH1000 are more genetically distinct than the 11 bp deletion in rsbU 487 
(52), perhaps suggesting that SNPs, and other genetic variations between these 2 strains 488 
influence sigS expression. 489 
 490 
With regards to environmental influence on sigS expression, those chemicals that induce DNA 491 
damage, such as methyl methanesulfonate (MMS), appear to have the most profound effects. 492 
These findings correlate well with our phenotypic studies, showing that sigS mutants have 493 
increased sensitivity to a broad range of DNA damage inducing stresses. These include 494 
alkylating and intercalating agents, reactive oxygen species and UV induced damage; each of 495 
which leads to the activation of specific and distinct repair pathways. Interestingly, when we 496 
analyzed transcription of a number of DNA repair pathway genes (ogt, uvrB and mutM) in both 497 
sigS mutants and S. aureus wild-type strains, we observed no alterations in expression (data 498 
not shown).  As such, our findings suggest that σS is involved in mediating a comprehensive 499 
response to DNA damage by an as yet unknown mechanism.  These findings are somewhat 500 
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novel, as the majority of ECF σ factors typically respond to perturbations in the cell wall. 501 
However, reports on ECF σ factors from other organisms reveals several examples that function 502 
in sensing and responding to cytoplasmic stress.  Specifically, both RpoE of Rhodobacter 503 
sphaeroides and Ecf of Neisseria gonorrhoeae respond to oxidative stress, which can in turn 504 
lead to DNA damage (6, 19, 25).   505 
 506 
Interestingly, a number of agents were identified as inducing sigS expression that are not 507 
typically thought of as inducing DNA damage, but can also induce this kind of stress.  For 508 
example, H202 resulted in sigS upregulation, and can react with intracellular iron to form hydroxyl 509 
radicals, which cause damage to DNA (8, 30, 31, 56).  Additionally, SOS and DNA damage 510 
repair genes have previously been shown in Escherichia coli to be upregulated during alkali 511 
stress caused by excess NaOH, which also upregulates sigS expression (23, 61).  Finally, the 512 
protein synthesis inhibiting antibiotic, chloramphenicol, upregulated sigS, and has been shown 513 
to lead to the degradation of dsDNA and the inhibition of DNA synthesis (47).  514 
 515 
A consideration with these DNA damage agent studies is that they may not be directly 516 
upregulating sigS expression, but might cause mutations within the S. aureus genome, leading 517 
to SNPs.  In such a scenario this could lead to disregulation of regulatory circuits, leading to 518 
sigS upregulation in a manner akin to that proposed for RN4220 and 8325-4.  To examine this 519 
we analyzed 8325-4 sigS-lacZ fusion strains exposed to DNA damaging agents for a 24 h 520 
period.  Upon removal of the stressor, strains were grown on agar plates containing X-gal.  We 521 
found no detectable blue coloration on such plates (data not shown), indicating DNA damage 522 
induced upregulation of sigS does not appear to be mediated via heritable SNPs, but results 523 
directly from exposure to these agents.  As such, the increase in expression of sigS is due 524 
solely to exposure to agents such as MMS, and suggests that σS is utilized by the cell to adapt 525 
during times of DNA damage.   526 
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 527 
We also observe substantial increases in expression of sigS following exposure to a number of 528 
cell wall targeting chemicals, suggesting a role for σS in protection against this type of stress.  529 
This correlates well with other work presented in this study, which demonstrate sigS mutants 530 
have increased sensitivity to the cell wall targeting antibiotics. These findings also corroborate 531 
our previous work, which demonstrates that sigS mutants are sensitive to growth in the 532 
presence of a number of cell wall disrupting agents, including Triton X-100 and SDS (64).  This 533 
suggests a role for σS in the S. aureus cell wall stress response, which is typical of ECF σ 534 
factors. For example, RpoE in Escherichia coli serves to upregulate genes involved in the heat-535 
shock response, and is triggered by misfolded proteins accumulating in the periplasm and outer 536 
membrane (13). Furthermore, σW and σM of Bacillus subtilis both respond to cell wall 537 
biosynthesis inhibiting antibiotics, with σM proving vital for survival during exposure to 538 
phosphomycin (7, 70). This information, alongside the observation that σS is the lone ECF σ 539 
factor in S. aureus, suggests it likely serves dual functions within the cell, protecting against 540 
both cytoplasmic and extracytoplasmic stresses.   541 
 542 
We have also demonstrated here that sigS transcription is increased considerably when S. 543 
aureus is challenged by complement during growth in pig serum.  We also present evidence for 544 
sigS upregulation during ex vivo infection, revealing high levels of expression upon 545 
phagocytosis by murine macrophage-like cells.  Phenotypically, we show that σS is important for 546 
survival during growth in whole human blood, and following phagocytosis.  Collectively this 547 
supports our previous work, which reveals a major requirement for σS during virulence (64).  As 548 
part of the microbicidal mechanism employed by macrophages, reactive oxygen species (ROS) 549 
and reactive nitrogen intermediates (RNI) are excreted at very high levels, leading to DNA 550 
damage in invading organisms during infection (33, 38, 42, 58, 66).  Moreover, it has been 551 
observed that pathogenic organisms such as Burkholderia spp., B. abortus and Vibrio cholerae 552 
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defective in DNA damage repair mechanisms are attenuated in virulence, underscoring their 553 
importance during infection (12, 14, 57, 77).  Together this suggests that, upon entry into the 554 
host, bacterial pathogens are faced with an array of DNA damaging conditions. Given that these 555 
conditions lead to activation of σS in S. aureus, this likely goes some way to explaining the 556 
avirulent phenotype of sigS mutants.   557 
 558 
In summary, we present extended characterization of the lone, and novel, ECF σ factor, σS, in 559 
S. aureus.  We reveal that, under standard conditions, its transcription remains low in a range of 560 
wild-type strains, but that it can be upregulated in response to external stimuli.  Specifically, 561 
chemicals leading to DNA damage and cell wall disruption strongly induce expression of sigS.  562 
This upregulation is seemingly of importance, as functional characterization reveals sigS 563 
mutants are sensitive to both of these types of stress.  Additionally, we reveal strong 564 
upregulation of this gene during growth in pig serum as well as upon phagocytosis by murine 565 
macrophage-like cells, which is seemingly protective to the cell. Collectively, our data suggests 566 
that σS likely serves dual functions within the cell, protecting against both cytoplasmic and 567 
extracytoplasmic stresses. This further argues for its important, and perhaps novel, role in the S. 568 
aureus stress and virulence responses. 569 
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Figure Legends 780 
 781 
Figure 1. Transcription profiling of sigS in a variety of S. aureus wild-type strains.  782 
(A) sigS-lacZ fusion strains in RN4220 (+), 8325-4 (◊), SH1000 (▲), USA300 (■) and 783 
Newman (□) were grown in TSB at 37oC and sampled every hour for 10 h and again at 784 
24 h. β-galactosidase activity was measured to determine levels of expression. Assays 785 
were performed on duplicate samples and the values averaged. The results presented 786 
herein were representative of three independent experiments that showed less than 10 787 
% variability.  (B) Quantitative real-time PCR was performed on S. aureus wild-type 788 
strains grown for 3h under the same conditions as in A, with primers specific to sigS.  789 
The data presented is from at least 3 independent experiments.  Error bars are shown 790 
as +/- SEM, *= p<0.05 using a student t test.  791 
 792 
Figure 2. Primer extension analysis reveals three sigS promoters. (A) Mapping of 793 
the 5’ ends of the sigS transcripts by primer extension. RNA was extracted from RN4220 794 
grown to exponential phase (3 h) and used in reactions (lane 1). (B) Transcriptional 795 
start sites (+1) for promoters P1, P2 and P3 are denoted with corresponding -35 and -10 796 
regions. 797 
 798 
Figure 3. RN4220 sigS mutants have a growth defect upon exit from stationary 799 
phase. Optical density readings (OD600) of the RN4220 wild-type (■), sigS mutant (□) 800 
and sigS complement (♦) strain were taken every hour for 6 hours and again at 24 h 801 
during growth at 37oC with shaking in TSB. Growth curves are representative of at least 802 
three independent experiments that showed less than 10 % variability. * = p<0.05 using 803 
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a Student t test and indicate significant difference in growth between the sigS mutant 804 
and its parental and complemented strains. 805 
 806 
Figure 4. sigS transcription is inducible in response to external stress. The 8325-4 807 
sigS-lacZ strain was grown (A-C) in either TSB (♦) or TSB supplemented with sub-lethal 808 
concentrations of the indicated stress chemicals (■). Cultures were sampled every hour 809 
for 10 h, and again at 24 h, to determine β-galactosidase activity. Additionally, growth 810 
was monitored via OD600 at the times indicated for both standard (◊) and supplemented 811 
(□) growth conditions. Assays were performed on duplicate samples and the values 812 
averaged. The results presented herein were representative of three independent 813 
replicates that showed less than 10 % variability. (D) Quantitative real-time PCR 814 
analysis was performed with strain 8325-4 grown for 5h under conditions identical to A-815 
C, using primers specific to sigS.  The data presented is from at least 3 independent 816 
experiments.  Error bars are shown as +/- SEM, *= p<0.05 using a Student t test.  817 
 818 
Figure 5. The inducibility of sigS expression is conserved across S. aureus 819 
strains. The SH1000 (∆) and USA300 (○) sigS-lacZ fusion strains were grown (A-B) in 820 
either TSB (open symbols) or TSB supplemented with sub-lethal concentrations of the 821 
indicated stress chemicals (closed symbols). Cultures were sampled every hour for 10 822 
h, and again at 24 h, to determine β-galactosidase activity.  Assays were performed on 823 
duplicate samples and the values averaged. The results presented herein were 824 
representative of three independent replicates that showed less than 10 % variability. 825 
(C) Quantitative real-time PCR analysis was performed with strain USA300 (grey) and 826 
SH1000 (black) grown for 2 h under conditions identical to A-B, using primers specific 827 
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to sigS.  The data presented is from at least 3 independent experiments.  Error bars are 828 
shown as +/- SEM, *= p<0.05 using a Student t test, and represent significant variation 829 
from standard conditions (TSB).  830 
 831 
Figure 6. Profiling of sigS expression during challenge by components of the 832 
innate immune system. Fusion strains were assayed for β-galactosidase activity (A) 833 
prior to (TSB), and during (1h, 5h and 24h), growth in pig serum; and (B) prior to 834 
phagocytosis (grey bars) and 24 h post phagocytosis (black bars) by RAW 264.7 murine 835 
macrophage-like cells.  Cells were infected at an MOI of 1:100 and incubations carried 836 
out at 37oC in a humidified atmosphere of 5% CO2. The data presented is from at least 837 
3 independent experiments. Error bars are presented as +/- SEM, *= p<0.001 using a 838 
Student t test.  839 
 840 
Figure 7.  sigS mutants are sensitive to a variety of DNA damage-inducing 841 
stresses.  The USA300 wild-type (W) and sigS mutant (M), along with a sigS 842 
complement strain (C), were analyzed for viability in the presence of DNA damage 843 
inducing stressors.  CFU counts were determined both pre- and post-exposure, and the 844 
survivability determined. The data is presented as fold change relative to the wild-type 845 
strain and is representative of at least three independent experiments that showed less 846 
than 10 % variability.  (A) 30 min exposure to 25 mM MMS (B) 5 min exposure to 150 847 
mM H2O2 (C) 15 min exposure to 5 mM EtBr (D) exposed to UV at 4,000 μJ per cm2. * = 848 
p<0.05 using a Student t test.  849 
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Figure 8.  sigS mutants are sensitive to a number of cell wall targeting antibiotics.  850 
The USA300 wild-type (W) and sigS mutant (M), were grown in TSB containing 851 
increasing concentrations of the cell wall targeting antibiotics, bacitracin, ampicilllin and 852 
penicillin G in a 96-well plate format.  The cultures were allowed to grow overnight  at 853 
37oC and subsequently analyzed for growth and the minimum inhibitory concentration  854 
(MIC) determined.  The data is representative of at least three independent experiments 855 
that showed less than 10% variability.  * = p<0.05 using a Student t test.  856 
 857 
Figure 9. σS aids in protection of the S. aureus cell during interaction with 858 
components of the innate immune system. The USA300 wild-type (W) and sigS 859 
mutant (M), along with a sigS complement strain (C), were analyzed for viability: (A) 4 h 860 
after exposure to whole human blood; and (B) 24 h post phagocytosis by 264.7 RAW 861 
murine macrophage-like cells.  CFU counts were determined both pre- and post-862 
exposure, and the percent survival determined. Error bars are shown as +/- SEM, *= 863 
p<0.05 using a Student t test. 864 
 865 
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Figure 1. Transcription profiling of sigS in a variety of S. aureus wild-type strains. (A) sigS-
lacZ fusion strains in RN4220 (+), 8325-4 (◊), SH1000 (▲), USA300 (■) and Newman (□) were grown in TSB at
37oC and sampled every hour for 10 h and again at 24 h. β-galactosidase activity was measured to determine
levels of expression. Assays were performed on duplicate samples and the values averaged. The results
t d h i t ti f th i d d t i t th t h d l th 10 % i bilitpresen e ere n were represen a ve o ree n epen en exper men s a s owe ess an var a y.
(B) Quantitative real-time PCR was performed on S. aureus wild-type strains grown for 3h under the same
conditions as in A, with primers specific to sigS. The data presented is from at least 3 independent experiments.
Error bars are shown as +/- SEM, *= p<0.05 using a student t test.
A * B
*
Time (hours)
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Figure 2. Primer extension analysis reveals three sigS promoters. (A) Mapping of the 5’ ends of
the sigS transcripts by primer extension. RNA was extracted from RN4220 grown to exponential phase (3 h) and
used in reactions (lane 1). (B) Transcriptional start sites (+1) for promoters P1, P2 and P3 are denoted with
corresponding -35 and -10 regions.
A B
TGTTACCTCCCGATTACAAATTTTGTTCTATCTA
A
+1P1
-35P1
-10P1 -35P2 -10P2
CTATTTAGCAAAGT ATAATACATCATATCACA
TTAAATTAATTACTTATGTCTTATATTTAACAC
+1P2
+1P3
-35P3
-10P3
TTAATTTAGCGATTACGCAAATGAATGATTTTTC
TAAATATTTTATTCTAACTTTATCCGGAAATATT
TGTTATACGTATAACTTGGAGAATGACTACTTG
RBS Start
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Figure 3. RN4220 sigS mutants have a growth defect upon exit from stationary phase. Optical density readings (OD600) of the
RN4220 wild-type (■), sigS mutant (□) and sigS complement (♦) strain were taken every hour for 6 hours and again at 24 h during
growth at 37oC with shaking in TSB. Growth curves are representative of at least three independent experiments that showed less
than 10 % variability. * = p<0.05 using a Student t test and indicate significant difference in growth between the sigS mutant and its
parental and complemented strains.
*
*
*
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Figure 4. sigS transcription is inducible in response to external stress. The 8325-4 sigS-lacZ strain was grown (A-
C) in either TSB (♦) or TSB supplemented with sub-lethal concentrations of the indicated stress chemicals (■). Cultures were
sampled every hour for 10 h, and again at 24 h, to determine β-galactosidase activity. Additionally, growth was monitored via OD600 at
the times indicated for both standard (◊) and supplemented (□) growth conditions. Assays were performed on duplicate samples and
the values averaged. The results presented herein were representative of three independent replicates that showed less than 10 %
variability. (D) Quantitative real-time PCR analysis was performed with strain 8325-4 grown for 5h under conditions identical to A-C,
using primers specific to sigS. The data presented is from at least 3 independent experiments. Error bars are shown as +/- SEM, *=
p<0.05 using a Student t test.
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Figure 5. The inducibility of sigS expression is conserved across S. aureus strains. The SH1000 (∆) and
USA300 (○) sigS-lacZ fusion strains were grown (A-B) in either TSB (open symbols) or TSB supplemented with sub-lethal
concentrations of the indicated stress chemicals (closed symbols). Cultures were sampled every hour for 10 h, and again at 24 h, to
determine β-galactosidase activity. Assays were performed on duplicate samples and the values averaged. The results presented
herein were representative of three independent replicates that showed less than 10 % variability. (C) Quantitative real-time PCR
analysis was performed with strain USA300 (grey) and SH1000 (black) grown for 2 h under conditions identical to A-B, using primers
specific to sigS. The data presented is from at least 3 independent experiments. Error bars are shown as +/- SEM, *= p<0.05 using
a Student t test, and represent significant variation from standard conditions (TSB).
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Figure 6. Profiling of sigS expression during challenge by components of the
innate immune system. Fusion strains were assayed for β-galactosidase activity (A) prior to (TSB), and
during (1h, 5h and 24h), growth in pig serum; and (B) prior to phagocytosis (grey bars) and 24 h post
phagocytosis (black bars) by RAW 264.7 murine macrophage-like cells. Cells were infected at an MOI of 1:100
and incubations carried out at 37oC in a humidified atmosphere of 5% CO2. The data presented is from at least 3
independent experiments. Error bars are presented as +/- SEM, *= p<0.001 using a Student t test.
BA
8325-4 SH1000 USA300
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Figure 7.  sigS mutants are sensitive to a variety of DNA damage-inducing stresses.  The USA300 wild-type (W) and sigS 
mutant (M), along with a sigS complement strain (C), were analyzed for viability in the presence of DNA damage inducing stressors.  
CFU counts were determined both pre- and post-exposure, and the survivability determined. The data is presented as fold change 
relative to the wild-type strain and is representative of at least three independent experiments that showed less than 10 % variability.  
(A) 30 min exposure to 25 mM MMS (B) 5 min exposure to 150 mM H2O2 (C) 15 min exposure to 5 mM EtBr (D) exposed to UV at 
4 000 μJ per cm2 * = p<0 05 using a Student t test,    .   .     .
A B H2O2MMS
* *
W M C
W M C
DC EtBr UV
* *
W M C
W M
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Figure 8.  sigS mutants are sensitive to a number of cell wall targeting antibiotics.  The USA300 wild-type (W) and sigS mutant 
(M), were grown in TSB  containing increasing concentrations of the cell wall targeting antibiotics, bacitracin, ampicilllin and penicillin 
G in a 96-well plate format.  The cultures were allowed to grow overnight  at 37oC and subsequently analyzed for growth and the 
minimum inhibitory concentration  (MIC) determined.  The data is representative of at least three independent experiments that 
showed less than 10% variability.  * = p<0.05 using a Student t test.
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Figure 9. σS aids in protection of the S. aureus cell during interaction with components of the innate 
immune system. The USA300 wild-type (W) and sigS mutant (M), along with a sigS complement strain (C), were 
analyzed for viability: (A) 4 h after exposure to whole human blood; and (B) 24 h post phagocytosis by 264.7 RAW 
murine macrophage-like cells.  CFU counts were determined both pre- and post-exposure, and the percent 
s r i al determined Error bars are sho n as +/ SEM * p<0 05 sing a St dent t testu v v  .    w   - , = .  u   u  .
A B
*
*
W M CW M C
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Table 1. Strains, plasmids and primers used in this study.
Strain, plasmid or primer Genotype or description        Reference or source
E. coli
DH5 80 (lacZ)M15 (argF-lac)U169 endA1 recA1 Sambrook et al., 1989
hsdR17 (rK-mK+) deoR thi-1 supE44 gyrA96 relA1
S. aureus
RN4220 Restriction deficient transformation recipient Lab Stocks
8325-4 Wild-Type Laboratory Strain rsbU mutant Lab Stocks
SH1000 Wild-Type Laboratory Strain rsbU functional Horsburgh et al., 2002
Newman Wild-Type Laboratory Strain, human clinical isolate Lab Stocks
USA300 USA300-LAC MRSA isolate cured of pUSA300-LAC-MRSA                  Paul Fey UNMC
LES57 SH1000 pAZ106::sigS-lacZ sigS + Shaw et al., 2008
HKM01 RN4220 pAZ106::sigS-lacZ sigS + This study
HKM02 8325-4 pAZ106::sigS-lacZ sigS + This study
HKM03 Newman pAZ106::sigS-lacZ sigS + This study
HKM04 USA300 pAZ106::sigS-lacZ sigS + This study
HKM05 RN4220 sigS::tet sigS – This study
HKM06 RN4220 sigS::tet pMK4::sigS + This study
HKM07 USA300 sigS::tet sigS – This study
HKM08 USA300 sigS::tet pMK4::sigS + This study
Plasmids
pMK4 Shuttle vector                                                                                        Sullivan et al., 1984
pHKM1 pMK4 containing a 2.1 kb sigS fragment This study
Primers1
OL281 ACT GGA TCC CAG TTG CAG ATG CAT CTC TCC
OL1715 ATG CTG CAG CAA GTC TAT CTG GCG TAC 
OL1036 CCG CGC ACA TTT CCC CGA AA 
OL1275 ACC TTG AAG GAT ACA AGC AA
OL1276 GGC ATT TAC GCT TAA CGG AC
OL1528 GTG GTG TTT GTT GTA TAC GTC
1 Restriction sites are underlined.
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Table 2. Compounds found to induce expression of a sigS-lacZ reporter fusion in strain 8325-4.
Agent / Condition                             Stress / Mode of Action           Overall Effect
Sodium Hydroxide (NaOH) Alkali Stress          DNA damage    
Hydrogen Peroxide (H2O2) Oxidative Stress          DNA damage    
Methyl methanesulfonate (MMS) Alkylates DNA          DNA damage    
Ethyl methanesulfonate (EMS) Alkylates DNA          DNA damage    
Ciprofloxacin Inhibits DNA gyrase          DNA damage    
Nalidixic Acid Inhibits DNA gyrase          DNA damage    
Chloramphenicol Inhibits protein synthesis          Miscellaneous
Pig Serum Components of the humoral immune system          Miscellaneous
Amino acid limiting media Minimal media          Miscellaneous
Metal limiting media Minimal media          Miscellaneous
Cefotaxime Inhibits transpeptidation Cell wall weakening/disruption
Ampicillin Inhibits transpeptidation Cell wall weakening/disruption
Oxacillin Inhibits transpeptidation Cell wall weakening/disruption
Sodium Dodecyl Sulfate (SDS) Disrupts cell walls Cell wall weakening/disruption
Phosphomycin Inhibits UDP-N-aceytglucosamine-3-
enolpyruvyltransferase
Cell wall weakening/disruption
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